As filed with the Securities and Exchange Commission on November 1, 2021

Registration No. 333-

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-1

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

EDIBLE GARDEN AG INCORPORATED

(Exact name of registrant as specified in its charter)

 

Delaware

 

100

 

85-0558704

(State or other jurisdiction of

incorporation or organization)

 

(Primary standard industrial

classification code number)

 

(I.R.S. employer

identification number)

 

283 County Road 519

Belvidere, NJ 07823

(908) 750-3953

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

James E. Kras
Chief Executive Officer

283 County Road 519

Belvidere, NJ 07823

(908) 750-3953

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

Alexander R. McClean, Esq.

Margaret K. Rhoda, Esq.

Harter Secrest & Emery LLP

1600 Bausch & Lomb Place

Rochester, NY 14604

Tel: (585) 232-6500

Fax: (585) 232-2152

 

Mitchell Nussbaum, Esq.

Angela M. Dowd, Esq.

Loeb & Loeb LLP

345 Park Avenue

New York, NY 10154

Tel: (212) 407-4000

Fax: (212) 407-4990

 

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 

 

 

CALCULATION OF REGISTRATION FEE

 

Title of Each Class of Security Being Registered(1)

 

Proposed

Maximum

Aggregate

Offering

Price(2)

 

 

Amount of

Registration

Fee

 

Common stock, par value $0.0001 per share

 

$

86,250,000

 

 

$

7,996

 

Representative’s warrants to purchase common stock(3)

 

 

 

 

 

 

Common stock underlying representative’s warrants(4)

 

 

6,641,250

 

 

 

616

 

Total

 

$

92,891,250

 

 

$

8,612

__________ 

(1)

Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.

 

 

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”) and includes shares of common stock that may be issued upon exercise of a 45-day option granted to the underwriters to cover over-allotments, if any.

 

 

(3)

In accordance with Rule 457(g) under the Securities Act, because the registrant’s shares of common stock underlying the representative’s warrants are registered hereby, no separate registration fee is required with respect to the warrants registered hereby.

 

 

(4)

The representative’s warrants are exercisable for a number of shares of common stock equal to 4.0% of the number of shares of common stock sold in this offering, excluding upon exercise of the option to purchase additional securities, at a per share exercise price equal to 125% of the public offering price. The representative’s warrants are exercisable commencing six months immediately following the closing of this offering for a period of five years after the closing of this offering, at any time, and from time to time, in whole or in part. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. Resales of shares of common stock issuable upon exercise of the representative’s warrants on a delayed or continuous basis pursuant to Rule 415 under the Securities Act are also registered hereby.

  

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 

 

 

The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

 

PRELIMINARY PROSPECTUS

 

SUBJECT TO COMPLETION, DATED NOVEMBER 1, 2021

 

[___] Shares of

Common Stock

 

EDIBLE GARDEN AG INCORPORATED

 

This is an initial public offering of our shares of common stock. We are offering on a firm commitment basis, shares of common stock, $0.0001 par value per share (“common stock”). The initial public offering price per share of common stock is expected to be between $____ and $______.

 

Prior to this offering, there has been no public market for our common stock. We have applied to list our common stock on the Nasdaq Capital Market under the symbol “EDBL.” No assurance can be given that our application will be approved. If our application is not approved or we otherwise determine that we will not be able to secure the listing of our common stock on the Nasdaq Capital Market, we will not complete this offering.

 

We are an “emerging growth company,” as defined under the federal securities laws and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. See “Prospectus Summary — Implications of Being an Emerging Growth Company and Smaller Reporting Company.”

 

Investing in our securities is speculative and involves a high degree of risk. You should carefully consider the risk factors beginning on page 7 of this prospectus before purchasing our securities.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

 

 

Per Share

 

 

Total

 

Public offering price

 

$

 

 

$

 

Underwriting discounts and commissions(1)

 

 

 

 

 

 

 

 

Proceeds to us, before expenses

 

 

 

 

 

 

 

 

____________

(1)

We have also agreed to issue warrants to purchase shares of common stock to the representative of the underwriters and reimburse the underwriters for certain expenses in connection with this offering. See “Underwriting” for additional information regarding total underwriting compensation, including information on underwriting discounts and offering expenses.

  

We have granted the representative of underwriters an option to purchase from us, at the public offering price, up to additional shares of common stock, less the underwriting discounts and commissions, within 45 days from the date of this prospectus to cover over-allotments, if any. If the representative of the underwriters exercises the option in full, the total underwriting discounts and commissions payable will be $ , and the total proceeds to us, before expenses, will be $ .

 

The underwriters expect to deliver the shares of common stock to purchasers on or about ________, 2021.

 

Sole Book-Running Manager

 

Maxim Group LLC

 

The date of this prospectus is _________, 2021

 

 

 

 

TABLE OF CONTENTS

 

PROSPECTUS SUMMARY

 

1

 

RISK FACTORS

 

7

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

19

 

USE OF PROCEEDS

 

20

 

DIVIDEND POLICY

 

20

 

CAPITALIZATION

 

21

 

DILUTION

 

21

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

23

 

BUSINESS

 

36

 

MANAGEMENT

 

46

 

CORPORATE GOVERNANCE

 

48

 

EXECUTIVE AND DIRECTOR COMPENSATION

 

51

 

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

 

52

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

54

 

DESCRIPTION OF SECURITIES

 

54

 

SHARES AVAILABLE FOR FUTURE SALE

 

56

 

UNDERWRITING

 

56

 

LEGAL MATTERS

 

63

 

EXPERTS

 

63

 

WHERE YOU CAN FIND MORE INFORMATION

 

63

 

 

 

i

Table of Contents

 

You should rely only on the information contained in this prospectus and in any free writing prospectus. We and the underwriters have not authorized anyone to provide you with information different from that contained in this prospectus. We and the underwriters are offering to sell, and seeking offers to buy, our securities only in jurisdictions where offers and sales are permitted. The information in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of our securities.

 

Neither we nor any of the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of our securities and the distribution of this prospectus outside of the United States.

  

We own or have rights to trademarks or trade names that we use in connection with the operation of our business, including our corporate names, logos and website names. In addition, we own or have the rights to copyrights, trade secrets and other proprietary rights that protect the content of our products. This prospectus may also contain trademarks, service marks and trade names of other companies, which are the property of their respective owners. Our use or display of third parties’ trademarks, service marks, trade names or products in this prospectus is not intended to, and should not be read to, imply a relationship with or endorsement or sponsorship of us. Solely for convenience, some of the copyrights, trade names and trademarks referred to in this prospectus are listed without their ©, ® and symbols, but we will assert, to the fullest extent under applicable law, our rights to our copyrights, trade names and trademarks. All other trademarks are the property of their respective owners.

 

 

ii

Table of Contents

 

 

PROSPECTUS SUMMARY

 

The following summary highlights information contained elsewhere in this prospectus and is qualified in its entirety by the more detailed information and financial statements included elsewhere in this prospectus. This summary does not contain all of the information you should consider before investing in our securities. Before you decide to invest in our securities, you should read and carefully consider the following summary together with the entire prospectus, including our financial statements and the related notes thereto and the matters discussed in the sections in this prospectus entitled “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Business.” Some of the statements in this prospectus constitute forward-looking statements that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements.” Our actual results could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those discussed in the “Risk Factors” and other sections of this prospectus. In this prospectus, unless otherwise stated or the context otherwise requires, references to “Edible Garden,” the “Company,” “we,” “us,” “our,” or similar references mean Edible Garden AG Incorporated and its subsidiaries on a consolidated basis.

 

Our Company

 

Edible Garden is a next generation controlled environment agriculture (“CEA”) farming company. We use traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. We use the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces. In our hydroponic greenhouse, we grow plants without soil. Instead of planting one row of lettuce in the ground, by using a vertical greenhouse, we can grow many towers of lettuce in the same area by planting up instead of planting across. Growing these products sustainably means that we avoid depleting natural resources in order to maintain an ecological balance, such as by renewing, reusing and recycling materials in order to lower the overall one-time use of materials.

 

Our controlled greenhouse facilities allow us to grow consistent quality herbs and lettuces year-round, first by eliminating some of the variability of outdoor farming with our CEA techniques, and second by leveraging our proprietary software, GreenThumb. In addition to using hydroponic and vertical greenhouse systems, we use a “closed loop” system in our greenhouses. Generally, in a “closed loop” system, drain water is recollected and reused for irrigation. In our closed loop system, we also cycle water back into the system that has been collected through reverse osmosis. When compared to conventional agriculture, our closed looped systems and hydroponic methods use less land, less energy and less water (than legacy farms), thus conserving some of the planet’s limited natural resources. Our advanced systems are also designed to help mitigate contamination from harmful pathogens, including salmonella, e-coli and others.

 

We have also developed patented software called GreenThumb that assists in tracking plants through our supply chain. Utilizing our GreenThumb software to track the status of our plants as they grow and move throughout the greenhouse allows us to add a layer of quality control due to the frequent monitoring of the growing process, leading to improved traceability. In this context, traceability means being able to track a plant through all stages of production and distribution. In addition to improving traceability, GreenThumb helps us better manage the day-to-day operations of our business. GreenThumb is a web-based greenhouse management and demand planning system that does the following:

 

·         integrates in real-time with our cloud business software suite for monitoring daily sales data;

 

·         generates reports by category, product, customer, and farm to allow us to analyze sales, trends, margins and retail shrink (spoiled product);

 

·         provides dynamic pallet mapping for packout, which enables us to more efficiently ship our products;

 

·         utilizes a proprietary algorithm that uses year-over-year and trending sales data to develop customer specific and aggregate product specific forecasting for our greenhouses;

 

·         aggregates all greenhouse activity input to provide real-time inventory and availability reports of all products in our greenhouses;

 

·         manages our online ordering system with user controlled product availability based upon greenhouse inventory;

 

·         provides a route management system for coordinating the logistics of our direct store delivery program; and

 

·         tracks all production activities at greenhouses, including sowing, spacing, dumping, spraying, picking and packing, using hand held devices.

 

We also use our GreenThumb software to help monitor the quality of our products, and we have dedicated quality assurance and quality control personnel that check and monitor our products. We have customer service personnel that answer any questions the consumers of our products may have, and we regularly ask for feedback from our customers on the quality of our products. The combination of the GreenThumb software, quality assurance and control processes (including compliance with food safety standards), and feedback from consumers and purchasers holds us accountable for maintaining the quality of our herbs and lettuce.

 

We focus our efforts on producing our herbs and vegetables in a sustainable manner that will reduce consumption of natural resources, by recycling water in our closed loop system and using LED lights instead of conventional lightbulbs to accelerate crop growth and yield, when necessary. In addition, the inventory management component of GreenThumb allows us to manage inventory levels, order quantities and fill rates while maximizing truck loads. This means that we are better able to control shipping our products in full truck loads, thus eliminating multiple deliveries and decreasing the excess emission of greenhouse gases that would result from many partially full trucks delivering our products. Together, these elements of our production and distribution process are intended to reduce our carbon footprint, or the total amount of greenhouse gases that are generated by our actions, as compared to a legacy farm business.

 

We believe our focus on our brand “Edible Garden” is a significant differentiator. The brand not only lends itself to our current portfolio of products but allows us to develop other products in the “Consumer Brands” category. Our focus on sustainability, traceability, and social contribution, which we define as an ongoing effort to improve employee relations, working conditions, and local communities, presents our value proposition to our customers and supermarket partners and distributors.

  

 

   

 
1

Table of Contents

 

 

We believe that Edible Garden’s state-of-the-art facilities comply with food safety and handling standards. We have food safety certifications from Primus GFS (“Primus”), a Global Food Safety Initiative (“GFSI”) certification program, the United States Department of Agriculture (“USDA”) for organic products (“USDA Organic”), and some of our products are verified as non-genetically modified (“non-GMO”) by the non-GMO Project. We are licensed under the Perishable Agricultural Commodities Act (“PACA”) to operate our business. We voluntarily comply with the Hazard Analysis Critical Control Point (“HACCP”) principles established by the United States Food and Drug Administration (“FDA”). See “Business — Overview” for more information about our certifications, license and the standards we follow.

 

We intend to use our approach to expand in key strategic markets across the country while supporting our existing operations. Our priority in the near term is to strengthen our existing business in part with the proceeds from this offering. We have a history of operating losses since inception and expect to incur additional near-term losses. As discussed further in “Management’s Discussion and Analysis — Liquidity and Capital Resources,” our auditors have issued an opinion that there is a substantial doubt about our ability to continue as a going concern if we are unable to complete this offering. However, we are pursuing this offering because we believe that we have the potential to take advantage of strategic growth opportunities. Our model of growing local produce near high population density centers and being able to provide fresh produce to our existing supermarket partners, who have a wider network than us, is intended to create organic growth in our business through those existing relationships. If we complete this offering, we intend to use part of the proceeds to either build or acquire greenhouses near population centers and distribution centers to be able to grow more produce close to where it is in demand and to deepen our relationships with regional and national supermarkets. Our model allows us to reduce transportation food miles, reduce fuel costs, and lower emissions related to food transportation.

 

It is our strong belief that the power of our brand together with the quality, innovative packaging and traceability of our products allow all of our customers to associate Edible Garden with locally grown and sustainably sourced packaged herbs and vegetables. Our tag line “Simply Local, Simply Fresh” is intended to describe our business plan: growing herbs and lettuce in local farms in the regional communities where our customers sell our products so that the products stay fresher for longer. We believe this strategy allows us to drive local grass roots brand awareness while we grow our business to support our plan to become a national brand.

 

 

 
2

Table of Contents

   

 

We currently offer 31 stock keeping units “SKU’s” and expect to further cross sell products across our supermarket partners to meet their demand. These products include:

 

 

 

 

·

10 types of individually potted, live herbs;

 

·

10 types of cut single-herb clamshells;

 

·

2 specialty herb items;

 

·

6 different types of lettuce;

 

·

hydro basil;

 

·

bulk basil; and

 

·

vegan protein powder.

 

 

 

We currently sell our products to a number of regional and national supermarkets. Since inception, a few of our customers constituted a majority of our total revenue. For example, during the six months ended June 30, 2021, we earned approximately 58% of our revenue from two customers, and we earned approximately 34% of our revenue from one customer in the period from our inception through December 31, 2020. While we value our strong relationship with these major customers, we face the risk of losing a significant source of revenue if our major customers do not continue to purchase our products. If that were to occur and we were unable to replace the revenue by selling our products to additional customers, our ability to earn revenue would be significantly negatively impacted. Part of our growth strategy is to reduce this customer concentration by expanding our production capacity, which would allow us to sell our products to more supermarket partners.

 

Corporate History and Structure

 

Our business is a successor business of Terra Tech Corp. (now known as Unrivaled Brands, Inc.)(“Terra Tech”). We purchased substantially all of the assets of Edible Garden Corp., a subsidiary of Terra Tech, from Terra Tech as of March 30, 2020.

 

Our company was incorporated on March 28, 2020 in the State of Wyoming as Edible Garden Inc. We subsequently changed our name to Edible Garden AG Incorporated on July 20, 2020. Effective July 7, 2021, our parent company, Edible Garden Holdings Inc., merged with and into us with us as the surviving entity. We converted into a Delaware corporation effective July 12, 2021. We have one wholly-owned subsidiary, EG Transportation, LLC, through which we manage the distribution of our products. Our current corporate structure is as shown below:

 

 

 

The outstanding common stock of our company is currently held by only a few individuals and one entity. An affiliate of Terra Tech, Sament Capital Investments, Inc. (“Sament”) owns 20.0% of our outstanding shares of common stock and is one of our creditors. Our executive officers collectively own 71.2% of our outstanding shares of common stock. As a result, our executive officers are able to exercise a significant level of control over all matters requiring stockholder approval. Our executive officers and Sament have significant influence over our business strategies and would have the ability to delay or prevent a change of control of our company or other significant corporate transactions.

 

Our principal address is 283 County Road 519, Belvidere, NJ 07823. Our telephone number is (908) 750-3953. We maintain a website at www.ediblegarden.com. The information contained on our website is not, and should not be interpreted to be, incorporated into this prospectus.

 

Recent Developments

 

Private Placement

 

On October 7, 2021, we closed on a private placement with Evergreen Capital Management LLC (“Evergreen”) and raised $1.0 million, which we intend to use to support our working capital requirements. In the private placement, we issued a 15% original issue discount secured promissory note to Evergreen (the “Evergreen Note”) and a warrant to purchase 751,623 shares of our common stock (the “Evergreen Warrant”). The Evergreen Note matures on July 7, 2022 and incurs interest at a rate of 5.0% per annum. The Evergreen Note is secured and subordinated to the notes held by Sament. Evergreen may elect to convert the Evergreen Note into shares of common stock at a conversion price of $1.53 per share. If the Evergreen Note is not converted into shares of common stock prior to the closing of this offering, we intend to repay the amount due under the Evergreen Note with some of the proceeds of this offering. The Evergreen Warrant may be exercised for the underlying shares of common stock at an exercise price of $1.53 per share until October 7, 2026. As part of the private placement, Maxim Group LLC, the representative of the underwriters in this offering, received a cash fee equal to 6% of the private placement proceeds. We have the option to issue up to $1.0 million in additional notes and warrants to Evergreen before January 10, 2022. The offering was conducted pursuant to an exemption from registration under the Securities Act of 1933, as amended (the “Securities Act”) in reliance upon Rule 506(b) promulgated under the Securities Act.

 

Exercise of Options by Sament 

 

On October 8, 2021, Sament exercised its option to purchase 5,000,000 shares of our common stock for an aggregate exercise price of $2.00.

 

Listing on the Nasdaq Capital Market

 

There is currently no public trading market for our shares of common stock. In connection with this offering, we have applied to list our common stock on the Nasdaq Capital Market (“Nasdaq”) under the symbol “EDBL.” If our listing application is approved, we expect to list our common stock on Nasdaq upon consummation of the offering. No assurance can be given that our listing application will be approved or that our common stock will be listed on Nasdaq. This offering will occur only if Nasdaq approves the listing of our common stock.

 

Summary Risk Factors

 

Our business is subject to a number of risks and uncertainties that you should understand before making an investment decision. These risks are discussed more fully in the section entitled “Risk Factors” following this prospectus summary. These include:

 

 

 

 

·

our history of losses and the substantial doubt about our ability to continue as a going concern, which could cause our stockholders to lose some or all of their investment in us;

 

·

our ability to continue to access and operate our Belvidere, New Jersey facility, since we are operating the property through an arrangement with our predecessor and the lessor instead of a lease;

 

·

our ability to raise additional capital in this offering or through additional offerings, which may not be available on favorable terms, if at all, and without which we may not be able to continue as a going concern;

 

·

our relatively short operating history;

 

·

the concentration of our revenue among a few customers and the risks of losing one of those customers;

 

·

the existence of a material weakness in our internal control over financial reporting;

 

·

the impact of any general and regional economic volatility or economic downturn;

 

·

our reliance on our management team and our ability to attract, train and retain qualified personnel;

 

·

the impact of any labor shortage or external price increases;

 

·

implementing any new lines of business or offering new products;

 

·

the impact of reputational damage;

 

·

the impact of product contamination or product liability claims;

 

·

our ability to protect our intellectual property rights;

 

 
3

Table of Contents

  

 

 

 

 

·

the impact of cyber-attacks or security breaches;

 

·

our ability to maintain the necessary permits and compliance with regulations and requirements as a producer and distributor of food products;

 

·

our ability to properly use hydroponic farming methods;

 

·

fluctuation in the market price and demand for agricultural products;

 

·

seasonality;

 

·

increases in the cost of commodities or raw product inputs;

 

·

our ability to comply with government policies and regulations specifically affecting the agricultural sector;

 

·

our ability to compete in our industry;

 

·

the immediate and substantial dilution investors in this offering will experience;

 

·

the broad discretion of our management team to apply the net proceeds of this offering;

 

·

the concentration of ownership among related parties, including existing executive officers and directors;

 

·

our status as an emerging growth company and a smaller reporting company;

 

·

our expectation that we will not declare dividends to our stockholders in the foreseeable future;

 

·

the potentially dilutive impact of seeking additional funds;

 

·

the public offering price in this offering was determined between us and the underwriter;

 

·

the potential impact of shares of common stock available for future sale after this offering;

 

·

a possible “short squeeze” due to a sudden increase in demand of our shares of common stock leading to price volatility;

 

·

our certificate of incorporation and bylaws could discourage a change in control or acquisition of us by a third party; and

 

·

the impact of the COVID-19 pandemic on our business.

 

 

 

Implications of Being an Emerging Growth Company and Smaller Reporting Company

 

We qualify as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As a result, we are permitted to, and intend to, rely on exemptions from certain disclosure requirements that are applicable to other companies that are not emerging growth companies. Accordingly, we have included detailed compensation information for only our three most highly compensated executive officers and have not included a compensation discussion and analysis of our executive compensation programs in this prospectus. In addition, for so long as we are an “emerging growth company,” we will not be required to:

 

 

 

 

·

engage an auditor to report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”);

 

·

comply with any requirement that may be adopted by the Public Company Accounting Oversight Board (“PCAOB”) regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements;

 

·

comply with new or revised accounting standards applicable to public companies as quickly as other public companies;

 

·

submit certain executive compensation matters to stockholder advisory votes, such as “say-on-pay,” “say-on-frequency,” and “say-on-golden parachutes;” or

 

·

disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparison of the chief executive officer’s compensation to median employee compensation.

 

 

 

In addition, the JOBS Act provides that an “emerging growth company” can use the extended transition period for complying with new or revised accounting standards.

 

We will remain an “emerging growth company” until the earliest to occur of:

 

 

 

 

·

our reporting $1.07 billion or more in annual gross revenues;

 

·

our issuance, in a three-year period, of more than $1 billion in non-convertible debt;

 

·

the end of the fiscal year in which the market value of our common stock held by non-affiliates exceeds $700 million on the last business day of our second fiscal quarter; and

 

·

December 31, 2026.

 

 

 

We cannot predict if investors will find our securities less attractive because we may rely on these exemptions, which could result in a less active trading market for our securities and increased volatility in the price of our securities.

 

Finally, we are a “smaller reporting company” (and may continue to qualify as such even after we no longer qualify as an emerging growth company) and accordingly may provide less public disclosure than larger public companies, including the inclusion of only two years of audited financial statements and only two years of management’s discussion and analysis of financial condition and results of operations disclosure. As a result, the information that we provide to our stockholders may be different than you might receive from other public reporting companies in which you hold equity interests.

 

 

 

   

 
4

Table of Contents

  

 

 

 

 THE OFFERING

 

 

 

Issuer:

 

 

 

Edible Garden AG Incorporated

 

Common stock being offered by us:

 

 

 

shares (or        shares of common stock if the underwriters exercise their over-allotment option in full).

 

Assumed public offering price:

 

 

 

$         per share, which is the mid-point of the price range indicated on the cover page of this prospectus.

 

Common stock outstanding immediately prior to this offering:

 

 

 

shares

 

Common stock to be outstanding immediately after this offering:

 

 

 

shares(1) (or shares of common stock if the underwriters exercise their over-allotment option in full), including shares issuable upon conversion of our Series 2020 Crowd SAFEs, the Evergreen Note and convertible notes held by our Messrs. Kras and James, our Chief Executive Officer and Chief Financial Officer.

Over-allotment option:

 

 

 

We have granted the underwriters an option, exercisable for 45 days after the date of this prospectus, to purchase up to an additional shares of common stock at the public offering price less the underwriting discounts payable by us, solely to cover over-allotments, if any.

 

Use of proceeds:

 

 

 

We intend to use the net proceeds from this offering for the construction and/or acquisition of existing greenhouses, working capital, organizational build out, including the hiring of a chief operating officer, chief marketing officer, head of sales, and support and operational staff, debt repayment, transaction bonuses for our executive officers and general corporate purposes. See “Use of Proceeds.”

 

Representative’s warrants:

 

 

 

Upon the closing of this offering, we will issue to Maxim Group LLC or its designee, as the representative of the underwriters in this offering, warrants entitling it to purchase a number of shares of common stock equal to 4.0% of the shares of common stock sold in this offering at an exercise price equal to 125% of the public offering price in this offering (the “Representative’s Warrants”). The Representative’s Warrants shall be exercisable commencing six months after the closing of this offering and will expire five years after the effective date of the registration statement of which this prospectus forms a part. This prospectus also relates to the offering of the shares of common stock issuable upon exercise of the Representative’s Warrants.

 

Underwriter compensation:

 

 

 

The underwriter will receive an underwriting discount equal to 7.0% of the gross proceeds from the sale of securities in the offering. We will also reimburse the underwriter for certain out-of-pocket actual expenses related to the offering. See “Underwriting.”

 

Proposed Nasdaq trading symbol:

 

 

 

We have applied to have our common stock listed on Nasdaq under the symbol “EDBL.” No assurance can be given that the listing will be approved or that a trading market will develop for the common stock. We will not complete this offering unless we receive approval for listing on Nasdaq.

 

Lock-up agreements:

 

 

 

We and our directors, officers and the holders of 1.0% or more of the outstanding shares of our common stock have agreed with the representative not to offer for sale, issue, sell, contract to sell, pledge or otherwise dispose of any of our common stock or securities convertible into common stock for a period of 180 days after the closing of this offering. See “Underwriting—Lock-Up Agreements.”

 

Transfer agent and registrar:

 

We are in the process of engaging a transfer agent and registrar for our common stock.

 

 

 

Risk factors:

 

The securities offered by this prospectus are speculative and involve a high degree of risk. Investors purchasing securities should not purchase the securities unless they can afford the loss of their entire investment. See “Risk Factors” beginning on page 7.

 

 
5

Table of Contents

    

(1)

The number of shares of our common stock to be outstanding following this offering is based on 25,000,000 outstanding shares of common stock as of October 22, 2021, and excludes:

 

 

 

 

·

751,623 shares of common stock issuable upon the exercise of a warrant held by Evergreen at an exercise price of $1.53 per share;

 

 

 

 

·

shares of our common stock issuable upon the exercise of the Representative’s Warrants to be issued in this offering.

 

Unless otherwise indicated, this prospectus reflects and assumes that the following are not converted into or exercised for shares of our common stock:

 

 

 

 

·

751,623 shares of common stock issuable upon the exercise of a warrant held by Evergreen at an exercise price of $1.53 per share;

 

·

753,200 shares of common stock issuable upon the conversion of the Evergreen Note;

 

·

shares of our common stock issuable upon the exercise of the Representative’s Warrants to be issued in this offering; and

 

·

no exercise by the underwriters of their option to purchase up to additional shares of our common stock from us to cover over-allotments, if any.

 

 
6

Table of Contents

 

 RISK FACTORS

 

Investing in our common stock is highly speculative and involves a significant degree of risk. You should carefully consider the risks described below and elsewhere in this prospectus, which could materially and adversely affect our business, results of operations or financial condition. Our business faces significant risks and the risks described below may not be the only risks we face. Additional risks not presently known to us or that we currently believe are immaterial may materially affect our business, results of operations, or financial condition. If any of these risks occur, the trading price of our common stock could decline and you may lose all or part of your investment.

 

Risks Related to Our Business

 

We have a history of losses, expect to continue to incur losses in the near term and may not achieve or sustain profitability in the future, and as a result, our management has identified and our auditors agreed that there is a substantial doubt about our ability to continue as a going concern.

 

We have incurred significant losses since our inception. We have experienced net losses of approximately $2.081 million for the period March 28, 2020 (inception) through December 31, 2020 and $2.345 million in the six months ended June 30, 2021. We expect our capital expenses and operational expenses to increase in the future due to expected increased sales and marketing expenses, operational costs, and general and administrative costs and, therefore, our operating losses will continue or even increase at least through the near term. Furthermore, to the extent that we are successful in increasing our customer base, we will also incur increased expenses because costs associated with generating and supporting customer agreements are generally incurred up front, while revenue is generally recognized ratably over the term of the relationship. You should not rely upon our recent revenue growth as indicative of future performance. We may not reach profitability in the near future or at any specific time in the future. If and when our operations do become profitable, we may not sustain profitability.

 

The report of our independent registered public accounting firm that accompanies our audited consolidated financial statements contains a going concern qualification in which such firm expressed substantial doubt about our ability to continue as a going concern. Our consolidated financial statements do not include any adjustments that might result if we are unable to continue as a going concern. If we are unable to continue as a going concern, holders of our securities might lose their entire investment. Although we plan to attempt to raise additional capital through one or more private placements or public offerings, the doubts raised relating to our ability to continue as a going concern may make our shares an unattractive investment for potential investors. These factors, among others, may make it difficult to raise any additional capital and may cause us to be unable to continue to operate our business.

 

We currently operate our flagship facility pursuant to an arrangement with our predecessor and the lessor of the land instead of a lease.

 

We currently do not have a formal lease to the land on which our flagship facility, in Belvidere, New Jersey, is built. We are currently party to an ongoing arrangement with our predecessor company, Edible Garden Corp., whereby we make lease payments of approximately $15,300 per month to the lessor of the land on which our flagship facility is built and for which our predecessor company is the lessee. We do not have a lease in place directly with the lessor of the property that gives us the right to operate the property. Accordingly, we are subject to the risk that we will lose access to the property if the lessor were to evict us from the facility and property. If we were unable to access the property and continue operations in Belvidere, New Jersey, we may lose the ability to continue growing as great a quantity of herbs and lettuce and may be unable to continue our business. If those risks occur, you could lose the entire value of your investment in us.

  

We may need to raise capital in addition to this offering, which may not be available on favorable terms, if at all, and which may cause dilution to holders of our common stock, restrict our operations or adversely affect our ability to operate and continue our business.

 

If we need to raise additional funds due to unforeseen circumstances or material expenditures or if our operating results are worse than expected, we cannot be certain that we will be able to obtain additional financing on favorable terms, if at all, and any additional financings could result in additional dilution to holders of our common stock. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions such as incurring additional debt, expending capital, or declaring dividends, or which impose financial covenants on us that limit our ability to achieve our business objectives. If we need additional capital and cannot raise it on acceptable terms, we may not be able to meet our business objectives, our stock price may fall and you may lose some or all of your investment.

 

We have a relatively short operating history, which makes it difficult to evaluate our business and future prospects.

 

We have a relatively short operating history, which makes it difficult to evaluate our business and future prospects. While the predecessor business has existed since 2013, our company has been in existence only since March 2020. We have encountered, and will continue to encounter, risks and difficulties frequently experienced by growing companies in rapidly changing industries, including those related to:

 

 

·

market acceptance of our current and future products and services;

 

·

changing regulatory environments and costs associated with compliance;

 

·

our ability to compete with other companies offering similar products and services;

 

·

our ability to effectively market our products and services and attract new customers;

 

·

the amount and timing of expenses, particularly sales and marketing expenses, related to the maintenance and expansion of our business, operations and infrastructure;

 

·

our ability to control costs, including our expenses;

 

·

our ability to manage organic growth; and

 

·

general economic conditions and events.

 

 
7

Table of Contents

 

If we do not manage these risks successfully, our business and financial performance will be adversely affected.

 

We earned approximately 58% of our revenue from two customers during the six months ended June 30, 2021 and approximately 34% of our revenue from one customer in the period from March 28, 2020 (inception) through December 31, 2020, and if we lose any of these customers or if we are unable to replace the revenue through the sale of our products to additional customers, our financial condition and results from operations would be materially and adversely affected.

 

During the six months ended June 30, 2021, two customers accounted for approximately 58% of our total revenue, and during the period from March 28, 2020 (inception) through December 31, 2020, one of our customers accounted for approximately 34% of our total revenue. This concentration of customers leaves us exposed to the risks associated with the loss of one or more of these significant customers, which would materially and adversely affect our revenues and results of operations. If these customers were to significantly reduce their relationship with us, or in the event that we are unable to replace the revenue through the sale of our products to additional customers, our financial condition and results from operations could be negatively impacted, and such impact would likely be significant.

 

The loss of one or more of the Company’s customers, or a reduction in the level of purchases made by these customers, could negatively impact the sales and profits of the Company.

 

The Company sells its products to national and local supermarket chains. If sales to one or more of the Company’s largest customers are reduced, this reduction may have a material adverse effect on the Company’s business and financial condition. These customers make purchase decisions based on a combination of price, product quality, consumer demand, customer service performance, desired inventory levels and other factors that may be important to them at the time the purchase decisions are made. Changes in these customers’ strategies or purchasing patterns may adversely affect the sales of the Company. For example, the customers may face financial or other difficulties, which may impact their operations and cause them to reduce their level of purchases, which could then adversely affect the Company’s results of operations. Any bankruptcy or other business disruption involving one of the Company’s significant customers also could adversely affect the results of operations as well.

 

Our relationships with customers are based on purchase orders rather than long-term purchase commitments.

 

We are subject to uncertainty because our relationships with customers are based on purchase orders rather than long-term purchase commitments. To ensure availability of our products, in some cases we start sowing our products in advance of receiving purchase orders for those products. Inaccuracies in our estimates of customer demand and product mix could negatively affect our ability to supply product to our customers and operating results. Our customers can cancel purchase orders or defer the shipments of our products under certain circumstances with little or no advance notice to us. If we grow more products than we are able to sell to our customers, we will incur losses and our results of operations and financial condition will be harmed.

 

Our secured indebtedness could have important consequences to you.

 

Our secured indebtedness could have important consequences to you. For example, it could:

 

 

·

limit our ability to obtain additional financing for working capital, capital expenditures, acquisitions and other general corporate requirements;

 

 

 

 

·

require us to dedicate a portion of our cash flow from operations to payments on our debt, thereby reducing the availability of our cash flow for operations and other purposes;

 

 

 

 

·

limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate; and

 

 

 

 

·

place us at a competitive disadvantage compared to competitors that may have proportionately less debt and greater financial resources.

  

Our secured indebtedness, held by Sament and Evergreen, is secured by a security interest in all of our assets. If we were to default on our obligations under the Sament Notes and Evergreen Note, Sament first, and then Evergreen, would have the right to our assets. We could be required to dispose of material assets or operations to meet our debt service and other obligations, and the value realized on such assets or operations will depend on market conditions and the availability of buyers. Accordingly, any such sale may not, among other things, be for a sufficient dollar amount. If we were to otherwise attempt to sell material assets or operations, the foregoing encumbrances may limit our ability to dispose of material assets or operations. In the event that Sament and Evergreen enforced their rights to our assets, we may have to discontinue our business, and our investors could lose all or a part of their investment in us.

 

We have a material weakness in our internal control over financial reporting, which if left unremediated could materially and adversely affect the market price of our common stock.

 

As of December 31, 2020 and June 30, 2021, we did not maintain effective controls over the control environment, including our internal control over financial reporting. Because we are a small company with few employees in our finance department, we lacked the ability to have adequate segregation of duties in the financial statement preparation process. Further, our Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K. Since these entity level controls have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness. If we are unable to remediate this material weakness as a newly public company, our financial reporting may not be reliable and the market price of our common stock may be adversely affected.

 

The Company’s performance may be impacted by general and regional economic volatility or an economic downturn.

 

An overall decline in economic activity could adversely impact the Company’s business and financial results. Economic uncertainty may reduce consumer spending as consumers make decisions on what to include in their food budgets. Economic uncertainty could also result in changing consumer preference. Shifts in consumer spending could result in increased pressure from competitors or customers that may require the Company to increase promotional spending or reduce the prices of some products, which could then lower revenue and profitability.

 

 
8

Table of Contents

 

Additionally, the Company is subject to regional economic volatilities since the Company’s growing operations are located in a few areas, including Belvidere, New Jersey; Half Moon Bay, California; Hilliard, Florida; Francesville, Indiana; Grand Rapids, Michigan; Berlin, New York; Cleveland, Ohio; and Hixton, Wisconsin. The Company’s use of hydroponic farming requires that it rely on local disease-free water sources and growing materials. Accordingly, any change in the availability of these local raw materials could adversely affect the Company’s operating results.

 

Our business would be adversely affected by the departure of members of our management team.

 

Our success depends, in large part, on the continued contributions of James E. Kras and Michael James. Although we have employment agreements in place for each of these executives, we cannot assure you that each will remain with us for a specified period. Although we have additional personnel that contribute to our business, the loss of either of these executives could harm our ability to implement our business strategy and respond to the rapidly changing market conditions in which we operate.

 

If we are unable to attract, train and retain qualified personnel, especially our management and sales personnel, we may not be able to effectively execute our business strategy.

 

Our future success depends on our ability to attract, retain and motivate qualified personnel, including our management, sales and marketing, operational, transportation, finance and administration personnel. For example, we currently have a limited number of personnel for our picking, packing and shipping group and greenhouse floor operations. We do not know whether we will be able to hire sufficient workers for these positions to meet our production goals or, if hired, retain all of these personnel as we continue to pursue our business strategy. The loss of the services of one or more of our key employees, or our inability to attract, retain and motivate qualified personnel could have a material adverse effect on our business, financial condition and operating results.

 

The costs of our operations may exceed our estimates due to factors outside of our control, such as labor shortages or external price increases, and we may be unable to pass those costs to our customers, which would negatively impact our financial results.

 

We depend on our employees and contracted grow operations teams to grow and distribute our products to our customers. We rely on access to competitive, local labor supply, including skilled and unskilled positions, to operate our business consistently and reliably. Any labor shortage, caused by the COVID-19 pandemic or other factors, and any disruption in our ability to hire workers would negatively affect our operations and financial condition. If we experience a sustained labor shortage, we may need to increase wages to attract workers, which would increase our costs of growing our products. Furthermore, if the prices of our raw materials, utilities or distributing our products were to increase, including due to inflationary pressures, we may be unable to pass those increased costs on to our customers. If we are unable to do so, our gross margin would decline, and our financial results would be negatively impacted.

 

We may implement new lines of business or offer new products and services within existing lines of business.

 

As an early-stage company, we may implement new lines of business at any time. There are substantial risks and uncertainties associated with these efforts, particularly in instances where the markets are not fully developed. In developing and marketing new lines of business and/or new products and services, we may invest significant time and resources. Initial timetables for the introduction and development of new lines of business and/or new products or services may not be achieved, and price and profitability targets may not prove feasible. We may not be successful in introducing new products and services in response to industry trends or developments in technology, or those new products may not achieve market acceptance. As a result, we could lose business, be forced to price products and services on less advantageous terms to retain or attract clients, or be subject to cost increases. As a result, our business, financial condition or results of operations may be adversely affected.

 

Damage to our reputation could negatively impact our business, financial condition and results of operations.

 

Our reputation and the quality of our brand are critical to our business and success in existing markets, and will be critical to our success as we enter new markets. Any incident that erodes consumer loyalty for our brand could significantly reduce its value and damage our business. We may be adversely affected by any negative publicity, regardless of its accuracy. Also, there has been a marked increase in the use of social media platforms and similar devices, including blogs, social media websites and other forms of internet-based communications that provide individuals with access to a broad audience of consumers and other interested persons. The availability of information on social media platforms is virtually immediate as is its impact. Information posted may be adverse to our interests or may be inaccurate, each of which may harm our performance, prospects or business. The harm may be immediate and may disseminate rapidly and broadly, without affording us an opportunity for redress or correction.

 

 
9

Table of Contents

  

The Company is subject to risk of product contamination and product liability claims.

 

The sales of our products involve the risk of injury to consumers. Such injuries may result from tampering by unauthorized personnel, product contamination or spoilage, including the presence of foreign objects, substances, chemicals, or residues introduced during the growing, packing, storage, handling or transportation phases. The Company cannot be sure that consumption of its products will not cause a health-related illness in the future or that it will not be subject to claims or lawsuits relating to such matters. Even if a product liability claim is unsuccessful, the negative publicity surrounding any assertion that the Company’s products caused illness or injury could adversely affect the Company’s reputation with existing and potential customers and its brand image.

 

We may incur substantial costs enforcing or acquiring intellectual property rights and defending against third-party claims as a result of litigation or other proceedings.

 

We may incur substantial costs enforcing or acquiring intellectual property rights and defending against third-party claims as a result of litigation or other proceedings. In connection with the enforcement of our own intellectual property rights, the acquisition of third-party intellectual property rights or disputes related to the validity or alleged infringement of third-party intellectual property rights, including patent rights, we may be subject to claims, negotiations or complex, protracted litigation. Intellectual property disputes and litigation may be costly and can be disruptive to our business operations by diverting attention and energies of management and key technical personnel, and by increasing our costs of doing business. If we fail to prevail in any future litigation and disputes, it could adversely affect our results of operations and financial condition. Third-party intellectual property claims asserted against us could subject us to significant liabilities, require us to enter into royalty and licensing arrangements on unfavorable terms, prevent us from assembling or licensing certain of our products, subject us to injunctions restricting our sale of products, cause severe disruptions to our operations or the marketplaces in which we compete or require us to satisfy indemnification commitments with our customers, including contractual provisions under various license arrangements. In addition, we may incur significant costs in acquiring the necessary third-party intellectual property rights for use in our products. Any of these could seriously harm our business.

 

If we are unable to obtain patent protection for our products or otherwise protect our intellectual property rights, our business could suffer.

 

Our success depends, in part, on our ability to obtain patent protection for or maintain as trade secrets our proprietary products, technologies and inventions and to maintain the confidentiality of our trade secrets and know‑how, operate without infringing upon the proprietary rights of others and prevent others from infringing upon our business proprietary rights. Despite our efforts to protect our proprietary rights, it is possible that competitors or other unauthorized third parties may obtain, copy, use or disclose our technologies, inventions, processes or improvements. We cannot assure you that any of our existing or future patents or other intellectual property rights will be enforceable, will not be challenged, invalidated or circumvented, or will otherwise provide us with meaningful protection or any competitive advantage. In addition, our four pending patent applications may not be granted. If our patents do not adequately protect our technology, our competitors may be able to offer products similar to ours. Our competitors may also be able to develop similar technology independently or design around our patents, and we may not be able to detect the unauthorized use of our proprietary technology or take appropriate steps to prevent such use. We may need to enter into intellectual property license agreements in the future, and if we are unable to obtain these licenses, our business could be harmed. Any of the foregoing events would lead to increased competition and lower revenues or gross margins, which could adversely affect our operating results.

 

Confidentiality agreements with employees and third parties may not prevent unauthorized disclosure of trade secrets and other proprietary information, and our inability to maintain the confidentiality of that information, due to unauthorized disclosure or use, or other event, could have a material adverse effect on our business.

 

In addition to the protection afforded by patents, we seek to rely on trade secret protection and confidentiality agreements to protect proprietary know-how that is not patentable or that we elect not to patent, processes for which patents are difficult to enforce, and any other elements of our product discovery and development processes that involve proprietary know-how, information, or technology that is not covered by patents. Trade secrets, however, may be difficult to protect. We seek to protect our proprietary processes, in part, by entering into confidentiality agreements with our employees, consultants, advisors, contractors and collaborators. Although we use reasonable efforts to protect our trade secrets, our employees, consultants, advisors, contractors, and collaborators might intentionally or inadvertently disclose our trade secret information to competitors. In addition, competitors may otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. Furthermore, the laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the United States. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the United States and abroad. If we are unable to prevent unauthorized material disclosure of our intellectual property to third parties, or misappropriation of our intellectual property by third parties, we will not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, operating results and financial condition.

 

 
10

Table of Contents

 

Our business could be negatively impacted by cyber security threats, attacks and other disruptions.

 

We face advanced and persistent attacks on our information infrastructure where we manage and store various proprietary information and sensitive/confidential data relating to our operations. These attacks may include sophisticated malware (viruses, worms, and other malicious software programs) and phishing emails that attack our products or otherwise exploit any security vulnerabilities. These intrusions sometimes may be zero-day malware that are difficult to identify because they are not included in the signature set of commercially available antivirus scanning programs. Experienced computer programmers and hackers may be able to penetrate our network security and misappropriate or compromise our confidential information or that of our customers or other third-parties, create system disruptions, or cause shutdowns. Additionally, sophisticated software and applications that we produce or procure from third-parties may contain defects in design or manufacture, including “bugs” and other problems that could unexpectedly interfere with the operation of the information infrastructure. A disruption, infiltration or failure of our information infrastructure systems or any of our data centers as a result of software or hardware malfunctions, computer viruses, cyber-attacks, employee theft or misuse, power disruptions, natural disasters or accidents could cause breaches of data security, loss of critical data and performance delays, which in turn could adversely affect our business.

 

Security breaches of confidential customer information or confidential employee information may adversely affect our business.

 

Our business requires the collection, transmission and retention of large volumes of customer and employee data, and other personally identifiable information, in various information technology systems that we maintain and in those maintained by third parties with whom we contract to provide services. The integrity and protection of that customer and employee data is critical to us. The information, security and privacy requirements imposed by governmental regulation are increasingly demanding. Our systems may not be able to satisfy these changing requirements and customer and employee expectations, or may require significant additional investments or time in order to do so. A breach in the security of our information technology systems or those of our service providers could lead to an interruption in the operation of our systems, resulting in operational inefficiencies and a loss of profits. Additionally, a significant theft, loss or misappropriation of, or access to, customers’ or other proprietary data or other breach of our information technology systems could result in fines, legal claims or proceedings.

 

Risks Related to Our Industry

 

Failure to obtain necessary permits or otherwise comply with USDA regulations and requirements could result in a ban or temporary suspension of our ability to grow, manufacture or market our products as organic, and thus could materially adversely affect our business.

 

As a producer and distributor of food products, we are subject to the laws and regulations in the jurisdictions where our facilities are located and where our products are distributed. In particular we are subject to the Federal Food, Drug and Cosmetic Act, as amended by the Food Safety Modernization Act in 2011 (the “FSM Act”), which is enforced by the FDA. The FDA has the authority to regulate the growing, harvesting manufacture, including composition and ingredients, processing, labeling, packaging import, distribution and marketing and safety of food in the United States. The FSM Act significantly enhances the FDA’s authority over various aspects of food regulation. For example, the FSM Act granted the FDA mandatory recall authority when the FDA determines there is a reasonable probability that a food is adulterated or misbranded and that the use of, or exposure to, the food will cause serious adverse health consequences or death to humans or animals. While the FDA has been active in implementing the requirements of the FSM Act through issuance of regulations designed to result in a reduction of the risk of contamination in food manufacturing, the full impact of the FSM Act is not yet known, and we cannot assure you that it will not materially impact our business. Regulatory agencies in other jurisdictions have similar authority to address the risk of contamination or adulteration, and to require that contaminated products be removed from the market. The failure to comply with these laws and regulations in any jurisdiction, or to obtain required approvals, could result in a ban or temporary suspension on the production of our products or limit or bar their distribution, and affect our development of new products, and thus could materially adversely affect our business and operating results. In addition, the United States Department of Agriculture (the “USDA”), regulates the import and export of certain fruits and vegetables into and from the United States, and the USDA also imposes growing, manufacturing and certification requirements for certain products labeled with organic claims. Failure to obtain necessary permits or otherwise comply with USDA regulations and requirements could result in a ban or temporary suspension of our ability to grow, manufacture or market our products as organic, and thus could materially adversely affect our business.

 

 
11

Table of Contents

 

The Company’s improper use of hydroponic farming methods may significantly impact the Company’s ability to maintain its operations and may adversely affect its financial results.

 

The Company’s improper use of indoor hydroponic farming techniques may adversely impact its operating results. For example, hydroponic farming commingles the use of water and electricity in close proximity which, if combined, may cause an electric shock or a power outage. As the nutrients supply in a hydroponic garden is powered by electricity, an outage could be detrimental to the garden. If an outage occurs, and lasts for a considerable period of time, the plants may die out if a supplementary system of nutrition is not implemented.

 

Hydroponic farming also necessitates proactive disease management practices to protect against pests and other natural conditions, outside of the control of the Company, from spreading through water sources. If the Company fails to properly manage its hydroponic farms, its operations and financial results may be adversely affected.

 

The Company is subject to fluctuations in market price and demand for agricultural products.

 

Fresh produce is highly perishable and generally must be brought to market and sold soon after harvest. The selling price received for the Company’s products may depend on a variety of factors, including timing of the sale, the availability and quality of the produce item in the market, and the availability and quality of competing produce.

 

In addition, general public perceptions regarding the quality, safety, or health risks associated with particular food products could reduce demand for some of the Company’s products. Food safety warnings, advisories, notices, and recalls, such as those administered by the FDA, the Center for Disease Control and Prevention, other federal/state government agencies, could also reduce demand. To the extent that consumers evolve away from products that the Company produces for health, food safety or other reasons, and the Company is unable to modify the product or to develop products that satisfy new consumer preferences, there will be a decreased demand for the Company’s products.

 

The Company’s results may vary from quarter to quarter depending on seasonal fluctuations related to the sale of the Company’s products.

 

Earnings may be affected by seasonal factors, including the availability, quality, and price of raw materials, the timing and effects of ripening and perishability, the ability to process perishable raw materials in a timely manner, the leveraging of certain fixed overhead costs during off-season months, and the slight impacts on consumer demand based on seasonal and holiday timing. Because we grow our products, the expenses incurred to meet consumer demand are often incurred in advance of the revenue earned by selling the herbs and lettuce. For example, we begin sowing our longest-growing crop 13 to 14 weeks in advance of delivery . The impact of seasonal demand and the sales cycle for our products may cause our results to vary from quarter to quarter, which may make an investment in us less attractive to some investors.

 

Increases in commodity or raw product input costs, such as fuel, packaging materials, could increase costs significantly.

 

The Company’s costs are determined in part by the prices of fuel and packaging materials. The Company may be adversely affected if sufficient quantities of these materials are not available. Additionally any significant increase in the cost of these items could also materially and adversely affect the Company’s operating results.

 

Specifically, the Company requires significant quantities of fuel for delivery vehicles and thus is exposed to the risks associated with fluctuations in the price for fuel. The price and supply of fuel can fluctuate significantly based on international, political, and economic circumstances, as well as other factors outside of the Company’s control.

 

Government policies and regulations specifically affecting the agricultural sector and related industries could adversely affect the Company’s operating results.

 

As a manufacturer of consumable products, the Company’s operations are subject to extensive regulation by various federal government agencies, including the FDA, the USDA and the Federal Trade Commission (“FTC”), as well as state and local agencies, such as the New Jersey Department of Agriculture, with respect to production processes, product attributes, packaging, labeling, storage, and distribution. Under various statutes and regulations, these agencies prescribe requirements and establish standards for safety, purity, and labeling. In addition, the advertising for the Company’s products is subject to regulation by the FTC, and the Company’s operations are subject to certain health and safety regulations, including those issued under the Occupational Safety and Health Act. Failure to comply with existing or modified regulations promulgated by these agencies may adversely affect the Company’s operating results.

 

 
12

Table of Contents

 

We face intense competition that could prohibit us from developing or increasing our customer base.

 

The indoor agriculture industry is highly competitive. We may compete with companies that have greater capital resources and facilities. More established companies with much greater financial resources which do not currently compete with us may be able to more easily adapt their existing operations to our line of business. Our competitors may also introduce new and improved products, and manufacturers may sell equipment direct to consumers. We may not be able to successfully compete with larger enterprises devoting significant resources to compete in our target market. Due to this competition, there is no assurance that we will not encounter difficulties in increasing revenues and maintaining and/or increasing market share. In addition, increased competition may lead to reduced prices and/or margins for products we sell.

 

Risks Related to this Offering and Ownership of our Securities

 

Investors in this offering will experience immediate and substantial dilution in the book value of their investment.

 

The public offering price will be substantially higher than the net tangible book value per share of our outstanding shares of common stock. As a result, investors in this offering will incur immediate dilution of $ per share based on the assumed public offering price of $ per share. Investors in this offering will pay a price per share that substantially exceeds the book value of our assets after subtracting our liabilities. See “Dilution” for a more complete description of how the value of your investment will be diluted upon the completion of this offering.

 

The public offering price of our common stock may have little or no relationship to the historical book value of our common stock or the implied value of our common stock in prior financing transactions.

 

Prior to the listing of our common stock, our shares have not been listed on any stock exchange or other public trading market, but we have issued options, SAFEs, warrants and convertible notes that are exercisable for or convertible into shares of our common stock. However, our historical book value and the exercise or conversion prices of the options, SAFEs, warrants and convertible notes may have little or no relation to broader market demand for our common stock and thus the public offering price in this offering and the public trading price of our common stock on the Nasdaq once trading begins, provided that our common stock is approved for listing on Nasdaq. As a result, you should not place undue reliance on these historical prices as they may differ materially from the public offering price in this offering.

 

Our management will have broad discretion over the use of the proceeds we receive in this offering and might not apply the proceeds in ways that increase the value of your investment.

 

Our management will have broad discretion over the use of our net proceeds from this offering, and you will be relying on the judgment of our management regarding the application of these proceeds. Our management might not apply our net proceeds in ways that ultimately increase the value of your investment. We expect to use the net proceeds from this offering for the construction and/or acquisition of existing greenhouses, working capital, organizational build out, including the hiring of a chief operating officer, chief marketing officer, head of sales, and support and operational staff, debt repayment, transaction bonuses for our executive officers and general corporate purposes. Our management might not be able to yield a significant return, if any, on any investment of these net proceeds. You will not have the opportunity to influence our decisions on how to use our net proceeds from this offering.

 

Concentration of ownership among related parties, including our existing executive officers and directors, may prevent new investors from influencing significant corporate decisions.

  

Currently, our executive officers and directors collectively own 71.2% of our outstanding shares of common stock. Sament, an affiliate of our predecessor and one of our creditors, owns 20% of our outstanding common stock.

 

Upon completion of this offering based on the assumed offering price, our executive officers and directors will beneficially own, in the aggregate, approximately % of our outstanding shares of common stock, with Mr. Kras and Mr. James owning approximately % each, and Sament owning approximately       %. As a result, these stockholders will be able to exercise a significant level of control over all matters requiring stockholder approval, including the election of directors, amendment of our certificate of incorporation and approval of significant corporate transactions. These stockholders acquired their shares of common stock for substantially less than the price of the shares of common stock being sold in this offering, and these stockholders may have interests, with respect to their common stock, that are different from those of investors in this offering. The concentration of voting power among these stockholders may have an adverse effect on the price of our common stock. In addition, this concentration of ownership might adversely affect the market price of our common stock by:

 

 

·

delaying, deferring or preventing a change of control of us;

 

 

 

 

·

impeding a merger, consolidation, takeover or other business combination involving us; or

 

 

 

 

·

discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.

  

This concentration of ownership among related parties, including our existing executive officers and directors, will make the approval of certain transactions difficult or impossible without the support of these stockholders.

 

 
13

Table of Contents

  

We are an “emerging growth company,” as defined in the JOBS Act, and a “smaller reporting company” within the meaning of the Securities Act, and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies or smaller reporting companies will make our common stock less attractive to investors.

 

We are an “emerging growth company,” as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including (1) not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, (2) reduced disclosure obligations regarding executive compensation in this prospectus and our periodic reports and proxy statements, (3) exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved, and (4) an extended transition period for complying with new or revised accounting standards applicable to public companies. Additionally, we may take advantage of certain reduced disclosure obligations as a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.

 

After we are no longer an “emerging growth company,” we expect to incur additional management time and cost to comply with the more stringent reporting requirements applicable to companies that are deemed accelerated filers or large accelerated filers, including complying with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. We cannot predict or estimate the amount of additional costs we may incur or the timing of such costs.

 

We have not and do not expect to declare any dividends to our stockholders in the foreseeable future.

 

We have not and do not anticipate declaring any cash dividends to holders of our common stock in the foreseeable future. Consequently, investors may need to rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investment. Investors seeking cash dividends should not purchase our common stock.

 

We may seek to raise additional funds, finance acquisitions or develop strategic relationships by issuing securities that would dilute your ownership. Depending on the terms available to us, if these activities result in significant dilution, it may negatively impact the trading price of our shares of common stock.

 

Any additional financing that we secure may require the granting of rights, preferences or privileges senior to, or pari passu with, those of our common stock. Any issuances by us of equity securities may be at or below the prevailing market price of our common stock and in any event may have a dilutive impact on your ownership interest, which could cause the market price of our common stock to decline. We may also raise additional funds through the incurrence of debt or the issuance or sale of other securities or instruments senior to our shares of common stock, which may be highly dilutive. The holders of any securities or instruments we may issue may have rights superior to the rights of our common stockholders. If we experience dilution from the issuance of additional securities and we grant superior rights to new securities over holders of our common stock, it may negatively impact the trading price of our shares of common stock and you may lose all or part of your investment.

 

The price of the shares of our common stock and other terms of this offering have been determined by us along with our underwriter.

 

If you purchase our shares of common stock in this offering, you will pay a price that was not established in a competitive market. Rather, you will pay a price that was determined by us along with our underwriters. The offering price for our shares of common stock may bear no relationship to our assets, book value, historical results of operations or any other established criterion of value. The trading price, if any, of our common stock that may prevail in any market that may develop in the future, for which there can be no assurance, may be higher or lower than the price you paid for our shares of common stock.

 

Shares eligible for future sale may adversely affect the market price of our common stock if the shares are successfully listed on Nasdaq or other stock markets, as the future sale of a substantial number of outstanding shares of common stock in the public marketplace could reduce the price of our common stock.

 

The market price of our shares could decline as a result of sales of substantial amounts of our shares in the public market, or the perception that these sales could occur. In addition, these factors could make it more difficult for us to raise funds through future offerings of our common stock. An aggregate of 25,000,000 shares will be issued and outstanding before the consummation of this offering all of which, except those held by management and holders subject to lock-up agreements, are or will be freely tradable immediately upon effectiveness of this registration statement. All of the shares sold in the offering will be freely transferable without restriction or further registration under the Securities Act. The remaining shares will be “restricted securities” as defined in Rule 144. These shares may be sold without registration under the Securities Act to the extent permitted by Rule 144 or other exemptions under the Securities Act. See “Shares Eligible for Future Sale.” 

 

 
14

Table of Contents

 

A possible “short squeeze” due to a sudden increase in demand of our shares of common stock that largely exceeds supply may lead to price volatility in our shares of common stock.

 

Following this offering, investors may purchase our shares of common stock to hedge existing exposure in our shares of common stock or to speculate on the price of our shares of common stock. Speculation on the price of our shares of common stock may involve long and short exposures. To the extent aggregate short exposure exceeds the number of shares of our common stock available for purchase in the open market, investors with short exposure may have to pay a premium to repurchase our shares of common stock for delivery to lenders of our shares of common stock. Those repurchases may in turn, dramatically increase the price of our shares of common stock until investors with short exposure are able to purchase additional common shares to cover their short position. This is often referred to as a “short squeeze.” A short squeeze could lead to volatile price movements in our shares of common stock that are not directly correlated to the performance or prospects of our company and once investors purchase the shares of common stock necessary to cover their short position the price of our common stock may decline.

 

Provisions in our certificate of incorporation and bylaws could discourage a change in control, or an acquisition of us by a third party, even if the acquisition would be favorable to you, thereby adversely affecting existing stockholders.

 

Our certificate of incorporation and bylaws contain provisions that may have the effect of making more difficult or delaying attempts by others to obtain control of our Company, even when these attempts may be in the best interests of our stockholders. For example, our certificate of incorporation authorizes our Board of Directors, without stockholder approval, to issue one or more series of preferred stock, which could have voting and conversion rights that adversely affect or dilute the voting power of the holders of common stock. These provisions and others that could be adopted in the future could deter unsolicited takeovers or delay or prevent changes in our control or management, including transactions in which stockholders might otherwise receive a premium for their shares over then-current market prices. These provisions may also limit the ability of stockholders to approve transactions that they may deem to be in their best interests.

 

General Risk Factors

 

Public health outbreaks, epidemics or pandemics, including the global COVID-19 pandemic, have disrupted and may continue to disrupt, our business and could materially affect our business, financial condition and results of operations.

 

The recent COVID-19 pandemic and resulting worldwide economic conditions have affected, and may continue to affect, our business, financial condition and results of operations.

 

The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. For example, government imposed mandatory closures and restrictions across various key markets of ours resulted in volatile supply and demand conditions, primarily due to reduced demand in the food service distribution channel. As a result, product in the industry was redirected to the retail channel and in some cases this led to an increased supply and lower pricing. While demand in our retail channels for certain products has increased due to the impact of COVID-19, there is no guarantee that this increased demand will continue. While these effects were pronounced to varying degrees throughout fiscal year 2020, the future extent of the impact of the COVID-19 pandemic on our financial performance, including our ability to execute our strategic initiatives, is still uncertain and will depend on future developments, including the duration and spread of the pandemic, related government restrictions and the success of vaccines and other treatments for COVID-19. Additionally, as the global economic impacts of COVID-19 continue, fluctuate and/or change, the pandemic’s impact on our operating results may change or be prolonged.

 

 
15

Table of Contents

 

In addition, our ability to continue to supply our products is highly dependent on our workforce, including our workers involved in the growing, harvesting, transportation, processing and distribution of our products. Our ability to maintain the safety of our workforce may be significantly impacted by individuals contracting or being exposed to COVID-19, and our operations and financial results may be negatively affected as a result. While we are following the requirements of governmental authorities and taking additional preventative and protective measures to ensure the safety of our workforce, we cannot be certain that these measures will be successful in ensuring the health of our workforce. Workforce disruptions related to COVID-19 may significantly impact our ability to maintain our operations and may adversely affect our financial results. Throughout the pandemic governments have restricted travel and transportation generally, and while these restrictions have not significantly impacted our ability to supply our products to date, there is no guarantee that future restrictions will not have a significant impact on our business. We also incurred costs in relation to safety precautions undertaken in our shipping operations and there can be no assurances that we would not be required to incur such costs or similar costs in the future.

 

The impact of the COVID-19 pandemic on our operating results can also impact our ability to meet our financial obligations. Our operating results have been and may continue to be impacted by the pandemic, and we cannot predict whether future developments associated with the COVID-19 pandemic will materially adversely affect our long-term liquidity position. In the event of a continued sustained market deterioration or further delayed recovery, we may need additional liquidity which would require us to evaluate available alternative strategies such as seeking additional debt or equity capital, which may be unsuccessful.

 

A prolonged economic downturn, particularly in light of the COVID-19 pandemic, could adversely affect our business.

 

Uncertain global economic conditions, in particular in light of the COVID-19 pandemic, could adversely affect our business. Negative global and national economic trends, such as decreased consumer and business spending, high unemployment levels and declining consumer and business confidence, pose challenges to our business and could result in declining revenues, profitability and cash flow. Although we continue to devote significant resources to support our brands, unfavorable economic conditions may negatively affect demand for our products.

 

Increases in costs, disruption of supply or shortage of raw materials could harm our business.

 

We may experience increases in the cost or a sustained interruption in the supply or shortage of raw materials. For example, the tariffs currently imposed for importing goods from China has significantly increased. Any such an increase or supply interruption could materially negatively impact our business, prospects, financial condition and operating results. We use various raw materials in our business including aluminum. The prices for these raw materials fluctuate depending on market conditions and global demand for these materials and could adversely affect our business and operating results. Substantial increases in the prices for our raw materials increase our operating costs, and could reduce our margins if we cannot recoup the increased costs through increased prices for our products and services.

 

Litigation may adversely affect our business, financial condition and results of operations.

 

From time to time in the normal course of our business operations, we may become subject to litigation involving intellectual property, data privacy and security, consumer protection, food safety, commercial disputes and other matters that may negatively affect our operating results if changes to our business operation are required. We may also be subject to claims involving health and safety, hazardous materials usage, other environmental impacts, or service disruptions or failures. The cost to defend such litigation may be significant and may require a diversion of our resources. There also may be adverse publicity associated with litigation that could negatively affect customer perception of our business, regardless of whether the allegations are valid or whether we are ultimately found liable. As a result, litigation may adversely affect our business, financial condition and results of operations. In addition, insurance may not cover existing or future claims, be sufficient to fully compensate us for one or more of such claims, or continue to be available on terms acceptable to us. A claim brought against us that is uninsured or underinsured could result in unanticipated costs, thereby adversely affecting our results of operations and resulting in a reduction in the trading price of our stock.

 

 
16

Table of Contents

 

An active, liquid and orderly trading market for our common stock may not develop, the price of our stock may be volatile, and you could lose all or part of your investment.

 

The trading price of our common stock may be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. Our stock price could be subject to wide fluctuations in response to a variety of factors, which include:

 

 

·

whether we achieve our anticipated corporate objectives;

 

 

 

 

·

actual or anticipated fluctuations in our quarterly or annual operating results;

 

 

 

 

·

changes in our financial or operational estimates;

 

 

 

 

·

our ability to implement our operational plans;

 

 

 

 

·

termination of the lock-up agreements or other restrictions on the ability of our stockholders to sell shares after this offering;

 

 

 

 

·

changes in the economic performance or market valuations of companies similar to ours; and

 

 

 

 

·

general economic or political conditions in the United States or elsewhere.

  

In addition, during the duration of the COVID-19 pandemic, the stock market has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors may seriously affect the market price of companies’ stock, including ours, regardless of actual operating performance. These fluctuations may be even more pronounced in the trading market for our stock shortly following this offering. In addition, in the past, following periods of volatility in the overall market and the market price of a particular company’s securities, securities class action litigation has often been instituted against these companies. This litigation, if instituted against us, could result in substantial costs and a diversion of our management’s attention and resources.

 

Our failure to meet the continuing listing requirements of Nasdaq could result in a delisting of our securities.

 

If we fail to satisfy the continuing listing requirements of Nasdaq, such as the corporate governance, stockholders equity or minimum closing bid price requirements, Nasdaq may take steps to delist our common stock. Such a delisting would likely have a negative effect on the price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of a delisting, we would likely take actions to restore our compliance with Nasdaq’s listing requirements, but we can provide no assurance that any such action taken by us would allow our common stock to become listed again, stabilize the market price or improve the liquidity of our securities, prevent our common stock from dropping below the Nasdaq minimum bid price requirement or prevent future non-compliance with Nasdaq’s listing requirements.

 

We will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies, which could adversely affect our operating results.

 

As a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company, including costs associated with public company reporting and corporate governance requirements. These requirements include compliance with Section 404 and other provisions of the Sarbanes-Oxley Act, as well as rules implemented by the Securities and Exchange Commission (“SEC”) and Nasdaq. In addition, our management team also has to adapt to the requirements of being a public company. We expect complying with these rules and regulations will substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly.

 

The increased costs associated with operating as a public company will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. Additionally, if these requirements divert our management’s attention from other business concerns, they could have a material adverse effect on our business, financial condition and operating results.

 

As a public company, we also expect that it may be more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified individuals to serve on our board of directors or as our executive officers.

 

As a public company, we are obligated to develop and maintain proper and effective internal control over financial reporting. We may not complete our analysis of our internal control over financial reporting in a timely manner, or these internal controls may not be determined to be effective, which may adversely affect investor confidence in our company and, as a result, the value of our common stock.

 

We will be required, pursuant to Section 404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting for the first fiscal year beginning after the effective date of the IPO. This assessment will need to include disclosure of any material weaknesses identified by our management in our internal control over financial reporting.

 

 
17

Table of Contents

 

We are in the early stages of the costly and challenging process of compiling the system and processing documentation necessary to perform the evaluation needed to comply with Section 404. We may not be able to remediate future material weaknesses, or to complete our evaluation, testing and any required remediation in a timely fashion. During the evaluation and testing process, if we identify one or more material weaknesses in our internal control over financial reporting, we will be unable to assert that our internal controls are effective. If we are unable to assert that our internal control over financial reporting is effective, we could lose investor confidence in the accuracy and completeness of our financial reports, which would have a material adverse effect on the price of our common stock.

 

If our shares of common stock become subject to the penny stock rules, it would become more difficult to trade our shares.

 

The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. If we do not retain a listing on Nasdaq and if the price of our common stock is less than $5.00, our common stock will be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive (i) the purchaser’s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our common stock, and therefore stockholders may have difficulty selling their shares.

 

If we were to dissolve, the holders of our securities may lose all or substantial amounts of their investments.

 

If we were to dissolve as a corporation, as part of ceasing to do business or otherwise, we may be required to pay all amounts owed to any creditors before distributing any assets to the investors. There is a risk that in the event of such a dissolution, there will be insufficient funds to repay amounts owed to holders of any of our indebtedness and insufficient assets to distribute to our other investors, in which case investors could lose their entire investment.

 

If securities or industry analysts do not publish or cease publishing research or reports about us, our business or our market, or if they change their recommendations regarding our stock adversely, our stock price and trading volume could decline.

 

The trading market for our common stock will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market or our competitors. If any of the analysts who may cover us change their recommendation regarding our stock adversely, or provide more favorable relative recommendations about our competitors, our stock price would likely decline. If any analyst who may cover us were to cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.

 

In making your investment decision, you should understand that we and the underwriters have not authorized any other party to provide you with information concerning us or this offering.

 

You should carefully evaluate all of the information in this prospectus before investing in our company. We may receive media coverage regarding our company, including coverage that is not directly attributable to statements made by our officers, that incorrectly reports on statements made by our officers or employees, or that is misleading as a result of omitting information provided by us, our officers or employees. We and the underwriters have not authorized any other party to provide you with information concerning us or this offering, and you should not rely on this information in making an investment decision.

 

 
18

Table of Contents

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This prospectus, including the sections entitled “Prospectus Summary,” “Risk Factors,” “Use of Proceeds,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Business” contains forward-looking statements. All statements other than statements of historical facts contained in this prospectus, including statements regarding our future results of operations and financial position, business strategy and plans and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “outlook” and similar expressions are intended to identify forward-looking statements. These forward-looking statements include statements relating to:

 

 

·

our ability to continue as a going concern;

 

 

 

 

·

our ability to continue to access and operate our Belvidere, New Jersey facility;

 

 

 

 

·

our market opportunity;

 

 

 

 

·

the effects of increased competition as well as innovations by new and existing competitors in our market;

 

 

 

 

·

our ability to retain our existing customers and to increase our customer base;

 

 

 

 

·

the future growth of the indoor agriculture industry and demands of our customers;

 

 

 

 

·

our ability to effectively manage or sustain our growth;

 

 

 

 

·

our ability to grow the business due to the uncertainty resulting from the COVID-19 pandemic or any future pandemic;

 

 

 

 

·

our expected use of proceeds from this offering;

 

 

 

 

·

our ability to maintain, or strengthen awareness of, our brand;

 

 

 

 

·

our ability to maintain, protect, and enhance our intellectual property;

 

 

 

 

·

future revenue, hiring plans, expenses and capital expenditures;

 

 

 

 

·

our ability to comply with new or modified laws and regulations that currently apply or become applicable to our business;

 

 

 

 

·

our ability to recruit and retain key employees and management personnel;

 

 

 

 

·

our financial performance and capital requirements following this offering;

 

 

 

 

·

the potential insufficiency of our disclosure controls and procedures to detect errors or acts of fraud;

 

 

 

 

·

the potential lack of liquidity and trading of our securities;

 

 

 

 

·

the lack of an established market for our securities; and

 

 

 

 

·

our potential ability to obtain additional financing.

   

We caution you that the foregoing list may not contain all of the forward-looking statements made in this prospectus. We have based these forward-looking statements largely on our current expectations about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in “Risk Factors.” Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

 

You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this prospectus to conform these statements to actual results or to changes in our expectations.

 

You should read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement of which this prospectus is a part with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect.

 

 
19

Table of Contents

 

USE OF PROCEEDS

 

We estimate that the net proceeds from this offering will be approximately $               after deducting estimated underwriting discounts and estimated offering expenses payable by us. If the over-allotment option is exercised in full, we estimate that our net proceeds will be approximately $         . We intend to use the net proceeds from this offering for the following purposes:

 

Proceeds:

 

 

 

Gross Proceeds

 

$ 75,000,000

 

Discounts

 

 

5,250,000

 

Estimated Fees and Expenses

 

 

700,000

 

Net Proceeds

 

$ 69,050,000

 

 

 

 

 

 

Uses:

 

 

 

 

Construction of new greenhouses and/or acquisition of existing greenhouses(1)

 

$ 50,000,000

 

Working capital

 

 

8,238,916

 

Organizational build-out(2)

 

 

5,000,000

 

Debt repayment(3)

 

 

4,411,084

 

Transaction bonuses(4)

 

 

1,400,000

 

Total Uses

 

$ 69,050,000

 

______________ 

(1)

We have no current plans to acquire existing greenhouses, but we may do so as part of our growth strategy in the future.

(2)

Includes the hiring of a chief operating officer, chief marketing officer, head of sales, and support and operational staff.

(3)

Includes repayment of the (i) Sament Notes and accrued interest for $3,791,624; and (ii) promissory and demand notes and accrued interest totaling $619,460 held by our Chief Financial Officer, as of October 22, 2021. See “Description of Securities” and “Certain Relationships and Related Party Transactions.”

(4)

Transaction bonuses of $700,000 each are payable to our Chief Executive Officer and Chief Financial Officer under the terms of their employment agreements upon the closing of this offering. See “Executive and Director Compensation – Employment Agreements” for more information.

 

A $1.00 increase (decrease) in the assumed public offering price of $             per share, would increase (decrease) the net proceeds to us from this offering by approximately $                 , assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions.

 

We intend to use $3.792 million of the net proceeds to repay the Sament Notes and accrued interest, which mature in June 2023 and March 2025. If the Evergreen Note is not converted into shares of common stock prior to the closing of this offering, we intend to repay the amount due under the Evergreen Note and accrued interest, or $1,152,396, with some of the proceeds of this offering. We intend to repay the promissory and demand notes held by our executive officers with part of the net proceeds of this offering, which include including $619,460 payable to our Chief Financial Officer. At their election, holders of our outstanding SAFEs may elect to receive cash instead of converting their SAFE into common stock upon the effectiveness of this offering. If all SAFE holders elected to receive cash, we would be required to pay them $538 thousand.

 

The actual allocation of proceeds realized from this offering will depend upon our operating revenues and cash position and our working capital requirements may change. Therefore, as of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering. Accordingly, we will have discretion in the application of the net proceeds, and investors will be relying on our judgment regarding the application of the proceeds of this offering. Pending our use of the net proceeds from this offering, we intend to invest the net proceeds in a variety of capital preservation investments, including short-term, investment-grade, interest-bearing instruments and U.S. government securities.

 

DIVIDEND POLICY

 

We have never paid cash dividends on any of our capital stock, and we do not anticipate paying any cash dividends on our common stock in the foreseeable future. We intend to retain all available funds and any future earnings to fund the development and expansion of our business. Any future determination to pay dividends will be at the discretion of our Board of Directors and will depend upon a number of factors, including our results of operations, financial condition, future prospects, contractual restrictions, restrictions imposed by applicable law and other factors our Board of Directors deems relevant.

 

 
20

Table of Contents

 

CAPITALIZATION

 

 

The following table sets forth our capitalization as of June 30, 2021 as follows:

 

 

·

on an actual basis;

 

 

 

 

·

on a pro forma basis to reflect (i) the exercise by Sament of options to purchase 5,000,000 shares of common stock as of October 8, 2021 for an aggregate purchase price of $2.00, (ii) the conversion of convertible notes held by Messrs. Kras and James, our CEO and CFO, respectively for 1,256,702 shares of our common stock upon the consummation of this offering, and (iii) the conversion of the Series 2020 Crowd SAFEs into 748,779 shares of our common stock upon the consummation of this offering; and

 

 

 

 

·

on a pro forma, as adjusted, basis to reflect the issuance and sale by us of $          in shares in this offering at the assumed public offering price of $          per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us and the receipt by us of the proceeds of such sale.

  

The pro forma information below is illustrative only, and our capitalization following the closing of this offering will change based on the actual initial public offering price and other terms of this offering determined at pricing. You should read this table in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the financial statements and related notes included elsewhere in this prospectus.

 

 

 

As of June 30, 2021

 

 

 

Unaudited,

 

 

Unaudited,

Pro

 

 

Unaudited,

Pro Forma as

 

(In thousands)

 

Actual

 

 

Forma(1)

 

 

Adjusted(1)

 

 

 

 

 

 

 

 

 

 

 

Cash and Cash Equivalents

 

$ 15

 

 

$ 15

 

 

$ -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and other accrued expenses

 

$ 3,280

 

 

$ 3,280

 

 

$ -

 

Short-term debt

 

 

433

 

 

 

33

 

 

 

-

 

Long-term debt, net of discounts

 

 

4,388

 

 

 

3,914

 

 

 

-

 

Long-term lease liabilities

 

 

167

 

 

 

167

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' Equity

 

 

 

 

 

 

 

 

 

 

 

 

Common stock ($0.0001 par value, 200,000,000 shares authorized, 20,000,000 shares outstanding as of June 30, 2021)

 

 

-

 

 

 

-

 

 

 

-

 

Additional paid in capital

 

 

6

 

 

 

880

 

 

 

-

 

Accumulated Deficit

 

 

(4,428 )

 

 

(4,428 )

 

 

-

 

Total stockholders' deficit

 

 

(4,422 )

 

 

(3,548 )

 

 

-

 

Total capitalization

 

$ 3,846

 

 

$ 3,846

 

 

$ -

 

 

(1)

The pro forma and pro forma as adjusted information is illustrative only and following the completion of this offering will be adjusted based on the actual initial public offering price and other terms of this offering determined at pricing.

   

The number of shares of our common stock outstanding set forth in the table above excludes:

 

 

·

751,623 shares of common stock issuable upon the exercise of a warrant held by Evergreen at an exercise price of $1.53 per share, as of October 22, 2021;

 

·

753,200 shares of common stock issuable upon the conversion of the Evergreen Note, as of October 22, 2021; and

 

·

shares of our common stock issuable upon the exercise of the Representative’s Warrants to be issued in this offering.

 

DILUTION

 

If you invest in our securities in this offering, your investment will be immediately and substantially diluted to the extent of the difference between the public offering price per share of our common stock and the pro forma net tangible book value per share of our common stock after giving effect to the offering.

 

Our net tangible book (deficit) as of June 30, 2021 was $(3.182) million, or approximately $(0.16) per share. Net tangible book value per share represents our total tangible assets less total liabilities, divided by the number of shares of common stock outstanding.

 

 
21

Table of Contents

 

Net tangible book value dilution per share of common stock to new investors represents the difference between the amount per share paid by purchasers in the offering and the pro forma net tangible book value per share of common stock immediately after completion of the offering. After giving effect to the offering and our sale of the  shares of common stock in the offering at a public offering price of $               per share, and after deduction of underwriting discounts and commissions from gross proceeds raised in the offering and estimated offering expenses payable by us, our pro forma net tangible book value as of June 30, 2021 would have been $              , or $       per share of common stock. This represents an immediate increase in pro forma net tangible book value of $     per share of common stock to existing stockholders and an immediate dilution in net tangible book value of $         per share of common stock to investors of the offering, as illustrated in the following table, based on shares outstanding as of June 30, 2021.

 

Offering price per share of common stock

 

 

 

Actual net tangible book value per share before this offering, as of June 30, 2021 (1)

 

$ (0.16 )

Conversion of convertible debt, SAFE Agreements and exercise of options (2)

 

 

0.07

 

Pro forma net tangible book value per share  after conversion of debt, SAFE agreements and exercise of options as of June 30, 2022

 

$ (0.09 )

Increase in net tangible book value per share attributable to new investors (3)

 

$

 

Pro forma net tangible book value per share of common stock after this offering, as of June 30, 2021 (4)

 

 

 

 

Dilution per share to new investors

 

 

 

 

 

(1)    

Determined by dividing (i) net tangible book value (total assets less intangible assets) less total liabilities by (ii) the total number of common shares issued and outstanding prior to the offering

 

 

(2)    

Represents the expected conversion of convertible debt held by our Chief Executive Officer and Chief Financial Officer, SAFE Agreement and the exercise of the options held by Sament into shares of common stock (which occurred as of October 8, 2021). 

 

 

(3)    

Represents the difference between (i) pro forma net tangible book value per share after this offering and (ii) net tangible book value per share as of June 30, 2021.

 

 

(4)

Determined by dividing (i) pro forma adjusted net tangible book value, which is our net tangible book value plus the cash proceeds of this offering, after deducting the estimated offering expenses payable by us, by (ii) the total number of our common shares to be outstanding following this offering.

  

Each $1.00 increase (decrease) in the assumed initial public offering price of $            per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma net tangible book value per share after this offering by $  per share and the dilution to new investors purchasing  common stock in this offering by $         per share, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.

 

If the underwriters exercise their option in full to purchase an additional       shares of  common stock in this offering, the pro forma net tangible book value per share after the offering would be $  per share, the increase in the net tangible book value per share to existing stockholders would be $               per share and the dilution to new investors purchasing our common stock in this offering would be $      per share.

 

The number of shares of our common stock outstanding set forth in the table above excludes:

 

 

·

751,623 shares of common stock issuable upon the exercise of a warrant held by Evergreen at an exercise price of $1.53 per share, as of October 22, 2021;

 

·

753,200 shares of common stock issuable upon the conversion of the Evergreen Note, as of October 22, 2021; and

 

·

shares of our common stock issuable upon the exercise of the Representative’s Warrants to be issued in this offering.

  

 
22

Table of Contents

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion and analysis of our financial condition and results of our operations together with our consolidated financial statements and the notes thereto appearing elsewhere in this prospectus. This discussion contains forward-looking statements reflecting our current expectations, whose actual outcomes involve risks and uncertainties. Actual results and the timing of events may differ materially from those stated in or implied by these forward-looking statements due to a number of factors, including those discussed in the sections entitled “Risk Factors,” “Cautionary Statement regarding Forward-Looking Statements,” and elsewhere in this prospectus.

 

Business Overview

 

Edible Garden is a next generation CEA farming company. We use traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. We use the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

 

Our business is a successor business of a subsidiary of Terra Tech. We purchased substantially all of the assets of Edible Garden Corp., a subsidiary of Terra Tech which we refer to in this section as “Predecessor”, from Terra Tech as of March 30, 2020 for approximately $3.0 million. Our company was incorporated on March 28, 2020 in the State of Wyoming as Edible Garden Inc. We are now a Delaware corporation with the name “Edible Garden AG Incorporated.”

  

Recent Developments

 

Private Placement

 

On October 7, 2021, we closed on a private placement with Evergreen and raised $1.0 million, which we intend to use to support our working capital requirements. In the private placement, we issued a 15% original issue discount secured promissory note to Evergreen (the “Evergreen Note”) and a warrant to purchase 751,623 shares of our common stock (the “Evergreen Warrant”). The Evergreen Note matures on July 7, 2022 and incurs interest at a rate of 5.0% per annum. The Evergreen Note is secured and subordinated to the Sament Notes. Evergreen may elect to convert the Evergreen Note into shares of common stock at a conversion price of $1.53 per share. If the Evergreen Note is not converted into shares of common stock prior to the closing of this offering, we intend to repay the amount due under the Evergreen Note with some of the proceeds of this offering. The Evergreen Warrant may be exercised for the underlying shares of common stock at an exercise price of $1.53 per share until October 7, 2026. As part of the private placement, Maxim received a cash fee equal to 6% of the private placement proceeds. We have the option to issue up to $1.0 million in additional notes and warrants to Evergreen before January 10, 2022. The offering was conducted pursuant to an exemption from registration under the Securities Act in reliance upon Rule 506(b) promulgated under the Securities Act.

 

Exercise of Options by Sament 

 

On October 8, 2021, Sament exercised its option to purchase 5,000,000 shares of our common stock for an aggregate exercise price of $2.00.

 

Impact of COVID-19

 

The COVID-19 pandemic and resulting worldwide economic conditions have affected, and may continue to affect, our business, financial condition and results of operations. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. For example, government imposed mandatory closures and restrictions across various key markets of ours resulted in volatile supply and demand conditions, primarily due to reduced demand in the food service distribution channel. As a result, product in the industry was redirected to the retail channel and in some cases this led to an increased supply and lower pricing. While demand in our retail channels for certain products has increased due to the impact of COVID-19, there is no guarantee that this increased demand will continue. While these effects were pronounced to varying degrees throughout fiscal year 2020, the future extent of the impact of the COVID-19 pandemic on our financial performance, including our ability to execute our strategic initiatives, is still uncertain and will depend on future developments, including the duration and spread of the pandemic, related government restrictions and the success of vaccines and other treatments for COVID-19. Additionally, as the global economic impacts of COVID-19 continue, fluctuate and/or change, the pandemic’s impact on our operating results may change or be prolonged.

 

In addition, our ability to continue to supply our products is highly dependent on our workforce, including our workers involved in the growing, harvesting, transportation, processing and distribution of our products. Our ability to maintain the safety of our workforce may be significantly impacted by individuals contracting or being exposed to COVID-19, and our operations and financial results may be negatively affected as a result. We are following the requirements of governmental authorities and taking additional preventative and protective measures to ensure the safety of our workforce, we cannot be certain that these measures will be successful in ensuring the health of our workforce. Workforce disruptions related to COVID-19 may significantly impact our ability to maintain our operations and may adversely affect our financial results. Throughout the pandemic governments have restricted travel and transportation generally, and while these restrictions have not significantly impacted our ability to supply our products to date, there is no guarantee that future restrictions will not have a significant impact on our business. We also incurred costs in relation to safety precautions undertaken in our shipping operations and there can be no assurances that we would not be required to incur such costs or similar costs in the future.

 

The impact of the COVID-19 pandemic on our operating results can also impact our ability to meet our financial obligations. Our operating results have been and may continue to be impacted by the pandemic, and we cannot predict whether future developments associated with the COVID-19 pandemic will materially adversely affect our long-term liquidity position. In the event of a continued sustained market deterioration or further delayed recovery, we may need additional liquidity which would require us to evaluate available alternative strategies such as seeking additional debt or equity capital, which may be unsuccessful.

 

Results of Operations

 

The comparability of our operating results in the year ended December 31, 2020 compared to the year ended December 31, 2019 includes the predecessor company, Edible Garden Corp., a subsidiary of Terra Tech (“Predecessor”) as well as the successor company, or Edible Garden AG Incorporated (us or the “Successor”).  The period from January 1, 2020 through March 31, 2020 relates to the Predecessor and the period from April 1, 2020 through December 31, 2020 relates to the Successor. The period from January 1, 2019 through December 31, 2019 relate to the Predecessor.

  

We present the information in this format to assist readers in understanding and assessing the trends and significant changes in our results of operations on a comparable basis. We believe this presentation is appropriate because it provides a meaningful comparison and relevant analysis of our results of operations for the relevant periods.

 

 
23

Table of Contents

 

Comparison of Results of Operations for the Year ended December 31, 2019 (Predecessor) compared to the Period from January 1, 2020 through March 31, 2020 (Predecessor) and the Period from March 28, 2020 (Inception) through December 31, 2020 (Successor)

 

 

 

Predecessor

 

 

Successor

 

(in thousands)

 

Year Ended

December 31,

2019

 

 

Period from

January 1, 2020

through

March 31,

2020

 

 

Period from

March 28, 2020

(inception)

through

December 31,

2020

 

Revenue

 

$ 5,634

 

 

$ 1,750

 

 

$ 7,691

 

Cost of goods sold

 

 

4,366

 

 

 

1,599

 

 

 

6,488

 

Gross Profit

 

 

1,268

 

 

 

151

 

 

 

1,203

 

Selling, general and administrative expenses

 

 

5,291

 

 

 

1,480

 

 

 

3,675

 

Impairment of assets

 

 

(34 )

 

 

 

 

 

 

(Gain) / Loss on sale of assets

 

 

 

 

 

303

 

 

 

 

Loss from operations

 

 

(3,988 )

 

 

(1,632 )

 

 

(2,472 )

Other income / (expense)

 

 

 

 

 

 

 

 

 

 

 

 

    Interest expense, net

 

 

 

 

 

 

 

 

(112 )

    Gain from Debt Forgiveness

 

 

 

 

 

 

 

 

503

 

    Total other income / (expense)

 

 

 

 

 

 

 

 

391

 

Income / (loss) from continuing operations

 

 

(3,988 )

 

 

(1,632 )

 

 

(2,081 )

NET LOSS

 

$ (3,988 )

 

$ (1,632 )

 

$ (2,081 )

 

Revenues

 

Revenues were $7.691 million for the period March 28, 2020 through December 31, 2020 (Successor) and $1.750 million for the period from January 1, 2020 through March 31, 2020 (Predecessor), compared to $5.634 million for the year ended December 31, 2019 (Predecessor).  On a combined basis, revenues for the Predecessor and Successor were $9.441 million for the year ended December 31, 2020, an increase of $3.807 million, or 67.57%, compared to the year ended December 31, 2019 for the Predecessor.  This represents growth from new accounts, growth from our existing customers taking in additional product lines due to the increased demand from consumers due to the impact of COVID-19 and overall category growth.

 

Cost of goods sold

 

Cost of goods sold were $6.488 million for the period March 28, 2020 through December 31, 2020 (Successor) and $1.599 million for the period from January 1, 2020 through March 31, 2020 (Predecessor), compared to $4.366 million for the year ended December 31, 2019 (Predecessor).  On a combined basis, cost of goods sold for the Predecessor and Successor were $8.087 million for the year ended December 31, 2020, an increase of $3.721 million, or 85.25%, compared to the year ended December 31, 2019 for the Predecessor.

 

The increase in cost of goods sold was primarily due to the raw material costs in the amount of $2.123 million, on a combined basis, to fulfill the orders placed by our customers and additional costs incurred due to additional supply chain pressure caused by COVID-19.  The increase in labor for both production to produce the products and in house delivery costs to get the products to market amounted to $654 thousand, on a combined basis.  The increase in the cost of freight to get the products to market amounted to $945 thousand, on a combined basis.

 

 
24

Table of Contents

 

Gross margin

 

Gross margin was $1.203 million or 15.64% of sales for the period March 28, 2020 through December 31, 2020 (Successor) and $151 thousand or 8.64% of sales for the period from January 1, 2020 through March 31, 2020 (Predecessor), compared to $1.268 million or 22.52% of sales for the year ended December 31, 2019 (Predecessor).  On a combined basis, gross margin for the Predecessor and Successor was $1.354 million or 14.34% of sales for the year ended December 31, 2020, an increase of $85 thousand, or 6.73%, compared to the year ended December 31, 2019 for the Predecessor, while gross margin as a percentage of sales declined by 8.16%.  Our margins dropped due to the increased costs incurred to fulfill the demand by our customers as a result of COVID-19 for our products which we were able to produce and deliver while beginning to leverage a small part of our operating efficiencies.

 

Selling, general and administrative

 

Selling, general and administrative expenses were $3.675 million for the period March 28, 2020 through December 31, 2020 (Successor) and $1.480 million for the period from January 1, 2020 through March 31, 2020 (Predecessor), compared to $5.291 million for the year ended December 31, 2019 (Predecessor).  On a combined basis, selling, general and administrative expenses for the Predecessor and Successor were $5.155 million for the year ended December 31, 2020, a decrease of $136 thousand, or 2.57%, compared to the year ended December 31, 2019 for the Predecessor.  Bad debt expense is attributable to the predecessor company for reserves established of approximately $162 thousand; commission expense, on a combined basis, increased by $78 thousand due to brokers we retained to help  increase revenue; depreciation and amortization, on a combined basis, increased by approximately $171 thousand based on the allocation of the assets acquired in the Asset Acquisition; employee benefits, on a combined basis, increased by approximately $71 thousand due to the higher rates paid for workmen’s compensation insurance due to the changes in our experience rating and other professional fees increased by approximately $165 thousand for outside contractors retained to establish better operating efficiencies.  Advertising, on a combined basis, decreased by approximately $72 thousand due to less advertising done during the COVID-19 pandemic; banking, on a combined basis, decreased by approximately $68 thousand since the successor company does not operate in the cannabis industry; salaries, on a combined basis, decreased by approximately $263 thousand due to the reduced headcount while deploying automation in the production facility; legal expense, on a combined basis, decreased by approximately $245 thousand since the predecessor company settled a lawsuit; trade shows, on a combined basis, decreased by approximately $35 thousand since there were no trade shows during the COVID-19 pandemic; and utilities, on a combined basis, decreased by approximately $91 thousand due to better controls put in place at the greenhouse.

 

Loss on sale of assets

 

Loss on the sale of assets in the period from January 1, 2020 to March 31, 2020 was approximately $303 thousand from the predecessor company recorded for the sale of the assets to the successor company.

  

Loss from operations

 

Loss from operations were $2.472 million for the period March 28, 2020 through December 31, 2020 (Successor) and $1.632 million for the period from January 1, 2020 through March 31, 2020 (Predecessor), compared to $3.988 million for the year ended December 31, 2019 (Predecessor).  On a combined basis, loss from operations for the Predecessor and Successor were $4.104 million for the year ended December 31, 2020, an increase of $116 thousand, or 2.83%, compared to the year ended December 31, 2019 for the Predecessor. 

  

Interest expense

 

Interest expense was $112 thousand for the period March 28, 2020 through December 31, 2020 (Successor) and zero for the period from January 1, 2020 through March 31, 2020 (Predecessor), compared to zero for the year ended December 31, 2019 (Predecessor).  On a combined basis, interest expense for the Predecessor and Successor was $112 thousand for the year ended December 31, 2020, an increase of $112 thousand compared to the year ended December 31, 2019 for the Predecessor.  The interest was incurred by the successor due to the seller financing notes for the Asset Acquisition.  

 

Gain on Debt Forgiveness

 

Gain on Debt Forgiveness in the amount of $503 thousand was from the successor due to the Paycheck Protection Program which was approved by the Small Business Administration.

    

Net Loss

 

Net Loss was $2.081 million for the period March 28, 2020 through December 31, 2020 (Successor) and $1.632 million for the period from January 1, 2020 through March 31, 2020 (Predecessor), compared to $3.988 million for the year ended December 31, 2019 (Predecessor).  On a combined basis, the net loss for the Predecessor and Successor was $3.713 million for the year ended December 31, 2020, an increase of $275 thousand, compared to $3.988 million net loss for the Predecessor in the year ended December 31, 2019.

 

Management will continue its efforts to attempt to lower operating expenses and increase revenue.  We continue to invest in further expanding our operations and promoting our name and products.  Given the fact that most of the operating expenses are fixed or have a quasi-fixed character, management expects that, as revenue increases, those expenses, as a percentage of revenue, will significantly decrease. Nevertheless, there can be no assurance that we will be able to increase our revenues in future periods.

 

 
25

Table of Contents

 

Comparison of Results of Operations for the three months ended March 31, 2020 (Predecessor) and the period March 28, 2020 (inception) through June 30, 2020 (Successor) are compared to the six months ended June 30, 2021 (Successor)

 

 

 

Predecessor

 

 

Successor

 

 

 

 

 

 

 

 

 

Period from

 

 

Successor

 

 

 

 

 

 

March 28, 2020

 

 

 

 

 

Three

 

 

(inception)

 

 

Six Months

 

 

 

Months Ended

 

 

through

 

 

Ended

 

 

 

March 31,

 

 

June 30,

 

 

June 30,

 

(in thousands)

 

2020

 

 

2020

 

 

2021

 

Revenue

 

$ 1,750

 

 

$ 2,649

 

 

$ 5,260

 

Cost of goods sold

 

 

1,599

 

 

 

2,327

 

 

 

4,823

 

Gross Profit

 

 

151

 

 

 

322

 

 

 

437

 

Selling, general and administrative expenses

 

 

1,480

 

 

 

1,276

 

 

 

2,684

 

Impairment of assets

 

 

 

 

 

 

 

 

 

(Gain) / Loss on sale of assets

 

 

303

 

 

 

 

 

 

 

Loss from operations

 

 

(1,632 )

 

 

(954 )

 

 

(2,247 )

Other income / (expense)

 

 

 

 

 

 

 

 

 

 

 

 

    Interest expense, net

 

 

 

 

 

(49 )

 

 

(100 )

    Total other income / (expense)

 

 

 

 

 

(49 )

 

 

(100 )

Income / (loss) from continuing operations

 

 

(1,632 )

 

 

(1,002 )

 

 

(2,347 )

NET LOSS

 

$ (1,632 )

 

$ (1,002 )

 

$ (2,347 )

 

Revenues

 

Revenues were $1.750 million for the three months ended March 31, 2020 (Predecessor) and $2.649 million for the period March 28, 2020 (inception) through June 30, 2020 (Successor) for a total of $4.399 million, compared to $5.260 million for the six months ended June 30, 2021 (Successor).  Revenues for the Successor increased of $861 thousand, or 19.57%, compared to the combined basis for the Predecessor and Successor for the six months ended June 30, 2020.  This represents growth from new accounts, growth from our existing customers taking in additional product lines due to the increased demand from consumers due to the impact of COVID-19 and overall category growth.

 

Cost of goods sold

 

Cost of goods sold were $1.599 million for the three months ended March 31, 2020 (Predecessor) and $2.327 million for the period March 28, 2020 (inception) through June 30, 2020 (Successor) for a total of $3.926 million, compared to $4.823 million for the six months ended June 30, 2020 (Successor).  Cost of goods sold for the Successor increased $897 thousand for the six months ended June 30, 2021, or 22.85%, compared to the combined basis for the Predecessor and Successor for the six months ended June 30, 2020.

 

The increase in cost of goods sold was primarily due to the raw material costs in the amount of $1.126 million, on a combined basis, to fulfill the orders placed by our customers and additional costs incurred due to additional supply chain pressure caused by COVID-19.  The increase in labor for both production to produce the products and in house delivery costs to get the products to market amounted to $43 thousand, on a combined basis.  This increase was offset by a decrease in the cost of freight to get the products to market, of $165 thousand on a combined basis, because our own employees are delivering our products instead of us incurring this cost from third-party carriers.

  

 
26

Table of Contents

 

Gross margin

 

Gross margin was $151 thousand or 8.64% of sales for the period three months ended March 31, 2020 (Predecessor) and $322 thousand or 12.16% of sales for the period March 28, 2020 (inception) through June 30, 2020 (Successor), compared to $437 thousand or 8.31% of sales for the six months ended June 30, 2021.  Gross margin for the Successor was $437 thousand or 8.31% of sales for the six months ended June 30, 2021, a decrease of $36 thousand, or 7.61%, compared to the combined basis for the Predecessor and Successor for the six months ended June 30, 2020, while gross margin as a percentage of sales declined by 2.44%.  Our margins decreased due to the increased costs incurred to fulfill the demand by our customers as a result of COVID-19 for our products which we were able to produce and deliver while beginning to leverage a small part of our operating efficiencies.

  

Selling, general and administrative

 

Selling, general and administrative expenses were $1.480 million for the three months ended March 31, 2020 (Predecessor) and $1.276 million for the period from March 28, 2020 (inception) through June 31, 2020 (Successor), compared to $2.684 million for the six months ended June 30, 2021 (Successor).  Selling, general and administrative expenses for the Successor were $2.684 million for the six months ended June 30, 2021, a decrease of $72 thousand, or 2.61%, compared to the combined basis for the Predecessor and Successor for the six months ended June 30, 2020.  Bad debt expense is attributable to the predecessor company for reserves established of approximately $176 thousand; commission expense, on a combined basis, increased by approximately $37 thousand due to brokers we retained to help increase revenue; employee benefits, on a combined basis, increased by approximately $111 thousand due to the higher rates paid for workmen’s compensation insurance due to the changes in our experience rating ; and other professional fees, on a combined basis, decreased by approximately $61 thousand for outside contractors retained to establish better operating efficiencies.  Salaries, on a combined basis, decreased by approximately $221 thousand due the reduced headcount while deploying automation in the production facility; legal expense, on a combined basis, increased by approximately $52 thousand.

  

Loss on sale of assets

 

Loss on the sale of assets was approximately $303 thousand from the predecessor company recorded for the sale of the assets to the successor company.

 

Loss from operations

 

Loss from operations were $1.632 million for the three months ended March 31, 2020 (Predecessor) and $954 thousand for the period March 28, 2020 (inception) through June 30, 2020 (Successor), compared to $2.247 million for the year six months ended June 30, 2021 (Successor).  Loss from operations for the Successor were $2.247 million for the six months ended June 30, 2021, a decrease of $339 thousand, or 13.11%, compared to the combined basis of the Predecessor and Successor of $2.586 million for the six months ended June 30, 2020. 

  

Interest expense

 

Interest expense was zero for the three months ended March 31, 2020 (Predecessor) and $34 thousand for the period March 28, 2020 through June 30, 2020 (Successor), compared to $99 thousand for the six months ended June 30, 2021 (Successor). On a combined basis, interest expense for the Predecessor and Successor was $49 thousand for the six months ended June 30, 2020. There was an increase for the Successor of $51 thousand for the six months ended June 30, 2021. The interest was incurred by the successor due to the seller financing notes for the Asset Acquisition as well as other working capital loans.

 

Net Loss

 

Net Loss was $1.632 million for the three months ended March 31, 2020 (Predecessor) and $1.002 million for the period March 28, 2020 through June 30, 2020 (Successor), compared to $2.347 million for the six months ended June 30, 2021 (Successor).  On a combined basis, the net loss for the Predecessor and Successor was $2.634 million for the six months ended June 30, 2020, a decrease for the Successor of $287 thousand for the six months ended June 30, 2021.

 

Management will continue its efforts to attempt to lower operating expenses and increase revenue.  We continue to invest in further expanding our operations and promoting our name and products.  Given the fact that most of the operating expenses are fixed or have a quasi-fixed character, management expects that, as revenue increases, those expenses, as a percentage of revenue, will significantly decrease. Nevertheless, there can be no assurance that we will be able to increase our revenues in future periods.

 

 
27

Table of Contents

 

Non-GAAP Financial Measures

 

In addition to our results determined in accordance with GAAP, we believe certain measures are useful in evaluating our operating performance. These measures constitute non-GAAP measures. These non-GAAP measures are used by management in making operating decisions, allocating financial resources, and internal planning and forecasting, and for business strategy purposes. Non-GAAP financial measures have inherent limitations and are not uniformly utilized by issuers. Therefore, these non-GAAP financial measures should not be considered in isolation, or as a substitute for comparable measures prepared in accordance with GAAP. A reconciliation is provided below for each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP.

 

Adjusted EBITDA and Adjusted EBITDA Margin

 

Management believes that Adjusted EBITDA and Adjusted EBITDA Margin, non-GAAP measures, are strong indicators of our overall operating performance and are useful to management and investors as measures of comparative operating performance from period to period. We define Adjusted EBITDA as net income before interest, taxes, depreciation, and amortization, and as further adjusted for loss on extinguishment of debt, share-based compensation, transaction and acquisition-related charges, integration and restructuring charges, and other non-cash charges. We exclude the impact of share-based compensation because it is a non-cash expense and we believe that excluding this item provides meaningful supplemental information regarding performance and ongoing cash generation potential. We exclude loss on extinguishment of debt, transaction and acquisition related charges, integration and restructuring charges, and other charges because such expenses are episodic in nature and have no direct correlation to the cost of operating our business on an ongoing basis. We define Adjusted EBITDA Margin as Adjusted EBITDA divided by total revenues.

 

Adjusted EBITDA was $(3.479) million for the year ended December 31, 2019 (Predecessor) and represented an Adjusted EBITDA Margin of (62)%. Adjusted EBITDA was $(1.182) million for the period from January 1, 2020 through March 31, 2020 (Predecessor) and represented an Adjusted EBITDA Margin of (68)%.  Adjusted EBITDA was $(1.402) million for the period from March 28, 2020 through December 31, 2020 (Successor) and represented an Adjusted EBITDA Margin of (18)%. On a combined basis, Adjusted EBITDA for the Predecessor and Successor was $(2.584) million for the year ended December 31, 2020 and represented an Adjusted EBITDA Margin of (27)%.  

 

Growth in Adjusted EBITDA was driven primarily from revenue growth attributed to new and existing customers offset by the contraction of margin due to supply chain issues during COVID-19 pandemic.

 

The following table presents the reconciliation of Adjusted EBITDA and Adjusted EBITDA margin to the comparable GAAP measures for the last two fiscal years.

 

 

 

Predecessor

 

 

Successor

 

 

 

 

 

 

Period from

 

 

Period from

 

 

 

 

 

 

January 1,

 

 

March 28, 2020

 

 

 

 

 

2020

 

 

(inception)

 

 

 

Year Ended

 

 

through

 

 

through

 

 

 

December 31,

 

 

March 31,

 

 

December 31,

 

(in thousands)

 

2019

 

 

2020

 

 

2020

 

Net Loss

 

$ (3,988 )

 

$ (1,632 )

 

$ (2,081 )

Interest expense, net

 

 

 

 

 

 

 

 

112

 

Depreciation and amortization

 

 

543

 

 

 

147

 

 

 

567

 

Impairment of assets

 

 

(34 )

 

 

 

 

 

 

(Gain) / Loss on sale of assets

 

 

 

 

 

303

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$ (3,479 )

 

$ (1,182 )

 

$ (1,402 )

 

 
28

Table of Contents

 

 

 

Predecessor

 

 

Successor

 

 

 

 

 

 

 

 

 

Period from

 

 

 

 

 

 

Period from

 

 

March 28, 2020

 

 

 

 

 

January 1, 2020

 

 

(inception)

 

 

 

Year Ended

 

 

through

 

 

through

 

 

 

December 31,

 

 

March 31,

 

 

December 31,

 

(in thousands)

 

2019

 

 

2020

 

 

2020

 

Adjusted EBITDA

 

$ (3,479 )

 

$ (1,182 )

 

$ (1,402 )

Total Revenues

 

 

5,634

 

 

 

1,750

 

 

 

7,691

 

Adjusted EBITDA Margin

 

$ -62 %

 

$ -68 %

 

$ -18 %

 

Adjusted EBITDA was $(1.182) million for the three months ended March 31, 2020 (Predecessor) and represented an Adjusted EBITDA Margin of (68)%. Adjusted EBITDA was $(765) thousand for the period from March 28, 2020 (inception) through June 30, 2020 (Successor) and represented an Adjusted EBITDA Margin of (29)%. On a combined basis, Adjusted EBITDA for the Predecessor and Successor was $(1.947) million for the period from January 1, 2020 through June 30, 2020 and represented an Adjusted EBITDA Margin of (44)%. Adjusted EBITDA was $(1.863) million for the six months ended June 30, 2021 represented an Adjusted EBITDA Margin of (35)%.

 

Growth in Adjusted EBITDA was driven primarily from revenue growth attributed to new and existing customers offset by the contraction of margin due to supply chain issues during COVID-19 pandemic.

 

The following table presents the reconciliation of Adjusted EBITDA and Adjusted EBITDA margin to the comparable GAAP measures for the six-month periods.

 

 

 

Predecessor

 

 

Successor

 

 

 

 

 

 

 

 

 

Period from

 

 

Successor

 

 

 

 

 

 

March 28, 2020

 

 

 

 

 

 

 Three

 

 

(inception)

 

 

Six Months

 

 

 

Months Ended

 

 

through

 

 

Ended

 

 

 

March 31,

 

 

June 30,

 

 

June 30,

 

(in thousands)

 

2020

 

 

2020

 

 

2021

 

Net Loss

 

$ (1,632 )

 

$ (1,002 )

 

$ (2,347 )

Interest expense, net

 

 

 

 

 

49

 

 

 

100

 

Depreciation and amortization

 

 

147

 

 

 

188

 

 

 

384

 

(Gain) / Loss on sale of assets

 

 

303

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$ (1,182 )

 

$ (765 )

 

$ (1,863 )

 

 
29

Table of Contents

 

 

 

Predecessor

 

 

Successor

 

 

 

 

 

 

 

Period from

 

 

Successor

 

 

 

 

 

March 28, 2020

 

 

 

 

 

 Three

 

 

(inception)

 

 

Six Months

 

 

 

Months Ended

 

 

through

 

 

Ended

 

 

 

March 31,

 

 

June 30,

 

 

June 30,

 

(in thousands)

 

2020

 

 

2020

 

 

2021

 

Adjusted EBITDA

 

$ (1,182 )

 

$ (765 )

 

$ (1,863 )

Total Revenues

 

 

1,750

 

 

 

2,649

 

 

 

5,260

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA Margin

 

 

-68 %

 

 

-29 %

 

 

-35 %

 

Liquidity and Capital Resources

 

Going Concern Considerations

 

We have incurred significant losses since our inception. We have experienced net losses of approximately $2.081 million for the period March 28, 2020 (inception) through December 31, 2020 and $2.345 million in the six months ended June 30, 2021. We expect our capital expenses and operational expenses, to increase in the future due to expected increased sales and marketing expenses, operational costs, and general and administrative costs and, therefore, our operating losses will continue or even increase at least through the near term.

 

Our financial statements have been prepared on a “going concern” basis, which implies we may not continue to meet our obligations and continue our operations for the next twelve months. The report of our independent registered public accounting firm that accompanies our audited consolidated financial statements contains a going concern qualification in which such firm expressed substantial doubt about our ability to continue as a going concern. Our consolidated financial statements do not include any adjustments that might result if we are unable to continue as a going concern. If we are unable to continue as a going concern, holders of our securities might lose their entire investment. Although we plan to attempt to raise additional capital through one or more private placements or public offerings, the doubts raised relating to our ability to continue as a going concern may make our shares an unattractive investment for potential investors. These factors, among others, may make it difficult to raise any additional capital and may cause us to be unable to continue to operate our business.

 

There is no assurance that we will ever be profitable or that debt or equity financing will be available to us in the amounts, on terms, and at times deemed acceptable to us, if at all. The issuance of additional equity or equity-linked securities by us would result in significant dilution in the equity interests of our current stockholders. Obtaining commercial loans, assuming those loans would be available, would increase our liabilities and future cash commitments. If we are unable to obtain financing in the amounts and on terms deemed acceptable to us, we may be unable to continue our business as planned and as a result may be required to scale back or cease operations, which could cause our stockholders to lose some or all of their investment in us. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should we be unable to continue as a going concern.

  

Liquidity

 

The Company’s primary liquidity requirements are for working capital, continued investments in capital expenditures, and other strategic investments. Income taxes are currently not a significant use of funds but after the benefits of our net operating loss carryforwards are fully recognized, could become a material use of funds, depending on our future profitability and future tax rates. The Company’s liquidity needs are met primarily through cash flows from operations, as well as funds available under our term loan borrowings and related party loans. Our cash flows from operations include cash received from customers, less cash costs to provide services to our customers, which includes general and administrative costs and interest payments.

 

As of December 31, 2020, we had $5 thousand in cash and cash equivalents, respectively, available.  As of June 30, 2021, we had $15 thousand in cash and cash equivalents, respectively, available.  As of December 31, 2020, we had $3.884 million of total debt outstanding. As of June 30, 2021, we had $4.821 million of total debt outstanding.  We believe our cash on hand, together with the proceeds of this offering, amounts available under our factoring facility, related party loans and cash provided by (used in) operating activities are and will continue to be adequate to meet our operational and business needs in the next twelve months. To the extent additional funds are necessary to meet our long-term liquidity needs as we continue to execute our business strategy, we anticipate that they will be obtained through the incurrence of additional indebtedness, additional equity financings or a combination of these potential sources of funds.  In the event that we need access to additional cash, we may not be able to access the credit markets on commercially acceptable terms or at all. Our ability to fund future operating expenses and capital expenditures and our ability to meet future debt service obligations or refinance our indebtedness will depend on our future operating performance, which will be affected by general economic, financial and other factors beyond our control, including those described under “Risk Factors.”

 

Long-Term Debt

 

Secured Promissory Note

 

On March 30, 2020, the Company issued a promissory note to Sament Capital Investments, Inc. (“Sament”), an affiliate of Terra Tech for $3,000,000 in connection with the acquisition of the Predecessor’s assets. The Note accrues interest at a rate of 3.5% per annum on a 360-day year basis and matures March 30, 2025. In addition, we granted a second secured promissory note to Sament as of June 3, 2020 for $653,870, which accrues interest at a rate of 3.5% until June 3, 2023 (together with the note due March 30, 2025, the “Sament Notes”). The Sament Notes are secured by all of the assets purchased in connection with the Asset Acquisition. Sament also currently owns 20.0% of our outstanding common stock.

  

 
30

Table of Contents

 

Small Business Administration (“SBA”) Loans

 

On June 22, 2020, the Company entered into a U.S. Small Business Administration Loan Authorization and Agreement pursuant to which the Company received loan proceeds of $150,000 (the “SBA Loan”). The SBA Loan was made under, and is subject to the terms and conditions of, the Economic Injury Disaster Loan Program, which was a program expanded for COVID-19 relief under the CARES Act and is administered by the U.S. Small Business Administration. The term of the SBA Loan is thirty (30) years with a maturity date of June 22, 2050 and the annual interest rate of the SBA Loan is a fixed rate of 3.75%. Under the terms of the CARES Act, the use of loan proceeds for the SBA Loan is limited to alleviating economic injury caused by the COVID-19 pandemic.

 

SAFE Agreements

 

During the year ended December 31, 2020, the Company entered into Simple Agreements for Future Equity (“SAFEs”) with investors in a series of transactions exempt from registration under the Securities Act pursuant to Regulation Crowdfunding (the “Crowdfunding offering”).

 

Upon a future equity financing of greater than $1,000,000 (not including our initial public offering), the SAFE securities are convertible at the option of the Company into securities identical to those issued in the future equity financing (“Shadow Securities”), except (1) they do not have the right to vote except as required by law, (2) they must vote in accordance with the majority of the investors in such future equity financing with respect to any such required vote and (3) they are not entitled to any inspection or information rights. If the Company elects to convert the securities upon the closing of a future equity financing, the investors will receive the number of Shadow Securities equal to the greater the quotient obtained by dividing the amount the investor paid (the “Purchase Amount”) for the securities by:

 

(a) the quotient of $18,500,000 divided by the aggregate number of issued and outstanding shares of capital stock, assuming full conversion or exercise of all convertible and exercisable securities then outstanding, including shares of convertible preferred stock and all outstanding vested or unvested options or warrants to purchase capital stock, but excluding (i) the issuance of all shares of capital stock reserved and available for future issuance under any of the Company’s existing equity incentive plans, (ii) convertible promissory notes issued by the Company, (iii) any SAFEs, and (iv) any equity securities that are issuable upon conversion of any outstanding convertible promissory notes or SAFEs, or

 

(b) the lowest price per share of the securities sold in such future equity financing.

 

The price (either (a) or (b)) determined above shall be deemed the “First Financing Price” and may be used to establish the conversion price of the securities at a later date, even if the Company does not choose to convert the SAFE securities upon the first future equity financing.

 

Upon our initial public offering of common stock or a change of control (a “Liquidity Event”) prior to any equity financing, the SAFE holders will receive, at the option of the holder, either (i) a cash payment equal to the purchase amount or (ii) a number of shares of common stock of the Company equal to the purchase amount divided by the quotient of (a) $18,500,000 divided by (b) the number, as of immediately prior to the Liquidity Event, of shares of the Company’s capital stock (on an as-converted basis) outstanding, assuming exercise or conversion of all outstanding, vested and unvested options, warrants and other convertible securities, but excluding (i) shares of common stock reserved and available for future grant under any equity incentive or similar plan; (ii) any SAFEs; and (iii) convertible promissory notes.

 

In the case of a Liquidity Event following any equity financing, the investors will receive, at the option of the investors, either (i) a cash payment equal to the Purchase Amount, or (ii) a number of shares of the most recently issued preferred stock equal to the Purchase Amount divided by the First Financing Price. Shares of preferred stock granted in connection shall have the same liquidation rights and preferences as the shares of preferred stock issued in connection with the Company’s most recent Equity Financing.

 

During the year ended December 31, 2020, the Company raised a total of $40 thousand in the Crowdfunding offering, which was made through Open Deal Portal LLC (the “Intermediary”), and a total of approximately $538 thousand. The Intermediary was entitled to receive a 6% commission fee and 2% of the securities issued in connection with the offering, which was closed subsequent to year-end.

 

 
31

Table of Contents

 

Related Party Loans

 

During 2020, the Company borrowed $32,000 from James E. Kras, the Company’s Chief Executive Officer and Director. The funds borrowed were utilized to fund ongoing operations and do not accrue interest.

 

During 2020, the Company borrowed $25,000 from Jeanne Ciccone, a close relative of James E. Kras. The funds borrowed were utilized to fund ongoing operations and do not accrue interest.

 

During 2020, the Company borrowed $25,000 from Michael James, the Company’s Chief Financial Officer and Director, of which $2,500 remained outstanding as of December 31, 2020. The funds borrowed were utilized to fund ongoing operations and do not accrue interest.

 

See “Certain Relationships and Related Party Transactions” for a summary of the convertible notes the Company has issued to Messrs. Kras and James in order to fund ongoing operations.

 

Vehicle Loan

 

On May 26, 2020, the Company entered into a financing agreement for the purchase of a vehicle. The loan, which accrues interest at a rate of 17.51%, matures on April 26, 2024. The loan is secured by the vehicle purchased.

 

Factoring Facility

 

On March 30, 2021, the Company entered into an accounts receivable purchasing agreement with Quasar Capital Partners, LLC (the “factoring facility”) pursuant to which the Company agreed to provide Quasar with the right to purchase the Company’s accounts receivable at book value less a discount. The Company’s Chief Financial Officer personally guaranteed the amounts payable under the factoring facility. On October 7, 2021, the Company repaid the amounts due under the factoring facility and the guarantee was released.

 

Evergreen Note

 

On October 7, 2021, we issued a 15% original issue discount secured promissory note to Evergreen. The Evergreen Note matures on July 7, 2022 and incurs interest at a rate of 5.0% per annum. The Evergreen Note is secured and subordinated to the Sament Notes. Evergreen may elect to convert the Evergreen Note into shares of common stock at a conversion price of $1.53 per share. If the Evergreen Note is not converted into shares of common stock prior to the closing of this offering, we intend to repay the amount due under the Evergreen Note with some of the proceeds of this offering. We have the option to issue up to $1.0 million in additional notes and warrants to Evergreen before January 10, 2022.

  

Cash Flow Analysis

 

Comparison of Cash Flows for the Period from March 28, 2020 through December 31, 2020 (Successor) and for the Period from January 1, 2020 through March 31, 2020 (Predecessor) compared to the Year ended December 31, 2019 (Predecessor).

 

The following table is a summary of our cash flow activity for the periods presented:

 

 

 

Predecessor

 

 

Successor

 

 

 

 

 

 

 

Period from

 

 

 

 

 

Period from

 

 

March 28, 2020

 

 

 

 

 

 

January 1, 2020

 

 

(inception)

 

 

 

Year Ended

 

 

through

 

 

through

 

 

 

December 31,

 

 

March 31,

 

 

December 31,

 

(in thousands)

 

2019

 

 

2020

 

 

2020

 

Net cash provided by (used in) operating activities

 

$ (3,519 )

 

$ (676 )

 

$ (1,351 )

Net cash provided by (used in) investing activities

 

$ (207 )

 

$ (79 )

 

$ (48 )

Net cash provided by (used in) financing activities

 

$ 3,714

 

 

$ 750

 

 

$ 1,404

 

 

Cash Flows from Operating Activities

 

For the period from March 28, 2020 through December 31, 2020 (Successor), the period from January 1, 2020 through March 31, 2020 (Predecessor), and for the year ended December 31, 2019 (Predecessor), net cash provided by (used in) operating activities was $(1.351) million, $(676) thousand, and $(3.519) million, respectively.  The cash flows used by operating activities were driven primarily by working capital needs offset by revenue growth from existing customers and new customers.

 

Cash Flows from Investing Activities

 

For the period from March 30, 2020 through December 31, 2020 (Successor), the period from January 1, 2020 through March 31, 2020 (Predecessor), and for the year ended December 31, 2019 (Predecessor), net cash used in investing activities was $(48) thousand, $(79) thousand, and $(207) thousand, respectively. Investing cash flows are driven primarily by capitalized purchases of property and equipment.

 

 
32

Table of Contents

 

Cash Flows from Financing Activities

 

For the period from March 28, 2020 through December 31, 2020 (Successor), the period from January 1, 2020 through March 31, 2020 (Predecessor), and for the year ended December 31, 2019 (Predecessor), net cash provided by financing activities was $1.404 million, $750 thousand and $3.714 million, respectively. Net cash provided by financing activities for the period from March 28, 2020 through December 31, 2020 (Successor) was driven by proceeds of debt issued.  For the January 1, 2020 through March 31, 2020 (Predecessor), and for the year ended December 31, 2019 (Predecessor), net cash provided was for contributions from the parent company.

 

Comparison of Cash Flows for the three months ended March 31, 2020 (Predecessor) and the period March 28, 2020 (inception) through June 30, 2020 (Successor) are compared to the six months ended June 30, 2021 (Successor)

 

The following table is a summary of our cash flow activity for the periods presented:

 

 

 

Predecessor

 

 

Successor

 

 

Successor

 

 

 

 

 

Period from

 

 

 

 

 

 

 

 

March 28, 2020

 

 

 

 

 

 

Three Months

Ended

 

 

(inception)

through

 

 

Six Months

Ended

 

 

 

March 31,

2020

 

 

June 30,

2020

 

 

June 30,

2021

 

Net cash provided by (used in) operating activities

 

$ (676 )

 

$ (1,089 )

 

$ (899 )

Net cash provided by (used in) investing activities

 

$ (79 )

 

$ (28 )

 

$ 284

 

Net cash provided by (used in) financing activities

 

$ 750

 

 

$ 1,316

 

 

$ 936

 

 

Cash Flows from Operating Activities

 

For the three months ended March 31, 2020 (Predecessor), the period from March 28, 2020 (inception) through June 30, 2020 (Successor), and the six months ended June 30, 2021 (Successor), net cash provided by (used in) operating activities was $(676) thousand, $(1.089) million, and $(899) thousand, respectively.  The cash flows used by operating activities were driven primarily by working capital needs offset by revenue growth from existing customers and new customers.

 

Cash Flows from Investing Activities

 

For the three months ended March 31, 2020 (Predecessor), the period from March 28, 2020 (inception) through June 30, 2020 (Successor), and the six months ended June 30, 2021 (Successor), net cash used in investing activities was $(79) thousand, $(28) thousand, and $284 thousand, respectively. Investing cash flows are driven primarily by capitalized purchases of property and equipment.

 

Cash Flows from Financing Activities

 

For the three months ended March 31, 2020 (Predecessor), the period from March 28, 2020 (inception) through June 30, 2020 (Successor), and the six months ended June 30, 2021 (Successor), net cash provided by financing activities was $750 thousand, $1.316 million and $936 thousand, respectively. For the three months ended March 31, 2020 (Predecessor), net cash provided was for contributions from the parent company.  Net cash provided by financing activities for the period from March 28, 2020 (inception) through June 30, 2020 (Successor) and the six months ended June 30, 2021 (Successor) were driven by proceeds of debt issued. 

 

Off Balance Sheet Arrangements

 

There were no material off-balance sheet arrangements as of December 31, 2020 or June 30, 2021.

 

 
33

Table of Contents

  

Critical Accounting Policies and Estimates

 

The preparation of the consolidated financial statements in conformity with GAAP requires management to use judgment in making estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. The following accounting policies are based on, among other things, judgments and assumptions made by management that include inherent risks and uncertainties. Management’s estimates are based on historical experience, the relevant information available at the end of each period, and their judgment. Although management believes the judgment applied in preparing estimates is reasonable based on circumstances and information known at the time, actual results could differ materially from these estimates under different assumptions or market conditions.

 

The most significant accounting estimates involve a high degree of judgment or complexity. Management believes the estimates and judgments most critical to the preparation of our consolidated financial statements and to the understanding of our reported financial results are described below.

 

Revenue Recognition

 

Revenues are recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company does not offer returns, discounts, loyalty programs or other sales incentive programs that are material to revenue recognition. Payments from our customers are due upon delivery or within a short period after delivery.

 

Property, Equipment and Leasehold Improvements

 

Property, equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Our fixed assets, which are comprised of leasehold improvements, equipment and vehicles, have useful lives of five years.  Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations.

 

The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property, equipment and leasehold improvements may not be recoverable in accordance with the provisions of ASC 360, “Property, Plant, and Equipment.” When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets.

 

Intangible Assets

 

Intangible assets continue to be subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment,” intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of December 31, 2020, Edible Garden held one intangible asset related to a non-compete agreement, which has a useful life of two years.  The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life.  Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall, or an adverse action or assessment by a regulator. If an impairment indicator exists, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities.  If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified.

 

 
34

Table of Contents

  

Income Taxes

 

The provision for income taxes is determined in accordance with ASC 740, “Income Taxes.” The Company files a consolidated United States federal income tax return.  The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expense are expected to be settled in our income tax return.  Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes.  At December 31, 2020 and 2019, such net operating losses were offset entirely by a valuation allowance.

 

The Company recognizes uncertain tax positions based on a benefit recognition model.  Provided that the tax position is deemed more likely than not of being sustained, the Company recognizes the largest amount of tax benefit that is greater than 50.0% likely of being ultimately realized upon settlement. The tax position is derecognized when it is no longer more likely than not of being sustained. The Company classifies income tax related interest and penalties as interest expense and selling, general and administrative expense, respectively, on the consolidated statements of operations.

 

Recent Accounting Pronouncements

 

See Note 2 of the consolidated financial statements included in this prospectus for information about recent accounting pronouncements.

 

Internal Controls and Procedures

 

We are not currently required to comply with the SEC’s rules implementing Section 404 of the Sarbanes-Oxley Act and are therefore not required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. Upon becoming a public company, we will be required to comply with the SEC’s rules implementing Section 302 of the Sarbanes Oxley Act, which will require our management to certify financial and other information in our quarterly and annual reports and provide an annual management report on the effectiveness of our internal control over financial reporting. Though we will be required to disclose material changes made to our internal controls and procedures on a quarterly basis, we will not be required to make our first annual assessment of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act until the year following our first annual report required to be filed with the SEC. We will not be required to have our independent registered public accounting firm attest to the effectiveness of our internal control over financial reporting until our first annual report subsequent to our ceasing to be an “emerging growth company.”

 

 
35

Table of Contents

 

BUSINESS

  

Overview

 

Edible Garden is a next generation controlled environment agriculture (“CEA”) farming company. We use traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. We use the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces. In our hydroponic greenhouse, we grow plants without soil. Instead of planting one row of lettuce in the ground, by using a vertical greenhouse, we can grow many towers of lettuce in the same area by planting up instead of planting across. Growing these products sustainably means that we avoid depleting natural resources in order to maintain an ecological balance, such as by renewing, reusing and recycling materials in order to lower the overall one-time use of materials.

   

Our controlled greenhouse facilities allow us to grow consistent quality herbs and lettuces year-round, first by eliminating some of the variability of outdoor farming with our CEA techniques, and second by leveraging our proprietary software, GreenThumb. In addition to using hydroponic and vertical greenhouse systems, we use a “closed loop” system in our greenhouses. Generally, in a “closed loop” system, drain water is recollected and reused for irrigation. In our closed loop system, we also cycle water back into the system that has been collected through reverse osmosis. When compared to conventional agriculture, our closed looped systems and hydroponic methods use less land, less energy and less water (than legacy farms), thus conserving some of the planet’s limited natural resources. Our advanced systems are also designed to help mitigate contamination from harmful pathogens, including salmonella, e-coli and others.

 

We have also developed patented software called GreenThumb that assists in tracking plants through our supply chain. Utilizing our GreenThumb software to track the status of our plants as they grow and move throughout the greenhouse allows us to add a layer of quality control due to the frequent monitoring of the growing process, leading to improved traceability. In this context, traceability means being able to track a plant through all stages of production and distribution. In addition to improving traceability, GreenThumb helps us better manage the day-to-day operations of our business. GreenThumb is a web-based greenhouse management and demand planning system that does the following:

 

 

·

integrates in real-time with our cloud business software suite for monitoring daily sales data;

 

·

generates reports by category, product, customer, and farm to allow us to analyze sales, trends, margins and retail shrink (spoiled product);

 

·

provides dynamic pallet mapping for packout, which enables us to more efficiently ship our products;

 

·

utilizes a proprietary algorithm that uses year-over-year and trending sales data to develop customer specific and aggregate product specific forecasting for our greenhouses;

 

·

aggregates all greenhouse activity input to provide real-time inventory and availability reports of all products in our greenhouses;

 

·

manages our online ordering system with user controlled product availability based upon greenhouse inventory;

 

·

provides a route management system for coordinating the logistics of our direct store delivery program; and

 

·

tracks all production activities at greenhouses, including sowing, spacing, dumping, spraying, picking and packing, using hand held devices.

  

We also use our GreenThumb software to help monitor the quality of our products, and we have dedicated quality assurance and quality control personnel that check and monitor our products. We have customer service personnel that answer any questions the consumers of our products may have, and we regularly ask for feedback from our customers on the quality of our products. The combination of the GreenThumb software, quality assurance and control processes (including compliance with food safety standards), and feedback from consumers and purchasers holds us accountable for maintaining the quality of our herbs and lettuce.

 

We focus our efforts on producing our herbs and vegetables in a sustainable manner that will reduce consumption of natural resources, by recycling water in our closed loop system and using LED lights instead of conventional lightbulbs to accelerate crop growth and yield, when necessary. In addition, the inventory management component of GreenThumb allows us to manage inventory levels, order quantities and fill rates while maximizing truck loads. This means that we are better able to control shipping our products in full truck loads, thus eliminating multiple deliveries and decreasing the excess emission of greenhouse gases that would result from many partially full trucks delivering our products. Together, these elements of our production and distribution process are intended to reduce our carbon footprint, or the total amount of greenhouse gases that are generated by our actions, as compared to a legacy farm business.

 

We believe our focus on our brand “Edible Garden” is a significant differentiator. The brand not only lends itself to our current portfolio of products but allows us to develop other products in the “Consumer Brands” category. Our focus on sustainability, traceability, and social contribution, which we define as an ongoing effort to improve employee relations, working conditions, and local communities, presents our value proposition to our customers and supermarket partners and distributors. 

  

 

 
36

Table of Contents

  

We believe that Edible Garden’s state-of-the-art facilities comply with food safety and handling standards.

 

 We have food safety certifications from Primus, a GFSI certification program, the USDA for organic products, and some of our products are verified as non-GMO by the non-GMO Project. We are licensed under PACA to operate our business. We voluntarily comply with the HACCP principles established by the FDA.

 

Primus annually audits our growing process and entire food safety management system to ensure that our process and products meet the standards established by the GFSI. We value this certification because our customers require purchasing products from producers who are GFSI certified. When we undergo the GFSI audit, Primus audits the following:

 

 

·

standard operating procedures and their documentation;

 

·

food safety testing (biological hazards) by an ISO 17025 accredited lab;

 

·

water testing by an ISO 17025 accredited lab;

 

·

quality control processes;

 

·

personnel health, hygiene and safety;

 

·

sanitation programs;

 

·

mock recalls/products on-hold process;

 

·

internal auditing system for organic, GFSI, non-GMO and HACCP certifications and verifications;

 

·

records retention;

 

·

food defense/food fraud;

 

·

supplier approval program;

 

·

pest management program; and

 

·

visual inspection of growing and packing processes.

  

To maintain our USDA Organic certification, we must submit:

 

 

·

our farm and handling plans annually;

 

·

to an annual inspection and audit of our greenhouse and how we handle aspects of our business;

 

·

to review of our organic documentation and records retention; and

 

·

to review and testing of our water usage and irrigation systems, harvest and post-harvest processing, and supplier monitoring and control.

  

In addition, we must:

 

 

·

use Organic Materials Review Institute (“OMRI”)-approved inputs, such as fertilizer, pesticides, disease management and media;

 

·

use organic in-house seedling production;

 

·

use organic pest management practices;

 

·

use organic crop management techniques;

 

·

perform nutritional deficiencies testing;

 

·

perform microbiological water testing;

 

·

conserve natural resources and promote biodiversity; and

 

·

maintain organic integrity (prevent conventional crops from contaminating organic crops).

  

 
37

Table of Contents

 

Some of our products are verified as non-GMO by the non-GMO Project. To have a product verified by the non-GMO Project, we submit to an annual review process of the relevant products. We must source seeds and cuts from reputable and safe suppliers, not use bio-engineered products or ingredients during the growing process, and not include bio-engineered ingredients or products in the final goods sold to customers.

 

To maintain our PACA license, we submit to an annual review of our business, including our history and principles, to ensure we are meeting our contractual obligations under the law. This includes abiding by fair trading practices, meeting our contractual agreements and specifications, promptly paying all contracts, and maintaining trust assets.

 

The HACCP principles require that we submit to USDA audits annually. We must also identify the various chemical, physical, and biological hazards that exist in crop production and manage and control those hazards so that they do not contaminate our products or packaging. We must also implement and document critical control points, and implement and document corrective actions taken when those critical control points do not adequately control a hazard.

 

We intend to use our approach to expand in key strategic markets across the country while supporting our existing operations. Our priority in the near term is to strengthen our existing business in part with the proceeds from this offering. We have a history of operating losses since inception and expect to incur additional near-term losses. As discussed further in “Management’s Discussion and Analysis — Liquidity and Capital Resources,” our auditors have issued an opinion that there is a substantial doubt about our ability to continue as a going concern if we are unable to complete this offering. However, we are pursuing this offering because we believe that we have the potential to take advantage of strategic growth opportunities. Our model of growing local produce near high population density centers and being able to provide fresh produce to our existing supermarket partners, who have a wider network than us, is intended to create organic growth in our business through those existing relationships. If we complete this offering, we intend to use part of the proceeds to either build or acquire greenhouses near population centers and distribution centers to be able to grow more produce close to where it is in demand and to deepen our relationships with regional and national supermarkets. Our model allows us to reduce transportation food miles, reduce fuel costs, and lower emissions related to food transportation.

  

It is our strong belief that the power of our brand together with the quality, innovative packaging and traceability of our products allow all of our customers to associate Edible Garden with locally grown and sustainably sourced packaged herbs and vegetables. Our tag line “Simply Local, Simply Fresh” is intended to describe our business plan: growing herbs and lettuce in local farms in the regional communities where our customers sell our products so that the products stay fresher for longer. We believe this strategy allows us to drive local grass roots brand awareness while we grow our business to support our plan to become a national brand.

 

 
38

Table of Contents

 

We currently offer 31 stock keeping units “SKU’s” and expect to further cross sell products across our supermarket partners to meet their demand. These products include:

  

 

·

10 types of individually potted, live herbs;

 

·

10 types of cut single-herb clamshells;

 

·

2 specialty herb items;

 

·

6 different types of lettuce;

 

·

hydro basil;

 

·

bulk basil; and

 

·

vegan protein powder.

    

 
39

Table of Contents

  

 

 

 

   

These products are currently sold at over 4000 supermarket stores and food distributors across the Northeast, Midwest and Mid-Atlantic regions of the country. Some of the supermarkets that sell our products include Walmart, Target, Meijer, and Wakefern Food Corporation/ShopRite.

  

 
40

Table of Contents

 

We also service a large number of food distributors. This market segment allows us greater penetration with smaller local and regional supermarkets and the food services business.

 

Since inception, a few of our customers constituted a majority of our total revenue. For example, during the six months ended June 30, 2021, we earned approximately 58% of our revenue from two customers, and we earned approximately 34% of our revenue from one customer in the period from our inception through December 31, 2020. While we value our strong relationship with these major customers, we face the risk of losing a significant source of revenue if our major customers do not continue to purchase our products. If that were to occur and we were unable to replace the revenue by selling our products to additional customers, our ability to earn revenue would be significantly negatively impacted. Part of our growth strategy is to reduce this customer concentration by expanding our production capacity, which would allow us to sell our products to more supermarket partners.

 

We  sell products to our customers on a purchase order basis, with no spend or purchase commitments, in the ordinary course of business. We and our customers enter into purchase orders on a daily basis. To date, no purchase order has exceeded 2.0% of our revenue for the particular quarter in which the products were delivered to the customer.

 

Our Zero-Waste Inspired™ packaging innovations leverage the latest technology to reduce plastics, extend the shelf life of our products, and reduce retail shrink - all leading to a reduced carbon footprint by reducing waste. Our packaging features bio-based (sugar cane) sleeves. Using this material, we are able to reduce our use of plastic in our business. Generally, retail shrink is a loss of inventory. For our supermarket customers, one source of this shrinkage is spoiled product, such as herbs that have been in packaging for so long that they become poor quality. We use herb bags that have micro-perforations that allow ethylene gas to escape from the product packaging. Ethylene gas accelerates spoilage of herbs and lettuce. By allowing this gas to escape, we are able to extend the shelf life of the product while reducing the likelihood that our customers experience retail shrink because they have to throw our products in the garbage. Using this technology, cilantro, for example, is in good quality after 11 days, while it would be in poor quality after seven days in other packaging. The CO2 laser perforation on our packaging creates well-defined holes which allow for a controllable and consistent environment in the bag, while other typical bagged herbs are perforated with a cold needle, which produce inconsistent holes and, therefore, an uncontrollable atmosphere. Less product spoilage means less waste, and less shrinkage means that we will not have to produce as many lettuce and herbs to achieve the same level of retail sales. Altogether, we should be able to produce less carbon and minimize the size of our carbon footprint by using these packaging innovations.

  

Impact of COVID-19

 

The COVID-19 pandemic and resulting worldwide economic conditions have affected, and may continue to affect, our business, financial condition and results of operations. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. For example, government imposed mandatory closures and restrictions across various key markets of ours resulted in volatile supply and demand conditions, primarily due to reduced demand in the food service distribution channel. As a result, product in the industry was redirected to the retail channel and in some cases this led to an increased supply and lower pricing. While demand in our retail channels for certain products has increased due to the impact of COVID-19, there is no guarantee that this increased demand will continue. While these effects were pronounced to varying degrees throughout fiscal year 2020, the future extent of the impact of the COVID-19 pandemic on our financial performance, including our ability to execute our strategic initiatives, is still uncertain and will depend on future developments, including the duration and spread of the pandemic, related government restrictions and the success of vaccines and other treatments for COVID-19. Additionally, as the global economic impacts of COVID-19 continue, fluctuate and/or change, the pandemic’s impact on our operating results may change or be prolonged.

 

In addition, our ability to continue to supply our products is highly dependent on our workforce, including our workers involved in the growing, harvesting, transportation, processing and distribution of our products. Our ability to maintain the safety of our workforce may be significantly impacted by individuals contracting or being exposed to COVID-19, and our operations and financial results may be negatively affected as a result. We are following the requirements of governmental authorities and taking additional preventative and protective measures to ensure the safety of our workforce, we cannot be certain that these measures will be successful in ensuring the health of our workforce. Workforce disruptions related to COVID-19 may significantly impact our ability to maintain our operations and may adversely affect our financial results. Throughout the pandemic governments have restricted travel and transportation generally, and while these restrictions have not significantly impacted our ability to supply our products to date, there is no guarantee that future restrictions will not have a significant impact on our business. We also incurred costs in relation to safety precautions undertaken in our shipping operations and there can be no assurances that we would not be required to incur such costs or similar costs in the future.

 

The impact of the COVID-19 pandemic on our operating results can also impact our ability to meet our financial obligations. Our operating results have been and may continue to be impacted by the pandemic, and we cannot predict whether future developments associated with the COVID-19 pandemic will materially adversely affect our long-term liquidity position. In the event of a continued sustained market deterioration or further delayed recovery, we may need additional liquidity which would require us to evaluate available alternative strategies such as seeking additional debt or equity capital, which may be unsuccessful.

 

Production and Properties

 

We utilize prime greenhouse locations in the Northeast, Midwest and Mid-Atlantic regions of the country allowing us to provide local fresh and organic products to these local communities. Our locally grown and delivered products using a network of sustainable greenhouse farms provide local communities, retailers and consumers the quality they demand with the food safety they expect. The communities, retailers and consumers benefit from this as this allows us to get our products to market in the shortest time without compromising the plant’s quality and nutritional value. The growing locations are chosen to be near key trucking lanes within hours of major cities to cut down on “food miles” and fuel costs. We believe our strategy enhances our products’ appeal to major consumer constituencies that desire products grown and delivered locally.

  

Consistent year round growing that adheres to our stringent sustainability protocols occurs in our owned and contracted greenhouse locations in California, Florida, Indiana, New Jersey, New York, Michigan, Ohio and Wisconsin, that can service approximately 55% of the country’s population. We develop long term contract growing relationships that require our herbs and produce to be grown in strict accordance with our proprietary grow process, but have no formal long-term contracts with these growers.  Our growing relationships require our produce to be grown in accordance with our proprietary growing process and to our specifications. Orders are placed with the contract growers based on purchase orders we receive from our customers and the proximity of the contract grower to the specific customer.  The contract grower determines the quantity sown based on the minimum purchase orders received and the contract grower bears the inventory risk, risk of loss and other cost if it over sows the specific crop. We take title of the produce after inspection has been made in accordance with the specifications agreed to by both parties.  Our 5 acre flagship greenhouse location in Belvidere, NJ, in conjunction with over 1 million square feet of contracted greenhouse growers, enables us to use standardized methods and a suite of proprietary technology innovations to operate these hydroponic greenhouses in order to provide supply chain excellence in delivering our fresh produce.

  

Our locations and capacity include:

 

Location

 

Growing capacity 

 

 

Belvidere, New Jersey

 

5 acres

 

Operated by Edible Garden

Half Moon Bay, California

 

55 acres

 

Contract grower

Hillard, Florida

 

2 acres

 

Contract grower

Francesville, Indiana

 

3 acres

 

Contract grower

Grand Rapids, Michigan

 

6 acres

 

Contract grower

Berlin, New York

 

3 acres

 

Contract grower

Cleveland, Ohio

 

3 acres

 

Contract grower

Hixton, Wisconsin

 

3 acres

 

Contract grower

 

Our 5 acre flagship facility in Belvidere, New Jersey began commercial operations in 2015. Our facility incorporates a hydroponic gutter system developed in Holland for the exclusive production of herbs. The flagship facility also includes a cold storage freezer which allows us to package herbs for our distribution partners and a 20,000 sq. ft packhouse, which is under construction. We are currently party to an ongoing arrangement with our predecessor company, Edible Garden Corp., whereby we make lease payments of approximately $15,300 per month to the lessor of the land on which our flagship facility is built and for which our predecessor company is the lessee. We do not have a lease in place directly with the lessor of the property that gives us the right to operate the property, although we have been operating under this arrangement with the lessor for more than one year and do not expect to lose access to the property.

  

 
41

Table of Contents

 

 

As of June 30, 2021, we had 39 full-time employees and four part-time employees located in or around Belvidere, New Jersey.

 

We source the raw materials for production from multiple suppliers, including Ball Horticulture, Brandt Box and Paper, PPC Flexible Packing, Sumit Plastics, Sun Gro Horticulture, Sunshine FPC, and expect that those supplies will continue to be available for our use.

 

Distribution

 

Edible Garden utilizes advanced, sustainable, environmentally controlled indoor agriculture to grow and process organic herbs and lettuces. Through our extensive distribution platform and proprietary predictive modeling, we pick, pack and ship to big box retailer’s distribution centers in our network. We distribute our products through more than 50 retail partners including national big box retailers, regional grocery stores, distributors, restaurants and local purveyors.

  

Our growing and distribution plans are designed to get our locally grown products to our retail partners and consumers immediately after harvest. We want to make sure that our products arrive as fresh, undegraded and nutrient rich as when they were harvested. In order for us to meet this objective we strive to deliver our products to market in no less than 24 hours from when they are picked. We currently rely on our own fleet of nine delivery vehicles, as well as other independent shipping operators. We continue to build a broader footprint and intend to increase our logistics and shipping fleet to include more energy efficient vehicles that will use less fuel and leave less waste in our environment. Our greenhouse farms have to be strategically located in order for us to deliver on this objective.

  

We hold our transportation-related assets and manage the distribution of our products through our wholly-owned subsidiary, EG Transportation, LLC.  This entity owns and leases the delivery vehicles we use to distribute products and holds the liability insurance needed for the transportation aspects of our business. As of October 22, 2021, we have nine delivery vehicles and approximately eight drivers.

  

Competition

 

The U.S. fruits and vegetable markets are highly competitive. Our main competitors are Aero Farms, Gotham Greens, Bright Farms, Bowery Farms, Plenty. Many of these companies may have significantly greater financial, technical, marketing and distribution resources, as well as greater experience in the industry than we have. Our services may not be competitive with their services. In addition, our current and potential competitors may establish cooperative relationships with larger companies, to gain access to greater development or marketing resources. Competition may result in price reductions, reduced gross margins and loss of market share. However, we believe the following elements will give us a competitive advantage in the rapidly growing CEA category:

 

 
42

Table of Contents

 

Customer Relationships and Brand. Our herbs and lettuce product portfolio is sold through our supermarket partners including Walmart, Target, Meijer, Wakefern Food Corporation/ShopRite and food distributors. These key partners make up the majority of our revenue. We believe that we will continue capture more opportunities with these partners as we expand our business and product offering. We also utilize an efficient marketing mix of social media, in-store signage and premium shelf positioning to drive consumer awareness and reinforce purchases.

  

Value Proposition. We are repositioning the way food is grown, packaged and distributed. We believe this is the next generation of farming that is good for people and our planet. We believe scaling our grow operations in a fully controlled environment will result in a higher optimization on yields together with freshness, taste and texture. In addition, our proposition focuses on intelligent common-sense approach to growing more with less resources. Our Zero Waste Inspired approach is in everything we do – from innovative recyclable packaging across our product portfolio and enterprise, using less water, electricity and land, zero pesticides and less road miles. Simply Local Simply Fresh delivers all of this together with our local farming partners with an accessible, traceable, organic product at a competitive price.

 

Technology Platform. Technology and data are competitive differentiators for Edible Garden. Rather than relying on “off-the-shelf” systems, we have created a data-driven technology platform to power traceability and integration across plant production, operations, data analytics and demand planning. Our proprietary platform allows us to consistently monitor and control plant production inputs across our flagship facility as well as integrate with all of our contract growers. This allows us to scale throughput with disruption and capture data analytics for better yield and predictability.

 

Management Team. Our management team has worked together for 6 years. Jim Kras, our CEO and Mike James, our CFO, have a strong working relationship and work collaboratively to advance our growth. We believe that they bring strong senior leadership in their respective roles and responsibilities and have been instrumental in our success to date, including growing our business during a pandemic. The unprecedented COVID-19 pandemic continues to challenge business and the economy.  In these uncertain times having a team that has worked together for many years can provide mature leadership and support to the organization at critical moments. Our management team is committed to developing young talent in our business and are committed to continue this employee development as the organization continues to grow.

 

Industry Overview

 

Traditional Outdoor Agriculture. The traditional agriculture industry in the United States consists primarily of field crop farms. According to the USDA, the United States had almost 900 million acres of farmland in 2019. Over the last few decades this acreage has shifted and consolidated to larger and larger farms. Today, large-scale family farms make up just 3 percent of farms in the United States and 42 percent of overall production. Production of produce is also regionalized. The American Farm Bureau Foundation reports that Monterey County in California, home of Salinas Valley, supplies 61% of all leaf lettuce and 56% of head lettuce in the United States.

 

This regional dependency contributes to long, complex distribution chains, with some produce traveling thousands of miles over several days before reaching store shelves. With the environmental and social macrotrends mentioned herein, we believe traditional field farming is also less prepared to support a growing world population, due to its reliance on large amounts of land and water, both of which are becoming scarcer and less available for food production. We also believe consumer trends continue to want to know where their food comes from together with traceability and food safety (food pathogens – listeria and salmonella) are becoming more important to all business partners and consumers.

 

 
43

Table of Contents

 

Traditional Greenhouse Operators and Controlled Environment Agriculture. CEA has gained market share in recent decades as an alternative source of food production. This consists of both greenhouse operating companies and more high-tech greenhouses selling to retailers and grocery stores throughout the country. Despite growth in select crops, greenhouses have not been able to take meaningful market share from traditional field farms in the United States or in the leafy greens market until now. This is a function of shifting consumer trends together with the realization that the planet has finite natural resources. Overall consumer behavior is shifting away from commoditized produce as they associate consumer branded produce as sustainable, safe, organic, pesticide free all year long that is good for them and the social fabric of our planet. That’s why we believe as a market innovator we can continue to capture market share and brand awareness.

  

   

Growth Strategy

 

We are at an important point as we are operating at commercially viable scale and ready for the next level of growth with additional greenhouses and capabilities. Our business plan is to develop, own and operate commercial greenhouses across North America. Presently and in the near term our greenhouse operations will continue to grow herbs and lettuces. Currently, herb production is grown at our flagship facility in Belvidere with an additional contract grower in Indiana. We expect to scale our business by building a portfolio of new, fully scaled commercial greenhouses across the Northeast, Midwest, Mid-Atlantic, South and Southwest. We plan to locate farms with easy access to distribution centers and major population demographic centers and to sell products into established supermarkets partners and distributors. We expect these full-scale commercial greenhouses to have more production capacity than our current facility and to benefit from economies of scale.

 

Site selection for future facilities is based on a detailed methodology that weighs factors we believe to be indicative of farm unit economics, operational reliability and market accessibility, among other criteria. Examples include customer access and market depth within a 300-mile radius. The availability, reliability and cost of electricity; construction costs, speed to build, site infrastructure and permitting; local labor are further inputs to our selection process.

 

Intellectual Property

 

We rely on a combination of trademark laws, trade secrets, confidentiality provisions, and other contractual provisions to protect our proprietary rights, which are primarily our inventions, brand names, marks, and proprietary pods and seeds. Edible Garden owns trademarks, three pending patent applications, and one issued patent in the United States. The issued patent includes claims related to greenhouse management software and systems (GreenThumb) and is expected to remain in force until November 2040, provided that all required maintenance fees are paid. One of the three pending patent applications is a recently filed continuation patent application related to greenhouse management software and systems. The two remaining patent applications are related to automatically watering display stands for herbs and other vegetation.

  

 
44

Table of Contents

 

Research and Product Development

 

Edible Garden recognizes the consumer acceptance and growth opportunities associated with plant-based derivatives of the products/plants it currently grows. As a leader in sustainability, research and development is a key focus for us moving forward. We have recently started shipping a new product category with plant based nutraceuticals, a derivative in the plant category. This new product will extend our product suite with major retailers in plant-based proteins under the Vitamin Way brand.  We intend to further develop expertise in plant science and horticulture coupled with brand equity in the “plant based” sector. We believe this will lead us to effectively develop and market proprietary industrial ingredients and consumer packaged goods. By unlocking the Company’s capabilities for multiple product lines, we believe significant revenue opportunities are available across a wide spectrum of ancillary markets.

 

Our Sustainability Plan — Renew, Reuse, Recycle & Innovate

 

We adhere to an Environmental, Social, and Governance (“ESG”) criteria and set of standards for our operations that is socially conscious. Our Environmental criteria considers how our company performs as a steward of nature. The Social criteria examines how we manage relationships with employees, suppliers, customers, and the communities where we operate. Our Governance deals with the company’s leadership, executive pay, audits, internal controls and shareholder rights. 

 

Environment: We operate our CEA greenhouse facilities with the goal of being a good steward of nature. With our closed loop systems, we recapture and recycle water into our growing process. We are harmful pesticide-free in our flagship facility as well as all contracted grow facilities. In vertical greenhouses, we are able to grow more herbs and lettuce per square foot than legacy farms. Our GreenThumb software allows us to be more efficient in our packing and shipping process with the goal of reducing excess emission of greenhouse gases and carbon that would result from more trucks transporting our products. Our Zero-Waste Inspired™ packaging innovations are intended to reduce food spoilage and food waste while utilizing bio-based materials, leading to a reduction of plastics in our packaging. In the future, we intend for our greenhouses to take advantage of areas with renewable energy alternatives such as solar, wind, and hydro together with suppliers that support greenhouse gas-free electricity generation, when available. We plan to continue to deliver innovation in our packaging and potting, further eliminating plastics from our products with recycled, biodegradable packaging. We intend to migrate to alternative fuel vehicles for our shipping needs. We commit to be carbon neutral by 2030, meaning that any carbon dioxide released into the atmosphere from our business activities will be balanced by an equivalent amount being removed.

 

Social – Employees: Being local and producing year-round not only allows for competitive produce prices and the opportunity for more consumers to access high quality produce, it also allows our facilities to offer full time, indoor jobs to members of the community, offsetting the seasonal work offered by more traditional agriculture businesses. We are also committed to paying at a living wage, hiring locally, and promoting internally by investing in internal and community training programs to train employees with a skill set that will allow them to be part of the 21st-century workforce in the next generation of farming. To accompany the rapidly expanding workforce demands of our industry we are committed to work with all of our employees to help us understand any issues and to develop and enhance our indoor agriculture training and internal development opportunities.

 

Social – Community: We will prioritize underserved communities whether urban or rural where our facilities are located. As a company we will continue to develop our corporate mission of giving back to these communities. Charitable contributions to food banks, school systems, community anti-hunger and social reintegration programs are all part of giving back to these communities. For example, we partner with Abilities of Northwest Jersey Inc. to offer skills training in hydroponics and greenhouse farming at our Belvidere, New Jersey, greenhouse for individuals with disabilities, and we were named the Employer of the Year for 2020 by Abilities of Northwest Jersey. These initiatives aim to provide better economic and social results for these underserved communities.  Our strategy will be to partner with both local, state and federal programs to help identify investment zones or redevelopment areas that would benefit from one of our greenhouse facilities in their community because of the expected local economic development and employment that would be associated with a new facility. We expect that each of our facilities will employ approximately 35-40 employees in these communities. We plan to consider underserved communities in all our future site selection process.

 

Governance: Edible Garden looks at diversity as a competitive advantage and strives to be fully supportive of diversity endeavors at all levels of the company. This alignment and focus will aid us in steering our long-term corporate actions in the right direction. Our goal is to build diversity across the whole enterprise with specific focus on the management team and board of directors. We plan on establishing a diversity committee with employees and members of our management team that will have complete oversight of these fundamental areas in conjunction with our nominating and governance committee.  In addition, we intend to meet the governance requirements of Nasdaq after this offering is complete and to establish a robust system of corporate governance.

  

 
45

Table of Contents

 

Regulatory Compliance

 

As a producer and distributor of food products, we are subject to the laws and regulations in the jurisdictions where our facilities are located and where are products are distributed. In particular we are subject to the FSM Act, which is enforced by the FDA. The FDA has the authority to regulate the growing, harvesting manufacture, including composition and ingredients, processing, labeling, packaging import, distribution and marketing and safety of food in the United States. The FSM Act significantly enhances the FDA's authority over various aspects of food regulation. For example, the FSM Act granted the FDA mandatory recall authority when the FDA determines there is a reasonable probability that a food is adulterated or misbranded and that the use of, or exposure to, the food will cause serious adverse health consequences or death to humans or animals. While the FDA has been active in implementing the requirements of the FSM Act through issuance of regulations designed to result in a reduction of the risk of contamination in food manufacturing, the full impact of the FSM Act is not yet known, and we cannot assure you that it will not materially impact our business. Regulatory agencies in other jurisdictions have similar authority to address the risk of contamination or adulteration, and to require that contaminated products be removed from the market. The failure to comply with these laws and regulations in any jurisdiction, or to obtain required approvals, could result in a ban or temporary suspension on the production of our products or limit or bar their distribution, and affect our development of new products, and thus could materially adversely affect our business and operating results. In addition, the USDA regulates the import and export of certain fruits and vegetables into and from the United States, and the USDA also imposes growing, manufacturing and certification requirements for certain products labeled with organic claims. Failure to obtain necessary permits or otherwise comply with USDA regulations and requirements could result in a ban or temporary suspension of our ability to grow, manufacture or market our products as organic, and thus could materially adversely affect our business.

 

Legal Proceedings

 

From time to time, we may be party to or otherwise involved in legal proceedings arising in the ordinary course of business. Management does not believe that there is any pending or threatened proceeding against us, which, if determined adversely, would have a material adverse effect on our business, results of operations or financial condition.

 

Corporate History and Structure

 

Our business is a successor business of a subsidiary of Terra Tech Corp. (now known as Unrivaled Brands, Inc.)(“Terra Tech”). Unrivaled Brands (OTCQX:UNRV) is a cannabis multi-state operator and the parent company of multiple cannabis brands spanning consumer products, cultivation, distribution, and retail. We purchased substantially all of the assets of Edible Garden Corp., a subsidiary of Terra Tech, from Terra Tech as of March 30, 2020 for approximately $3.0 million, which did not include the purchase of any cannabis assets. To finance the asset purchase, we issued a secured promissory note of $3.0 million to Sament, an affiliate of Terra Tech, which accrues interest at a rate of 3.5% per annum until March 30, 2025. In addition, we granted a second secured promissory note to Sament as of June 3, 2020 for $653,870, which accrues interest at a rate of 3.5% until June 3, 2023. These Sament Notes are secured by the tangible greenhouse assets at our corporate headquarters and any proceeds thereof. Also in connection with the asset purchase, we issued two options to Sament. These options were exercised as of October 8, 2021 for 5.0 million shares of common stock at an aggregate exercise price of $2.00 and are no longer outstanding, as further described below in “Description of Securities.” As a result of this exercise, Sament currently owns 20.0% of our outstanding common stock.

 

Our company was incorporated on March 28, 2020 in the State of Wyoming as Edible Garden Inc. We subsequently changed our name to Edible Garden AG Incorporated on July 20, 2020, and we effected a stock split of 20 for 1 as of October 14, 2020. Effective July 7, 2021, our parent company, Edible Garden Holdings Inc., merged with and into us with us as the surviving entity. We converted into a Delaware corporation effective July 12, 2021. On September 8, 2021, we effected an additional forward stock split of 20 for 1. We have one wholly-owned subsidiary, EG Transportation, LLC, through which we manage the distribution of our products. Our current corporate structure is as shown below:

   

 

Our principal address is 283 County Road 519, Belvidere, NJ 07823. Our telephone number is (908) 750-3953. We maintain a website at www.ediblegarden.com. The information contained on our website is not, and should not be interpreted to be, incorporated into this prospectus. The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

 

MANAGEMENT

 

The following table sets forth certain information about our executive officers, key employees, directors, and director nominees as of the date of this prospectus.

 

Name

 

Age

 

Position

James E. Kras

 

52

 

Chief Executive Officer, President and Director

Michael James

 

63

 

Chief Financial Officer, Treasurer, Secretary and Director

Mathew McConnell

 

62

 

Director nominee

Tracy A. Nazzaro

 

52

 

Director nominee

Ryan Rogers

 

40

 

Director nominee

 

 
46

Table of Contents

 

Executive Officers and Directors

 

James E. Kras. Mr. Kras is one of our founders, and has served as Chief Executive Officer and a director since our inception in March 2020. Mr. Kras served as President and Chief Marketing Officer of Edible Garden Corp., a wholly-owned subsidiary of Unrivaled Brands (formerly Terra Tech), from March 2016 to March 2020. Prior to that service, Mr. Kras held senior leadership positions in marketing at global leaders Ajinomoto and The Bountiful Company (formerly The Nature’s Bounty Company). Mr. Kras started his career on Madison Avenue in advertising with companies including Grey Advertising and Dentsu/Carat. As our Chief Executive Officer and one of our founders, Mr. Kras brings to the Board of Directors extensive knowledge of our products, structure, and culture as well as years of expertise in the industry.

 

Michael James. Mr. James is one of our founders, and has served as Chief Financial Officer and a director since our inception in March 2020. Mr. James also currently serves on the board of directors of Guided Therapeutics, Inc. as chairman, audit committee chair and as a member of the compensation committee. Mr. James previously served as Chief Financial Officer of Unrivaled Brands, Inc. (formerly Terra Tech) from February 2012 to March 2020. In addition to this role, Mr. James served as the Chief Executive Officer and Chief Financial Officer of Inergetics, Inc. from June 2012 until January 2016. Previously, Mr. James served as Chief Executive Officer of Nestor, Inc. (“Nestor”), where he successfully completed a financial restructuring of Nestor prior to its sale in September 2009 from the Receiver’s Estate in Superior Court of the State of Rhode Island. He also served on Nestor’s Board of Directors from 2006 to 2009. Mr. James was the Managing Partner of Kuekenhof Capital Management, LLC, a private investment management company, from 1999 to 2015. During his career, Mr. James has served as a Partner at Moore Capital Management, Inc., a premiere private investment management company; Chief Financial and Administrative Officer at Buffalo Partners, L.P., a private investment management company; and Treasurer and Chief Financial Officer of National Discount Brokers. Mr. James began his career in 1980 as a staff accountant with Eisner, LLP. Mr. James is a retired CPA. As our Chief Financial Officer and one of our founders, Mr. James brings to the Board of Directors extensive knowledge of our products, structure, and culture as well as years of expertise in the industry.

 

Director Nominees

 

Mathew McConnell. Mr. McConnell has served as Chief Executive Officer of Marco Polo Securities, Inc.’s MPS Chaperone and Distribution business since March 2020. In this position, he oversees international equities, trading, and capital markets processes for this U.S. broker-dealer offering cross-border regulatory and distribution solutions to a robust network of local securities firms across the world. From 2018 to 2020, Mr. McConnell served as Managing Director, Head of Equity Capital Markets of Tellimer (Exotix Capital), including as a member of its U.S. executive committee. Prior to Tellimer, Mr. McConnell was Head of Capital Markets at Auerbach Grayson from 2014 to 2018. Mr. McConnell was chosen to serve as a director because of his extensive international financial and capital markets experience, which we believe will continue to be important as we implement our growth strategy.

 

Tracy A. Nazzaro.  Ms. Nazzaro is presently the President, Chief Financial Officer and General Manager for Traders Hill Farm, an innovative aquaponics greenhouse farming operation in Hilliard, Florida, that produces specialty leafy greens and tilapia year-round. She joined Traders Hill Farm as Chief Financial Officer in late 2015. Prior to joining Traders Hill Farm, Ms. Nazzaro was a certified business analyst with the University of North Florida SBDC where she provided strategic advisory and financial consulting services to businesses in Northeast Florida. Ms. Nazzaro is also the Executive Director of the RWB Foundation, Inc., a non-profit organization providing financial assistance and operating guidance to small agriculture businesses in Florida. Ms. Nazzaro was chosen to serve as a director because of her extensive experience in our industry and her experience in growing agricultural businesses.

 

Ryan Rogers. Mr. Rogers has spent nearly two decades working in the food retail industry in various merchandising, sales and sourcing positions. Since June 2021, he has served as a brand manager for FDM Sales, a brand development organization helping accelerate growth for food and beverage brands. Prior to joining FDM Sales, Mr. Roger spent 18 years at Target Corp, where he held merchandising and sourcing roles of increasing responsibility within its food division, including produce buyer, where he led the growth strategy for packaged salads, vegetarian, and healthy snacking. Mr. Rogers was chosen to serve as a director because of his extensive experience in our industry and his ability to help organizations like ours accelerate growth.

 

 
47

Table of Contents

 

Key Employees

 

Scott Prendergast. Mr. Prendergast has served as our Chief Data Officer since June 2020. Prior to joining Edible Garden, Mr. Prendergast served as VP of Technology for Springbok Energy Partners and Director of Digital Strategy & Analytics for Moroch Partners. Some of Mr. Prendergast’s accomplishments include designing and developing real time well tracking and management portal utilized by Springbok Energy Partners to track well data and optimize mineral right valuations in real time, as well as developing the GreenThumb system that manages real time greenhouse inventory and activities for us and many of our partner farms. Mr. Prendergast started his career after graduating Worcester Polytechnic Institute with a B.S. Aerospace Engineering with a position with Bechtel Corp in the Nuclear Piping Analysis department, working on refueling and NRC compliance at Comanche Peak Nuclear Power Plant and Browns Ferry Nuclear Power Plant.

 

Stacey Eng. Ms. Eng has served as the Vice President of Logistics for us since inception and our predecessor company since March 2016. Ms. Eng previously worked as the Director of Operations for Inergetics, where she was responsible for developing the company’s supply chain and vendor relationships. Ms. Eng’s accomplishments include building an integrated supply chain to service a complex network of owned and contracted greenhouses throughout the United States while constantly streamlining our business. She has continually ensured that all deliverables were met on time for any size project, reduced lead-time for delivery in conjunction with implementing cost-cutting measures that drove gross margin improvements. Ms. Eng holds B.S. in Supply Chain Management & MIS from Rutgers University where she graduated Magna Cum Laude.

 

Nick Simons. Mr. Simons joined our predecessor company in 2019 at the flagship Belvidere facility, where he currently supervises over 40 employees. Mr. Simons immediately impacted our results by overseeing improvements that lead his team to break major milestones in case counts we shipped out. With a passion for sustainability, he strives to have our facilities surpass what was previously thought possible. Prior to joining Edible Garden, Mr. Simons worked for Georgia-Pacific where he oversaw and taught Performance Standard Qualification training to production operators, resulting in a decrease in maintenance personal during the shift by over 35%. He also led the night shift to be the first in Dixie’s 85-year history to produce 4.0 million cases during a 12-hour shift. Mr. Simons is a certified 5S Process Leader, has been trained in FDA, cGMP, ISO, ICH Q7 regulations and standards and is Certified Lean Six Sigma Green Belt. Mr. Simons holds B.A. from DeSales University and earned his MBA from East Stroudsburg University.

 

CORPORATE GOVERNANCE

 

Director Independence

 

Our current Board of Directors consists of James E. Kras and Michael James, neither of whom is considered independent based on the listing standards of Nasdaq. We are not currently listed on a national securities exchange or in an inter-dealer quotation system that requires a majority of the Board be independent. We have nominated Mathew McConnell, Tracy Nazzaro and Ryan Rogers, each of whom is considered independent under the Nasdaq listing standards, for appointment to the Board. We expect that these nominees will commence service on the Board at the time of effectiveness of the registration statement of which this prospectus forms a part. As required under applicable Nasdaq rules, we anticipate that our independent directors will meet in regularly scheduled executive sessions at which only independent directors are present.

 

Committees

 

Our Board intends to establish three standing committees: audit committee; compensation committee; and nominating and governance committee. Each of these committees will consist solely of independent directors. We will adopt written charters for each of these committees that will be available on our website. Our Board may establish other committees as it deems necessary or appropriate from time to time.

 

 
48

Table of Contents

  

Audit Committee

 

The audit committee will be responsible for, among other matters:

 

 

·

appointing, compensating, retaining, evaluating, terminating, and overseeing our independent registered public accounting firm;

 

·

discussing with our independent registered public accounting firm the independence of its members from its management;

 

·

reviewing with our independent registered public accounting firm the scope and results of their audit;

 

·

approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm;

 

·

overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the interim and annual financial statements that we file with the SEC;

 

·

reviewing and monitoring our accounting principles, accounting policies, financial and accounting controls, and compliance with legal and regulatory requirements;

 

·

coordinating the oversight by our board of directors of our code of business conduct and our disclosure controls and procedures;

 

·

establishing procedures for the confidential and/or anonymous submission of concerns regarding accounting, internal controls or auditing matters; and

 

·

reviewing and approving related-person transactions.

  

The Nasdaq rules require us to have one independent audit committee member upon the listing of our common stock, a majority of independent directors within 90 days of the date of this prospectus and all independent audit committee members within one year of the date of this prospectus. Our Board will appoint nominees to serve on the audit committee that meet the definition of “independent director” for purposes of serving on an audit committee under Rule 10A-3 under the Exchange Act and Nasdaq rules. One of these nominees will qualify as an “audit committee financial expert,” as such term is defined in Item 407(d)(5) of Regulation S-K.

 

Compensation Committee

 

The compensation committee will be responsible for, among other matters:

 

 

·

reviewing key employee compensation goals, policies, plans and programs;

 

·

reviewing and approving the compensation of our directors and executive officers;

 

·

reviewing and approving employment agreements and other similar arrangements between us and our executive officers; and

 

·

appointing and overseeing any compensation consultants or advisors.

 

Our Board will appoint nominees to serve on the compensation committee that meet the definition of “independent director” for purposes of serving on a compensation committee under Nasdaq rules.

 

Nominating and Governance Committee

 

The nominating and governance committee will be responsible for assisting the Board in identifying qualified individuals to become directors, in determining the composition of the Board and in monitoring the process to assess Board effectiveness.

 

Board Leadership Structure

 

Our Board of Directors and management believe that the choice of whether the Chair of our Board of Directors should be an executive of the Company, or a non-executive or independent director, depends upon a number of factors, taking into account the candidates for the position and the best interests of the Company and its stockholders. We do not currently have a Board Chair. Upon the effectiveness of this registration statement, we intend to appoint Mr. Kras, our Chief Executive Officer, as the Board Chair. Mr. Kras’s operating and leadership experience as an officer and director of our company since its inception and combined six years of experience with us and our predecessor company make him a compelling choice for Board Chair.

 

We intend to appoint Mr. McConnell as lead independent director when each of our independent directors joins our Board of Directors. The lead independent director will preside over executive sessions of the independent directors and serve as a liaison between the independent directors and our management team.

 

Risk Oversight

 

Our Board will oversee a company-wide approach to risk management. Our Board will determine the appropriate risk level for us generally, assess the specific risks faced by us and review the steps taken by management to manage those risks. While our Board will have ultimate oversight responsibility for the risk management process, its committees will oversee risk in certain specified areas.

 

 
49

Table of Contents

 

Specifically, our compensation committee will be responsible for overseeing the management of risks relating to our executive compensation plans and arrangements, and the incentives created by the compensation awards it administers. Our audit committee will oversee management of enterprise risks and financial risks, as well as potential conflicts of interest. Our Board is responsible for overseeing the management of risks associated with the independence of our board of directors.

 

Compensation Committee Interlocks and Insider Participation

 

None of our officers currently serves, or has served during the last completed fiscal year, on the compensation committee or board of directors of any other entity that has one or more officers serving as a member of our board of directors.

 

Code of Business Conduct and Ethics

 

Our Board intends to adopt a Code of Business Conduct and Ethics that applies to our directors, officers and employees. A copy of this code will be available on our website. We intend to disclose on our website any amendments to the Code of Business Conduct and Ethics and any waivers of the Code of Business Conduct and Ethics that apply to our principal executive officer, principal financial officer, principal accounting officer, controller, or persons performing similar functions.

 

Director and Officer Indemnification Agreements

 

We intend to enter into separate indemnification agreements with our directors and executive officers, in addition to the indemnification provided for in our bylaws. These agreements, among other things, require us to indemnify our directors and executive officers for certain expenses, including attorneys’ fees, judgments, penalties, fines and settlement amounts incurred by a director or executive officer in any action or proceeding arising out of their services as one of our directors or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services at our request. The indemnification agreements and our certificate of incorporation and bylaws require us to indemnify our directors and officers to the fullest extent permitted by Delaware law.

 

 
50

Table of Contents

  

EXECUTIVE AND DIRECTOR COMPENSATION

 

Summary Compensation Table

 

The following table provides information regarding the compensation paid from our inception on March 28, 2020 through December 31, 2020 to each of the executive officers named below, who are collectively referred to as “named executive officers” elsewhere in this prospectus.

 

Name and Principal Position

 

Year

 

Salary

($)

 

Bonus ($)

 

Stock

Awards

($)

 

Option

Awards

($)

 

Non-Equity

Incentive Plan

Compensation

($)

 

Non-qualified

Deferred

Compensation

Earnings

($)

 

All Other

Compensation

($)

 

Total

($)

 

James E. Kras,

 

2020

 

 

137,916

 

 

 

 

 

 

 

 

137,916

 

Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Michael James,

 

2020

 

 

164,449

 

 

 

 

 

 

 

 

164,449

 

Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dennis Rodrigues,(1)

 

2020

 

 

15,000

 

 

 

 

 

 

 

 

15,000

 

Secretary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

____________ 

(1)

Mr. Rodrigues served as our Secretary and a director from our inception until September 10, 2021, when he resigned both positions. His resignation was not as a result of any disagreement with the Company.

 

Employment Agreements

 

We did not have employment agreements with our named executive officers in the year ended December 31, 2020. On August 18, 2021, we entered into employment agreements with Messrs. Kras and James pursuant to which each will serve as Chief Executive Officer and Chief Financial Officer, respectively, for a term of two years. These agreements will automatically renew for one additional one-year period unless we or the executive provides written notice prior to the end of the term. Pursuant to these employment agreements. Messrs. Kras and James are entitled to an annual base salary of $300,000, which amount may be increased by the compensation committee or the Board in their discretion. Each executive is eligible to receive an annual cash performance bonus with a target award amount equal to 100% of his base salary in the year of performance (“Performance Bonus”). This Performance Bonus will be based on performance and achievement of Company goals and objectives as defined by the Board or compensation committee. For the year ending December 31, 2021, no performance goals have been set in advance, and the 2021 Performance Bonus will be awarded at the discretion of the Board, or if formed, the compensation committee. In addition, each executive is entitled to four weeks’ paid time off pursuant to our practices for senior executives, and is entitled to the health, welfare and retirement benefits provided generally to our other employees.

 

Each executive is entitled to a special cash bonus (the “Transaction Bonus”) upon the first to occur of our IPO or the closing of a transaction contemplated by a business combination agreement between us and a special purpose acquisition company that results in the surviving corporation’s securities being listed on a national securities exchange. The Transaction Bonus is equal to $700,000 for each executive.

 

Potential Payments Upon Termination or Change in Control

 

Under the employment agreements for Messrs. Kras and James, if the executive is terminated for cause, resigns without good reason, or his employment ends due to his death or permanent disability, he will be entitled to any earned but unpaid base salary plus accrued benefits earned through the date of termination.

 

Under the employment agreements for Messrs. Kras and James, in the event of an executive’s termination for a reason other than for cause or if an executive terminates voluntarily under one or more of the specified circumstances that constitute a good reason, the executive will receive an amount equal to two times his then-current base salary payable monthly, less any required tax withholdings, plus the pro-rata portion of the Performance Bonus earned during the calendar year of termination, and an aggregate amount equal to 12 times the applicable monthly premium for his group medical, dental and vision coverage. In addition, any stock options held by the executive will accelerate and become fully vested, and any restrictions relating to restricted stock or restricted stock units will lapse and become fully vested.

 

 
51

Table of Contents

 

The executives are subject to non-competition and non-solicitation provisions under their employment agreements effective for the period of time equal to the greater of: (i) the period of time during which the executive is receiving any compensation or benefits from us; or (ii) a period of one year following the executive’s termination of employment. In all cases, the executive’s payments and benefits will be reduced, if necessary, to ensure that the payments and benefits to the executive will not be subject to the “golden parachute” excise tax imposed by Section 4999 of the Internal Revenue Code and the payments will be deductible by us.

 

Outstanding Equity Incentive Awards At Fiscal Year-End

 

There were no stock awards held by our named executive officers as of December 31, 2020.

 

Stock Incentive Plan

 

The Company intends to establish a stock incentive plan prior to the effectiveness of the registration statement of which this prospectus forms a part.

 

Director Compensation

 

Since inception, none of the directors has received any compensation solely for their service as director.

 

After this offering, pursuant to letter agreements we have with our director nominees, we intend to pay our independent directors $150,000 per year, comprised of $75,000 in cash compensation and $75,000 in restricted stock to be granted under the stock incentive plan we plan to approve prior to the effectiveness of this registration statement. We intend for the compensation committee of the Board of Directors, once formed, to determine the future compensation of our independent directors.

  

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

 

The following sets forth a summary of transactions since January 1, 2019, or any currently proposed transaction, in which the Company was to be a participant and the amount involved exceeded or exceeds $120,000 and in which any related person had or will have a direct or indirect material interest.

 

Working Capital Funding from Executive Officers

 

Since inception, we have relied on debt financing from our officers for some of our working capital and, as of October 22, 2021, owe our Chief Financial Officer $619,460 represented by promissory notes. During this period, we have entered into promissory notes, which do not accrue interest, with the following officers on the following dates:

 

Date

 

Payee

 

Original

Amount

 

 

Remaining Amount

 

 

Maturity Date

 

4/28/2020

 

Michael James

 

$ 25,000

 

 

$ 2,500

 

 

Upon Demand

 

11/17/2020

 

James E. Kras

 

$ 5,000

 

 

$ 0

 

 

Upon Demand

 

11/18/2020

 

James E. Kras

 

$ 2,000

 

 

$ 0

 

 

Upon Demand

 

12/11/2020

 

James E. Kras

 

$ 25,000

 

 

$ 0

 

 

Upon Demand

 

 

$25,200 of the aggregate amount of the promissory notes that were issued to Mr. Kras on November 18 and December 11, 2020 were replaced with a convertible note as of July 1, 2021, as shown in the table below.

 

We have entered into the following convertible notes with our officers, which accrue interest at 12% per annum and convert, at the option of the holder in whole or in part, into shares of our common stock by dividing the total principal and interest due under the note by 0.925, subject to adjustment as set forth in the note:

 

Date

 

Holder

 

Amount

 

 

Maturity Date

 

6/22/2021

 

Michael James

 

$ 175,000

 

 

6/21/2022

 

6/23/2021

 

Michael James

 

$ 125,000

 

 

6/22/2022

 

6/29/2021

 

Michael James

 

$ 100,000

 

 

6/28/2022

 

7/1/2021

 

James E. Kras

 

$ 25,200

 

 

6/30/2022

 

7/2/2021

 

Michael James

 

$ 100,000

 

 

7/1/2022

 

7/12/2021

 

Michael James

 

$ 75,000

 

 

7/11/2022

 

7/19/2021

 

Michael James

 

$ 75,000

 

 

7/18/2022

 

7/23/2021

 

Michael James

 

$ 75,000

 

 

7/22/2022

 

7/29/2021

 

Michael James

 

$ 100,000

 

 

7/28/2022

 

8/4/2021

 

Michael James

 

$ 100,000

 

 

8/3/2022

 

8/13/2021

 

Michael James

 

$ 100,000

 

 

8/12/2022

 

8/20/2021

 

Michael James

 

$ 75,000

 

 

8/19/2022

 

8/26/2021

 

Michael James

 

$ 100,000

 

 

8/25/2022

 

 

 
52

Table of Contents

 

The conversion price of the convertible notes is subject to downward adjustment if we issue equity-linked securities with a per share value of less than $0.925 per share.  We may prepay the note if we provide the holder 10 days’ notice, during which time the holder may elect to convert the note into shares of common stock.

 

We have entered into the following promissory notes with Mr. James which accrue interest at 12% per annum and will mature at the earlier of one year after issuance or the closing of this offering:

 

Date

 

Holder

 

Amount

 

9/1/2021

 

Michael James

 

$ 25,000

 

9/3/2021

 

Michael James

 

$ 75,000

 

9/10/2021

 

Michael James

 

$ 100,000

 

9/15/2021

 

Michael James

 

$ 60,000

 

9/17/2021

 

Michael James

 

$ 100,000

 

9/22/2021

 

Michael James

 

$ 90,000

 

9/29/2021

 

Michael James

 

$ 50,000

 

10/1/2021

 

Michael James

 

$ 60,000

 

10/4/2021

 

Michael James

 

$ 50,000

 

 

 We expect to repay the indebtedness to our officers represented by the demand notes and promissory notes with the proceeds of this offering. See “Use of Proceeds.”

 

Sament Notes

 

On March 30, 2020, we issued a secured promissory note to Sament, an affiliate of Terra Tech and currently an owner of 20.0% of our common stock, for $3,000,000 in connection with the acquisition of our predecessor’s assets. This note accrues interest at a rate of 3.5% per annum on a 360-day year basis and matures March 30, 2025. In addition, we granted a second secured promissory note to Sament as of June 3, 2020 for $653,870, which accrues interest at a rate of 3.5% until June 3, 2023 (together with the note due March 30, 2025, the “Sament Notes”). The Sament Notes are secured by all of the assets purchased in connection with the Asset Acquisition. We expect to repay the Sament Notes with the proceeds of this offering. See “Use of Proceeds.”

 

Other Arrangements

 

Mr. James personally guaranteed the amounts payable by the Company under the factoring facility with Quasar Capital Partners, LLC. This guaranty was released when the factoring facility was repaid in October 2021. See "Management's Discussion and Analysis – Liquidity and Capital Resources – Long -Term Debt” for a discussion of the factoring facility.

   

Each of Messrs. Kras and James is also entitled to a Transaction Bonus pursuant to the terms of his employment agreement at the closing of this offering. See “Executive and Director Compensation – Employment Agreements.”

 

Policies and Procedures for Transactions With Related Persons

 

Prior to this offering, we have not had a formal policy regarding approval of transactions with related parties. In connection with this offering, we intend to adopt a written policy that our executive officers, directors, beneficial owners of more than 5% of any class of our capital stock, and any members of the immediate family of any of the foregoing persons (a “related party”) are not permitted to enter into a related party transaction with us without the prior consent of our audit committee. Any request for us to enter into a transaction with a related party in which the related party would have a direct or indirect interest must first be presented to our audit committee for review, consideration, and approval. In approving or rejecting any such proposal, our audit committee will consider the relevant facts and circumstances of the transaction available to it, including, but not limited to, whether the transaction is on terms no less favorable than terms generally available to an unrelated third party or to employees under the same or similar circumstances, and the extent of the related party’s interest in the transaction. The written policy will require that, in determining whether to approve or reject a related person transaction, our audit committee must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our stockholders, as our audit committee determines in good faith.

 

 
53

Table of Contents

  

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The following table sets forth certain information regarding the beneficial ownership of our common stock as of October 22, 2021, and as adjusted to reflect the sale of common stock being offered in this offering by:

  

 

·

each person, or group of affiliated persons, known to us to own beneficially more than 5% of our common stock;

 

·

each of our current directors;

 

·

each of our named executive officers; and

 

·

all of our current directors and executive officers as a group.

  

The information in the following table has been presented in accordance with the rules of the SEC. Under such rules, beneficial ownership of a class of capital stock includes any shares of such class as to which a person, directly or indirectly, has or shares voting power or investment power and also any shares as to which a person has the right to acquire such voting or investment power within 60 days through the exercise of any stock option, warrant or other right. If two or more persons share voting power or investment power with respect to specific securities, each such person is deemed to be the beneficial owner of such securities. Except as we otherwise indicate below and under applicable community property laws, we believe that the beneficial owners of the common stock listed below, based on information they have furnished to us, have sole voting and investment power with respect to the shares shown. Except as otherwise indicated, each stockholder named in the table is assumed to have sole voting and investment power with respect to the number of shares listed opposite the stockholder’s name.

 

The calculations of beneficial ownership in this table are based on (i) 25,000,000 shares of common stock outstanding prior to the offering and (ii)              shares of common stock to be issued in this offering.

 

Name and Address of Beneficial Owner(1)

 

Shares

Beneficially

Owned

 

 

Percentage

Prior to

Offering

 

 

Percentage After This

Offering

 

Executive Officers and Directors:

 

 

 

 

 

 

 

 

 

James E. Kras(2)

 

 

8,900,000

 

 

 

35.6 %

 

%

Michael James(3)

 

 

8,900,000

 

 

 

35.6

 

 

 

 

All directors and executive officers as a group (2 persons)

 

 

17,800,000

 

 

 

71.2 %

 

%

 

 

 

 

 

 

 

 

 

 

 

 

5% shareholders:

 

 

 

 

 

 

 

 

 

 

 

Sament Capital Investments, Inc.(4)

 

 

5,000,000

 

 

 

20.0 %

 

%

Dennis Rodrigues

 

 

2,000,000

 

 

 

8.0 %

 

%

____________

(1)   

Unless otherwise indicated, the address of each individual is c/o Edible Garden AG Incorporated, 283 County Road 519, Belvidere, NJ 07823.

 

 

(2)   

Includes 2,000,000 shares held by an immediate family member.

 

 

(3)   

Includes 2,400,000 shares held by immediate family members.

 

 

(4)

The business address for Sament Capital Investments, Inc. is 3242 S. Halliday St., Suite 202, Santa Ana, CA 92705.

  

DESCRIPTION OF SECURITIES

 

General

 

Our certificate of incorporation authorizes the issuance of up to 200,000,000 shares of common stock, par value $0.0001 per share, and up to 10,000,000 shares of preferred stock, par value $0.0001 per share. As of the date of this prospectus, there were 25,000,000 shares of common stock outstanding, which were held by approximately nine stockholders of record. No shares of preferred stock are outstanding.

  

Common Stock

 

Each holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of the stockholders, including the election of directors. Our certificate of incorporation and bylaws do not provide for cumulative voting rights.

 

 
54

Table of Contents

 

Subject to preferences that may be applicable to any then outstanding preferred stock, the holders of our outstanding shares of common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. In the event of our liquidation, dissolution or winding up, holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock.

 

Holders of our common stock have no preemptive, conversion or subscription rights, and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that are outstanding or that we may designate and issue in the future.

 

Evergreen Note and Warrant

 

On October 7, 2021, we closed on a private placement with Evergreen and raised $1.0 million, which we intend to use to support our working capital requirements. In the private placement, we issued the Evergreen Note to Evergreen at a 15% original issue discount. The Evergreen Note matures on July 7, 2022 and incurs interest at a rate of 5.0% per annum. The Evergreen Note is secured and subordinated to the Sament Notes. Evergreen may elect to convert the Evergreen Note into shares of common stock at a conversion price of $1.53 per share. If the Evergreen Note is not converted into shares of common stock prior to the closing of this offering, we intend to repay the amount due under the Evergreen Note with some of the proceeds of this offering. The Note is subject to a prepayment penalty of 15% of the principal amount to be prepaid until November 30, 2021, 20% after November 30, 2021 until January 1, 2022, and 30% on or after January 1, 2022. If we sell common stock or securities convertible into common stock at a per share price lower than the conversion price of the Evergreen Note while the note is outstanding and prior to the closing of this offering, the conversion price of the note will be reduced to that lower per share price.

 

In the private placement, we also issued the Evergreen Warrant, which Evergreen may exercise for up to 751,623 shares of common stock at an exercise price of $1.53 per share until October 7, 2026. The Evergreen Warrant may be exercised via cashless exercise after April 7, 2022 if there is no effective registration statement registering the resale of the shares underlying the Evergreen Warrant. If we sell common stock or securities convertible into common stock at a per share price lower than the exercise price of the Evergreen Warrant while it is outstanding and prior to the closing of this offering, the exercise price of the Evergreen Warrant will be reduced to that lower per share price.

 

We have the option to issue up to $1.0 million in additional notes and warrants to Evergreen before January 10, 2022. In those subsequent issuances, the conversion price of the note and the exercise price of the warrant would be $4.15 instead of $1.53 per share of common stock.

  

Crowd SAFE (Crowdfunding Simple Agreement for Future Equity)

 

From October 2020 through April 2021, we issued $538 thousand in our Series 2020 Crowd SAFEs in a series of transactions exempt from registration under the Securities Act pursuant to Regulation Crowdfunding. The Crowd SAFEs do not entitle the holder to the rights of our stockholders, such as voting or dividend rights. However, the Crowd SAFE is contractually preferred in the event of our dissolution over the holders of our common stock. The Crowd SAFEs do not give us the right to repurchase the Crowd SAFEs at our option and will not terminate until we achieve a liquidity event. Accordingly, in connection with this offering and at the Crowd SAFE holder’s option, we will either (1) pay the holder an amount in cash equal to the amount the holder invested in the Crowdfunding offering or (2) issue a number of shares of common stock to the holder equal to (a) the amount of their investment divided by (b) $18.5 million divided by 25 million shares (outstanding as of immediately prior to the offering). If the holder does not notify us of its choice, the holder’s SAFE will convert into common stock. If all SAFE holders convert their SAFE into shares of common stock, 726,923 shares of common stock would be issuable to SAFE holders.

  

Sament Options

 

At the time we purchased the assets constituting our business from Terra Tech, we also issued two options to Sament, which is one of our creditors. The first option granted Sament the right to purchase 2,225,000 shares of our common stock. The exercise price to purchase all of the shares underlying this option was $1.00. The second option granted Sament the right to purchase 2,775,000 shares of our common stock at an exercise price of $1.00 for all of the shares underlying the option any time prior to March 30, 2025. Sament exercised both of these options as of October 8, 2021 and neither remains outstanding. 

    

Preferred Stock

 

Our board of directors is authorized, without vote or action by our stockholders, to issue from time to time up to an aggregate of 10,000,000 shares of preferred stock in one or more series and to fix or alter the designations, preferences, rights and any qualifications, limitations or restrictions of the shares of each of these series, including, if applicable, the dividend rights and preferences, conversion rights, voting rights, terms and rights of redemption, including without limitation sinking fund provisions, redemption price or prices, liquidation rights and preferences, and the number of shares constituting any series. The issuance of preferred stock may have the effect of delaying, deferring or preventing a change in control of us without further action by our stockholders and may adversely affect the dividend, liquidation and voting and other rights of the holders of common stock. The issuance of preferred stock with voting and conversion rights may adversely affect the voting power of the holders of common stock, including the loss of voting control to others. We currently have no plans to issue any shares of preferred stock.

 

 
55

Table of Contents

 

We believe that the ability to issue preferred stock without the expense and delay of a special stockholders’ meeting provides us with increased flexibility in structuring possible future financings and acquisitions, and in meeting other corporate needs that might arise. This also permits the board of directors to issue preferred stock containing terms which could impede the completion of a takeover attempt. This could discourage an acquisition attempt or other transaction which stockholders might believe to be in their best interests or in which they might receive a premium for their stock over the then market price of the stock.

 

Transfer Agent

 

We are in the process of engaging a transfer agent for our common stock.

 

Potential Listing

 

We have applied to list our shares of common stock on Nasdaq under the symbol “EDBL.” If our listing application is approved, we expect to list our common stock on Nasdaq upon consummation of the offering. No assurance can be given that our listing application will be approved or that our common stock will be listed on Nasdaq. This offering will occur only if Nasdaq approves the listing of our common stock.

  

SHARES AVAILABLE FOR FUTURE SALE

 

Future sales of substantial amounts of our common stock in the public market could adversely affect prevailing market prices of our common stock from time to time and could impair our future ability to raise equity capital in the future. Furthermore, because only a limited number of shares of our common stock will be available for sale shortly after this offering due to certain contractual and legal restrictions on resale described below, sales of substantial amounts of our common stock in the public market after such restrictions lapse, or the anticipation of such sales, could adversely affect the prevailing market price of our common stock and our ability to raise equity capital in the future.

 

Based upon the number of shares outstanding as of October 22, 2021, upon the closing of this offering, we will have outstanding an aggregate of                     shares of common stock, assuming the conversion of all SAFEs and convertible notes, but no exercise of the underwriters’ over-allotment option. All of the shares sold in this offering by us will be freely tradable without restrictions or further registration under the Securities Act, unless held by our affiliates, as that term is defined under Rule 144 under the Securities Act, or subject to lock-up agreements. The remaining shares of common stock outstanding upon the closing of this offering are restricted securities as defined in Rule 144. Restricted securities may be sold in the U.S. public market only if registered or if they qualify for an exemption from registration, including by reason of Rule 144 under the Securities Act. These remaining shares will generally become available for sale in the public market as follows:

  

 

·

no shares will be eligible for sale in the public market on the date of this prospectus; and

 

·

26,921,832 shares will be eligible for sale in the public market upon expiration of lock-up agreements 181 days after the closing date of this offering, subject in certain circumstances to the volume, manner of sale and other limitations of Rule 144.

 

We may issue shares of common stock from time to time to raise additional funds or as consideration for future acquisitions, investments or other corporate purposes. In the event that any such financing, acquisition, investment or other transaction is significant, the number of shares of common stock that we may issue may in turn be significant. We may also grant registration rights covering those shares of common stock issued in connection with any such transaction.

 

UNDERWRITING

 

We are offering our shares of common stock described in this prospectus through the underwriter named below. Maxim Group LLC, or Maxim, is acting as representative of the underwriter. We have entered into an underwriting agreement with the underwriter. Subject to the terms and conditions of the underwriting agreement, the underwriter has agreed to purchase, and we have agreed to sell to the underwriter, the number of shares of common stock listed next to its name in the following table.

 

 
56

Table of Contents

 

Underwriter

 

Number
of Shares

 

Maxim Group LLC

 

 

 

 

 

 

 

Total

 

 

 

 

 

The underwriting agreement provides that the underwriter must buy all of our shares of common stock being sold in this offering if they buy any of them. However, the underwriter is not required to take or pay for the shares covered by the underwriter’s option to purchase additional shares as described below.

 

 Our shares of common stock are offered subject to a number of conditions, including:

 

 

·

receipt and acceptance of our shares of common stock by the underwriter; and

 

 

 

 

·

the underwriter’s right to reject orders in whole or in part.

  

We have been advised by Maxim that the underwriter intends to make a market in our shares of common stock but that it is not obligated to do so and may discontinue making a market at any time without notice.

 

In connection with this offering, the underwriter or securities dealers may distribute prospectuses electronically.

 

Option to Purchase Additional Common Stock

 

We have granted the underwriter an option to buy up to an aggregate of        additional shares of common stock. The underwriter has 45 days from the date of this prospectus to exercise this option. If the underwriter exercises this option, it will purchase additional shares of common stock approximately in proportion to the amounts specified in the table above.

 

Underwriting Discount

 

Shares sold by the underwriter to the public will initially be offered at the initial offering price set forth on the cover of this prospectus. Any shares sold by the underwriter to securities dealers may be sold at a discount of up to $ ____ per share from the initial public offering price. The underwriter may offer the shares through one or more of their affiliates or selling agents. If all the shares are not sold at the initial public offering price, Maxim may change the offering price and the other selling terms. Upon execution of the underwriting agreement, the underwriter will be obligated to purchase the shares at the prices and upon the terms stated therein.

 

The following table shows the per share and total underwriting discount we will pay to the underwriter assuming both no exercise and full exercise of the underwriter’s option to purchase up to additional shares of common stock.

 

 

 

Per Share

 

 

Total without
Over-Allotment
Option

 

 

Total with
Over-Allotment
Option

 

Public offering price

 

$

 

 

 

$

 

 

 

$

 

 

Underwriting discounts and commissions (7.0%)

 

$

 

 

 

$

 

 

 

$

 

 

Proceeds, before expenses to us

 

$

 

 

 

$

 

 

 

$

 

 

 

We have agreed to pay Maxim’s out-of-pocket accountable expenses, including Maxim’s legal fees, up to a maximum amount of $100,000 if this offering is completed. We have paid $20,000 to Maxim as an advance to be applied towards reasonable out-of-pocket expenses, or the Advance. Any portion of the Advance shall be returned back to us to the extent not actually incurred.

 

We estimate that the total expenses of the offering payable by us, not including the underwriting discount, will be approximately $0.35 million. We have also agreed to reimburse the underwriter for certain expenses incurred by them.

 

 
57

Table of Contents

   

Representative’s Warrants

 

We have also agreed to issue to Maxim (or its permitted assignees) warrants to purchase a number of our shares of common stock equal to an aggregate of 4.0% of the total number of shares of common stock sold in this offering, or the Representative’s Warrants. The Representative’s Warrants will have an exercise price equal to 125% of the offering price of our shares of common stock sold in this offering and may be exercised on a cashless basis. The Representative’s Warrants are exercisable commencing six months after the effective date of the registration statement related to this offering, and will expire five years after the effective date of such registration statement. The Representative’s Warrants are not redeemable by us. We have agreed to a one-time demand registration of our shares of common stock underlying the Representative’s Warrants at our expense and an additional demand registration at the holders’ expense for a period of five years from the effective date of the registration statement related to this offering. The Representative’s Warrants also provide for unlimited “piggyback” registration rights at our expense with respect to the underlying shares of common stock during the five-year period commencing from the effective date of the registration statement related to this offering. The Representative’s Warrants and our shares of common stock underlying the Representative’s Warrants, have been deemed compensation by the Financial Industry Regulatory Authority, or FINRA, and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA. The underwriter (or permitted assignees under the Rule) may not sell, transfer, assign, pledge or hypothecate the Representative’s Warrants or the securities underlying the Representative’s Warrants, nor will they engage in any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of the Representative’s Warrants or the underlying securities for a period of six months from the effective date of this offering, except to any FINRA member participating in the offering and their bona fide officers or partners. The Representative’s Warrants will provide for adjustment in the number and price of such Representative’s Warrants (and our shares of common stock underlying such Representative’s Warrants) to prevent dilution in the event of a forward or reverse stock split, stock dividend or similar recapitalization.

  

Right of First Refusal

 

 We have agreed to grant Maxim, for the 24-month period following the effective date of the registration statement related to this offering, a right of first refusal to act as sole manager and book runner and/or sole placement agent, for any and all future public and private equity, convertible or debt offerings of the Company’s securities, or as exclusive financial advisor for any strategic transaction, including a merger, acquisition, joint venture, minority investment or asset sale.

 

Lock-Up Agreements

 

We and our directors, officers any other holder(s) of one percent (1.0%) or more of our outstanding our shares of common stock as of the effective date of the Registration Statement (and all holders of securities exercisable for or convertible into shares of common stock) shall enter into customary “lock-up” agreements in favor of Maxim pursuant to which such persons and entities shall agree, for a period of one hundred and eighty (180) days after this offering is completed, that they shall neither offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any securities of the Company without Maxim’s prior written consent.

 

Indemnification

 

We have agreed to indemnify the underwriter against certain liabilities, including certain liabilities under the Securities Act. If we are unable to provide this indemnification, we have agreed to contribute to payments the underwriter may be required to make in respect of those liabilities.

 

Other Relationships

 

The underwriter and its affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions.

 

No Public Market

 

 Prior to this offering, there has not been a public market for our securities in the U.S. and the public offering price for our shares of common stock will be determined through negotiations between us and the underwriter. Among the factors to be considered in these negotiations will be prevailing market conditions, our financial information, market valuations of other companies that we and the underwriter believe to be comparable to us, estimates of our business potential, the present state of our development and other factors deemed relevant.

 

 We offer no assurances that the initial public offering price will correspond to the price at which our shares of common stock will trade in the public market subsequent to this offering or that an active trading market for our shares of common stock will develop and continue after this offering.

 

 
58

Table of Contents

 

Stock Exchange

 

 We have applied to list our common stock on the Nasdaq Capital Market under the symbol “EDBL.” There can be no assurance that we will be successful in listing our common stock on the Nasdaq Capital Market.

  

Electronic Distribution

 

 A prospectus in electronic format may be made available on websites or through other online services maintained by the underwriter of this offering, or by their affiliates. Other than the prospectus in electronic format, the information on any underwriter’s website and any information contained in any other website maintained by an underwriter is not part of this prospectus or the registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or any underwriter in its capacity as underwriter, and should not be relied upon by investors.

 

Price Stabilization, Short Positions

 

In connection with this offering, the underwriter may engage in activities that stabilize, maintain or otherwise affect the price of our shares of common stock during and after this offering, including:

 

 

·

stabilizing transactions;

 

·

short sales;

 

·

purchases to cover positions created by short sales;

 

·

imposition of penalty bids; and

 

·

syndicate covering transactions.

  

Stabilizing transactions consist of bids or purchases made for the purpose of preventing or retarding a decline in the market price of our shares of common stock while this offering is in progress. Stabilization transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. These transactions may also include making short sales of our shares of common stock, which involve the sale by the underwriter of a greater number of shares of common stock than they are required to purchase in this offering and purchasing shares of common stock on the open market to cover short positions created by short sales. Short sales may be “covered short sales,” which are short positions in an amount not greater than the underwriter’s option to purchase additional shares referred to above, or may be “naked short sales,” which are short positions in excess of that amount.

 

The underwriter may close out any covered short position by either exercising their option, in whole or in part, or by purchasing shares in the open market. In making this determination, the underwriter will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the over-allotment option.

 

Naked short sales are short sales made in excess of the over-allotment option. The underwriter must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriter is concerned that there may be downward pressure on the price of our shares of common stock in the open market that could adversely affect investors who purchased in this offering.

 

The underwriter also may impose a penalty bid. This occurs when a particular underwriter repays to the underwriter a portion of the underwriting discount received by it because Maxim has repurchased shares sold by or for the account of that underwriter in stabilizing or short covering transactions.

 

These stabilizing transactions, short sales, purchases to cover positions created by short sales, the imposition of penalty bids and syndicate covering transactions may have the effect of raising or maintaining the market price of our shares of common stock or preventing or retarding a decline in the market price of our shares of common stock. As a result of these activities, the price of our shares of common stock may be higher than the price that otherwise might exist in the open market. The underwriter may carry out these transactions on the Nasdaq Capital Market, in the over-the-counter market or otherwise. Neither we nor the underwriter make any representation or prediction as to the effect that the transactions described above may have on the price of the shares. Neither we, nor the underwriter make any representation that the underwriter will engage in these stabilization transactions or that any transaction, once commenced, will not be discontinued without notice. 

 

 
59

Table of Contents

 

Determination of Offering Price

 

 Prior to this offering, there was no public market for our shares of common stock. The initial public offering price will be determined by negotiation between us and Maxim, and does not necessarily bear any relationship to the value of our assets, our net worth, revenue or other established criteria of value, and should not be considered indicative of the actual value of the securities. The principal factors to be considered in determining the initial public offering price include, but not limited to:

 

 

·

the information set forth in this prospectus and otherwise available to Maxim;

 

·

our history and prospects and the history and prospects for the industry in which we compete;

 

·

our past and present financial performance;

 

·

our prospects for future earnings and the present state of our development;

 

·

the general condition of the securities market at the time of this offering;

 

·

the recent market prices of, and demand for, publicly traded shares of generally comparable companies; and

 

·

other factors deemed relevant by the underwriter and us.

   

The estimated public offering price range set forth on the cover page of this preliminary prospectus is subject to change as a result of market conditions and other factors. Neither we nor the underwriter can assure investors that an active trading market will develop for our shares of common stock or that our shares of common stock will trade in the public market at or above the initial public offering price.

 

Affiliations

 

 The underwriter and its respective affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. The underwriter and its affiliates may from time to time in the future engage with us and perform services for us or in the ordinary course of their business for which they will receive customary fees and expenses. In the ordinary course of their various business activities, the underwriter and its respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may involve securities and/or instruments of us. The underwriter and its respective affiliates may also make investment recommendations and/or publish or express independent research views in respect of these securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in these securities and instruments.

  

Selling Restrictions

 

Canada. The securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31 103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.

 

Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus supplement (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser’s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser’s province or territory for particulars of these rights or consult with a legal advisor.

 

Pursuant to section 3A.3 of National Instrument 33 105 Underwriting Conflicts (NI 33 105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriters conflicts of interest in connection with this offering.

 

 
60

Table of Contents

  

European Economic Area. In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a “Relevant Member State”) an offer to the public of any securities may not be made in that Relevant Member State, except that an offer to the public in that Relevant Member State of any securities may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member State:

 

 

·

to any legal entity which is a qualified investor as defined in the Prospectus Directive;

 

 

 

 

·

to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive, 150, natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the representatives for any such offer; or

 

 

 

 

·

in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of securities shall result in a requirement for the publication by us or any underwriters of a prospectus pursuant to Article 3 of the Prospectus Directive.

  

For the purposes of this provision, the expression an “offer to the public” in relation to any securities in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any securities to be offered so as to enable an investor to decide to purchase any securities, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State, the expression “Prospectus Directive” means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in the Relevant Member State, and the expression “2010 PD Amending Directive” means Directive 2010/73/EU.

 

United Kingdom. Each underwriter has represented and agreed that:

 

 

·

it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000 (the FSMA) received by it in connection with the issue or sale of the securities in circumstances in which Section 21(1) of the FSMA does not apply to us; and

 

 

 

 

·

it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the securities in, from or otherwise involving the United Kingdom.

 

Switzerland. The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (the SIX) or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the securities or the offering may be publicly distributed or otherwise made publicly available in Switzerland.

 

Neither this document nor any other offering or marketing material relating to the offering, or the securities have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, and the offer of securities has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (CISA). Accordingly, no public distribution, offering or advertising, as defined in CISA, its implementing ordinances and notices, and no distribution to any non-qualified investor, as defined in CISA, its implementing ordinances and notices, shall be undertaken in or from Switzerland, and the investor protection afforded to acquirers of interests in collective investment schemes under CISA does not extend to acquirers of securities.

 

 
61

Table of Contents

 

Australia. No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and Investments Commission (ASIC), in relation to the offering.

 

This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001 (the Corporations Act) and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act.

 

Any offer in Australia of the securities may only be made to persons (the Exempt Investors) who are “sophisticated investors” (within the meaning of section 708(8) of the Corporations Act), “professional investors” (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section 708 of the Corporations Act so that it is lawful to offer the securities without disclosure to investors under Chapter 6D of the Corporations Act.

 

The securities applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12 months after the date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or where the offer is pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring securities must observe such Australian on-sale restrictions.

 

This prospectus contains general information only and does not take account of the investment objectives, financial situation or particular needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.

 

Notice to Prospective Investors in the Cayman Islands. No invitation, whether directly or indirectly, may be made to the public in the Cayman Islands to subscribe for our securities.

 

Taiwan. The securities have not been and will not be registered with the Financial Supervisory Commission of Taiwan pursuant to relevant securities laws and regulations and may not be sold, issued or offered within Taiwan through a public offering or in circumstances which constitutes an offer within the meaning of the Securities and Exchange Act of Taiwan that requires a registration or approval of the Financial Supervisory Commission of Taiwan. No person or entity in Taiwan has been authorized to offer, sell, give advice regarding or otherwise intermediate the offering and sale of the securities in Taiwan.

 

Notice to Prospective Investors in Hong Kong. The contents of this prospectus have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any of the contents of this prospectus, you should obtain independent professional advice. Please note that (i) our shares may not be offered or sold in Hong Kong, by means of this prospectus or any document other than to “professional investors” within the meaning of Part I of Schedule 1 of the Securities and Futures Ordinance (Cap.571, Laws of Hong Kong) (SFO) and any rules made thereunder, or in other circumstances which do not result in the document being a “prospectus” within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong) (CO) or which do not constitute an offer or invitation to the public for the purpose of the CO or the SFO, and (ii) no advertisement, invitation or document relating to our shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere) which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to the shares which are or are intended to be disposed of only to persons outside Hong Kong or only to “professional investors” within the meaning of the SFO and any rules made thereunder.

 

Notice to Prospective Investors in the People’s Republic of China. This prospectus may not be circulated or distributed in the PRC and the shares may not be offered or sold, and will not offer or sell to any person for re-offering or resale directly or indirectly to any resident of the PRC except pursuant to applicable laws, rules and regulations of the PRC. For the purpose of this paragraph only, the PRC does not include Taiwan and the special administrative regions of Hong Kong and Macau.

 

 
62

Table of Contents

     

LEGAL MATTERS

 

The validity of the shares of the common stock offered by this prospectus will be passed upon by Harter Secrest & Emery LLP, Rochester, New York, NY. Loeb & Loeb LLP, New York, NY, is acting as counsel to the underwriters.

 

EXPERTS

 

Marcum LLP, an independent registered public accounting firm, has audited our consolidated financial statements at December 31, 2020 and 2019 as set forth in its report. We have included our financial statements in the prospectus and elsewhere in the registration statement in reliance on Marcum LLP’s report, given on their authority as experts in accounting and auditing.

 

WHERE YOU CAN FIND MORE INFORMATION

 

We have filed with the SEC a registration statement on Form S-1, which includes amendments and exhibits, under the Securities Act and the rules and regulations under the Securities Act for the registration of common stock being offered by this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all the information that is in the registration statement and its exhibits and schedules. Certain portions of the registration statement have been omitted as allowed by the rules and regulations of the SEC. Statements in this prospectus that summarize documents are not necessarily complete, and in each case you should refer to the copy of the document filed as an exhibit to the registration statement. All filings we make with the SEC are available on the SEC’s web site at www.sec.gov.

 

Upon completion of this offering, we will be subject to the information requirements of the Exchange Act and will file annual, quarterly and current event reports, proxy statements and other information with the SEC. We also maintain a website at www.ediblegarden.com. The information contained on, or that can be accessed through, our website is not part of, and is not incorporated into, this prospectus. We have included our website in this prospectus solely as an inactive textual reference, and you should not consider the contents of our website in making an investment decision with respect to our securities.

 

 
63

Table of Contents

 

EDIBLE GARDEN AG INCORPORATED

 

Index to Consolidated Financial Statements

 

 

Page

 

Audited Financial Statements As of and For the Years Ended December 31, 2020 and 2019

 

 

 

Report of Independent Registered Public Accounting Firm

 

 

F-2

 

Consolidated Balance Sheets

 

F-3

 

Consolidated Statement of Operations

 

F-4

 

Consolidated Statement of Cash Flows

 

 

F-5

 

Consolidated Statement of Stockholders' Deficit

 

F-6

 

Notes to the Consolidated Financial Statements

 

F-7

 

 

Unaudited Interim Condensed Consolidated Financial Statements for the Three and Six-Month Periods Ended June 30, 2021

 

 

 

Condensed Consolidated Balance Sheet

 

 

F-22

 

Condensed Consolidated Statement of Operations

 

F-23

 

Condensed Consolidated Statement of Cash Flows

 

 

F-24

 

Condensed Consolidated Statement of Stockholders' Deficit

 

F-25

 

Notes to the Unaudited Consolidated Financial Statements

 

F-26

 

 

 
F-1

Table of Contents

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Stockholders and Board of Directors of Edible Garden AG, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Edible Garden AG, Inc. (the “Company”) as of December 31, 2020 (Successor balance sheet) and 2019 (Predecessor balance sheet), the related consolidated statements of operations, stockholders’ equity (deficit) and cash flows for the period from March 28, 2020 to December 31, 2020 (Successor operations) and the period from January 1, 2020 to March 31, 2020 and the year ended December 31, 2019 (Predecessor operations), and the related notes (collectively referred to as the “financial statements”). In our opinion, the Successor financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020, and the results of its operations and its cash flows for the period from March 28, 2020 to December 31, 2020, in conformity with accounting principles generally accepted in the United States of America. Further, in our opinion, the Predecessor financial statements present fairly, in all material respects, the financial position of the Predecessor as of December 31, 2019, and the results of its operations and its cash flows for the period from January 1, 2020 to March 31, 2020 and for the year ended December 31, 2019, in conformity with accounting principles generally accepted in the United States of America.

 

Explanatory Paragraph – Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 13, the Company has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 13. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ Marcum LLP

 

Marcum LLP

 

We have served as the Company’s auditor since 2021

Costa Mesa, California

September 10, 2021

 

 
F-2

Table of Contents

 

EDIBLE GARDEN AG INCORPORATED
CONSOLIDATED BALANCE SHEETS

(in thousands, except shares)

 

 

 

Predecessor

 

 

Successor

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2020

 

ASSETS

 

Current assets:

 

 

 

 

 

 

Cash

 

$ 5

 

 

$ 5

 

Accounts receivable, net

 

 

604

 

 

 

629

 

Inventory

 

 

524

 

 

 

314

 

Prepaid expenses and other current assets

 

 

109

 

 

 

122

 

Total current assets

 

 

1,242

 

 

 

1,070

 

Property, equipment and leasehold improvements, net

 

 

4,187

 

 

 

3,053

 

Intangible assets, net

 

 

85

 

 

 

25

 

Other assets

 

 

2,704

 

 

 

331

 

TOTAL ASSETS

 

$ 8,218

 

 

$ 4,479

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

LIABILITIES:

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable and other accrued expenses

 

$ 1,868

 

 

$ 2,466

 

Total current liabilities

 

 

1,868

 

 

 

2,466

 

Long-term liabilities:

 

 

 

 

 

 

 

 

Long-term debt, net of discounts

 

 

-

 

 

 

3,884

 

Long-term lease liabilities

 

 

2,139

 

 

 

204

 

Total long-term liabilities

 

 

2,139

 

 

 

4,088

 

Total liabilities

 

 

4,007

 

 

 

6,554

 

 

 

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES (Note 11)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ DEFICIT:

 

 

 

 

 

 

 

 

Common stock ($0.0001 par value, 100 and 200,000,000 shares authorized, 100 and 20,000,000 shares outstanding as of December 31, 2019 and 2020, respectively)(1)

 

 

-

 

 

 

-

 

Additional paid-in capital

 

 

20,118

 

 

 

6

 

Accumulated deficit

 

 

(15,907 )

 

 

(2,081 )

Total stockholders’ deficit

 

 

4,211

 

 

 

(2,075 )

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

$ 8,218

 

 

$ 4,479

 

________

(1) Adjusted to reflect the stock splits as described in Note 1.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 
F-3

Table of Contents

 

EDIBLE GARDEN AG INCORPORATED
CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except shares and per share information)

 

 

 

Predecessor

 

 

Successor

 

 

 

Year Ended
December 31,
2019

 

 

Period from
January 1, 2020
through
March 31,
2020

 

 

Period from
March 28, 2020 (inception)
through
December 31,
2020

 

Revenue

 

$ 5,634

 

 

$ 1,750

 

 

$ 7,691

 

Cost of goods sold

 

 

4,366

 

 

 

1,599

 

 

 

6,488

 

Gross profit

 

 

1,268

 

 

 

151

 

 

 

1,203

 

Selling, general and administrative expenses

 

 

5,291

 

 

 

1,480

 

 

 

3,675

 

Impairment of assets

 

 

(34 )

 

 

-

 

 

 

-

 

(Gain) / Loss on sale of assets

 

 

-

 

 

 

303

 

 

 

-

 

Loss from operations

 

 

(3,988 )

 

 

(1,632 )

 

 

(2,472 )

Other income / (expense)

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

-

 

 

 

-

 

 

 

(112 )

Gain from debt forgiveness

 

 

-

 

 

 

-

 

 

 

503

 

Total other income / (expense)

 

 

-

 

 

 

-

 

 

 

391

 

NET LOSS

 

$ (3,988 )

 

$ (1,632 )

 

$ (2,081 )

Net Income / (Loss) per common share - basic and diluted

 

$ (39,880.00 )

 

$ (16,320.00 )

 

$ (0.10 )

Weighted-Average Number of Common Shares Outstanding – Basic and Diluted(1)

 

 

100

 

 

 

100

 

 

 

20,000,000

 

___________ 

(1) Successor periods are adjusted to reflect the stock splits as described in Note 1.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 

 

F-4

Table of Contents

 

EDIBLE GARDEN AG INCORPORATED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

 

Predecessor

 

 

Successor

 

 

 

Year Ended
December 31,
2019

 

 

Period from
January 1, 2020
through
March 31,
2020

 

 

Period from
March 28, 2020 (inception)
through
December 31,
2020

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

$ (3,988 )

 

$ (1,632 )

 

$ (2,081 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Bad debt expense

 

 

14

 

 

 

172

 

 

 

3

 

Depreciation and amortization

 

 

543

 

 

 

147

 

 

 

567

 

Amortization of operating lease right of use asset

 

 

71

 

 

 

16

 

 

 

42

 

Loss from sale of assets

 

 

-

 

 

 

303

 

 

 

-

 

Gain from forgiveness of debt

 

 

-

 

 

 

-

 

 

 

(504 )

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(8 )

 

 

73

 

 

 

(196 )

Inventory

 

 

25

 

 

 

1

 

 

 

208

 

Prepaid expenses and other current assets

 

 

(75 )

 

 

29

 

 

 

(48 )

Other assets

 

 

(2,712 )

 

 

(110 )

 

 

-

 

Accounts payable and accrued expenses

 

 

472

 

 

 

351

 

 

 

700

 

Operating lease liabilities

 

 

2,139

 

 

 

(28 )

 

 

(42 )

NET CASH PROVIDED BY / (USED IN) OPERATING ACTIVITIES

 

 

(3,519 )

 

 

(676 )

 

 

(1,351 )

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, equipment and leasehold improvements

 

 

(107 )

 

 

(45 )

 

 

(82 )

Purchase of intangible assets

 

 

(100 )

 

 

-

 

 

 

-

 

Cash transferred in sale/purchase of assets

 

 

-

 

 

 

(34 )

 

 

34

 

NET CASH PROVIDED BY / (USED IN) INVESTING ACTIVITIES

 

 

(207 )

 

 

(79 )

 

 

(48 )

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Contribution from parent company

 

 

3,714

 

 

 

750

 

 

 

-

 

Proceeds from debt

 

 

-

 

 

 

-

 

 

 

1,484

 

Payments of debt principal

 

 

-

 

 

 

-

 

 

 

(80 )

NET CASH PROVIDED BY / (USED IN) FINANCING ACTIVITIES

 

 

3,714

 

 

 

750

 

 

 

1,404

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET CHANGE IN CASH

 

 

(12 )

 

 

(5 )

 

 

5

 

Cash at beginning of period

 

 

17

 

 

 

5

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH AT END OF PERIOD

 

$ 5

 

 

$ -

 

 

$ 5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

 

$ -

 

 

$ -

 

 

$ 3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Debt and equity issued to acquire Predecessor's assets

 

$ -

 

 

$ -

 

 

$ 2,966

 

Debt issued to purchase vehicles

 

$ -

 

 

$ -

 

 

$ 24

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 
F-5

Table of Contents

 

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(in thousands, except for shares) (1)

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-In

 

 

Accumulated

 

 

 

 

Predecessor:

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

Balance at December 31, 2018

 

 

100

 

 

$ -

 

 

$ 16,405

 

 

$ (11,919 )

 

$ 4,486

 

Contributions from parent company

 

 

-

 

 

 

-

 

 

 

3,714

 

 

 

-

 

 

 

3,714

 

Net Income (Loss)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,988 )

 

 

(3,988 )

Balance at December 31, 2019

 

 

100

 

 

 

-

 

 

$ 20,118

 

 

$ (15,907 )

 

$ 4,211

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2020

 

 

100

 

 

$ -

 

 

$ 20,118

 

 

$ (15,907 )

 

$ 4,211

 

Contributions from parent company

 

 

-

 

 

 

-

 

 

 

750

 

 

 

-

 

 

 

750

 

Net Income (Loss)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,632 )

 

 

(1,632 )

Balance at March 31, 2020

 

 

100

 

 

 

-

 

 

$ 20,869

 

 

$ (17,539 )

 

$ 3,330

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-In

 

 

Accumulated

 

 

 

 

Successor:

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

Balance at March 28, 2020 (inception)

 

 

20,000,000

 

 

$ -

 

 

$ -

 

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options issued for acquisition of assets

 

 

-

 

 

 

-

 

 

 

6

 

 

 

-

 

 

 

6

 

Net Income (Loss)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,081 )

 

 

(2,081 )

Balance at December 31, 2020

 

 

20,000,000

 

 

$ -

 

 

$ 6

 

 

$ (2,081 )

 

$ (2,075 )

(1) Adjusted to reflect the stock splits as described in Note 1.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 
F-6

Table of Contents

 

EDIBLE GARDEN AG INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – ORGANIZATION, NATURE OF BUSINESS, AND BASIS OF PRESENTATION

 

Organization and Recent Developments

 

Edible Garden Corp., a Nevada corporation, was incorporated on April 9, 2013. On March 28, 2020, Edible Garden AG Inc., a Wyoming corporation, was incorporated for the purpose of acquiring substantially all of the operating assets of Edible Garden Corp., which was a separately identified reportable segment of its parent company Unrivaled Brands, Inc. (formerly known as Terra Tech Corporation). The acquisition was completed on March 30, 2020. Prior to March 30, 2020 Edible Garden AG, Inc. had no operations. Hereafter, Edible Garden AG, Inc. and its subsidiaries will collectively be referred to as “Edible Garden,” “we,” “us,” “our,” or the “Successor.” Edible Garden Corp., a wholly-owned subsidiary of Unrivaled Brands, Inc. will be referred to as the “Predecessor.” Throughout these financial statements, the Successor and the Predecessor are also referred to as “the Company” and used interchangeably, unless otherwise noted.

 

We authorized 100,000 shares of common stock at formation. On October 14, 2020, we simultaneously declared a 20-for-1 forward stock split of our common stock and increased the number of authorized common shares to 20,000,000. On June 30, 2021, we simultaneously (1) converted Edible Garden from a Wyoming into a Delaware corporation, (2) declared a 1-for-2 reverse stock split of our common stock, and (3) increased the total number of authorized common shares to 50,000,000. On September 8, 2021, we simultaneously declared a 20-for-1 forward stock split of our common stock and increased the number of authorized common shares to 200,000,000. All historical share and per share amounts reflected throughout this report have been adjusted to reflect the stock splits described above.

 

Nature of Business

 

Edible Garden is a retail seller of locally grown hydroponic produce, which is distributed throughout the Northeast, Midwest and Florida. Currently, Edible Garden’s products are sold at approximately 4,500 supermarkets. Our target customers are those individuals seeking fresh produce locally grown using environmentally sustainable methods.

 

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany transactions and balances have been eliminated. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of December 31, 2020 and 2019, and the consolidated results of operations and cash flows for the years ended December 31, 2020 and 2019 have been included.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that we will continue as a going concern. In an effort to achieve liquidity that would be sufficient to meet all of our commitments, we have undertaken a number of actions, including minimizing capital expenditures and reducing recurring expenses.

 

However, we believe that even after taking these actions, we will not have sufficient liquidity to satisfy all of our future financial obligations. The risks and uncertainties surrounding our ability to raise capital and our limited capital resources raise substantial doubt as to our ability to continue as a going concern. See Note 13, “Going Concern” of the Notes to Consolidated Financial Statements for additional information.

 

 
F-7

Table of Contents

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates

 

The preparation of the consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reported period. Changes in these estimates and assumptions may have a material impact on the consolidated financial statements and accompanying notes.

 

Examples of significant estimates and assumptions include provisions for doubtful accounts, accrued liabilities, discount rates used in the measurement and recognition of lease liabilities and valuation of our common stock. These estimates generally involve complex issues and require us to make judgments, involve analysis of historical and future trends, can require extended periods of time to resolve, and are subject to change from period to period. In all cases, actual results could differ materially from our estimates.

 

Trade and other Receivables

 

The Company extends non-interest-bearing trade credit to its customers in the ordinary course of business which is not collateralized. Accounts receivable are shown on the face of the consolidated balance sheets, net of an allowance for doubtful accounts. The Company analyzes the aging of accounts receivable, historical bad debts, customer creditworthiness and current economic trends, in determining the allowance for doubtful accounts. The Company does not accrue interest receivable on past due accounts receivable. The reserve for doubtful accounts was $38,287 and $116,759 as of December 31, 2020 (Successor) and 2019 (Predecessor), respectively.

 

Inventory

 

We value our inventory at the lower of the actual cost of our inventory, as determined using the first-in, first-out method, or its net realizable value. We periodically review our physical inventory for excess, obsolete, and potentially impaired items and reserve accordingly. Our reserve estimate for excess and obsolete is based on expected future use. Our reserve estimates have historically been consistent with our actual experience as evidenced by actual sale or disposal of the goods.

  

Prepaid Expenses and Other Current Assets

 

Prepaid expenses consist of various payments that the Company has made in advance for goods or services to be received in the future. These prepaid expenses include advertising, insurance, and service or other contracts requiring up-front payments.

 

Property, Equipment and Leasehold Improvements, Net

 

Property, equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Our fixed assets, which are comprised of leasehold improvements, equipment and vehicles, have useful lives of five years.

 

Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property, equipment and leasehold improvements may not be recoverable in accordance with the provisions of ASC 360, “Property, Plant, and Equipment.” When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. See Note 5, “Property, Equipment and Leasehold Improvements, Net” for further information.

 

 
F-8

Table of Contents

 

Intangible Assets

 

Intangible assets continue to be subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment,” intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of December 31, 2020, Edible Garden held one intangible asset related to a non-compete agreement, which has a useful life of two years.

 

The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall, or an adverse action or assessment by a regulator. If an impairment indicator exists, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified.

 

Revenue Recognition and Performance Obligations

 

Revenues are recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company does not offer returns, discounts, loyalty programs or other sales incentive programs that are material to revenue recognition. Payments from our customers are due upon delivery or within a short period after delivery.

 

Disaggregation of Revenue

 

The following table includes revenue disaggregated by revenue stream for the year ended December 31, 2019 (Predecessor), the three months ended March 31, 2020 (Predecessor) and the year ended December 31, 2020 (Successor):

 

 

 

(in thousands)

 

 

 

Predecessor

 

 

Successor

 

 

 

December 31, 2019

 

 

Period from
January 1, 2020
through
March 31,
2020

 

 

Period from
March 28, 2020 (inception)
through
December 31,
2020

 

Herbs & Produce

 

$ 5,284

 

 

$ 1,685

 

 

$ 7,482

 

Vitamins and Supplements

 

 

350

 

 

 

65

 

 

 

209

 

Total

 

$ 5,634

 

 

$ 1,750

 

 

$ 7,691

 

 

Contract Balances

 

Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC Topic 606.

 

 
F-9

Table of Contents

 

Contract Estimates and Judgments

 

The Company’s revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or variable consideration.

 

Cost of Goods Sold

 

Cost of goods sold includes materials, labor and overhead costs incurred in cultivating and producing our products.

 

Advertising Expenses

 

The Company expenses advertising costs as incurred in accordance with ASC 720-35, “Other Expenses – Advertising Cost.” Advertising expenses totaled $222,038 and $22,025 in the year ended December 31, 2019 (Predecessor) and three months ended March 31, 2020 (Predecessor), respectively. For year ended December 31, 2020 (Successor), the advertising expense totaled $92,681.

 

Loss Per Common Share

 

In accordance with the provisions of ASC 260, “Earnings Per Share,” net loss per share is computed by dividing net loss by the weighted-average shares of common stock outstanding during the period. During a loss period, the effect of the potential exercise of stock options, warrants, convertible preferred stock, and convertible debt are not considered in the diluted loss per share calculation since the effect would be anti-dilutive. The results of operations were a net loss for the years ended December 31, 2020 and 2019. Therefore, the basic and diluted weighted-average shares of common stock outstanding were the same for all years.

 

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive include 5,000,000 options issued by Edible Garden to acquire the assets of the Predecessor. Refer to Note 3, “Asset Acquisition” for details.

 

Income Taxes

 

The provision for income taxes is determined in accordance with ASC 740, “Income Taxes”. The Company files a consolidated United States federal income tax return. The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expense are expected to be settled in our income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes. At December 31, 2020 and 2019, such net operating losses were offset entirely by a valuation allowance.

 

The Company recognizes uncertain tax positions based on a benefit recognition model. Provided that the tax position is deemed more likely than not of being sustained, the Company recognizes the largest amount of tax benefit that is greater than 50.0% likely of being ultimately realized upon settlement. The tax position is derecognized when it is no longer more likely than not of being sustained. The Company classifies income tax related interest and penalties as interest expense and selling, general and administrative expense, respectively, on the consolidated statements of operations.

 

Segment reporting

 

The Company is not organized by multiple operating segments for the purpose of making operating decisions or assessing performance. Accordingly, the Company operates in one reportable operating segment. The Company’s principal decision makers are the Chief Executive Officer and its Chief Financial Officer. Management believes that its business operates as one reportable segment because: a) the Company measures profit and loss as a whole; b) the principal decision makers do not review information based on any operating segment; c) the Company does not maintain discrete financial information on any specific segment; d) the Company has not chosen to organize its business around different products and services, and e) the Company has not chosen to organize its business around geographic areas.

 

 
F-10

Table of Contents

 

Recently Adopted Accounting Standards

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Start-ups Act of 2012, (the “JOBS Act”). Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 13(a) of the Securities Exchange Act of 1934, as amended, for complying with new or revised accounting standards applicable to public companies. As an emerging growth company we plan to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.

 

FASB ASU No. 2014-09 (Topic 606), “Revenue from Contracts with Customers” – In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers”. The Company adopted ASC Topic 606, “Revenue from Contracts with Customers”, effective January 1, 2019. The adoption had no material impact on the financial statements.

 

FASB ASU No. 201602 (Topic 842), “Leases” – Issued in February 2016, ASU No. 2016-02 established ASC Topic 842, “Leases,” as amended by subsequent ASUs on the topic, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. ASU 2016-02 requires lessees to apply a two-method approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase. Lessees are required to record a right of use asset and a lease liability for all leases with a term greater than 12 months. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases. Lessees will recognize expense based on the effective interest method for finance leases or on a straight-line basis for operating leases. The accounting applied by the lessor is largely unchanged from that applied under the existing lease standard. We adopted this standard effective January 1, 2020. The adoption had no material impact on the financial statements.

 

FASB Accounting Standards Update (“ASU”) No. 2016-13, “Measurement of Credit Losses on Financial Instruments” Issued in June 2016, ASU 2016-13 replaces the “incurred loss” credit losses framework with a new accounting standard that requires management's measurement of the allowance for credit losses to be based on a broader range of reasonable and supportable information for lifetime credit loss estimates. The Company adopted the standard January 1, 2020. Adoption had no material impact on the Company’s financial position or results of operations.

 

Recently Issued Accounting Standards

 

FASB ASU No. 2020-06 “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” - Issued in August 2020, ASU 2020-06 simplifies the accounting for convertible instruments by eliminating the requirement to separate embedded conversion features from the host contract when the conversion features are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital. By removing the separation model, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost and the interest rate on convertible debt instruments will typically be closer to the coupon interest rate when applying the guidance in Topic 835, Interest. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those years. The Company will adopt the standard beginning January 1, 2021. Adoption is not expected to have a material impact on the Company’s financial position or results of operations.

 

NOTE 3 – ASSET ACQUISITION

 

On March 30, 2020, the Successor entered into and closed an Asset Purchase Agreement (the “Purchase Agreement”) with the Predecessor’s parent company, pursuant to which Edible Garden Inc. purchased substantially all of the assets of the Predecessor. The transaction did not meet the definition of the purchase of a business as defined in ASC 805, “Business Combinations” because a substantive process was not acquired. Michael James, the former Chief Financial Officer of the Predecessor’s parent company, is the Chief Financial Officer of the Successor.

 

 
F-11

Table of Contents

 

The consideration paid for the assets included (1) a five year three million secured promissory note bearing interest at 3.5% per annum, (2) options to purchase up to 5,000,000 shares of the Successor for a nominal amount and (3) $2,011,782 of liabilities assumed.

 

Stock Options

 

The first option gives Sament Capital Investments, Inc., an affiliate of the Predecessor (“Sament”), the right, but not the obligation, to acquire 2,225,000 common shares of the Successor at any time between the one- and five-year anniversary of the date of the agreement, or at any time in the event of a change in control or a public offering, for a strike price of $1.00. The second option gives Sament the right, but not the obligation, to purchase 2,775,000 common shares of the Successor at any time between the one- and five-year anniversary of the agreement. The second option is automatically terminated upon payment in full of the secured promissory note.

 

Given the absence of an active market for the Successor’s common stock, the Company was required to estimate the enterprise value of the Successor company as of the date of the options. Management considered numerous objective and subjective factors in determining the value of the Company’s common stock, including the following: (1) valuations performed by an independent valuation specialist; (2) the Company’s stage of development and revenue growth, (3) the fact that the awards involved illiquid securities in a private company and (4) the likelihood of achieving a liquidity event for the shares of common stock underlying the awards, such as an initial public offering or sale of the Company, given prevailing market conditions. As the Company’s common stock is not actively traded, the determination of fair value involves assumptions, judgments, and estimates. If different assumptions were made, the initial purchase price allocation could have been significantly different. The Company estimated the fair value of the stock options using the Black-Scholes-Merton option-pricing (“Black-Scholes”) model, with the following weighted-average assumptions:

  

Expected term (years)

 

 

2.7

 

Volatility

 

 

22.0 %

Risk-free interest rate

 

 

0.3 %

Dividend yield

 

 

0.0 %

 

The fair value of the consideration was allocated to the assets acquired based on their relative fair values, as follows:

 

 

 

(in thousands)

 

Consideration

 

 

 

Fair value of promissory note

 

$ 2,960

 

Fair value of options issued

 

 

6

 

Total fair value of consideration:

 

$ 2,966

 

 

 

 

 

 

Net book value of assets acquired

 

 

 

 

Cash

 

$ 34

 

Accounts receivable

 

 

437

 

Inventory

 

 

522

 

Prepaids and other assets

 

 

115

 

Property, plant and equipment

 

 

3,497

 

Intangible assets

 

 

62

 

Right-of-use asset

 

 

311

 

Liabilities assumed

 

 

(2,012 )

Total Net Assets Acquired

 

$ 2,966

 

 

NOTE 4 – INVENTORY

 

Inventory as of December 31, 2019 (Predecessor) and December 31, 2020 (Successor) consisted of the following:

 

 
F-12

Table of Contents

 

 

 

(in thousands)

 

 

 

Predecessor

 

 

Successor

 

 

 

December 31,

 

 

December 31,

 

 

2019

 

2020

 

Raw materials

 

$ 251

 

 

$ 156

 

Work-in-progress

 

 

283

 

 

 

168

 

Inventory reserve

 

 

(10 )

 

 

(10 )

 

 

 

 

 

 

 

 

 

Total inventory

 

$ 524

 

 

$ 314

 

 

NOTE 5 – PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS, NET

 

Property, equipment and leasehold improvements as of December 31, 2019 (Predecessor) and December 31, 2020 (Successor) consisted of the following:

 

 

 

(in thousands)

 

 

 

Predecessor

 

 

Successor

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2020

 

 

 

$ -

 

 

$ -

 

Furniture and equipment

 

 

2,172

 

 

 

537

 

Computer hardware

 

 

108

 

 

 

4

 

Leasehold improvements

 

 

3,573

 

 

 

3,009

 

Vehicles

 

 

-

 

 

 

28

 

Construction in progress

 

 

1,299

 

 

 

4

 

Subtotal

 

 

7,152

 

 

 

3,583

 

Less accumulated depreciation

 

 

(2,965 )

 

 

(530 )

Property, equipment and leasehold improvements, net

 

$ 4,187

 

 

$ 3,053

 

 

Depreciation expense related to property, equipment and leasehold improvements for the year ended December 31, 2019 (Predecessor) was $528,702. Depreciation expense for the three months ended March 31, 2020 (Predecessor) was $134,874. Depreciation expense for the nine months ended December 31, 2020 (Successor) was $529,732.

 

NOTE 6 – INTANGIBLE ASSETS

 

Intangible assets consisted of the following as of December 31, 2019 (Predecessor) and 2020 (Successor) (in thousands):

 

 
F-13

Table of Contents

 

 

 

 

 

 

Predecessor

 

 

Successor

 

 

 

 

 

 

December 31, 2019

 

 

December 31, 2020

 

 

 

Estimated Useful Life in Years

 

 

Gross

Carrying Amount

 

 

Accumulated Amortization

 

 

Net

Carrying Value

 

 

Gross

Carrying Amount

 

 

Accumulated Amortization

 

 

Net

Carrying

Value

 

Amortizing Intangible Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non Compete

 

 

2

 

 

 

100

 

 

 

(15 )

 

 

85

 

 

 

62

 

 

$ (37 )

 

 

25

 

Total Intangible Assets, net

 

 

 

 

 

 

100

 

 

 

(15 )

 

 

85

 

 

 

62

 

 

 

(37 )

 

 

25

 

 

The total future amortization expense of $25,000 will be recognized during 2021.

 

NOTE 7 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consisted of the following as of December 31, 2019 (Predecessor) and December 31, 2020 (Successor):

 

 

 

(in thousands)

 

 

Predecessor

 

Successor

 

 

December 31,

2019

 

December 31, 2020

 

 

 

 

 

 

 

 

Accounts Payable

 

$ 1,216

 

 

$ 1,929

 

Accrued Expenses

 

 

25

 

 

 

173

 

Accrued Interest Payable

 

 

0

 

 

 

96

 

Accrued Payroll

 

 

125

 

 

 

106

 

Accrued Vacation

 

 

58

 

 

 

97

 

Current Lease Liability

 

 

444

 

 

 

65

 

 

 

 

 

 

 

 

 

 

Total Accounts Payable and Accrued Expenses

 

$ 1,868

 

 

$ 2,466

 

 

NOTE 8 – NOTES PAYABLE

 

Notes payable consisted of the following as of December 31, 2019 (Predecessor) and December 31, 2020 (Successor):

 

 

 

(in thousands)

 

 

 

Predecessor

 

 

Successor

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2020

 

Secured promissory note

 

$ -

 

 

$ 3,653

 

SBA loan

 

 

-

 

 

 

150

 

SAFE agreements

 

 

-

 

 

 

40

 

Related party loans

 

 

-

 

 

 

60

 

Vehicle Loan

 

 

-

 

 

 

21

 

Total Gross Debt

 

$ -

 

 

$ 3,923

 

 

 

 

 

 

 

 

 

 

Less: Debt discount

 

 

-

 

 

 

(40 )

Net Long Term Debt

 

$ -

 

 

$ 3,884

 

 

 
F-14

Table of Contents

 

Scheduled maturities of long-term debt as of December 31, 2020, are as follows (in thousands):

 

Years Ending December 31,

 

 

 

2021

 

$ -

 

2022

 

 

3

 

2023

 

 

654

 

2024

 

 

21

 

2025

 

 

3,000

 

Thereafter

 

 

247

 

 

 

$ 3,924

 

 

Secured Promissory Notes

 

On March 30, 2020, the Company entered into a promissory note (the “Note”) for $3,000,000 with Sament in connection with the acquisition of the Predecessor’s assets. The Note accrues interest at a rate of 3.5% per annum on a 360-day year basis and matures March 30, 2025. The Note is secured by the assets purchased in connection with the asset acquisition. See Note 3, “Asset Acquisition” for additional details.

 

On June 2, 2020, the Company entered into a promissory note for $653,870 with Sament, which accrues interest at a rate of 3.50% per annum and matures on June 3, 2023. The promissory note is secured by the assets purchased in connection with the asset acquisition.

 

Small Business Administration (“SBA”) Loans

 

On April 30, 2020, the Company received approval from the U.S. Small Business Administration (“SBA”) to fund the Company’s request for a loan under the Paycheck Protection Program (“PPP Loan”) created as part of the recently enacted Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) administered by the SBA. In connection with the PPP Loan, the Company entered into a promissory note in the principal amount of $503,655. The Company used the entire loan amount for qualifying expenses and the loan was forgiven in its entirety on December 27, 2020.

 

On June 22, 2020, the Company entered into a U.S. Small Business Administration Loan Authorization and Agreement pursuant to which the Company received loan proceeds of $150,000 (the “SBA Loan”). The SBA Loan was made under, and is subject to the terms and conditions of, the Economic Injury Disaster Loan Program, which was a program expanded for COVID-19 relief under the CARES Act and is administered by the U.S. Small Business Administration. The term of the SBA Loan is thirty (30) years with a maturity date of June 22, 2050 and the annual interest rate of the SBA Loan is a fixed rate of 3.75%. Under the terms of the CARES Act, the use of loan proceeds for the SBA Loan is limited to alleviating economic injury caused by the COVID-19 pandemic.

 

SAFE Agreements

 

During the year ended December 31, 2020, the Company entered into Simple Agreements for Future Equity (“SAFEs”) with investors through a Regulation Crowdfunding campaign in exchange for cash investments. Upon a future equity financing of greater than $1,000,000, the SAFE securities are convertible at the option of the Company into securities identical to those issued in the future equity financing (“Shadow Securities”), except (1) they do not have the right to vote except as required by law, (2) they must vote in accordance with the majority of the investors in such future equity financing with respect to any such required vote and (3) they are not entitled to any inspection or information rights. If the Company elects to convert the securities upon the closing of a future equity financing, the investors will receive the number of Shadow Securities equal to the greater the quotient obtained by dividing the amount the investor paid (the “Purchase Amount”) for the securities by:

 

 
F-15

Table of Contents

 

 

(a)

the quotient of $18,500,000 divided by the aggregate number of issued and outstanding shares of capital stock, assuming full conversion or exercise of all convertible and exercisable securities then outstanding, including shares of convertible preferred stock and all outstanding vested or unvested options or warrants to purchase capital stock, but excluding (i) the issuance of all shares of capital stock reserved and available for future issuance under any of the Company’s existing equity incentive plans, (ii) convertible promissory notes issued by the Company, (iii) any SAFEs, and (iv) any equity securities that are issuable upon conversion of any outstanding convertible promissory notes or SAFEs, or

 

 

 

 

(b)

the lowest price per share of the securities sold in such future equity financing.

  

The price (either (a) or (b)) determined above shall be deemed the “First Financing Price” and may be used to establish the conversion price of the securities at a later date, even if the Company does not choose to convert the SAFE securities upon the first future equity financing.

 

Upon an initial public offering of the Company’s common shares or a change of control (a “Liquidity Event”) prior to any equity financing, the investors will receive, at the option of the investors, either (i) a cash payment equal to the purchase amount or (ii) a number of shares of common stock of the Company equal to the purchase amount divided by the quotient of (a) $18,500,000 divided by (b) the number, as of immediately prior to the Liquidity Event, of shares of the Company’s capital stock (on an as-converted basis) outstanding, assuming exercise or conversion of all outstanding, vested and unvested options, warrants and other convertible securities, but excluding (di) shares of common stock reserved and available for future grant under any equity incentive or similar plan; (ii) any SAFEs; and (iii) convertible promissory notes.

 

In the case of a Liquidity Event following any equity financing, the investors will receive, at the option of the investors, either (i) a cash payment equal to the Purchase Amount, or (ii) a number of shares of the most recently issued preferred stock equal to the Purchase Amount divided by the First Financing Price. Shares of preferred stock granted in connection shall have the same liquidation rights and preferences as the shares of preferred stock issued in connection with the Company’s most recent Equity Financing.

 

During the year ended December 31, 2020, the Company raised a total of $39,618 in the Regulation Crowdfunding campaign, which was made through OpenDeal Portal LLC (the “Intermediary”). The Intermediary will be entitled to receive a 6% commission fee and 2% of the securities issued in connection with the offering, which was closed subsequent to year-end. Refer to Note 14, “Subsequent Events” for additional details.

 

Related Party Loans

 

During 2020, the Company borrowed $32,000 from James Kras, the Company’s Chief Executive Officer and Director. The funds borrowed were utilized to fund ongoing operations and do not accrue interest.

 

During 2020, the Company borrowed $25,000 from Jeanne Ciccone, a close relative of Mr. Kras. The funds borrowed were utilized to fund ongoing operations and do not accrue interest.

 

During 2020, the Company borrowed $25,000 from Michael James, the Company’s Chief Financial Officer and Director, of which $2,500 remained outstanding as of December 31, 2020. The funds borrowed were utilized to fund ongoing operations and do not accrue interest.

 

Vehicle Loan

 

On May 26, 2020, the Company entered into a financing agreement for the purchase of a vehicle. The loan, which has a principal amount of $21,000 and accrues interest at a rate of 17.51%, matures on April 26, 2024. The loan is secured by the vehicle purchased.

 

 
F-16

Table of Contents

 

NOTE 9 – LEASES

 

A lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. Operating lease right-of-use assets (“Lease Assets”) are included within “Other assets” on the Company’s consolidated balance sheet.

 

Lease assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines if an arrangement is a lease at inception. Lease assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

The discount rate used to determine the commencement date present value of lease payments is the interest rate implicit in the lease, or when that is not readily determinable, the Company utilizes its secured borrowing rate. Lease assets include any lease payments required to be made prior to commencement and exclude lease incentives. Both lease assets and lease liabilities exclude variable payments not based on an index or rate, which are treated as period costs. The Company’s lease agreements do not contain significant residual value guarantees, restrictions, or covenants.

 

During the year ended December 31, 2019 (Predecessor), total operating lease cost was $657,558, of which $428,727 was associated with short-term leases. During the three months ended March 31, 2020 (Predecessor), total operating lease cost was $196,321, of which $116,813 was associated with short-term leases. During the nine months ended December 31, 2020 (Successor), total operating lease cost was $413,000, of which $332,720 was associated with short-term leases. As of December 31, 2019 (Predecessor) and December 31, 2020 (Successor), short term lease liabilities of $37,570 and $65,019 are included in “Accounts Payable and Accrued Expenses” on the consolidated balance sheets, respectively. The table below presents total operating lease assets and lease liabilities as of December 31, 2020 (Successor):

 

 

 

Successor

 

 

 

(in thousands)

 

 

 

December 31,

 

 

 

2020

 

Operating lease assets

 

$ 269

 

Operating lease liabilities

 

$ 269

 

 

 

 

 

 

 

(in thousands)

 

 

 

Operating

 

 

 

Leases

 

2021

 

$ 107

 

2022

 

 

107

 

2023

 

 

107

 

2024

 

 

36

 

Total lease payments

 

 

357

 

Less: discount

 

 

(88 )

Total operating lease liabilities

 

$ 269

 

 

The table below presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease right-of-use assets:

 

 

 

December 31,

 

 

 

2020

 

Remaining lease term (years)

 

 

3.3

 

Discount rate

 

 

17.5 %

 

 
F-17

Table of Contents

 

NOTE 10 – TAX EXPENSE

 

The components of deferred income tax assets and (liabilities) are as follows:

 

 

 

 (in thousands)

 

 

 

Predecessor

 

 

Successor

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2020

 

Deferred tax assets:

 

 

 

 

 

 

Net Operating Losses

 

$ 4,429

 

 

$ 1,350

 

Inventory

 

 

-

 

 

 

20

 

Reserves & Allowances

 

 

4

 

 

 

41

 

Deferred Revenue

 

$ 4

 

 

$ -

 

Other

 

 

-

 

 

 

 

 

Gross deferred tax assets

 

 

4,433

 

 

 

1,411

 

Valuation allowance

 

 

(3,792 )

 

 

(762 )

Total deferred tax assets

 

 

641

 

 

 

649

 

Deferred tax Liabilities:

 

 

 

 

 

 

 

 

Depreciable asset basis differences

 

 

(641 )

 

 

(649 )

Total deferred tax liabilities

 

 

(641 )

 

 

(649 )

Net deferred tax assets (liabilities)

 

$ -

 

 

$ -

 

 

The Company did not incur income tax expense or benefit for the years ended December 31, 2019 (Predecessor) or December 31, 2020 (Successor). The reconciliation between the Company’s effective tax rate and the statutory tax rate is as follows:

 

 

(in thousands)

 

 

 

Predecessor

 

 

Successor

 

 

 

Year Ended
December 31,
2019

 

 

Period from January 1, 2020 through March 31, 2020

 

 

Period from
March 28, 2020 (inception)
through December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

Expected income tax benefit at statutory tax rate, net

 

$ (838 )

 

$ (343 )

 

$ (437 )

State taxes (net of federal tax benefits):

 

 

(362 )

 

 

(132 )

 

 

(228 )

Increase in valuation allowance

 

 

1,204

 

 

 

537

 

 

 

762

 

Loss on disposal

 

 

-

 

 

 

(62 )

 

 

-

 

Debt Forgiveness

 

 

-

 

 

 

-

 

 

 

(97 )

Asset Impairment

 

 

(7 )

 

 

-

 

 

 

-

 

Other

 

 

2

 

 

 

-

 

 

 

-

 

Reported income tax expense (benefit)

 

$ -

 

 

$ -

 

 

$ -

 

 

 
F-18

Table of Contents

 

The Company believes that income tax filing positions will be sustained upon examination and does not anticipate any adjustments that would result in a material adverse effect on the Company's financial position, results of operations or cash flows. Accordingly, the Company has not recorded any reserves, or related accruals or uncertain income tax positions as of December 31, 2020 (Successor).

 

Federal and New Jersey tax laws impose significant restrictions on the utilization of net operating loss carryforwards in the event of a change in ownership of the Company, as defined by Internal Revenue Code Section 382 (Section 382). The Company does not believe a change in ownership, as defined by Section 382, has occurred but a formal study has not been completed.

 

The Company has net operating loss carryforwards for federal and New Jersey income tax purposes of approximately $5,354,203 and $2,506,825, respectively, as of December 31, 2020 (Successor). The federal net operating loss carryforwards, if not utilized, will carryover indefinitely. The state net operating loss carryforwards, if not utilized, will expire beginning in 2040.

 

NOTE 11 – COMMITMENTS AND CONTINGENCIES

 

The Company is not currently involved with and does not know of any pending or threatening litigation against the Company.

 

NOTE 12 – RELATED PARTY TRANSACTIONS

 

The Company has entered into loan agreements with certain Officers and close relatives of Officers of the Company, the terms of which are disclosed in Note 8, “Notes Payable.”

 

During the year ended December 31, 2019 and the three-month period ended March 31, 2020, the parent company of the predecessor company provided cash contributions of $3,713,712 and $750,293, respectively, to the predecessor company, which were utilized to fund operating expenses incurred in the ordinary course of business.

 

The Company is party to an ongoing arrangement with the Predecessor whereby the Company makes lease payments of approximately $15,300 per month to the lessor of land for which the Predecessor was the lessee. The lease agreement is associated with land the Company utilizes for its ongoing operations.

 

NOTE 13 – GOING CONCERN

 

These financial statements are prepared on a going concern basis. The Company began operation in 2020. For the year ended December 31, 2020, we incurred a net loss of $2.1 million. We expect to experience further significant net losses in 2021 and the foreseeable future. At December 31, 2020, we had a cash balance of approximately $5,000. We have not been able to generate sufficient cash from operating activities to fund our ongoing operations. Since our inception, we have raised capital through our issuance of debt securities. Our future success is dependent upon our ability to achieve profitable operations and generate cash from operating activities. There is no guarantee that we will be able to generate enough revenue and/or raise capital to support our operations.

 

We will be required to raise additional funds through public or private financing, additional collaborative relationships or other arrangements until we are able to raise revenues to a point of positive cash flow. We are evaluating various options to further reduce our cash requirements to operate at a reduced rate, as well as options to raise additional funds, including obtaining loans and selling common stock. There is no guarantee that we will be able to generate enough revenue and/or raise capital to support our operations, or if we are able to raise capital, that it will be available to us on acceptable terms, on an acceptable schedule, or at all.

 

The issuance of additional securities may result in a significant dilution in the equity interests of our current stockholders. Obtaining loans, assuming these loans would be available, will increase our liabilities and future cash commitments. There is no assurance that we will be able to obtain further funds required for our continued operations or that additional financing will be available for use when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our other obligations as they become due and we will be forced to scale down or perhaps even cease our operations.

 

 
F-19

Table of Contents

 

The risks and uncertainties surrounding our ability to continue to raise capital and our limited capital resources raise substantial doubt as to our ability to continue as a going concern for twelve months from the issuance of these financial statements.

 

NOTE 14 – SUBSEQUENT EVENTS

 

In preparing the consolidated financial statements, the Company has evaluated subsequent events through September 9, 2021, which is the date the audited consolidated financial statements were available for issuance.

 

Issuances of Convertible Promissory Notes to Related Parties

 

Subsequent to December 31, 2020, the Company issued Convertible Promissory Notes (the “Notes”) with principal amounts totaling $1,200,000 and $25,200 to Mr. James and Mr. Kras (the “Holders”), respectively. The Notes mature on the earlier of (1) one year after issuance, (2) upon the closing of the Company’s next sale of equity securities in which the Company raises at least $5 million in gross proceeds (excluding the value of any instruments converting into equity in such equity financing), (3) the sale, lease, license or other disposition of all or substantially all of the assets of the Company, (4) a transaction or series of related transactions in which any person becomes the beneficial owner of more than 50% of the Company’s outstanding voting securities, or (5) upon the occurrence of an event of default.

 

The principal and interest due and owed under the Notes, which bear interest at a rate of 12.0% per annum, are convertible into shares of Common Stock at any time at the election of the Holders at a conversion price equal to $0.925 (subject to adjustment for forward reverse stock splits and the like after the issuance date). The Company may prepay any portion of the principal and accrued interest due under the Notes at any time and without penalty, upon providing ten days written notice to the Holders.

 

Subsequent to December 31, 2020 the Company issued promissory notes with principal amounts totaling $100,000 to Michael James, the Company’s Chief Financial Officer, which accrue interest at a rate of 12.00% per annum. The promissory notes mature on the earlier of (a) August 31, 2022, (b) the closing of a sale of equity securities in which the Company raises at least $5 million in gross proceeds (excluding the value of any instruments converting into equity in such equity financing), (c) the sale, lease, license or other disposition of all or substantially all of the assets of the Company, or (d) a transaction or series of related transactions in which any person becomes the beneficial owner of more than 50% of the Company’s outstanding voting securities. Payment and enforcement of the Promissory Notes is subordinate to any other debt of the Company.

  

Regulation Crowdfunding Borrowing

 

Subsequent to December 31, 2020, the Company received an additional $433,000 from the SAFE Crowdfunding campaign prior to the close of the campaign in January of 2021.

 

Accounts Receivable Factoring Agreement

 

On March 30, 2021, we entered into an accounts receivable factoring program with Quasar Capital Partners, LLC (the “Purchaser”), pursuant to which the Company agreed to provide the Purchaser with the right, but not the obligation, to purchase the Company’s receivables at book value less a discount, with full recourse.

 

Stock Split

 

On June 30, 2021, we simultaneously (1) converted Edible Garden from a Wyoming into a Delaware corporation, (2) declared a 1-for-2 reverse stock split of our common stock, and (3) increased the total number of authorized common shares to 50,000,000. On September 8, 2021, we simultaneously declared a 20-for-1 forward stock split of our common stock and increased the number of authorized common shares to 200,000,000. All historical share and per share amounts reflected throughout this report have been adjusted to reflect the stock splits described above.

 

 
F-20

Table of Contents

 

Employment Agreement

 

James Kras

 

On August 18, 2021, the Company entered into an employment agreement with James Kras whereby he will serve as Chief Executive Officer of the Company, effective as of August 18, 2021 (the “Commencement Date”) for a term of 2 years. Commencing on the second anniversary of the Commencement Date and on each anniversary of the Commencement Date thereafter (each, an "Extension Date"), the term of the Mr. Kras’ employment under the employment agreement shall be automatically extended for an additional one-year period, unless the Company or Mr. Kras provides the other at least ninety (90) days prior written notice before the next Extension Date that the term shall not be extended.

 

During the term of the agreement, the Company agreed to pay Mr. Kras an annual base salary of $300,000, subject to increase if approved by the Board or the Compensation Committee in their discretion. Mr. Kras shall be eligible to receive an annual cash bonus of up to 100% of his base salary, upon approval by the Board or the Compensation Committee.

 

Michael James

 

On August 18, 2021, the Company entered into an employment agreement with Michael James whereby he will serve as Chief Financial Officer of the Company, effective as of August 18, 2021 for a term of 2 years. Commencing on the second anniversary of the Commencement Date and on each anniversary of the Commencement Date thereafter, the term of Mr. James’ employment under the employment agreement shall be automatically extended for an additional one-year period, unless the Company or Mr. James’ provides the other at least ninety (90) days prior written notice before the next Extension Date that the term shall not be extended.

 

During the term of the agreement, the Company agreed to pay Mr. James an annual base salary of $300,000, subject to increase if approved by the Board or the Compensation Committee in their discretion. Mr. James shall be eligible to receive an annual cash bonus of up to 100% of his base salary, upon approval by the Board or the Compensation Committee.

 

 
F-21

Table of Contents

 

EDIBLE GARDEN AG INCORPORATED

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except shares)

 

 

 

December 31,

 

 

June 30,

 

 

 

2020

 

 

2021

 

ASSETS

 

Current assets:

 

 

 

 

 

 

Cash

 

$ 5

 

 

$ 15

 

Accounts receivable, net

 

 

629

 

 

 

574

 

Inventory

 

 

314

 

 

 

153

 

Prepaid expenses and other current assets

 

 

122

 

 

 

85

 

 

 

 

 

 

 

 

 

 

Total current assets

 

 

1,070

 

 

 

826

 

Property, equipment and leasehold improvements, net

 

 

3,053

 

 

 

2,722

 

Intangible assets, net

 

 

25

 

 

 

-

 

Other assets

 

 

331

 

 

 

300

 

TOTAL ASSETS

 

$ 4,479

 

 

$ 3,848

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

LIABILITIES:

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable and other accrued expenses

 

$ 2,466

 

 

$ 3,280

 

Short-term debt

 

 

-

 

 

 

433

 

Total current liabilities

 

 

2,466

 

 

 

3,714

 

Long-term liabilities:

 

 

 

 

 

 

 

 

Long-term debt, net of discounts

 

 

3,884

 

 

 

4,388

 

Long-term lease liabilities

 

 

204

 

 

 

167

 

Total long-term liabilities

 

 

4,088

 

 

 

4,555

 

Total liabilities

 

 

6,554

 

 

 

8,270

 

 

 

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES (Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ DEFICIT:

 

 

 

 

 

 

 

 

Common stock ($0.0001 par value, 200,000,000 shares authorized and outstanding as of December 31, 2020 and June 30, 2021, respectively)(1)

 

 

-

 

 

 

-

 

Additional paid-in capital

 

 

6

 

 

 

6

 

Accumulated deficit

 

 

(2,081 )

 

 

(4,428 )

Total stockholders’ deficit

 

 

(2,075 )

 

 

(4,422 )

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

$ 4,479

 

 

$ 3,848

 

_________

 

 

 

 

 

 

 

 

(1) Adjusted to reflect the stock splits as described in Note 1.

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 
F-22

Table of Contents

 

EDIBLE GARDEN AG INCORPORATED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per-share information)

 

Predecessor

 

 

Successor

 

 

 

Period from
January 1, 2020
through
March 31,
2020

 

 

Period from
April 1, 2020
through
June 30,
2020

 

 

Six Months
Ended
June 30, 2021

 

Revenue

 

$ 1,750

 

 

$ 2,649

 

 

$ 5,260

 

Cost of goods sold

 

 

1,599

 

 

 

2,327

 

 

 

4,823

 

Gross profit

 

 

151

 

 

 

322

 

 

 

437

 

Selling, general and administrative expenses

 

 

1,480

 

 

 

1,276

 

 

 

2,684

 

(Gain) / Loss on sale of assets

 

 

303

 

 

 

-

 

 

 

-

 

Loss from operations

 

 

(1,632 )

 

 

(954 )

 

 

(2,247 )

Other income / (expense)

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

-

 

 

 

(49 )

 

 

(100 )

Total other income / (expense)

 

 

-

 

 

 

(49 )

 

 

(100 )

NET LOSS

 

$ (1,632 )

 

$ (1,002 )

 

$ (2,347 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income / (Loss) per common share - basic and diluted(1)

 

$ (16,320.00 )

 

$ (0.05 )

 

$ (0.12 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average Number of Common Shares Outstanding – Basic and Diluted(1)

 

 

100

 

 

 

20,000,000

 

 

 

20,000,000

 

________ 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Successor periods are adjusted to reflect the stock splits as described in Note 1.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 
F-23

Table of Contents

  

EDIBLE GARDEN AG INCORPORATED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, except share and per-share information)

 

 

 

Predecessor

 

 

Successor

 

 

 

Period from
January 1, 2020
through
March 31,
2020

 

 

Period from
April 1, 2020
through
June 30,
2020

 

 

Six Months
Ended
June 30, 2021

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

$ (1,632 )

 

$ (1,002 )

 

$ (2,347 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Bad debt expense

 

 

172

 

 

 

3

 

 

 

-

 

Depreciation and amortization

 

 

147

 

 

 

188

 

 

 

384

 

Amortization of operating lease right of use asset

 

 

16

 

 

 

13

 

 

 

31

 

Loss from sale of assets

 

 

303

 

 

 

-

 

 

 

-

 

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

73

 

 

 

(221 )

 

 

56

 

Inventory

 

 

1

 

 

 

54

 

 

 

162

 

Prepaid expenses and other current assets

 

 

29

 

 

 

(101 )

 

 

147

 

Other assets

 

 

(110 )

 

 

-

 

 

 

-

 

Accounts payable and accrued expenses

 

 

351

 

 

 

(9 )

 

 

699

 

Operating lease liabilities

 

 

(28 )

 

 

(13 )

 

 

(31 )

NET CASH PROVIDED BY / (USED IN) OPERATING ACTIVITIES

 

 

(676 )

 

 

(1,089 )

 

 

(899 )

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, equipment and leasehold improvements

 

 

(45 )

 

 

(62 )

 

 

(28 )

Cash transferred in sale/purchase of assets

 

 

(34 )

 

 

34

 

 

 

-

 

NET CASH PROVIDED BY / (USED IN) INVESTING ACTIVITIES

 

 

(79 )

 

 

(28 )

 

 

(28 )

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Contributions from parent company

 

 

750

 

 

 

-

 

 

 

-

 

Proceeds from debt

 

 

-

 

 

 

1,322

 

 

 

906

 

Payments of debt principal

 

 

-

 

 

 

(6 )

 

 

30

 

NET CASH PROVIDED BY / (USED IN) FINANCING ACTIVITIES

 

 

750

 

 

 

1,316

 

 

 

936

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET CHANGE IN CASH

 

 

(5 )

 

 

199

 

 

 

10

 

Cash at beginning of period

 

 

5

 

 

 

-

 

 

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH AT END OF PERIOD

 

$ -

 

 

$ 199

 

 

$ 15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

 

$ -

 

 

 

3

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Debt and equity issued to acquire Predecessor's assets

 

$ -

 

 

$ 2,966

 

 

$ -

 

Debt issued to purchase vehicles

 

$ -

 

 

$ 24

 

 

$ -

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 
F-24

Table of Contents

 

EDIBLE GARDEN AG INCORPORATED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF STOCKHOLDERS’ DEFICIT

(in thousands, except shares)(1)

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-In

 

 

Accumulated

 

 

 

 

Predecessor:

 

Shares

 

 

Amount

 

 

 Capital

 

 

Deficit

 

 

Total

 

Balance at January 1, 2020

 

 

100

 

 

$ -

 

 

$ 20,118

 

 

$ (15,907 )

 

$ 4,211

 

Contributions from parent company

 

 

-

 

 

 

-

 

 

 

750

 

 

 

-

 

 

 

750

 

Net Income (Loss)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,632 )

 

 

(1,632 )

Balance at March 31, 2020

 

 

100

 

 

 

-

 

 

$ 20,869

 

 

$ (17,539 )

 

$ 3,330

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-In

 

 

Accumulated

 

 

 

 

Successor:

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

Balance at April 1, 2020

 

 

20,000,000

 

 

$ -

 

 

$ -

 

 

$ -

 

 

$ -

 

Options issued for acquisition of assets

 

 

-

 

 

 

-

 

 

 

6

 

 

 

-

 

 

 

6

 

Net Income (Loss)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,003

 

 

 

1,003

 

Balance at June 30, 2020

 

 

20,000,000

 

 

$ -

 

 

$ 6

 

 

$ 1,003

 

 

$ 1,009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30, 2021

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-In

 

 

Accumulated

 

 

 

 

Successor:

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

Balance at December 31, 2020

 

 

20,000,000

 

 

$ -

 

 

$ 6

 

 

$ (2,081 )

 

$ (2,075 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,347 )

 

 

(2,347 )

Balance at June 30, 2021

 

 

20,000,000

 

 

$ -

 

 

$ 6

 

 

$ (4,428 )

 

$ (4,422 )

___________ 

(1) Adjusted to reflect the stock splits as described in Note 1.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 
F-25

Table of Contents

 

EDIBLE GARDEN AG, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – ORGANIZATION, NATURE OF BUSINESS, AND BASIS OF PRESENTATION

 

Organization and Recent Developments

 

Edible Garden Corp., a Nevada corporation, was incorporated on April 9, 2013. On March 28, 2020, Edible Garden AG Inc., a Wyoming corporation, was incorporated for the purpose of acquiring substantially all of the operating assets of Edible Garden Corp., which was a separately identified reportable segment of its parent company Unrivaled Brands, Inc. (formerly known as Terra Tech Corporation). The acquisition was completed on March 30, 2020. Prior to March 30, 2020 Edible Garden AG, Inc. had no operations. Hereafter, Edible Garden AG, Inc. and its subsidiaries will collectively be referred to as “Edible Garden,” “we,” “us,” “our,” or the “Successor.” Edible Garden Corp., a wholly-owned subsidiary of Unrivaled Brands, Inc. will be referred to as the “Predecessor.” Throughout these financial statements, the Successor and the Predecessor are also referred to as “the Company” and used interchangeably, unless otherwise noted.

 

We authorized 100,000 shares of common stock at formation. On October 14, 2020, we simultaneously declared a 20-for-1 forward stock split of our common stock and increased the number of authorized common shares to 20,000,000. On June 30, 2021, we simultaneously (1) converted Edible Garden from a Wyoming into a Delaware corporation, (2) declared a 1-for-2 reverse stock split of our common stock, and (3) increased the total number of authorized common shares to 50,000,000. On September 8, 2021, we simultaneously declared a 20-for-1 forward stock split of our common stock and increased the number of authorized common shares to 200,000,000. All historical share and per share amounts reflected throughout this report have been adjusted to reflect the stock splits described above.

 

Nature of Business

 

Edible Garden is a retail seller of locally grown hydroponic produce, which is distributed throughout the Northeast, Midwest and Florida. Currently, Edible Garden’s products are sold at approximately 4,500 supermarkets. Our target customers are those individuals seeking fresh produce locally grown using environmentally sustainable methods.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany transactions and balances have been eliminated. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of December 31, 2020 and June 30, 2021, and the consolidated results of operations and cash flows for the six-month periods ended June 30, 2021 and 2020 have been included. For a more comprehensive understanding of the Company and its unaudited condensed consolidated financial statements, these interim financial statements should be read in conjunction with the Company’s audited financial statements for the year ended December 31, 2020 included elsewhere in this registration statement.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that we will continue as a going concern. In an effort to achieve liquidity that would be sufficient to meet all of our commitments, we have undertaken a number of actions, including minimizing capital expenditures and reducing recurring expenses.

 

However, we believe that even after taking these actions, we will not have sufficient liquidity to satisfy all of our future financial obligations. The risks and uncertainties surrounding our ability to raise capital and our limited capital resources raise substantial doubt as to our ability to continue as a going concern. See Note 12, “Going Concern” of the Notes to Consolidated Financial Statements for additional information.

 

 
F-26

Table of Contents

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates

 

The preparation of the consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reported period. Changes in these estimates and assumptions may have a material impact on the consolidated financial statements and accompanying notes.

 

Examples of significant estimates and assumptions include provisions for doubtful accounts, accrued liabilities, discount rates used in the measurement and recognition of lease liabilities and valuation of our common stock. These estimates generally involve complex issues and require us to make judgments, involve analysis of historical and future trends, can require extended periods of time to resolve, and are subject to change from period to period. In all cases, actual results could differ materially from our estimates.

 

Trade and other Receivables

 

The Company extends non-interest-bearing trade credit to its customers in the ordinary course of business which is not collateralized. Accounts receivable are shown on the face of the consolidated balance sheets, net of an allowance for doubtful accounts. The Company analyzes the aging of accounts receivable, historical bad debts, customer creditworthiness and current economic trends, in determining the allowance for doubtful accounts. The Company does not accrue interest receivable on past due accounts receivable. The reserve for doubtful accounts was $38,287 and $38,287 as of December 31, 2020 (Successor) and June 30, 2021 (Successor), respectively.

 

On March 30, 2021, we entered into an accounts receivable factoring program with Quasar Capital Partners, LLC (the “Purchaser”), pursuant to which the Company agreed to provide the Purchaser with the right, but not the obligation, to purchase the Company’s receivables at book value less a discount, with full recourse.

 

Inventory

 

We value our inventory at the lower of the actual cost of our inventory, as determined using the first-in, first-out method, or its net realizable value. We periodically review our physical inventory for excess, obsolete, and potentially impaired items and reserve accordingly. Our reserve estimate for excess and obsolete is based on expected future use. Our reserve estimates have historically been consistent with our actual experience as evidenced by actual sale or disposal of the goods.

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses consist of various payments that the Company has made in advance for goods or services to be received in the future. These prepaid expenses include advertising, insurance, and service or other contracts requiring up-front payments.

 

Property, Equipment and Leasehold Improvements, Net

 

Property, equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Our fixed assets, which are comprised of leasehold improvements, equipment and vehicles, have useful lives of five years.

 

Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property, equipment and leasehold improvements may not be recoverable in accordance with the provisions of ASC 360, “Property, Plant, and Equipment.” When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. See Note 5, “Property, Equipment and Leasehold Improvements, Net” for further information.

 

 
F-27

Table of Contents

 

Intangible Assets

 

Intangible assets continue to be subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment,” intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of June 30, 2021, Edible Garden held one intangible asset related to a non-compete agreement, which is fully amortized and has a net book value of $0.

 

The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall, or an adverse action or assessment by a regulator. If an impairment indicator exists, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified.

 

Revenue Recognition and Performance Obligations

 

Revenues are recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company does not offer returns, discounts, loyalty programs or other sales incentive programs that are material to revenue recognition. Payments from our customers are due upon delivery or within a short period after delivery.

 

Disaggregation of Revenue

 

The following table includes revenue disaggregated by revenue stream for the three months ended March 31, 2020 (Predecessor), three months ended June 30, 2020 (Successor) and the six months ended June 30, 2021 (Successor):

 

 

 

(in thousands)

 

 

 

Predecessor

 

 

Successor

 

 

 

Period from
January 1, 2020
through
March 31,
2020

 

 

Period from
April 1, 2020
through
June 30,
2020

 

 

Six months ended
June 30, 2021

 

Herbs & Produce

 

$ 1,685

 

 

$ 2,584

 

 

$ 4,967

 

Vitamins and Supplements

 

 

65

 

 

 

65

 

 

 

293

 

Total

 

$ 1,750

 

 

$ 2,649

 

 

$ 5,260

 

 

 
F-28

Table of Contents

 

Contract Balances

 

Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC Topic 606.

 

Contract Estimates and Judgments

 

The Company’s revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or variable consideration.

 

Cost of Goods Sold

 

Cost of goods sold includes materials, labor and overhead costs incurred in cultivating and producing our products.

 

Advertising Expenses

 

The Company expenses advertising costs as incurred in accordance with ASC 720-35, “Other Expenses – Advertising Cost.” Advertising expenses totaled $15,225 and $8,087 in the three months ended March 31, 2020 (Predecessor) and three months ended June 30, 2020 (Successor), respectively. For the six months ended June 30, 2021 (Successor), the advertising expense totaled $74,767.

 

Loss Per Common Share

 

In accordance with the provisions of ASC 260, “Earnings Per Share,” net loss per share is computed by dividing net loss by the weighted-average shares of common stock outstanding during the period. During a loss period, the effect of the potential exercise of stock options, warrants, convertible preferred stock, and convertible debt are not considered in the diluted loss per share calculation since the effect would be anti-dilutive. The results of operations were a net loss for the year ended December 31, 2020 and six months ended June 30, 2021. Therefore, the basic and diluted weighted-average shares of common stock outstanding were the same for all years.

 

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive include 5,000,000 options issued by Edible Garden to acquire the assets of the Predecessor. Refer to Note 3, “Asset Acquisition” for details.

 

Income Taxes

 

The provision for income taxes is determined in accordance with ASC 740, “Income Taxes”. The Company files a consolidated United States federal income tax return. The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expense are expected to be settled in our income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes. At December 31, 2020 and June 30, 2021, such net operating losses were offset entirely by a valuation allowance.

 

The Company recognizes uncertain tax positions based on a benefit recognition model. Provided that the tax position is deemed more likely than not of being sustained, the Company recognizes the largest amount of tax benefit that is greater than 50.0% likely of being ultimately realized upon settlement. The tax position is derecognized when it is no longer more likely than not of being sustained. The Company classifies income tax related interest and penalties as interest expense and selling, general and administrative expense, respectively, on the consolidated statements of operations.

 

 
F-29

Table of Contents

 

Segment reporting

 

The Company is not organized by multiple operating segments for the purpose of making operating decisions or assessing performance. Accordingly, the Company operates in one reportable operating segment. The Company’s principal decision makers are the Chief Executive Officer and its Chief Financial Officer. Management believes that its business operates as one reportable segment because: a) the Company measures profit and loss as a whole; b) the principal decision makers do not review information based on any operating segment; c) the Company does not maintain discrete financial information on any specific segment; d) the Company has not chosen to organize its business around different products and services, and e) the Company has not chosen to organize its business around geographic areas.

 

Recently Adopted Accounting Standards

 

FASB ASU No. 2020-06 “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” – Issued in August 2020, ASU 2020-06 simplifies the accounting for convertible instruments by eliminating the requirement to separate embedded conversion features from the host contract when the conversion features are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital. By removing the separation model, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost and the interest rate on convertible debt instruments will typically be closer to the coupon interest rate when applying the guidance in Topic 835, Interest. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those years. The Company adopted ASU 2020-06 as of January 1, 2021, utilizing the modified retrospective method of adoption. Adoption of the new standard did not have a material impact on the Company’s financial condition or results of operations.

 

NOTE 3 – ASSET ACQUISITION

 

On March 30, 2020, the Successor entered into and closed an Asset Purchase Agreement (the “Purchase Agreement”) with the Predecessor’s parent company, pursuant to which Edible Garden Inc. purchased substantially all of the assets of the Predecessor. The transaction did not meet the definition of the purchase of a business as defined in ASC 805, “Business Combinations” because a substantive process was not acquired. Michael James, the former Chief Financial Officer of the Predecessor’s parent company, is the Chief Financial Officer of the Successor.

 

The consideration paid for the assets included (1) a five year three million secured promissory note bearing interest at 3.5% per annum, (2) options to purchase up to 5,000,000 shares of the Successor for a nominal amount and (3) $2,011,782 of liabilities assumed.

 

Stock Options

 

The first option gives Sament the right, but not the obligation, to acquire 2,225,000 common shares of the Successor at any time between the one- and five-year anniversary of the date of the agreement, or at any time in the event of a change in control or a public offering, for a strike price of $1.00. The second option gives Sament the right, but not the obligation, to purchase 2,775,000 common shares of the Successor at any time between the one- and five-year anniversary of the agreement. The second option is automatically terminated upon payment in full of the secured promissory note.

 

Given the absence of an active market for the Successor’s common stock, the Company was required to estimate the enterprise value of the Successor company as of the date of the options. Management considered numerous objective and subjective factors in determining the value of the Company’s common stock, including the following: (1) valuations performed by an independent valuation specialist; (2) the Company’s stage of development and revenue growth, (3) the fact that the awards involved illiquid securities in a private company and (4) the likelihood of achieving a liquidity event for the shares of common stock underlying the awards, such as an initial public offering or sale of the Company, given prevailing market conditions. As the Company’s common stock is not actively traded, the determination of fair value involves assumptions, judgments, and estimates. If different assumptions were made, the initial purchase price allocation could have been significantly different. The Company estimated the fair value of the stock options using the Black-Scholes-Merton option-pricing (“Black-Scholes”) model, with the following weighted-average assumptions:

  

Expected term (years)

 

 

2.7

 

Volatility

 

 

22.0 %

Risk-free interest rate

 

 

0.3 %

Dividend yield

 

 

0.0 %

 

 
F-30

Table of Contents

 

The fair value of the consideration was allocated to the assets acquired based on their relative fair values, as follows:

 

 

 

(in thousands)

 

Consideration

 

 

 

Fair value of promissory note

 

$ 2,960

 

Fair value of options issued

 

 

6

 

Total fair value of consideration:

 

$ 2,966

 

Net book value of assets acquired

 

 

 

 

Cash

 

$ 34

 

Accounts receivable

 

 

437

 

Inventory

 

 

522

 

Prepaids and other assets

 

 

115

 

Property, plant and equipment

 

 

3,497

 

Intangible assets

 

 

62

 

Right-of-use asset

 

 

311

 

Liabilities assumed

 

 

(2,012 )

Total Net Assets Acquired

 

$ 2,966

 

 

NOTE 4 – INVENTORY

 

Inventory as of December 31, 2020 (Successor) and June 30, 2021 (Successor) consisted of the following:

 

 

 

(in thousands)

 

 

 

Successor

 

 

Successor

 

 

 

December 31,

 

 

June 30,

 

 

2020

 

2021

 

Raw materials

 

$ 156

 

 

$ 52

 

Work-in-progress

 

 

168

 

 

 

110

 

Inventory reserve

 

 

(10 )

 

 

(10 )

Total inventory

 

$ 314

 

 

$ 153

 

 

NOTE 5 – PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS, NET

 

Property, equipment and leasehold improvements (net) as of December 31, 2020 (Successor) and June 30, 2021 (Successor) consisted of the following:

 

 

 

(in thousands)

 

 

 

Successor

 

 

Successor

 

 

 

December 31,

 

 

June 30,

 

 

2020

 

2021

 

 

 

$ -

 

 

$ -

 

Furniture and equipment

 

 

537

 

 

 

563

 

Computer hardware

 

 

4

 

 

 

6

 

Leasehold improvements

 

 

3,009

 

 

 

3,009

 

Vehicles

 

 

28

 

 

 

28

 

Construction in progress

 

 

4

 

 

 

4

 

 

 

 

 

 

 

 

 

 

Subtotal

 

 

3,583

 

 

 

3,610

 

Less accumulated depreciation

 

 

(530 )

 

 

(889 )

Property, equipment and leasehold improvements, net

 

$ 3,053

 

 

$ 2,722

 

 

 
F-31

Table of Contents

 

Depreciation expense related to property, equipment and leasehold improvements for the three months ended March 31, 2020 (Predecessor) was $134,874. Depreciation expense for the three months ended June 30, 2020 (Successor) was $40,173. Depreciation expense for the six months ended June 30, 2021 (Successor) was $359,066.

 

NOTE 6 – INTANGIBLE ASSETS

 

Intangible assets consisted of the following as of December 31, 2020 and June 30, 2021:

 

 

(in Thousands)

 

 

 

 

 

Successor

 

 

Successor

 

 

 

 

 

 

December 31, 2020

 

 

June 30, 2021

 

 

 

Estimated Useful Life in Years

 

 

Gross

Carrying Amount

 

 

Accumulated Amortization 

 

 

Net

Carrying

Value

 

 

Gross

Carrying Amount 

 

 

Accumulated Amortization

 

 

Net

Carrying Value 

 

Amortizing Intangible Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non Compete

 

 

2

 

 

 

62

 

 

 

(37 )

 

 

25

 

 

 

62

 

 

$ (62 )

 

 

-

 

Total Intangible Assets, net

 

 

 

 

 

 

62

 

 

 

(37 )

 

 

25

 

 

 

62

 

 

 

(62 )

 

 

-

 

  

NOTE 7 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consisted of the following as of December 31, 2020 (Successor) and June 30, 2021 (Successor):

 

 

 

(in thousands)

 

 

Successor

 

Successor

 

 

December 31,

2020

 

June 30,

2020

 

 

 

 

 

 

 

 

Accounts payable

 

$ 1,929

 

 

$ 2,666

 

Accrued expenses

 

 

173

 

 

 

217

 

Accrued interest payable

 

 

96

 

 

 

41

 

Accrued payroll

 

 

106

 

 

 

188

 

Accrued vacation

 

 

97

 

 

 

97

 

Current lease liability

 

 

65

 

 

 

71

 

 

 

 

 

 

 

 

 

 

Total Accounts Payable and Accrued Expenses

 

$ 2,466

 

 

$ 3,280

 

 

 
F-32

Table of Contents

 

NOTE 8 – NOTES PAYABLE

 

Notes payable consisted of the following as of December 31, 2020 (Successor) and June 30, 2021 (Successor):

 

 

 

(in thousands)

 

 

 

Successor

 

 

Successor

 

 

 

December 31,

 

 

June 30,

 

 

2020

 

2021

 

Secured promissory note

 

$ 3,653

 

 

$ 3,760

 

SBA loan

 

 

150

 

 

 

150

 

SAFE agreements

 

 

40

 

 

 

474

 

Related party loans

 

 

60

 

 

 

428

 

Vehicle Loan

 

 

21

 

 

 

18

 

Other loans

 

 

-

 

 

 

30

 

Total Gross Debt

 

$ 3,923

 

 

$ 4,860

 

 

 

 

 

 

 

 

 

 

Less: Short term debt

 

 

-

 

 

 

(433 )

Less:  Debt discount

 

 

(40 )

 

 

(39 )

Net Long Term Debt

 

$ 3,884

 

 

$ 4,388

 

 

Scheduled maturities of long-term debt as of June 30, 2021, are as follows (in thousands):

 

Years Ending June 30,

 

 

 

2021

 

$ 30

 

2022

 

 

403

 

2023

 

 

654

 

2024

 

 

18

 

2025

 

 

3,106

 

Thereafter

 

 

649

 

 

 

$ 4,860

 

 

Secured Promissory Notes

 

On March 30, 2020, the Company entered into a promissory note (the “Note”) for $3,000,000 with Sament in connection with the acquisition of the Predecessor’s assets. The Note accrues interest at a rate of 3.5% per annum on a 360-day year basis and matures March 30, 2025. During the six-month period ended June 30, 2021, accrued interest of $106,458 was added to the principal. The Note is secured by the assets purchased in connection with the asset acquisition. See Note 3, “Asset Acquisition” for additional details.

 

On June 2, 2020, the Company entered into a promissory note for $653,870 with Sament, which accrues interest at a rate of 3.50% per annum and matures on June 3, 2023. The promissory note is secured by the assets purchased in connection with the asset acquisition.

 

 
F-33

Table of Contents

 

Small Business Administration (“SBA”) Loans

 

On April 30, 2020, the Company received approval from the U.S. Small Business Administration (“SBA”) to fund the Company’s request for a loan under the Paycheck Protection Program (“PPP Loan”) created as part of the recently enacted Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) administered by the SBA. In connection with the PPP Loan, the Company entered into a promissory note in the principal amount of $503,655. The Company used the entire loan amount for qualifying expenses and the loan was forgiven in its entirety on December 27, 2020.

 

On June 22, 2020, the Company entered into a U.S. Small Business Administration Loan Authorization and Agreement pursuant to which the Company received loan proceeds of $150,000 (the “SBA Loan”). The SBA Loan was made under, and is subject to the terms and conditions of, the Economic Injury Disaster Loan Program, which was a program expanded for COVID-19 relief under the CARES Act and is administered by the U.S. Small Business Administration. The term of the SBA Loan is thirty (30) years with a maturity date of June 22, 2050 and the annual interest rate of the SBA Loan is a fixed rate of 3.75%. Under the terms of the CARES Act, the use of loan proceeds for the SBA Loan is limited to alleviating economic injury caused by the COVID-19 pandemic.

 

SAFE Agreements

 

During the year ended December 31, 2020, the Company entered into Simple Agreements for Future Equity (“SAFEs”) with investors through a Regulation Crowdfunding campaign in exchange for cash investments. Upon a future equity financing of greater than $1,000,000, the SAFE securities are convertible at the option of the Company into securities identical to those issued in the future equity financing (“Shadow Securities”), except (1) they do not have the right to vote except as required by law, (2) they must vote in accordance with the majority of the investors in such future equity financing with respect to any such required vote and (3) they are not entitled to any inspection or information rights. If the Company elects to convert the securities upon the closing of a future equity financing, the investors will receive the number of Shadow Securities equal to the greater the quotient obtained by dividing the amount the investor paid (the “Purchase Amount”) for the securities by:

 

 

(c)

the quotient of $18,500,000 divided by the aggregate number of issued and outstanding shares of capital stock, assuming full conversion or exercise of all convertible and exercisable securities then outstanding, including shares of convertible preferred stock and all outstanding vested or unvested options or warrants to purchase capital stock, but excluding (i) the issuance of all shares of capital stock reserved and available for future issuance under any of the Company’s existing equity incentive plans, (ii) convertible promissory notes issued by the Company, (iii) any SAFEs, and (iv) any equity securities that are issuable upon conversion of any outstanding convertible promissory notes or SAFEs, or

 

 

 

 

(d)

the lowest price per share of the securities sold in such future equity financing.

  

The price (either (a) or (b)) determined above shall be deemed the “First Financing Price” and may be used to establish the conversion price of the securities at a later date, even if the Company does not choose to convert the SAFE securities upon the first future equity financing.

 

Upon an initial public offering of the Company’s common shares or a change of control (a “Liquidity Event”) prior to any equity financing, the investors will receive, at the option of the investors, either (i) a cash payment equal to the purchase amount or (ii) a number of shares of common stock of the Company equal to the purchase amount divided by the quotient of (a) $18,500,000 divided by (b) the number, as of immediately prior to the Liquidity Event, of shares of the Company’s capital stock (on an as-converted basis) outstanding, assuming exercise or conversion of all outstanding, vested and unvested options, warrants and other convertible securities, but excluding (di) shares of common stock reserved and available for future grant under any equity incentive or similar plan; (ii) any SAFEs; and (iii) convertible promissory notes.

 

 
F-34

Table of Contents

 

In the case of a Liquidity Event following any equity financing, the investors will receive, at the option of the investors, either (i) a cash payment equal to the Purchase Amount, or (ii) a number of shares of the most recently issued preferred stock equal to the Purchase Amount divided by the First Financing Price. Shares of preferred stock granted in connection shall have the same liquidation rights and preferences as the shares of preferred stock issued in connection with the Company’s most recent Equity Financing.

 

During the year ended December 31, 2020, the Company raised a total of $39,618 in the Regulation Crowdfunding campaign, which was made through OpenDeal Portal LLC (the “Intermediary”). The Intermediary will be entitled to receive a 6% commission fee and 2% of the securities issued in connection with the offering, which was closed in January 2021. The Company received an additional $433,000 from the SAFE Crowdfunding campaign prior to the close of the campaign in January of 2021.

 

Related Party Loans

 

The Company borrowed $32,000 from James Kras, the Company’s Chief Executive Officer and Director. During 2021, the Company borrowed and additional $3,200 from Mr. Kras. The funds borrowed were utilized to fund ongoing operations and do not accrue interest. The outstanding balance as of June 30, 2021 is $25,200.

 

During 2020, the Company borrowed $25,000 from Jeanne Ciccone, a close relative of James Kras. The funds borrowed were utilized to fund ongoing operations and do not accrue interest. The debt was fully repaid in January 2021 and there is no outstanding amount as of June 30, 2021.

 

During 2020, the Company borrowed $25,000 from Michael James, the Company’s Chief Financial Officer and Director, of which $2,500 remained outstanding as of December 31, 2020. The funds borrowed were utilized to fund ongoing operations and do not accrue interest.

 

During 2021, the Company issued Convertible Promissory Notes (the “Notes”) with principal amounts totaling $400,000 Michael James, the Company’s Chief Financial Officer (the “Holder”). The Notes mature on the earlier of (1) one year after issuance, (2) upon the closing of the Company’s next sale of equity securities in which the Company raises at least $5.00 million in gross proceeds (excluding the value of any instruments converting into equity in such equity financing), (3) the sale, lease, license or other disposition of all or substantially all of the assets of the Company, (4) a transaction or series of related transactions in which any person becomes the beneficial owner of more than 50% of the Company’s outstanding voting securities, or (5) upon the occurrence of an event of default.

 

The principal and interest due and owed under the Notes, which bear interest at a rate of 12.00% per annum, are convertible into shares of Common Stock at any time at the election of the Holders at a conversion price equal to $0.925 (subject to adjustment for forward reverse stock splits and the like after the issuance date). The Company may prepay any portion of the principal and accrued interest due under the Notes at any time and without penalty, upon providing ten days written notice to the Holders.

 

Other Loans

 

During 2021, the Company issued promissory notes with principal amounts totaling $70,000 to an unaffiliated third party, of which $30,000 was outstanding as of June 30, 2021. The outstanding note accrues interest at a simple rate of 1.50% per month. In the event the note is not repaid by July 21, 2021, a penalty of 10.0% is added to the final payment and interest accrues at the rate of 2.00% per month.

 

Vehicle Loan

 

On May 26, 2020, the Company entered into a financing agreement for the purchase of a vehicle. The loan, which accrues interest at a rate of 17.51%, matures on April 26, 2024. The loan is secured by the vehicle purchased.

 

 
F-35

Table of Contents

 

NOTE 9 – LEASES

 

A lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. Operating lease right-of-use assets (“Lease Assets”) are included within “Other assets” on the Company’s consolidated balance sheet.

 

Lease assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines if an arrangement is a lease at inception. Lease assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

The discount rate used to determine the commencement date present value of lease payments is the interest rate implicit in the lease, or when that is not readily determinable, the Company utilizes its secured borrowing rate. Lease assets include any lease payments required to be made prior to commencement and exclude lease incentives. Both lease assets and lease liabilities exclude variable payments not based on an index or rate, which are treated as period costs. The Company’s lease agreements do not contain significant residual value guarantees, restrictions, or covenants.

 

During the six month period ended June 30, 2021, total operating lease cost was $242,623, of which $189,103 was associated with short-term leases. During the three months ended March 31, 2020 (Predecessor), total operating lease cost was $196,321, of which $116,813 was associated with short-term leases. During the three months ended June 30, 2020 (Successor), total operating lease cost was $122,633, of which $95,873 was associated with short-term leases. As of December 31, 2020 (Successor) and June 30, 2021 (Successor), short term lease liabilities of $65,019 and $70,923 are included in “Accounts Payable and Accrued Expenses” on the consolidated balance sheets, respectively. The table below presents total operating lease assets and lease liabilities as of June 30, 2021 (Successor):

 

 

 

Successor

 

 

 

(in thousands)

 

 

 

June 30,

 

 

 

2021

 

Operating lease assets

 

$ 238

 

Operating lease liabilities

 

$ 238

 

 

 

 

 

 

 

 

(in thousands)

 

 

 

Operating

 

Leases

2021

 

$ 54

 

2022

 

 

107

 

2023

 

 

107

 

2024

 

 

36

 

Total lease payments

 

 

303

 

Less: discount

 

 

(65 )

Total operating lease liabilities

 

$ 238

 

 

The table below presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease right-of-use assets:

 

 

 

June 30,

 

 

 

2021

 

Remaining lease term (years)

 

 

2.8

 

Discount rate

 

 

17.5 %

 

 
F-36

Table of Contents

 

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

The Company is not currently involved with and does not know of any pending or threatening litigation against the Company.

 

NOTE 11 – RELATED PARTY TRANSACTIONS

 

The Company has entered into loan agreements with certain Officers and close relatives of Officers of the Company, the terms of which are disclosed in Note 8, “Notes Payable.”

 

The Company is party to an ongoing arrangement with the Predecessor whereby the Company makes lease payments of approximately $15,300 per month to the lessor of land for which the Predecessor is the lessee. The lease agreement is associated with land the Company utilizes for its ongoing operations.

 

NOTE 12 – GOING CONCERN

 

These financial statements are prepared on a going concern basis. The Company began operation in 2020. For the year ended December 31, 2020, and six months ended June 30, 2021 we incurred a net loss of $2.1 million and 2.3 million respectively. We expect to experience further significant net losses in 2021 and the foreseeable future. At June 30, 2021, we had a cash balance of approximately $15,000. We have not been able to generate sufficient cash from operating activities to fund our ongoing operations. Since our inception, we have raised capital through our issuance of debt securities. Our future success is dependent upon our ability to achieve profitable operations and generate cash from operating activities. There is no guarantee that we will be able to generate enough revenue and/or raise capital to support our operations.

 

We will be required to raise additional funds through public or private financing, additional collaborative relationships or other arrangements until we are able to raise revenues to a point of positive cash flow. We are evaluating various options to further reduce our cash requirements to operate at a reduced rate, as well as options to raise additional funds, including obtaining loans and selling common stock. There is no guarantee that we will be able to generate enough revenue and/or raise capital to support our operations, or if we are able to raise capital, that it will be available to us on acceptable terms, on an acceptable schedule, or at all.

 

The issuance of additional securities may result in a significant dilution in the equity interests of our current stockholders. Obtaining loans, assuming these loans would be available, will increase our liabilities and future cash commitments. There is no assurance that we will be able to obtain further funds required for our continued operations or that additional financing will be available for use when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our other obligations as they become due and we will be forced to scale down or perhaps even cease our operations.

 

The risks and uncertainties surrounding our ability to continue to raise capital and our limited capital resources raise substantial doubt as to our ability to continue as a going concern for twelve months from the issuance of these financial statements.

 

NOTE 13 – SUBSEQUENT EVENTS

 

In preparing the unaudited consolidated financial statements, the Company has evaluated subsequent events through November 1, 2021, which is the date the unaudited consolidated financial statements were available for issuance.

 

Issuances of Convertible Promissory Notes to Related Parties

 

Subsequent to June 30, 2021, the Company issued Convertible Promissory Notes (the “Notes”) with principal amounts totaling $725,000 and $25,200 to Mr. James and Mr. Kras (the “Holders”), respectively. The Notes mature on the earlier of (1) one year after issuance, (2) upon the closing of the Company’s next sale of equity securities in which the Company raises at least $5 million in gross proceeds (excluding the value of any instruments converting into equity in such equity financing), (3) the sale, lease, license or other disposition of all or substantially all of the assets of the Company, (4) a transaction or series of related transactions in which any person becomes the beneficial owner of more than 50% of the Company’s outstanding voting securities, or (5) upon the occurrence of an event of default.

 

 
F-37

Table of Contents

 

The principal and interest due and owed under the Notes, which bear interest at a rate of 12.0% per annum, are convertible into shares of Common Stock at any time at the election of the Holders at a conversion price equal to $0.925 (subject to adjustment for forward reverse stock splits and the like after the issuance date). The Company may prepay any portion of the principal and accrued interest due under the Notes at any time and without penalty, upon providing ten days written notice to the Holders.

 

Subsequent to June 30, 2021 the Company issued Promissory Notes with principal amounts totaling $610,000 to Michael James, the Company’s Chief Financial Officer, which accrue interest at a rate of 12.00% per annum. The Promissory Notes mature on the earlier of (a) August 31, 2022, (b) the closing of a sale of equity securities in which the Company raises at least $5 million in gross proceeds (excluding the value of any instruments converting into equity in such equity financing), (c) the sale, lease, license or other disposition of all or substantially all of the assets of the Company, or (d) a transaction or series of related transactions in which any person becomes the beneficial owner of more than 50% of the Company’s outstanding voting securities. Payment and enforcement of the Promissory Notes is subordinate to any other debt of the Company.

 

Evergreen Private Placement

 

Subsequent to June 30, 20201, the Company issued a 15% original issue discount secured promissory note to Evergreen Capital Management LLC and a warrant to purchase 751,623 shares of our common stock. The Note matures on July 7, 2022 and incurs interest at a rate of 5.0% per annum. The Note is secured and subordinated to the notes held by Sament. Evergreen may elect to convert the Note into shares of common stock at a conversion price of $1.53 per share. If the Note is not converted into shares of common stock prior to the closing of an public offering, then the Company will repay the amount due under the Note with some of the proceeds of the offering. The Warrant may be exercised for the underlying shares of common stock at an exercise price of $1.53 per share until October 7, 2026.  The Company has the option to issue up to $1.0 million in additional notes and warrants to Evergreen before January 10, 2022.

  

Stock Split

 

On September 8, 2021, we simultaneously declared a 20-for-1 forward stock split of our common stock and increased the number of authorized common shares to 200,000,000. All historical share and per share amounts reflected throughout this report have been adjusted to reflect the stock splits described above.

 

Employment Agreement

 

James Kras

 

On August 18, 2021, the Company entered into an employment agreement with James Kras whereby he will serve as Chief Executive Officer of the Company, effective as of August 18, 2021 (the “Commencement Date”) for a term of 2 years. Commencing on the second anniversary of the Commencement Date and on each anniversary of the Commencement Date thereafter (each, an "Extension Date"), the term of the Mr. Kras’ employment under the employment agreement shall be automatically extended for an additional one-year period, unless the Company or Mr. Kras provides the other at least ninety (90) days prior written notice before the next Extension Date that the term shall not be extended.

 

During the term of the agreement, the Company agreed to pay Mr. Kras an annual base salary of $300,000, subject to increase if approved by the Board or the Compensation Committee in their discretion. Mr. Kras shall be eligible to receive an annual cash bonus of up to 100% of his base salary, upon approval by the Board or the Compensation Committee.

 

Michael James

 

On August 18, 2021, the Company entered into an employment agreement with Michael James whereby he will serve as Chief Financial Officer of the Company, effective as of August 18, 2021 for a term of 2 years. Commencing on the second anniversary of the Commencement Date and on each anniversary of the Commencement Date thereafter, the term of Mr. James’ employment under the employment agreement shall be automatically extended for an additional one-year period, unless the Company or Mr. James’ provides the other at least ninety (90) days prior written notice before the next Extension Date that the term shall not be extended.

 

During the term of the agreement, the Company agreed to pay Mr. James an annual base salary of $300,000, subject to increase if approved by the Board or the Compensation Committee in their discretion. Mr. James shall be eligible to receive an annual cash bonus of up to 100% of his base salary, upon approval by the Board or the Compensation Committee.

  

 
F-38

Table of Contents

 

Through and including            , 2021 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This requirement is in addition to a dealers’ obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or membership.

 

 

 

Shares of

Common Stock

 

EDIBLE GARDEN AG INCORPORATED

_________________________

 

PROSPECTUS

_________________________

 

Sole Book-Running Manager

Maxim Group LLC

 

, 2021

 

 

 

 

Table of Contents

  

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 13. Other Expenses of Issuance and Distribution

 

The following table sets forth the various expenses, all of which will be borne by the registrant, in connection with the sale and distribution of the securities being registered, other than the underwriting discounts and commissions. All amounts shown are estimates except for the SEC registration fee and the FINRA filing fee.

 

SEC registration fee

 

$

8,612

 

FINRA fees

 

$

14,434

 

Printing and engraving expenses

 

$

1,500

 

Accounting fees and expenses

 

$

100,000

 

Legal fees and expenses

 

$

550,000

 

Miscellaneous

 

$

25,454

 

Total

 

$

700,000

 

 

Item 14. Indemnification of Directors and Officers.

 

Section 102(b)(7) of the Delaware General Corporation Law (“DGCL”) provides that a Delaware corporation, in its certificate of incorporation, may limit the personal liability of a director to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except for liability for any:

 

 

·

transaction from which the director derived an improper personal benefit;

 

·

act or omission not in good faith or that involved intentional misconduct or a knowing violation of law;

 

·

unlawful payment of dividends or redemption of shares; or

 

·

breach of the director’s duty of loyalty to the corporation or its stockholders.

  

Under Section 145 of the DGCL, we can indemnify our directors and officers against liabilities they may incur in such capacities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Our certificate of incorporation (Exhibit 3.1 to this registration statement) provides that we must indemnify our directors and officers to the fullest extent permitted by law and requires us to pay expenses incurred in defending or other participating in any proceeding in advance of its final disposition upon our receipt of an undertaking by the director or officer to repay such advances if it is ultimately determined that the director or officer is not entitled to indemnification. Our certificate of incorporation further provides that rights conferred under such certificate of incorporation do not exclude any other right such persons may have or acquire under the certificate of incorporation, the bylaws, any statute, agreement, vote of stockholders or disinterested directors or otherwise.

 

The amended and restated certificate of incorporation also provides that, pursuant to Delaware law, our directors shall not be liable for monetary damages for breach of the directors’ fiduciary duty of care to us and our stockholders. This provision in the certificate of incorporation does not eliminate the duty of care, and in appropriate circumstances equitable remedies such as injunctive or other forms of non-monetary relief will remain available under Delaware law. In addition, each director will continue to be subject to liability for breach of the director’s duty of loyalty to us for acts or omissions not in good faith or involving intentional misconduct, or knowing violations of law, for actions leading to improper personal benefit to the director, and for payment of dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The provision also does not affect a director’s responsibilities under any other law, such as the federal securities laws or state or federal environmental laws. We also intend to obtain directors’ and officers’ liability insurance pursuant to which our directors and officers are insured against liability for actions taken in their capacities as directors and officers.

 

In addition, we intend to enter into agreements to indemnify our directors and certain of our officers in addition to the indemnification provided for in the certificate of incorporation. These agreements, among other things, indemnify our directors and some of our officers for certain expenses (including attorney’s fees), judgments, fines and settlement amounts incurred by such person in any action or proceeding, including any action by or in our right, on account of services by that person as a director or officer of our company or as a director or officer of our subsidiary, or as a director or officer of any other company or enterprise that the person provides services to at our request.

 

 
II-1

Table of Contents

 

The underwriting agreement(s) that the Registrant may enter into may provide for indemnification by any underwriters of the Registrant, its directors, its officers who sign the registration statement and the Registrant’s controlling persons for some liabilities, including liabilities arising under the Securities Act.

 

Item 15. Recent Sales of Unregistered Securities.

 

The information below lists all of the securities sold by us during the past three years which were not registered under the Securities Act:

 

 

·

On October 7, 2021, we issued a 15% original issue discount secured promissory note to Evergreen Capital Management LLC and a warrant to purchase 751,623 shares of our common stock for an aggregate of $1.0 million. As part of the private placement, Maxim received a cash fee equal to 6% of the private placement proceeds. The offering was conducted pursuant to an exemption from registration under the Securities Act in reliance upon Rule 506(b) promulgated under the Securities Act.

 

 

 

 

·

From April 28, 2020 through October 4, 2021, we issued demand, convertible and promissory notes to our officers pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act. See “Certain Relationships and Related Party Transactions” for more information.

 

 

 

 

·

From October 2020 through April 2021, we issued approximately $538 thousand in our Series 2020 Crowd SAFEs pursuant to an exemption from registration under the Securities Act available under Regulation Crowdfunding for cash. The Crowd SAFEs may convert into this offering at the option of the holder at a conversion price equal to their investment divided by $18.5 million divided by 25 million shares (outstanding as of immediately prior to the offering).

 

 

 

 

·

In March 2020, we issued two options to Sament Capital Investments, Inc. to purchase an aggregate of 5,000,000 shares of our common stock pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act. The first option granted Sament the right to purchase 2,225,000 shares of our common stock at an exercise price of $1.00 for all of the underlying shares. The second option granted Sament the right to purchase 2,775,000 shares of our common stock at an exercise price of $1.00 for all of the shares underlying the option any time prior to March 30, 2025. Both options were exercised as of October 8, 2021 for the aggregate exercise price of $2.00 pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act.

 

 

 

 

·

Upon our inception in March 2020, we issued 9,000,000, 9,000,000, and 2,000,000 shares of common stock (after the effect of all forward stock splits to date) to Mr. Kras, Mr. James, and Mr. Rodrigues, respectively, pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act.

  

Item 16. Exhibits and Financial Statement Schedules.

 

The following exhibits to this registration statement included in the Index to Exhibits are incorporated by reference.

 

 
II-2

Table of Contents

 

INDEX TO EXHIBITS

 

Exhibit No.

 

Description

1.1**

 

Form of Underwriting Agreement

3.1*

 

Certificate of Incorporation

3.2*

 

Certificate of Amendment to the Certificate of Incorporation

3.3**

 

Amended and Restated Bylaws of Edible Garden AG Incorporated

4.1*

 

Form of Series 2020 SAFE

4.2**

 

Form of Representative's Warrant

5.1**

 

Opinion of Harter Secrest & Emery LLP

10.1*±

 

Asset Purchase Agreement, by and between Edible Garden Corp. and the Company, effective as of March 30, 2020

10.2*

 

Purchase Agreement, by and between Terra Tech Corporation and the Company, effective as of March 30, 2020

10.3*

 

Secured Promissory Note by the Company in favor of Sament Capital Investments, Inc., dated March 30, 2020

10.4*

 

Security Agreement, by and between Sament Capital Investments, Inc. and the Company, dated March 30, 2020

10.5*

 

Option Agreement #1, by and between Sament Capital Investments, Inc. and the Company, dated as of March 30, 2020

10.6*

 

Option Agreement #2, by and between Sament Capital Investments, Inc. and the Company, dated as of March 30, 2020

10.7*

 

Secured Promissory Note by the Company in favor of Sament Capital Investments, Inc., dated June 3, 2020

10.8*

 

Form of Demand Note to Officer

10.9*

 

Form of Convertible Note to Officer

10.10*

 

Form of Promissory Note to Officer

10.11*

 

Accounts Receivable Purchasing Agreement by and between the Company and Quasar Capital Partners, LLC, dated as of March 30, 2021

10.12*

 

Security Agreement by and between the Company and Quasar Capital Partners, LLC, dated as of March 30, 2021

10.13*

 

Intercreditor Agreement and Amendment among Sament Capital Investments, Inc., the Company, and Quasar Capital Partners, LLC, dated as of April 13, 2021

10.14*

 

Performance Guaranty and Suretyship by and between Michael James and Quasar Capital Partners, LLC, dated as of April 13, 2021

10.15*+

 

Executive Employment Agreement, by and between the Company and James E. Kras, dated as of August 18, 2021

10.16*+

 

Executive Employment Agreement, by and between the Company and Michael C. James, dated as of August 18, 2021

10.17*±

 

Securities Purchase Agreement, by and between the Company and Evergreen Capital Management LLC, dated as of October 7, 2021

10.17a*

 

15% OID Senior Secured Promissory Note Due July 7, 2022

10.17b*

 

Common Stock Purchase Warrant, dated October 7, 2021

10.18*

 

Amendment to Securities Purchase Agreement, by and between the Company and Evergreen Capital Management LLC, dated as of October 14, 2021.

10.19*±

 

Security Agreement, by and between the Company and Evergreen Capital Management LLC, dated as of October 7, 2021

10.20*

 

Guaranty and Security Agreement, by and between the Company and Evergreen Capital Management LLC, dated as of October 7, 2021

10.21*

 

Intercreditor Agreement, by and between the Company, Sament Capital Investments, Inc. and Evergreen Capital Management LLC, dated as of October 7, 2021

10.22**+

 

Edible Garden AG Incorporated 2021 Equity Incentive Plan

14**

 

Code of Business Conduct and Ethics

21.1*

 

List of Subsidiaries

23.1*

 

Consent of Marcum LLP

23.2**

 

Consent of Harter Secrest & Emery LLP (included in Exhibit 5.1)

24.1**

 

Power of Attorney (included on signature page to this Registration Statement)

99.1*

 

Consent of Mathew McConnell

99.2*

 

Consent of Tracy A. Nazzaro

99.3*

 

Consent of Ryan Rogers

____________

* Filed herewith.

 

** To be filed by amendment.

 

+ Management contract or compensatory arrangement.

 

± Certain information has been omitted from this exhibit in reliance upon Item 601(a)(5) of Regulation S-K and will be furnished to the Securities and Exchange Commission upon request.

  

 
II-3

Table of Contents

  

Item 17. Undertakings.

 

The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.

 

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

The undersigned registrant hereby undertakes that:

 

 

(1)

For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act of 1933 shall be deemed to be part of this registration statement as of the time it was declared effective.

 

 

 

 

(2)

For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

 
II-4

Table of Contents

  

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Belvidere, State of New Jersey, on November 1, 2021.

 

 

EDIBLE GARDEN AG INCORPORATED

 

 

 

By:

/s/ James E. Kras

 

 

Name:

James E. Kras

 

 

Title:

Chief Executive Officer and President

 

 

 

(principal executive officer)

 

 

POWER OF ATTORNEY

 

Each person whose signature appears below appoints James E. Kras and Michael James, and each of them, each of whom may act without the joinder of the other, as his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for him and in his name, place and stead, in any and all capacities to sign any and all amendments (including post-effective amendments) to this registration statement (and to any registration statement filed pursuant to Rule 462 under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or would do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ James E. Kras

 

Chief Executive Officer, President and Director

 

November 1, 2021

James E. Kras

 

(principal executive officer)

 

 

 

 

 

 

 

/s/ Michael James

 

Chief Financial Officer, Treasurer, Secretary and Director

 

November 1, 2021

Michael James

 

(principal financial and accounting officer)

 

 

 

 

64

 

EXHIBIT 3.1

 

CERTIFICATE OF INCORPORATION
OF
EDIBLE GARDEN AG INCORPORATED

 

ARTICLE ONE

 

The name of the Corporation is Edible Garden AG Incorporated.

 

ARTICLE TWO

 

The address of the Corporation’s registered office in the State of Delaware is 300 Creek View Road, Suite 209, in the City of Newark, County of New Castle, State of Delaware, 19711. The name of its registered agent at such address is Universal Registered Agents, Inc.

 

ARTICLE THREE

 

The nature of the business or purposes to be conducted or promoted is to engage in any lawful act or activity for which Corporations may be organized under the General Corporation Law of the State of Delaware.

 

ARTICLE FOUR

 

The total number of shares of stock which the Corporation has authority to issue is Fifty Million (50,000,000) shares of Common Stock, par value $0.0001 per share.

 

ARTICLE FIVE

 

The name and mailing address of the sole incorporator are as follows:

 

James Kras

30 N. Gould Street, Suite R

Sheridan, Wyoming 82801

 

ARTICLE SIX

 

The Corporation is to have perpetual existence.

 

ARTICLE SEVEN

 

In furtherance and not in limitation of the powers conferred by statute, the board of directors of the Corporation is expressly authorized to make, alter or repeal the by-laws of the Corporation.

 

ARTICLE EIGHT

 

Meetings of stockholders may be held within or without the State of Delaware, as the by-laws of the Corporation may provide. The books of the Corporation may be kept outside the State of Delaware at such place or places as may be designated from time to time by the board of directors or in the by-laws of the Corporation. Election of directors need not be by written ballot unless the by-laws of the Corporation so provide.

 

 
1

 

 

ARTICLE NINE

 

To the fullest extent permitted by the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended, a director of this Corporation shall not be liable to the Corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director. Any repeal or modification of this Article Nine shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification.

 

ARTICLE TEN

 

The Corporation expressly elects not to be governed by Section 203 of the General Corporation Law of the State of Delaware.

 

ARTICLE ELEVEN

 

The Corporation reserves the right to amend, alter, change or repeal any provision contained in this certificate of incorporation in the manner now or hereafter prescribed herein and by the laws of the State of Delaware, and all rights conferred upon stockholders herein are granted subject to this reservation.

 

ARTICLE TWELVE

 

Each person who was or is a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a “proceeding”), by reason of the fact that he or she, or a person of whom he or she is the legal representative, is or was a director or officer of the Corporation or who is or was serving at the request of the Corporation as a director, manager, officer, trustee, employee or agent of another corporation or of a partnership, limited liability company, joint venture, trust, nonprofit entity or other enterprise, including service with respect to employee benefit plans (an “indemnitee”), whether the basis of the proceeding is alleged action in an official capacity as a director, manager, officer, trustee, employee or agent or in any other capacity while serving as a director, manager, officer, trustee, employee or agent, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the General Corporation Law of the State of Delaware, as the same now or may hereafter exist (but, in the case of any change, only to the extent that such change authorizes the Corporation to provide broader indemnification rights than the law permitted the Corporation to provide prior to such change) against all expenses, liabilities and losses (including attorneys’ fees, judgments, fines, ERISA excise taxes or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by the indemnitee in connection therewith and such indemnification shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the indemnitee’s heirs, executors and administrators. The Corporation shall be required to indemnify a person in connection with a proceeding (or part thereof) initiated by such person, only if the proceeding (or part thereof) was authorized by the Board of Directors of the Corporation. The right to indemnification conferred in this Article Twelve shall not be exclusive of any other right which any indemnitee may have or hereafter acquire under any statute, certificate of incorporation, bylaw, agreement, vote of stockholders or disinterested directors, or otherwise. In any suit brought by the indemnitee to enforce a right to indemnification hereunder or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article Twelve or otherwise shall be on the Corporation. Any amendment, modification or repeal of any provision of this Article Twelve, whether by the stockholders or Board of Directors of the Corporation, shall not adversely affect any right or protection of an indemnitee in respect of any act or omission occurring prior to the time of such amendment, modification or repeal.

 

 
2

 

 

ARTICLE THIRTEEN

 

To the maximum extent permitted from time to time under the law of the State of Delaware, the Corporation renounces any interest or expectancy of the Corporation in, or in being offered an opportunity to participate in, business opportunities that are from time to time presented to its officers, directors or stockholders, other than those officers, directors or stockholders who are also employees of the Corporation. No amendment or repeal of this Article Thirteen shall apply to or have any effect on the liability or alleged liability of any officer, director or stockholder of the Corporation for or with respect to any opportunities of which such officer, director or stockholder becomes aware prior to such amendment or repeal.

 

ARTICLE FOURTEEN

 

The Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director or officer or other employee of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim against the Corporation arising pursuant to any provision of the General Corporation Law of the State of Delaware or the Corporation’s certificate of incorporation or by-laws or (iv) any action asserting a claim against the Corporation governed by the internal affairs doctrine.

 

* * * * * *

 

 
3

 

 

I, THE UNDERSIGNED, being the sole incorporator hereinbefore named, for the purpose of forming a Corporation pursuant to the General Corporation Law of the State of Delaware, do make this certificate, hereby declaring and certifying that this is my act and deed and the facts stated herein are true, and accordingly have hereunto set my hand on the 30th day of June, 2021.

 

 

/s/ James Kras

 

 

James Kras, Sole Incorporator

 

 

 
4

 

EXHIBIT 3.2

 

CERTIFICATE OF AMENDMENT

OF THE

CERTIFICATE OF INCORPORATION

OF

EDIBLE GARDEN AG INCORPORATED

 

EDIBLE GARDEN AG INCORPORATED, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “General Corporation Law”), hereby certifies as follows:

 

FIRST: The name of the corporation is Edible Garden AG Incorporated (the “Corporation”).

 

SECOND: The Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on July 12, 2021.

 

THIRD: Article IV of the Corporation’s Certificate of Incorporation is hereby amended in its entirety to provide as follows:

 

“The total number of shares of capital stock which the Corporation has authority to issue is Two Hundred and Ten Million (210,000,000). These shares shall be divided into two classes, with Two Hundred Million (200,000,000) shares designated as Common Stock, par value $0.0001 per share (the “Common Stock”) and Ten Million (10,000,000) shares designated as Preferred Stock, par value $0.0001 per share (the “Preferred Stock”).

 

Upon the filing and effectiveness (the “Effective Time”), pursuant to the General Corporation Law, of this Certificate of Amendment to the Certificate of Incorporation of the Corporation, each share of Common Stock issued and outstanding immediately prior to the Effective Time shall, automatically and without any action on the part of the respective holders thereof, be split and converted into 20 shares of Common Stock (the “Stock Split”). No fractional shares shall be issued in connection with the Stock Split. Each certificate that immediately prior to the Effective Time represented shares of Common Stock (“Old Certificates”), shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been split, subject to the elimination of fractional share interests as described above.

 

The Preferred Stock of the Corporation shall be issued by the Board of Directors of the Corporation in one or more classes or one or more series within any class and such classes or series shall have such voting powers, full or limited, or no voting powers, and such designations, preferences, rights, qualifications, limitations or restrictions of such rights as the Board of Directors of the Corporation may determine from time to time.

 

Holders of shares of Common Stock shall be entitled to cast one vote for each share held at all stockholders’ meetings for all purposes, including the election of directors. The Common Stock does not have cumulative voting rights.

 

 
1

 

 

No holder of shares of stock of any class shall be entitled as a matter of right to subscribe for, purchase or receive any part of any new or additional issue of shares of stock of any class, or of securities convertible into shares of stock of any class, whether now or hereafter authorized or whether issued for money, for consideration other than money, or by way of dividend.”

 

FOURTH: These amendments were duly adopted by the written consent of the Board of Directors and the holders of all of the issued and outstanding capital stock of the Corporation in accordance with the provisions of Section 242 and 228 of the General Corporation Law of the State of Delaware.

 

[Signature page follows.]

 

 
2

 

 

IN WITNESS WHEREOF, the Company has caused this Certificate of Amendment to be signed by its duly authorized officer on this 8th day of September, 2021.

 

       
By: /s/ James Kras

 

 

James Kras  
    President and Chief Executive Officer  

 

 
3

 

 

EXHIBIT 4.1

 

THIS INSTRUMENT HAS BEEN ISSUED PURSUANT TO SECTION 4(A)(6) OF THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND NEITHER IT NOR ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED BY RULE 501 OF REGULATION CROWDFUNDING UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR EXEMPTION THEREFROM.

 

IF THE INVESTOR LIVES OUTSIDE THE UNITED STATES, IT IS THE INVESTOR’S RESPONSIBILITY TO FULLY OBSERVE THE LAWS OF ANY RELEVANT TERRITORY OR JURISDICTION OUTSIDE THE UNITED STATES IN CONNECTION WITH ANY PURCHASE OF THE SECURITIES, INCLUDING OBTAINING REQUIRED GOVERNMENTAL OR OTHER CONSENTS OR OBSERVING ANY OTHER REQUIRED LEGAL OR OTHER FORMALITIES. THE COMPANY RESERVES THE RIGHT TO DENY THE PURCHASE OF THE SECURITIES BY ANY FOREIGN PURCHASER.

 

Edible Garden AG Incorporated

 

Crowd SAFE
(Crowdfunding Simple Agreement for Future Equity)

 

Series 2020

 

THIS CERTIFIES THAT in exchange for the payment by [Investor Name] (the “Investor, and together with all other Series 2020 Crowd SAFE holders, “Investors) of $ [_______] (the “Purchase Amount”) on or about [Date of Crowd SAFE], Edible Garden AG Incorporated, a Wyoming corporation (the “Company), hereby issues to the Investor the right to certain shares of the Company’s Capital Stock (defined below), subject to the terms set forth below.

 

The “Valuation Cap” is $18,500,000.

 

See Section 2 for certain additional defined terms.

 

1. Events

 

(a) Equity Financing.

 

(i) If an Equity Financing occurs before this instrument terminates in accordance with Sections 1(b)-(d) (First Equity Financing”), the Company shall promptly notify the Investor of the closing of the First Equity Financing and of the Company’s discretionary decision to either (1) continue the term of this Crowd SAFE without converting the Purchase Amount to Capital Stock; or (2) issue to the Investor a number of shares of the CF Shadow Series of the Capital Stock (whether Preferred Stock or another class issued by the Company) sold in the First Equity Financing. The number of shares of the CF Shadow Series of such Capital Stock shall equal the quotient obtained by dividing (x) the Purchase Amount by (y) the First Equity Financing Price.

 

(ii) If the Company elects to continue the term of this Crowd SAFE past the First Equity Financing and another Equity Financing occurs before the termination of this Crowd SAFE in accordance with Sections 1(b)-(d) (each, a Subsequent Equity Financing”), the Company shall promptly notify the Investor of the closing of the Subsequent Equity Financing and of the Company’s discretionary decision to either (1) continue the term of this Crowd SAFE without converting the Investor’s Purchase Amount to Capital Stock; or (2) issue to the Investor a number of shares of the CF Shadow Series of the Capital Stock (whether Preferred Stock or another class issued by the Company) sold in the Subsequent Equity Financing. The number of shares of the CF Shadow Series of such Preferred Stock shall equal to the quotient obtained by dividing (x) the Purchase Amount by (y) the First Equity Financing Price.

 

 
1

 

 

(b) Liquidity Event.

 

(i) If there is a Liquidity Event before the termination of this instrument and before any Equity Financing, the Investor will, at its option, either (i) receive a cash payment equal to the Purchase Amount (subject to the following paragraph) or (ii) automatically receive from the Company a number of shares of Common Stock equal to the Purchase Amount divided by the Liquidity Price, if the Investor fails to select the cash option. In connection with this Section 1(b)(i), the Purchase Amount will be due and payable by the Company to the Investor immediately prior to, or concurrent with, the consummation of the Liquidity Event. If there are not enough funds to pay the Investor and holders of other Crowd SAFEs (collectively, the Cash-Out Investors”) in full, then all of the Company’s available funds will be distributed with equal priority and pro rata among the Cash-Out Investors in proportion to their Purchase Amounts.

 

(ii) If there is a Liquidity Event after one or more Equity Financings have occurred but before the termination of this instrument, the Investor will, at its option, either (i) receive a cash payment equal to the Purchase Amount (as described in the foregoing paragraph) or (ii) automatically receive from the Company a number of shares of the most recent issued Capital Stock (whether Preferred Stock or another class issued by the Company) equal to the Purchase Amount divided by the First Equity Financing Price, if the Investor fails to select the cash option. Shares of Capital Stock granted in connection therewith shall have the same liquidation rights and preferences as the shares of Capital Stock issued in connection with the Company’s most recent Equity Financing.

 

(iii) If the Company’s board of directors determines in good faith that delivery of Capital Stock to the Investor pursuant to Section 1(b)(i)(2) or Section 1(b)(ii)(2) would violate applicable law, rule or regulation, then the Company shall deliver to Investor in lieu thereof, a cash payment equal to the fair market value of such Capital Stock, as determined in good faith by the Company’s board of directors.

 

(c) Dissolution Event. If there is a Dissolution Event before this instrument terminates in accordance with Sections 1(a) or 1(b), subject to the preferences applicable to any series of Preferred Stock, the Company will distribute its entire assets legally available for distribution with equal priority among the (i) Investors (on an as converted basis based on a valuation of Common Stock as determined in good faith by the Company’s board of directors at the time of Dissolution Event), (ii) all other holders of instruments sharing in the assets of the Company at the same priority as holders of Common Stock upon a Dissolution Event and (iii) and all holders of Common Stock.

 

(d) Termination. This instrument will terminate (without relieving the Company or the Investor of any obligations arising from a prior breach of or non-compliance with this instrument) upon the earlier to occur: (i) the issuance of shares, whether in Capital Stock or in the CF Shadow Series, to the Investor pursuant to Section 1(a) or Section 1(b); or (ii) the payment, or setting aside for payment, of amounts due to the Investor pursuant to Sections 1(b) or 1(c).

 

2. Definitions

 

“Capital Stock” means the capital stock of the Company, including, without limitation, Common Stock and Preferred Stock.

 

“CF Shadow Series” shall mean a series of Capital Stock that is identical in all respects to the shares of Capital Stock (whether Preferred Stock or another class issued by the Company) issued in the relevant Equity Financing (e.g., if the Company sells Series A Preferred Stock in an Equity Financing, the Shadow Series would be Series A-CF Preferred Stock), except that:

 

 
2

 

 

(i) CF Shadow Series shareholders shall have no voting rights and shall not be entitled to vote on any matter that is submitted to a vote or for the consent of the stockholders of the Company;

 

(ii) Each of the CF Shadow Series shareholders shall enter into a proxy agreement, in the form of Exhibit A attached hereto, appointing the Intermediary as its irrevocable proxy with respect to any matter to which CF Shadow Series shareholders are entitled to vote by law. Entering into such proxy agreement is a condition of receiving CF Shadow Shares and such agreement provides that the Intermediary will vote with the majority of the holders of the relevant class of the Company’s Capital Stock on any matters to which the proxy agreement applies; and

 

(iii) CF Shadow Series shareholders have no information or inspection rights, except with respect to such rights deemed not waivable by laws.

 

“Change of Control” means (i) a transaction or series of related transactions in which any “person” or “group” (within the meaning of Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of more than 50% of the outstanding voting securities of the Company having the right to vote for the election of members of the Company’s board of directors, (ii) any reorganization, merger or consolidation of the Company, other than a transaction or series of related transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction or series of related transactions retain, immediately after such transaction or series of related transactions, at least a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity or (iii) a sale, lease or other disposition of all or substantially all of the assets of the Company.

 

“Common Stock” means common stock of the Company.

 

“Dissolution Event” means (i) a voluntary termination of operations, (ii) a general assignment for the benefit of the Company’s creditors, (iii) the commencement of a case (whether voluntary or involuntary) seeking relief under Title 11 of the United States Code (the “Bankruptcy Code”), or (iv) any other liquidation, dissolution or winding up of the Company (excluding a Liquidity Event), whether voluntary or involuntary.

 

“Equity Financing” shall mean the next sale (or series of related sales) by the Company of its Equity Securities to one or more third parties following the date of this instrument from which the Company receives gross proceeds of not less than $1,000,000 cash or cash equivalent (excluding the conversion of any instruments convertible into or exercisable or exchangeable for Capital Stock, such as SAFEs or convertible promissory notes) with the principal purpose of raising capital.

 

“Equity Securities” shall mean Common Stock or Preferred Stock or any securities convertible into, exchangeable for or conferring the right to purchase (with or without additional consideration) Common Stock or Preferred Stock, except in each case, (i) any security granted, issued and/or sold by the Company to any director, officer, employee, advisor or consultant of the Company in such capacity for the primary purpose of soliciting or retaining his, her or its services, (ii) any convertible promissory notes issued by the Company, and (iii) any SAFEs issued.

 

“First Equity Financing Price” shall mean (x) if the pre-money valuation of the Company immediately prior to the First Equity Financing is less than or equal to the Valuation Cap, the lowest price per share of the Equity Securities sold in the First Equity Financing or (y) if the pre-money valuation of the Company immediately prior to the First Equity Financing is greater than the Valuation Cap, the SAFE Price.

 

 
3

 

 

“Fully Diluted Capitalization” shall mean the aggregate number, as of immediately prior to the First Equity Financing, of issued and outstanding shares of Capital Stock, assuming full conversion or exercise of all convertible and exercisable securities then outstanding, including shares of convertible Preferred Stock and all outstanding vested or unvested options or warrants to purchase Capital Stock, but excluding (i) the issuance of all shares of Capital Stock reserved and available for future issuance under any of the Company’s existing equity incentive plans, (ii) convertible promissory notes issued by the Company, (iii) any SAFEs, and (iv) any equity securities that are issuable upon conversion of any outstanding convertible promissory notes or SAFEs.

 

“Intermediary” means OpenDeal Portal LLC, a registered securities crowdfunding portal CRD#283874, or a qualified successor.

 

“IPO” means the closing of the Company’s first firm commitment underwritten initial public offering of Common Stock pursuant to an effective registration statement filed under the Securities Act.

 

“Liquidity Capitalization” means the number, as of immediately prior to the Liquidity Event, of shares of the Company’s capital stock (on an as-converted basis) outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and other convertible securities, but excluding: (i) shares of Common Stock reserved and available for future grant under any equity incentive or similar plan; (ii) any SAFEs; and (iii) convertible promissory notes.

 

“Liquidity Event” means a Change of Control or an IPO.

 

“Liquidity Price” means the price per share equal to (x) the Valuation Cap divided by (y) the Liquidity Capitalization.

 

“Lock-up Period” means the period commencing on the date of the final prospectus relating to the Company’s IPO, and ending on the date specified by the Company and the managing underwriter(s). Such period shall not exceed one hundred eighty (180) days, or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (i) the publication or other distribution of research reports, and (ii) analyst recommendations and opinions.

 

“Preferred Stock” means the preferred stock of the Company.

 

“Regulation CF” means Regulation Crowdfunding promulgated under the Securities Act.

 


“SAFE” means any simple agreement for future equity (or other similar agreement), including a Crowd SAFE, which is issued by the Company for bona fide financing purposes and which may convert into Capital Stock in accordance with its terms.

 

“SAFE Price” means the price per share equal to (x) the Valuation Cap divided by (y) the Fully Diluted Capitalization.

 

3. Company Representations

 

(a) The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the state of its incorporation, and has the power and authority to own, lease and operate its properties and carry on its business as now conducted.

 

(b) The execution, delivery and performance by the Company of this instrument is within the power of the Company and, other than with respect to the actions to be taken when equity is to be issued to Investor, has been duly authorized by all necessary actions on the part of the Company. This instrument constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity. To the knowledge of the Company, it is not in violation of (i) its current charter or bylaws; (ii) any material statute, rule or regulation applicable to the Company; or (iii) any material indenture or contract to which the Company is a party or by which it is bound, where, in each case, such violation or default, individually, or together with all such violations or defaults, could reasonably be expected to have a material adverse effect on the Company.

 

 
4

 

 

(c) The performance and consummation of the transactions contemplated by this instrument do not and will not: (i) violate any material judgment, statute, rule or regulation applicable to the Company; (ii) result in the acceleration of any material indenture or contract to which the Company is a party or by which it is bound; or (iii) result in the creation or imposition of any lien upon any property, asset or revenue of the Company or the suspension, forfeiture, or nonrenewal of any material permit, license or authorization applicable to the Company, its business or operations.

 

(d) No consents or approvals are required in connection with the performance of this instrument, other than: (i) the Company’s corporate approvals; (ii) any qualifications or filings under applicable securities laws; and (iii) necessary corporate approvals for the authorization of shares of CF Shadow Series issuable pursuant to Section 1.

 

(e) The Company shall, prior to the conversion of this instrument, reserve from its authorized but unissued shares of Capital Stock for issuance and delivery upon the conversion of this instrument, such number of shares of the Capital Stock as necessary to effect the conversion contemplated by this instrument, and, from time to time, will take all steps necessary to amend its charter to provide sufficient authorized numbers of shares of the Capital Stock issuable upon the conversion of this instrument. All such shares shall be duly authorized, and when issued upon any such conversion, shall be validly issued, fully paid and non-assessable, free and clear of all liens, security interests, charges and other encumbrances or restrictions on sale and free and clear of all preemptive rights, except encumbrances or restrictions arising under federal or state securities laws.

 

(f) The Company is (i) not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act, (ii) not an investment company as defined in Section 3 of the Investment Company Act of 1940 (the Investment Company Act”), and is not excluded from the definition of investment company by Section 3(b) or Section 3(c) of the Investment Company Act, (iii) not disqualified from selling securities under Rule 503(a) of Regulation CF, (iv) not barred from selling securities under Section 4(a)(6) of the Securities Act due to a failure to make timely annual report filings, (vi) not planning to engage in a merger or acquisition with an unidentified company or companies, and (vii) organized under, and subject to, the laws of a state or territory of the United States or the District of Columbia.

 

(g) The Company has, or will shortly after the issuance of this instrument, engage a transfer agent registered with the U.S. Securities and Exchange Commission to act as the sole registrar and transfer agent for the Company with respect to the Crowd SAFE.

 

(h) The Company is (i) not required to file reports pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 (the Exchange Act”), (ii) not an investment company as defined in section 3 of the Investment Company Act of 1940, and is not excluded from the definition of investment company by section 3(b) or section 3(c) of such Act, (iii) not disqualified from selling securities under Rule 503(a) of Regulation CF, (iv) not barred from selling securities under §4(a)(6) due to a failure to make timely annual report filings, (vi) not planning to engage in a merger or acquisition with an unidentified company or companies, and (vii) organized under, and subject to, the laws of a state or territory of the United States or the District of Columbia.

 

4. Investor Representations

 

(a) The Investor has full legal capacity, power and authority to execute and deliver this instrument and to perform its obligations hereunder. This instrument constitutes a valid and binding obligation of the Investor, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity.

 

 
5

 

 

(b) The Investor has been advised that this instrument and the underlying securities have not been registered under the Securities Act or any state securities laws and are offered and sold hereby pursuant to Section 4(a)(6) of the Securities Act. The Investor understands that neither this instrument nor the underlying securities may be resold or otherwise transferred unless they are registered under the Securities Act and applicable state securities laws or pursuant to Rule 501 of Regulation CF, in which case certain state transfer restrictions may apply.

 

(c) The Investor is purchasing this instrument and the securities to be acquired by the Investor hereunder for its own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and the Investor has no present intention of selling, granting any participation in, or otherwise distributing the same. The Investor understands that the Securities have not been, and will not be, registered under the Securities Act or any state securities laws, by reason of specific exemptions under the provisions thereof which depend upon, among other things, the bona fide nature of the investment intent and the accuracy of each Investor’s representations as expressed herein.

 

(d) The Investor acknowledges, and is purchasing this instrument in compliance with, the investment limitations set forth in Rule 100(a)(2) of Regulation CF, promulgated under Section 4(a)(6)(B) of the Securities Act.

 

(e) The Investor acknowledges that the Investor has received all the information the Investor has requested from the Company and the Investor considers necessary or appropriate for deciding whether to acquire this instrument and the underlying securities, and the Investor represents that the Investor has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of this instrument and the underlying securities and to obtain any additional information necessary to verify the accuracy of the information given to the Investor. In deciding to purchase this instrument, the Investor is not relying on the advice or recommendations of the Company or of Republic.co and the Investor has made its own independent decision that an investment in this instrument and the underlying securities is suitable and appropriate for the Investor. The Investor understands that no federal or state agency has passed upon the merits or risks of an investment in this instrument and the underlying securities or made any finding or determination concerning the fairness or advisability of this investment.

 

(f) The Investor understands and acknowledges that as a Crowd SAFE investor, the Investor shall have no voting, information or inspection rights, aside from any disclosure requirements the Company is required to make under relevant securities regulations.

 

(g) The Investor understands that no public market now exists for any of the securities issued by the Company, and that the Company has made no assurances that a public market will ever exist for this instrument and the securities to be acquired by the Investor hereunder.

 

(h) The Investor is not (i) a citizen or resident of a geographic area in which the purchase or holding of the Crowd SAFE and the underlying securities is prohibited by applicable law, decree, regulation, treaty, or administrative act, (ii) a citizen or resident of, or located in, a geographic area that is subject to U.S. or other applicable sanctions or embargoes, or (iii) an individual, or an individual employed by or associated with an entity, identified on the U.S. Department of Commerce’s Denied Persons or Entity List, the U.S. Department of Treasury’s Specially Designated Nationals List, the U.S. Department of State’s Debarred Parties List or other applicable sanctions lists. Investor hereby represents and agrees that if Investor’s country of residence or other circumstances change such that the above representations are no longer accurate, Investor will immediately notify Company. Investor further represents and warrants that it will not knowingly sell or otherwise transfer any interest in the Crowd SAFE or the underlying securities to a party subject to U.S. or other applicable sanctions.

 

 
6

 

 

(i) If the Investor is not a United States person (as defined by Section 7701(a)(30) of the Internal Revenue Code of 1986, as amended), the Investor hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation, subscription and payment for, and continued ownership of, its beneficial interest in the Crowd SAFE and the underlying securities will not violate any applicable securities or other laws of the Investor’s jurisdiction, including (i) the legal requirements within its jurisdiction for the subscription and the purchase of its beneficial interest in the Crowd SAFE; (ii) any foreign exchange restrictions applicable to such subscription and purchase; (iii) any governmental or other consents that may need to be obtained; and (iv) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, conversion, redemption, sale, or transfer of its beneficial interest in the Crowd SAFE and the underlying securities. The Investor acknowledges that the Company has taken no action in foreign jurisdictions with respect to the Crowd SAFE (and the Investor’s beneficial interest therein) and the underlying securities.

 

(j) If the Investor is a corporate entity: (i) such corporate entity is duly incorporated, validly existing and in good standing under the laws of the state of its incorporation, and has the power and authority to enter into this Agreement; (ii) the execution, delivery and performance by the Investor of the Agreement is within the power of the Investor and has been duly authorized by all necessary actions on the part of the Investor; (iii) to the knowledge of the Investor, it is not in violation of its current charter or bylaws, any material statute, rule or regulation applicable to the Investor; and (iv) the performance the Agreement does not and will not violate any material judgment, statute, rule or regulation applicable to the Investor; result in the acceleration of any material indenture or contract to which the Investor is a party or by which it is bound, or otherwise result in the creation or imposition of any lien upon the Purchase Amount.

 

(k) The Investor further acknowledges that it has read, understood, and had ample opportunity to ask Company questions about its business plans, “Risk Factors,” and all other information presented in the Company’s Form C and the offering documentation filed with the SEC.

 

(l) The Investor represents that the Investor understands the substantial likelihood that the Investor will suffer a TOTAL LOSS of all capital invested, and that Investor is prepared to bear the risk of such total loss.

 

5. Transfer Restrictions.

 

(a) The Investor hereby agrees that during the Lock-up Period it will not, without the prior written consent of the managing underwriter: (A) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common Stock (whether such shares or any such securities are then owned by the Investor or are thereafter acquired); or (B) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities; whether any such transaction described in clause (A) or (B) above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise.

 

(b) The foregoing provisions of Section 5(a) will: (x) apply only to the IPO and will not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement; (y) not apply to the transfer of any shares to any trust for the direct or indirect benefit of the Investor or the immediate family of the Investor, provided that the trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and provided further that any such transfer will not involve a disposition for value; and (z) be applicable to the Investor only if all officers and directors of the Company are subject to the same restrictions and the Company uses commercially reasonable efforts to obtain a similar agreement from all stockholders individually owning more than 5% of the outstanding Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common Stock. Notwithstanding anything herein to the contrary, the underwriters in connection with the IPO are intended third-party beneficiaries of Section 5(a) and will have the right, power and authority to enforce the provisions hereof as though they were a party hereto. The Investor further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with the IPO that are consistent with Section 5(a) or that are necessary to give further effect thereto.

 

 
7

 

 

(c) In order to enforce the foregoing covenant, the Company may impose stop transfer instructions with respect to the Investor’s registrable securities of the Company (and the Company shares or securities of every other person subject to the foregoing restriction) until the end of the Lock-up Period. The Investor agrees that a legend reading substantially as follows will be placed on all certificates representing all of the Investor’s registrable securities of the Company (and the shares or securities of the Company held by every other person subject to the restriction contained in Section 5(a)):

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD BEGINNING ON THE EFFECTIVE DATE OF THE COMPANY’S REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE COMPANY’S PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SECURITIES.

 

(d) Without in any way limiting the representations and warranties set forth in Section 4 above, the Investor further agrees not to make any disposition of all or any portion of this instrument or the underlying securities unless and until the transferee has agreed in writing for the benefit of the Company to make the representations and warranties set out in Section 4 and the undertaking set out in Section 5(a) and:

 

(i) There is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is made in accordance with such registration statement; or

 

(ii) The Investor shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition and, if reasonably requested by the Company, the Investor shall have furnished the Company with an opinion of counsel reasonably satisfactory to the Company that such disposition will not require registration of such shares under the Securities Act.

 

(e) The Investor agrees that it shall not make any disposition of this instrument or any underlying securities to any of the Company’s competitors, as determined by the Company in good faith.

 

(f) The Investor understands and agrees that the Company will place the legend set forth below or a similar legend on any book entry or other forms of notation evidencing this Crowd SAFE and any certificates evidencing the underlying securities, together with any other legends that may be required by state or federal securities laws, the Company’s charter or bylaws, any other agreement between the Investor and the Company or any agreement between the Investor and any third party:

 

THIS INSTRUMENT HAS BEEN ISSUED PURSUANT TO SECTION 4(A)(6) OF THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND NEITHER IT NOR ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED BY RULE 501 OF REGULATION CROWDFUNDING UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR EXEMPTION THEREFROM.

 

 
8

 

 

6. Miscellaneous

 

(a) The Investor agrees to take any and all actions determined in good faith by the Company’s board of directors to be advisable to reorganize this instrument and any shares of Capital Stock issued pursuant to the terms of this instrument into a special purpose vehicle or other entity designed to aggregate the interests of holders of Crowd SAFEs.

 

(b) Any provision of this instrument may be amended, waived or modified only upon the written consent of either (i) the Company and the Investor, or (ii) the Company and the majority of the Investors (calculated based on the Purchase Amount of each Investors Crowd SAFE).

 

(c) Any notice required or permitted by this instrument will be deemed sufficient when delivered personally or by overnight courier or sent by email to the relevant address listed on the signature page, or 48 hours after being deposited in the U.S. mail as certified or registered mail with postage prepaid, addressed to the party to be notified at such party’s address listed on the signature page, as subsequently modified by written notice.

 

(d) The Investor is not entitled, as a holder of this instrument, to vote or receive dividends or be deemed the holder of Capital Stock for any purpose, nor will anything contained herein be construed to confer on the Investor, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action or to receive notice of meetings, or to receive subscription rights or otherwise until shares have been issued upon the terms described herein.

 

(e) Neither this instrument nor the rights contained herein may be assigned, by operation of law or otherwise, by either party without the prior written consent of the other; provided, however, that this instrument and/or the rights contained herein may be assigned without the Company’s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor; and provided, further, that the Company may assign this instrument in whole, without the consent of the Investor, in connection with a reincorporation to change the Company’s domicile.

 

(f) In the event any one or more of the terms or provisions of this instrument is for any reason held to be invalid, illegal or unenforceable, in whole or in part or in any respect, or in the event that any one or more of the terms or provisions of this instrument operate or would prospectively operate to invalidate this instrument, then such term(s) or provision(s) only will be deemed null and void and will not affect any other term or provision of this instrument and the remaining terms and provisions of this instrument will remain operative and in full force and effect and will not be affected, prejudiced, or disturbed thereby.

 

(g) All securities issued under this instrument may be issued in whole or fractional parts.

 

(h) All rights and obligations hereunder will be governed by the laws of the State of Wyoming, without regard to the conflicts of law provisions of such jurisdiction.

 

(i) Any dispute, controversy or claim arising out of, relating to or in connection with this instrument, including the breach or validity thereof, shall be determined by final and binding arbitration administered by the American Arbitration Association (the “AAA”) under its Commercial Arbitration Rules and Mediation Procedures (“Commercial Rules”). The award rendered by the arbitrator shall be final, non-appealable and binding on the parties and may be entered and enforced in any court having jurisdiction. There shall be one arbitrator agreed to by the parties within twenty (20) days of receipt by respondent of the request for arbitration or, in default thereof, appointed by the AAA in accordance with its Commercial Rules. The place of arbitration shall be Belvidere, New Jersey. Except as may be required by law or to protect a legal right, neither a party nor the arbitrator may disclose the existence, content or results of any arbitration without the prior written consent of the other parties.

 

(j) The parties acknowledge and agree that for United States federal and state income tax purposes this Crowd SAFE is, and at all times has been, intended to be characterized as stock, and more particularly as common stock for purposes of Sections 304, 305, 306, 354, 368, 1036 and 1202 of the Internal Revenue Code of 1986, as amended. Accordingly, the parties agree to treat this Crowd SAFE consistent with the foregoing intent for all United States federal and state income tax purposes (including, without limitation, on their respective tax returns or other informational statements).

 

(Signature page follows)

 

 
9

 

 

 

IN WITNESS WHEREOF, the undersigned have caused this instrument to be duly executed and delivered.

 

EDIBLE GARDEN AG INCORPORATED
     
By: /s/ James Kras

Name:

James Kras   
Title: Chief Executive Officer   
  Address: 283 County Road 519, Belvidere, 

NJ, United States

Email: JKras@ediblegarden.com

 

 

 

 

INVESTOR:

 

 

 

 

By:

 

 

Name:

 

 

  

 
10

 

 

Exhibit A – CF Shadow Share Proxy

 

Irrevocable Proxy

 

Reference is hereby made to a certain Crowdfunding Simple Agreement for Future Equity (the “Crowd SAFE”) dated [crowd_safe_dated] between Edible Garden AG Incorporated, a Wyoming corporation (the “Company”) and $investor_name$ (“Stockholder”). In connection with a conversion of Stockholder’s investment in the Crowd SAFE into Capital Stock of a CF Shadow Series (as defined in the Crowd SAFE) pursuant to the Crowd SAFE, the Stockholder and OpenDeal Portal LLC (the “Intermediary”) as another holder of Capital Stock of a CF Shadow Series hereby agree as follows:

 

1. Grant of Irrevocable Proxy.

 

a. With respect to all of the shares of Capital Stock of CF Shadow Series owned by the Stockholder as of the date of this Irrevocable Proxy or any subsequent date (the “Shares”), Stockholder hereby grants to Intermediary an irrevocable proxy under Section 212 of the Delaware General Corporation Law to vote the Shares in any manner that the Intermediary may determine in its sole and absolute discretion. For the avoidance of doubt, the Intermediary, as the holder of the irrevocable proxy (rather than the Stockholder) will vote the Shares with respect to all shareholder meetings and other actions (including actions by written consent in lieu of a meeting) on which holders of Shares may be entitled to vote. The Intermediary hereby agrees to vote all Shares consistently with the majority of the shares on which the CF Shadow Series is based. This proxy revokes any other proxy granted by the Stockholder at any time with respect to the Shares.

 

b. The Intermediary shall have no duty, liability or obligation whatsoever to the Stockholder arising out of the Intermediary’s exercise of the this irrevocable proxy. The Stockholder expressly acknowledges and agrees that (i) the Stockholder will not impede the exercise of the Intermediary’s rights under this irrevocable proxy and (ii) the Stockholder waives and relinquishes any claim, right or action the Stockholder might have, as a stockholder of the Company or otherwise, against the Intermediary or any of its affiliates or agents (including any directors, officers, managers, members, and employees) in connection with any exercise of the irrevocable proxy granted hereunder.

 

c. This irrevocable proxy shall expire as to those Shares on the earlier of (i) the date that such Shares are converted into Common Stock of the Company or (ii) the date that such Shares are converted to cash or a cash equivalent, but shall continue as to any Shares not so converted.

 

2. Legend. The Stockholder agrees to permit an appropriate legend on certificates evidencing the Shares or any transfer books or related documentation of ownership reflecting the grant of the irrevocable proxy contained in the foregoing Section 1.

 

3. Representations and Warranties. The Stockholder represents and warrants to the Intermediary as follows:

 

a. The Stockholder has the all necessary rights, power and authority to execute, deliver and perform his obligations under this Irrevocable Proxy. This Irrevocable Proxy has been duly executed and delivered by the Stockholder and constitutes such Stockholder’s legal and valid obligation enforceable against the Stockholder in accordance with its terms.

 

b. The Stockholder is the record owner of the Shares listed under the name on this Appendix A and the Stockholder has plenary voting and dispositive power with respect to such Shares; the Stockholder owns no other shares of the capital stock of the Company; there are no proxies, voting trusts or other agreements or understandings to which such Stockholder is a party or bound by and which expressly require that any of the Shares be voted in any specific manner other than pursuant to this irrevocable proxy; and the Stockholder has not entered into any agreement or arrangement inconsistent with this Irrevocable Proxy.

 

 
11

 

 

4. Equitable Remedies. The Stockholder acknowledges that irreparable damage would result if this Irrevocable Proxy is not specifically enforced and that, therefore, the rights and obligations of the Intermediary may be enforced by a decree of specific performance issued by arbitration pursuant to the Crowd SAFE, and appropriate injunctive relief may be applied for and granted in connection therewith. Such remedies shall, however, not be exclusive and shall be in addition to any other remedies that the Intermediary may otherwise have available.

 

5. Defined Terms. All terms defined in this Irrevocable Proxy shall have the meaning defined herein. All other terms will be interpreted in accordance with the Crowd SAFE.

 

6. Amendment. Any provision of this instrument may be amended, waived or modified only upon the written consent of the (i) the Stockholder and (ii) the Intermediary.

 

7. Assignment.

 

a. In the event the Stockholder wishes to transfer, sell, hypothecate or otherwise assign any Shares, the Stockholder hereby agrees to require, as a condition of such action, that the counterparty or counterparties thereto must enter into a proxy agreement with the Intermediary substantially identical to this Irrevocable Proxy.

 

b. The Intermediary may transfer its rights as Holder under this instrument after giving prior written notice to the Stockholder.

 

8. Severability. In the event any one or more of the terms or provisions of this instrument is for any reason held to be invalid, illegal or unenforceable, in whole or in part or in any respect, or in the event that any one or more of the terms or provisions of this instrument operate or would prospectively operate to invalidate this instrument, then such term(s) or provision(s) only will be deemed null and void and will not affect any other term or provision of this instrument and the remaining terms and provisions of this instrument will remain operative and in full force and effect and will not be affected, prejudiced, or disturbed thereby.

 

IN WITNESS WHEREOF, the undersigned have caused this instrument to be duly executed and delivered.

 

INVESTOR:

  INTERMEDIARY:  

 

 

 

 

By:

  By:  

Name:

  Name: Authorized Signatory, OpenDeal Portal  
    LLC d/b/a Republic  

Date

 

Date

 

  

 
12

 

EXHIBIT 10.1

 

ASSET PURCHASE AGREEMENT

 

This ASSET PURCHASE AGREEMENT (this “Agreement”) is effective as of March 30, 2020, by and between Edible Garden Corp., a Nevada corporation (the “Seller”), and Edible Garden Incorporated, a Wyoming corporation (the “Purchaser” and together with Seller, each a “Party” and collectively, the “Parties”).

 

RECITALS

 

A. Purchaser is interested in purchasing, and Seller is interested in selling, certain assets related to the Seller’s business (the “Business”), as more fully described herein .

 

B. The parties hereto desire that Seller sell, assign, transfer and convey to Purchaser, and that Purchaser purchase from Seller, the Assets (as defined below) in exchange for the consideration set forth herein, all according to the terms and subject to the conditions set forth in this Agreement (the “Transaction”).

 

NOW, THEREFORE, in consideration of the mutual promises and covenants herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

 

AGREEMENT

 

ARTICLE 1
PURCHASE AND SALE

 

1.1 Purchase and Sale. Upon the terms and subject to the conditions set forth in this Agreement, effective as of the Closing Date (as defined below), Seller agrees to sell, assign, transfer, convey and deliver to Purchaser, and Purchaser agrees to purchase from Seller, all of Seller’s right, title and interest in and to the Assets (as defined below), free and clear of all liens, claims, interests, encumbrances, charges, claims, community property interests, pledges and other security interests, conditions, equitable interests, options, rights of first refusal, or restrictions of any kind, including any restriction on use, voting, transfer, receipt of income or exercise of any other attribute of ownership of any nature (collectively, “Encumbrances”), except as set forth in Section 3.4 of the Disclosure Schedules. In connection with the Transaction, on the Closing Date, Seller shall take any and all actions that may be required, or reasonably requested by Purchaser, to transfer good, valid and marketable title to all of the Assets, free and clear of all Encumbrances, except as set forth in Section 3.4 of the Disclosure Schedules, to Purchaser, and Seller shall deliver possession of all of the Assets to Purchaser on the Closing Date. Seller shall further deliver to Purchaser proper assignments, bills of sale, conveyances and other instruments of sale and/or transfer in forms reasonably satisfactory to Purchaser to convey to Purchaser good title to all Assets, as well as such other instruments of sale and/or transfer as Purchaser may reasonably request (whether on or after the Closing Date) to evidence and effect the Transaction contemplated herein.

 

1.2 Assets. As used in this Agreement, the term “Assets” means, collectively, all of Seller’s right, title and interest in and to all the assets, properties and rights which are used exclusively in connection with the operation of the Seller’s Business, in each case only those specifically related to or located at the Seller’s premises, excluding the Excluded Assets (as defined below).

 

 
1

 

 

1.3 Excluded Assets. Notwithstanding anything herein to the contrary, it is hereby expressly acknowledged and agreed that the Assets shall not include, and Seller is not selling, conveying, assigning, transferring or delivering to Purchaser, and Purchaser is not purchasing, acquiring or accepting from Seller, any of the rights, properties or assets set forth or described below (the “Excluded Assets”):

 

(a) all rights, claims or causes of action of Seller arising under this Agreement;

 

(b) the corporate charter, qualifications to conduct business as a foreign corporation, arrangements with registered agents relating to foreign qualifications, taxpayer and other identification numbers, seals, minute books, stock transfer books, blank stock certificates, and other documents relating to the organization, maintenance, and existence of Seller; and

 

(d) any other assets identified on Schedule 1.3 hereto.

 

1.4 Assumed Liabilities. Subject to and upon the terms and conditions of this Agreement, effective as of the Closing Date, Purchaser agrees to assume from Seller and to pay, perform and discharge according to their terms the following Liabilities (collectively, the “Assumed Liabilities”): (i) all Liabilities, if any, of Seller specifically set forth herein, (ii) all Liabilities incurred with respect to the Assets, and (iii) any Transfer Taxes, Fees and Property Taxes, in each case, to the extent specifically allocated to Purchaser pursuant to Article VI.

 

1.5 Excluded Liabilities. Purchaser shall not assume any Liabilities of Seller other than the Assumed Liabilities (the “Excluded Liabilities”), which in each case shall remain obligations and Liabilities of Seller.

 

1.6 Purchase Price and Payment. In consideration for the Assets, Purchaser shall (a) issue to Seller or an Affiliate of Seller a Three Million Dollar ($3,000,000) principal secured note (the “Secured Note”) with three and one-half percent (3.50%) interest (the “Purchase Consideration”) with a five-year maturity, substantially in the form attached hereto as Exhibit A.

 

1.7 Consent of Third Parties. Notwithstanding anything to the contrary in this Agreement, this Agreement shall not constitute an agreement to assign or transfer any Asset, lease, Permit or other agreement or arrangement or any claim, right or benefit arising thereunder or resulting therefrom if an assignment or transfer or an attempt to make such an assignment or transfer without the consent of a third party would constitute a material breach or violation thereof or affect adversely the rights of Purchaser or Seller thereunder; and any assignment or transfer to Purchaser by Seller of any interest under any such Asset, lease, Permit or other agreement or arrangement that requires the consent of a third party shall be made subject to such consent or approval being obtained. Nothing in this Section 1.7 shall be deemed to constitute an agreement to exclude from the Assets any assets described under Section 1.2.

 

1.8 Allocation. Following the Closing, Seller and Purchaser shall use commercially reasonable efforts to prepare a joint schedule allocating the aggregate consideration (including the Assumed Liabilities) payable for the Assets in accordance with Section 1060 of the Internal Revenue Code of 1986, as amended (the “Code”) and the Treasury regulations promulgated thereunder (and any similar provision of state, local or foreign Law, as appropriate) (the “Allocation Schedule”). If Seller and Purchaser are able to agree upon the Allocation Schedule within thirty (30) days following the Closing Date, Seller and Purchaser shall each file IRS Form 8594, and all federal, state, local and foreign tax returns, in accordance with the Allocation Schedule. If Purchaser and Seller are unable to agree upon the Allocation Schedule within 30 days after the Closing Date, any dispute or disagreement between Purchaser and Seller regarding any matter set forth in the Allocation Schedule shall be resolved promptly by the Independent Auditor, the costs of which shall be borne equally by Purchaser, on the one hand, and Seller, on the other hand. Purchaser and Seller shall prepare and file all Tax Returns and other statements in a manner consistent with the Allocation Schedule and shall not make any inconsistent statement or adjustment on any Tax Returns or otherwise during the course of an audit, investigation or other dispute with a Taxing authority, provided, however, that nothing contained herein shall prevent Purchaser or Seller from settling any proposed deficiency or adjustment by any Taxing authority based upon or arising out of the Allocation Schedule, and neither Purchaser nor Seller shall be required to litigate before any court any proposed deficiency or adjustment by any Taxing authority challenging such Allocation Schedule.

 

 
2

 

 

1.9 Withholding. Purchaser shall be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement to Seller such amounts as Purchaser is required to deduct and withhold under the Code, or any Tax Law, with respect to the making of such payment. To the extent that amounts are so withheld, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of whom such deduction and withholding was made.

 

ARTICLE 2
THE CLOSING

 

2.1 The Closing. The closing (the “Closing”) of the transactions contemplated by this Agreement, including the sale of the Assets and issuance of the Secured Note (the “Transactions”), shall be by electronic transmission to the respective offices of legal counsel for the parties of the requisite documents, duly executed where required, delivered upon actual confirmed receipt at 12:00 P.M. Eastern Time on the date hereof or on such other date and/or time as is mutually agreed to in writing by Purchaser and Seller (the “Closing Date”).

 

2.2 Closing Deliverables. At Closing:

 

(a) Seller shall deliver to Purchaser:

 

(i) the Secured Note, the Security Agreement substantially in the form attached hereto as Exhibit B, and the Transition Services Agreement substantially in the form attached hereto as Exhibit C, each duly executed by Seller; and

 

(ii) such other certificates, instruments or documents as may be reasonably necessary or appropriate to carry out the Transactions, each in form and content satisfactory to Purchaser (in its reasonable discretion).

 

(b) Purchaser shall deliver to Seller:

 

(i) the Assets;

 

(ii) the Security Agreement and the Transition Services Agreement, each duly executed by Purchaser; and

 

(iii) such other certificates, instruments or documents as may be reasonably necessary or appropriate to carry out the Transactions, each in form and content satisfactory to Seller (in its reasonable discretion).

 

2.3 Post-Closing Deliveries by the Seller. Promptly following the Closing, Seller shall deliver to Purchaser, to the extent such documents are not at the Seller’s offices or facilities, copies of all agreements, instruments, documents, deeds, books, records, files and other data and information within the possession of the Seller pertaining to the Business (collectively, the “Records”); provided, however, that for the avoidance of doubt Seller may retain (i) copies of any tax returns and copies of Records relating thereto, (ii) copies of all Records that Seller is reasonably likely to need for complying with any legal requirements or contractual commitments, and (iii) copies of any Records that in the reasonable opinion of Seller will be or could reasonably be expected to be required in connection with the performance of Seller’s obligations hereunder.

 

 
3

 

 

ARTICLE 3
REPRESENTATIONS AND WARRANTIES OF SELLER

 

Except as set forth in the correspondingly numbered Section of the Disclosure Schedules, Seller represents and warrants to Purchaser that the statements contained in this Article 3 are true and correct as of the date hereof and as of the Closing Date.

 

3.1 Organization and Authority of Seller. Seller is a corporation duly organized, validly existing and in good standing under the laws of the state of Nevada. Seller has full corporate power and authority to enter into the Transaction Documents to which Seller is a party, to carry out its obligations hereunder and thereunder and to consummate the Transactions. The execution and delivery by Seller of the Transaction Documents to which Seller is a party, the performance by Seller of its obligations hereunder and thereunder, and the consummation by Seller of the Transactions have been duly authorized by all requisite corporate action on the part of Seller. This Agreement has been duly executed and delivered by Seller, and (assuming due authorization, execution, and delivery by Purchaser) this Agreement constitutes a legal, valid and binding obligation of Seller enforceable against Seller in accordance with its terms. When each Transaction Document to which Seller is or will be a party has been duly executed and delivered by Seller, such Transaction Document will constitute a legal and binding obligation of Seller enforceable against it in accordance with its terms.

 

3.2 No Conflicts. The execution, delivery and performance by Seller of the Transaction Documents, and the consummation of the Transactions, do not and will not: (a) conflict with or result in a violation or breach of, or default under, any provision of the Organizational Documents of Seller; (b) conflict with or result in a violation or breach of any provision of any Law or Order applicable to Seller; (c) require the consent, notice or other action by any Person under, conflict with, result in a violation or breach of, constitute a default or an event that, with or without notice or lapse of time or both, would constitute a default under, result in the acceleration of or create in any party the right to accelerate, terminate, modify or cancel any Contract to which Seller or the Seller is a party or by which Seller is bound or to which any of their respective properties and assets are subject or any Permit affecting the properties, assets or business of the Seller; or (d) result in the creation or imposition of any Encumbrance on any properties or assets of the Seller. No consent, approval, Permit, Order, declaration or filing with, or notice to, any Governmental Entity is required by or with respect to Seller or the Seller in connection with the execution and delivery of the Transaction Documents and the consummation of the Transactions.

 

3.3 Absence of Certain Changes. Since December 31, 2019: (a) Seller has operated in all respects only in the ordinary course of business and consistent with past practice; and (b) there has not been any event, occurrence or development which has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

3.4 Title to Assets. Except as set forth in Section 3.4 of the Disclosure Schedules, to the Seller’s Knowledge, the Seller has good and valid title to the Assets.

 

3.5 Insurance. All of the Seller’s active insurance policies and fidelity bonds covering the Seller and its businesses, properties, assets, product liability, directors, officers and employees (collectively, the “Insurance Policies”) have been provided. The Seller is not in violation or breach of or default under any of its obligations under any such Insurance Policy. The Seller has not received any written notice that any Insurance Policy has been canceled or cover prejudiced or suspended. There are no material claims individually or in the aggregate by the Seller pending under any of the Insurance Policies as to which coverage has been questioned, denied or disputed by the underwriters of such Insurance Policy, as applicable, in writing or in respect of which such underwriters have reserved their rights in writing.

 

 
4

 

 

3.6 Litigation. The Seller has not received written notice that any investigation, audit or assessment by a Governmental Entity is currently pending involving the Assets or the Transactions, and to Seller’s Knowledge, there is no investigation, audit or assessment pending or threatened by any Governmental Entity with respect to Seller involving the Assets or that challenge or seek to prevent, enjoin or otherwise delay the Transactions.

 

3.7 Environmental Compliance and Conditions.

 

(a) The Seller does not have any material liability under any Environmental and Safety Requirement or with respect to Hazardous Substances.

 

(b) (i) The Seller has not received notice of a civil, criminal or administrative suit, claim, action, proceeding or investigation pending or, to Seller’s Knowledge, threatened against the Purchaser under any Environmental and Safety Requirement or with respect to Hazardous Substances; and (ii) the Seller has not received from any Governmental Entity written notice that it has been named or may be named as a responsible or potentially responsible party under any Environmental and Safety Requirement for any site Contaminated by Hazardous Substances.

 

(c) The Seller has not released Hazardous Substances in violation of applicable Environmental and Safety Requirement in a manner that would, individually or in the aggregate, result in material liability to, or require Response Action by, the Seller.

 

3.8 Taxes.

 

(a) All returns, declarations, reports, information returns and statements, and other documents relating to Taxes (including amended returns and claims for refund) (“Tax Returns”) required to be filed by the Seller on or before the Closing Date have been timely filed. Such Tax Returns are true, correct, and complete in all respects. All Taxes due and owing by the Seller (whether or not shown on any Tax Return) have been timely paid. No extensions or waivers of statutes of limitations have been given or requested with respect to any Taxes of the Seller. Seller has delivered to Purchaser copies of all Tax Returns and examination reports of the Seller and statements of deficiencies assessed against, or agreed to by, the Seller for all Tax periods ending after December 31, 2018.

 

(b) There are no liens for Taxes (other than for current Taxes not yet due and payable) upon the assets of the Seller.

 

(c) The Seller is not a "foreign person" as that term is used in Treasury Regulations Section 1.1445-2. The Purchaser is not, nor has it been, a United States real property holding corporation (as defined in Section 897(c)(2) of the Code) during the applicable period specified in Section 897(c)(1)(a) of the Code.

 

3.9 Broker’s Fees. No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission payable by or on behalf of the Seller in connection with the Transactions.

 

 
5

 

 

ARTICLE 4
REPRESENTATIONS AND WARRANTIES OF PURCHASER

 

4.1 Organization and Authority. Purchaser is a corporation duly organized, validly existing and in good standing under the laws of the state of Wyoming. Purchaser has full corporate power and authority to enter into the Transaction Documents, to carry out its obligations hereunder and thereunder and to consummate the Transactions and thereby. The execution and delivery by Purchaser of Transaction Documents, the performance by Purchaser of its obligations hereunder and thereunder, and the consummation by Purchaser of the Transactions and thereby have been duly authorized by all requisite corporate action on the part of Purchaser. This Agreement has been duly executed and delivered by Purchaser, and (assuming due authorization, execution, and delivery by Seller) this Agreement constitutes a legal, valid and binding obligation of Purchaser enforceable against Purchaser in accordance with its terms. When each Transaction Document to which Purchaser is or will be a party has been duly executed and delivered by Purchaser, such Transaction Document will constitute a legal and binding obligation of Purchaser enforceable against it in accordance with its terms.

 

4.2 No Conflicts. The execution, delivery and performance by Purchaser of this Agreement and any Transaction Document to which it is a party, and the consummation of the Transactions and thereby, do not and will not: (a) conflict with or result in a violation or breach of, or default under, any provision of the Organizational Documents of Purchaser; (b) conflict with or result in a violation or breach of any provision of any Law or Order applicable to Purchaser; or (c) require the consent, notice or other action by any Person under, conflict with, result in a violation or breach of, constitute a default or an event that, with or without notice or lapse of time or both, would constitute a default under, result in the acceleration of or create in any party the right to accelerate, terminate, modify or cancel any Contract to which Purchaser is a party or by which Purchaser is bound or to which any of their respective properties and assets are subject or any Permit affecting the properties, assets or business of the Seller. No consent, approval, Permit, Order, declaration or filing with, or notice to, any Governmental Entity is required by or with respect to Purchaser in connection with the execution and delivery of the Transaction Documents and the consummation of the Transactions.

 

4.3 Litigation. Purchaser has not received written notice that any investigation, audit or assessment by a Governmental Entity is currently pending involving the Assets or the Transactions, and to Purchaser’s Knowledge, there is no investigation, audit or assessment pending or threatened by any Governmental Entity with respect to Purchaser involving the Assets or that challenge or seek to prevent, enjoin or otherwise delay the Transactions.

 

4.4 Broker’s Fees. No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission payable by or on behalf of the Purchaser in connection with the Transactions.

 

ARTICLE 5
COVENANTS

 

5.1 Covenants.

 

(a) After Closing, Seller and Purchaser will take all actions, execute and deliver all documents and do all other acts and things as the other may reasonably request to carry out and document the intent of this Agreement and any other Transaction Documents;

 

(b) Purchaser shall cover the all costs of road expansion and completing the pack house located at the Seller’s premises; and

 

 
6

 

 

(c) Seller shall loan to Purchaser an amount in cash every two weeks in the amount of Purchaser’s payroll. Purchaser shall issue Seller a note for each loan, on terms substantially similar to the Secured Note, the aggregate of such notes shall not exceed three hundred thousand dollars ($300,000).

 

ARTICLE 6
TAX MATTERS

 

6.1 Tax Covenants.

 

(a) Without the prior written consent of Purchaser, Seller shall not, to the extent it may affect or relate to the Seller: (i) make, change, or rescind any Tax election: (ii) amend any Tax Return; or (iii) take any position on any Tax Return, take any action, omit to take any action, or enter into any other transaction that would have the effect of increasing the Tax liability or reducing any Tax asset of Purchaser or the Seller in respect of any taxable period that begins after the Closing Date or, in respect of any taxable period that begins before and ends after the Closing Date (each such period, a “Straddle Period”), the portion of such Straddle Period beginning after the Closing Date.

 

(b) All transfer, documentary, sales, use, stamp, registration, value added, and other such Taxes and fees (including any penalties and interest) incurred in connection with this Agreement and the other Transaction Documents shall be borne and paid by Seller when due. Seller shall, at its own expense, timely file any Tax Return or other document with respect to such Taxes or fees (and Purchaser shall cooperate with respect thereto as necessary).

 

(c) Purchaser shall prepare, or cause to be prepared, all Tax Returns required to be filed by the Seller after the Closing Date with respect to any taxable period or portion thereof ending on or before the Closing Date and all Straddle Period Tax Returns. Any such Tax Return shall be prepared in a manner consistent with past practice (unless otherwise required by Law) and without a change of any election or any accounting method.

 

6.2 Tax Indemnification. From and after the Closing, the Purchaser Indemnified Persons shall be entitled to indemnification for, without duplication, all Losses attributable to:

 

(a) (i) any Taxes imposed on or payable by or with respect to the Seller (other than Transfer Taxes) for any Pre-Closing Period or Straddle Period (to the extent allocable to the Pre-Closing Period pursuant to Section 6.1); (ii) any Taxes (other than Transfer Taxes) of the Sellers or their Affiliates for any period (whether before or after the Closing Date); (iii) Transfer Taxes to the extent required to be borne by Sellers pursuant to Section 6.7; and (iv) any Taxes of any member of an affiliated, consolidated, combined or unitary group of which Seller is or was a member on or prior to the Closing Date, including pursuant to Treasury Regulations Section 1.1502-6 or any analogous or similar state, local or foreign law or regulation. For the avoidance of doubt, Excluded Taxes shall not include any Taxes arising from or attributable to actions by Purchaser or its Affiliates taken on the Closing Date after the Closing outside the ordinary course of business;

 

(b) any Taxes resulting from the failure of any of the representations or warranties made by the Seller or the Seller in this Agreement to be true and correct on the date hereof and at and as of the Closing Date (except those representations and warranties that address matters only as of a particular date, which need only be true and correct as of such date);

 

(c) any Taxes resulting from any breach by the Seller of any of its covenants or agreements contained herein which are to be performed by the Seller on or before the Closing Date, and any breach by the Seller of any of its covenants or agreements contained herein; and (D) reasonable legal fees and expenses, attributable to any item in clauses; and

 

 
7

 

 

(d) reasonable legal fees and expenses, attributable to any item in clauses (a) - (c) of this Section 6.2.

 

6.3 Straddle Period. In the case of Taxes that are payable with respect to a Straddle Period, the portion of any such Taxes that are allocated any Pre-Closing Period for purposes of this Agreement shall be: (a) in the case of Taxes (i) based upon, or related to, income, receipts, profits, wages, capital, or net worth, (ii) imposed in connection with the sale, transfer, or assignment of property, or (iii) required to be withheld, the amount of Taxes which would be payable if the taxable year ended with the Closing Date; and (b) in the case of other Taxes, the amount of such Taxes for the entire period multiplied by a fraction, the numerator of which is the number of days in the period ending on the Closing Date and the denominator of which is the number of days in the entire period.

 

6.4 Termination of Tax Sharing. Any and all existing Tax sharing agreements (whether written or not) binding upon the Seller shall be terminated as of the Closing Date. After such date neither the Seller, Seller, nor any of Seller’s Affiliates and their respective Representatives shall have any further rights or liabilities thereunder.

 

6.5 Tax Proceedings.

 

(a) If any Governmental Entity asserts a Tax Proceeding, then the party first receiving notice of such Tax Proceeding promptly shall provide written notice thereof to the other party or parties hereto; provided, however, that the failure to so notify shall not relieve the party from whom indemnification is being sought of its obligations hereunder, except to the extent that the party from whom indemnification is being sought is materially prejudiced by such failure. Such notice shall specify in reasonable detail the basis for such Tax Proceeding and shall include a copy of the relevant portion of any correspondence received from the Governmental Entity.

 

(b) Seller shall, subject to Section 6.5(d), have the right to control, at Seller’s expense, any Tax Proceeding in respect of the Seller for any Pre-Closing Period; provided, however, that (i) Seller shall provide Purchaser with a timely and reasonably detailed account of each phase of such Tax Proceedings, (ii) Seller shall consult with Purchaser before taking any significant action in connection with such Tax Proceedings, (iii) Seller shall consult with Purchaser and offer Purchaser an opportunity to comment before submitting any written materials prepared or furnished in connection with such Tax Proceedings, (iv) Purchaser shall be entitled to participate, at its sole expense, in such Tax Proceedings and receive copies of any written materials relating to such Tax Proceedings received from the relevant Governmental Entity, and (v) Seller shall not settle, compromise or abandon any such Tax Proceedings without obtaining the prior written consent of Purchaser, which consent shall not be unreasonably withheld, conditioned or delayed.

 

(c) Purchaser shall have the exclusive right to control any Tax Proceedings in respect of Taxes of the Seller for any Straddle Period of the Seller; provided, however, that with respect to any such Tax Proceeding which could reasonably be expected to result in a Tax for which Seller is liable under Section 6.2: (i) Purchaser shall provide Seller with a timely and reasonably detailed account of each phase of such Tax Proceedings, (ii) Purchaser shall consult with Seller before taking any significant action in connection with such Tax Proceedings, (iii) Purchaser shall consult with Seller and offer Seller an opportunity to comment before submitting any written materials prepared or furnished in connection with such Tax Proceedings, (iv) Seller shall, at its sole expense, be entitled to participate in such Tax Proceedings and receive copies of any written materials relating to such Tax Proceedings received from the relevant Governmental Entity, and (v) Purchaser shall not settle, compromise or abandon any such Tax Proceedings without obtaining the prior written consent of Seller, which consent shall not be unreasonably withheld, conditioned or delayed.

 

 
8

 

 

(d) Notwithstanding anything in this Agreement to the contrary, Purchaser shall have the exclusive right to control (i) any Tax Proceedings in respect of the Seller not described in Section 6.5(b) or 6.5(c), and (ii) any Tax Proceedings in respect of the Seller described in Section 6.5(b) if Seller fails to diligently defend such Tax Proceedings.

 

6.6 Tax Cooperation. Seller, Purchaser, the Seller, their respective Affiliates and their directors, officers, employees, shareholders, agents, representatives, successors and assigns shall reasonably cooperate with each other in connection with (a) the preparation and filing of any U.S. federal, state, local or foreign Tax Returns that include the business and operations of the Seller and (b) any Tax Proceeding. Such cooperation shall include the furnishing or making available of employees on a mutually convenient basis and records, books of account or other materials of the Seller necessary or helpful for the preparation of such Tax Returns or the defense against assertions of any Governmental Entity.

 

6.7 Transfer Taxes. All transfer, documentary, excise, sales, use, registration, stamp, duty, recording, property and similar Taxes or fees, including any penalties, interest and additions to Tax, imposed in respect of the Transactions (the “Transfer Taxes”) shall be borne fifty percent (50%) by Purchaser, on the one hand, and fifty percent (50%) by Seller, on the other hand. The Seller shall be responsible for preparing and filing all Tax Returns or other applicable documents in connection with all Transfer Taxes, to the extent permitted by applicable law; provided, however, that Purchaser and Seller shall cooperate in the preparation and filing of all Tax Returns or other applicable documents for or with respect to Transfer Taxes, including timely signing and delivering such Tax Returns, documents, and certificates as may be necessary or appropriate to file such Tax Returns or establish an exemption from (or otherwise reduce) Transfer Taxes.

 

6.8 Coordination; Survival. Claims for indemnification with respect to Taxes, and the procedures with respect thereto, shall be governed exclusively by this Article 6 and, except with respect to Sections 7.1 and 7.4, the provisions of Article 7 shall not apply.

 

6.9 Tax Treatment of Indemnity Payments. The parties hereto agree to treat any payment made pursuant to Section 6.2 or Article 7 as an adjustment to the Purchase Consideration for all Tax purposes, except to the extent otherwise required by applicable Law.

 

ARTICLE 7
SURVIVAL; INDEMNIFICATION

 

7.1 Survival. All representations, warranties, covenants, and agreements contained herein and all related rights to indemnification shall survive the Closing and shall remain in full force and effect until the date that is the first anniversary of the Closing Date. Notwithstanding the foregoing, any claims which are timely asserted in good faith with reasonable specificity (to the extent known at such time) and in writing by notice from the non-breaching party to the breaching party prior to the expiration date of the applicable survival period shall not thereafter be barred by the expiration of the relevant representation or warranty and such claims shall survive until finally resolved except for Fundamental Representations, which shall survive the Closing until the date which is sixty (60) calendar days following the expiration of all applicable statutes of limitations.

 

 
9

 

 

7.2 Indemnification by Seller. Subject to the limitations on liability set forth in this Agreement, Seller agrees to save, defend, indemnify and hold harmless Purchaser, its successors and assigns, and their respective officers, directors, employees an agents (collectively, the “Seller Indemnified Persons”) from and against any and all claims, counterclaims, charges, complaints, demands, actions, causes of action, suits, remedies, rights, sums of money, costs, losses, covenants, contracts, controversies, agreements, promises, damages, obligations, liabilities and expenses (including reasonable attorneys’ fees and costs) (collectively, “Losses”), suffered or incurred by it or them, directly or indirectly, to the extent arising from, related to or as a result of (i) any untrue representation or breach of warranty by Seller under this Agreement, (ii) the non-fulfillment of any covenant or other agreement of Seller contained herein, (iii) any and all Losses relating to any of the foregoing or in enforcing this indemnity, or (iv) reasonable legal expenses incurred by Purchaser in connection with a potential direct claim made against Purchaser in connection with a breach of this Agreement.

 

7.3 Indemnification by Purchaser. Subject to the limitations on liability set forth in this Agreement, Purchaser agrees to save, defend, indemnify and hold harmless Seller, its successors and assigns, and their respective officers, directors, employees an agents (collectively, the “Purchaser Indemnified Persons” and together with Seller Indemnified Persons, collectively, the “Indemnified Persons”) from and against any and all Losses, suffered or incurred by it or them, directly or indirectly, to the extent arising from, related to or as a result of (i) any untrue representation or breach of warranty by Purchaser under this Agreement, (ii) the non-fulfillment of any covenant or other agreement of Purchaser contained herein, or (iii) any and all Losses incident to any of the foregoing or in enforcing this indemnity or (iv) reasonable legal expenses incurred by Purchaser in connection with a potential direct claim made against Purchaser in connection with a breach of this Agreement.

 

7.4 Claims.

 

(a) Any Indemnified Person shall promptly deliver to Seller in the case of claims brought by a Purchaser Indemnified Person and to Purchaser in the case of claims brought by a Seller Indemnified Person, (such notified party, the “Responsible Party”) notice (a “Claim Notice”) of any matter which such Indemnified Person has determined has given or could give rise to a right of indemnification under Section 7.2 or Section 7.3 (a “Claim”), within twenty (20) days of such determination, stating the nature of the claim, to the extent then known by the Indemnified Person, a good-faith estimate of the Loss and method of computation thereof, to the extent then reasonably estimable, and containing a reference to the provisions of this Agreement in respect of which such right of indemnification is claimed or arises; provided that the failure to so timely notify shall not relieve the Responsible Party of its obligations hereunder, except to the extent that the Responsible Party is materially prejudiced by such failure. With respect to any recovery or indemnification sought by an Indemnified Person from the Responsible Party, if the Responsible Party does not notify the Indemnified Person within thirty (30) days from its receipt of the Claim Notice that the Responsible Party disputes such claim (the “Dispute Notice”), the Responsible Party shall be deemed to have accepted and agreed with such claim. If the Responsible Party has disputed a claim for indemnification under Section 7.2 or Section 7.3, the Responsible Party and the Indemnified Person shall proceed in good faith to negotiate a resolution to such dispute. If the Responsible Party and the Indemnified Person cannot resolve such dispute in thirty (30) days after delivery of the Dispute Notice, such dispute shall be resolved pursuant to the terms of Section 8.5.

 

 
10

 

 

(b) Third-Party Claims. If an Action by a third party (a “Third-Party Claim”) is made against any Indemnified Person, and if such Indemnified Person intends to seek indemnity with respect thereto under Section 8.2 or Section 8.3, such Indemnified Person shall promptly notify the Responsible Party of such claims; provided that the failure to so notify shall not relieve the Responsible Party of its obligations hereunder, except to the extent that the Responsible Party is materially prejudiced thereby. Other than in connection with a Third-Party Claim by a Governmental Entity, the Responsible Party shall have the right to assume, within thirty (30) days after receipt of such notice, the conduct and control, through counsel reasonably acceptable to the Indemnified Person at the expense of the Responsible Party, of the settlement or defense thereof), by sending notice thereof to the Indemnified Person, which notice shall state that Responsible Party shall indemnify the Indemnified Person for the entirety of all Losses the Indemnified Person may suffer resulting from, arising out of, relating to, in the nature of, or caused by the Third-Party Claim, and the Indemnified Person shall cooperate with it in connection therewith; provided that the Responsible Party shall permit the Indemnified Person to participate in such settlement or defense through counsel chosen by such Indemnified Person; provided, further, that the fees and expenses of such counsel shall be borne by such Indemnified Person. Notwithstanding an election to assume the defense of such Third-Party Claim, the Indemnified Person shall have the right to employ separate co-counsel and to participate in the defense as counsel of record, if applicable, in such action or proceeding (and the parties shall jointly control the defense), and the Responsible Party shall bear the reasonable fees, costs and expenses of such separate counsel if (i) there exists any actual or potential conflict of interest between the Indemnified Person and the Responsible Party in connection with the defense of the Third-Party Claim that would make representation by the same counsel or the counsel selected by the Responsible Party inappropriate, (ii) such Third-Party Claim seeks an injunction or other equitable relief against the Indemnified Person, (iii) such Third-Party Claim is related to or otherwise arises in connection with any criminal or regulatory enforcement Action, or (iv) the resolution of the Third-Party Claim could materially affect the operations or business of Purchaser Purchaser’s Subsidiaries.

 

(c) Settlement of Third-Party Claims. So long as the Responsible Party is reasonably contesting any such Third-Party Claim in good faith, the Indemnified Person shall not pay or settle any Third-Party Claim without the prior consent of the Responsible Party, which consent shall not be unreasonably withheld). If the Responsible Party does not notify the Indemnified Person within thirty (30) days after the receipt of the Indemnified Person’s notice of a Third-Party Claim of indemnity hereunder that it elects to undertake the defense thereof, the Indemnified Person shall have the right to contest, settle or compromise the Third-Party Claim but shall not thereby waive any right to indemnity therefor pursuant to this Agreement. The Responsible Party shall not, except with the consent of the Indemnified Person, enter into any settlement that (i) does not include as an unconditional term thereof the giving by the Person or Persons asserting such Third-Party Claim to all Indemnified Parties of an unconditional release from all Liability with respect to such Third-Party Claim or consent to entry of any judgment, (ii) does not involve only the payment of money damages, (iii) imposes an injunction or other equitable relief upon the Indemnified Person or (iv) includes any admission of wrongdoing or misconduct by the Indemnified Person.

 

(d) Any Indemnified Person shall cooperate in all reasonable respects with the Responsible Party and its attorneys in the investigation, trial and defense of any Third-Party Claim and any appeal arising therefrom and shall furnish such records, information and testimony, and attend such conferences, discovery proceedings, hearings, trials and appeals as may be reasonably requested in connection therewith. Such cooperation shall include reasonable access during normal business hours afforded to the Responsible Party and its agents and representatives to, and reasonable retention by the Indemnified Person of, records and information which have been identified by the Responsible Party as being reasonably relevant to such Third-Party Claim, and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. The parties shall cooperate with each other in any notifications to insurers.

 

7.5 Limitations on Liability. In no event shall either party be liable for any punitive, consequential, special or indirect damages, including loss of future revenue or income, loss of business reputation or opportunity, and/or diminution of value relating to the breach or alleged breach of this Agreement. Notwithstanding the forgoing or anything else contained herein, any claim for indemnification by Seller indemnified Person or any other Losses incurred by a Seller Indemnified Person as a result of a breach of this Agreement by a Seller, shall be capped at the Purchase Consideration actually received by Seller pursuant to this Agreement.

 

 
11

 

 

7.6 Remedies Not Exclusive. No remedy conferred by any of the specific provisions of this Agreement is intended to be exclusive of any other remedy, and each and every remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or in equity by statute or otherwise. The election of any one or more remedies shall not constitute a waiver of the right to pursue other remedies.

 

ARTICLE 8
MISCELLANEOUS

 

8.1 Notices. All notices, demands and requests required or permitted to be given under the provisions of this Agreement shall be in writing and shall be deemed delivered (i) upon personal delivery if during business hours or, if not, on the next business day, (ii) three (3) business days after deposit of the same in the U.S. mail if mailed by certified mail (return receipt requested), or (iii) one (1) business day after deposit of the same with a nationally recognized overnight courier service if mailed for next business day delivery, in each case, to the addressee thereof at its address set forth below (or at such other address of such party as such party shall have specified in a notice to the other party):

 

If to Purchaser:

 

Edible Garden Incorporated

283 County Road 519

Belvidere, NJ 07823

Attention: Michael James

Email: MJames@ediblegarden.com

 

If to Seller:

 

Edible Garden Corp.

2040 Main Street, Suite 225

Irvine, CA 92614

Attention: Michael Nahass

Email: Mike@terratechcorp.com

 

8.2 Successors and Assigns; Assignment. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective heirs, legal representatives, successors and assigns of the parties hereto; provided, that, no party may assign any of its rights or obligations under this Agreement without the prior written consent of the other non-assigning party. Any purported assignment in contravention of the foregoing shall be deemed null and void.

 

8.3 Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If the final judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, the Parties agree that the court making the determination of invalidity or unenforceability shall have the power to reduce the scope, duration or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified after the expiration of the time within which the judgment may be appealed.

 

 
12

 

 

8.4 Governing Law. All issues and questions concerning the construction, validity, interpretation and enforceability of this Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the Laws of the State of New Jersey, without giving effect to any choice of Law or conflict of Law rules or provisions (whether of the State of New Jersey or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of New Jersey.

 

8.5 Arbitration. Any and all claims or disputes between the parties that arise from or relate or pertain in any way to this Agreement, to the parties’ rights or obligations under this Agreement, to the subject matter of this Agreement, or the arbitrability of any such claim or dispute shall be resolved solely and exclusively by binding arbitration in Warren County, New Jersey before a panel of three Arbitrators in a confidential arbitration proceeding to be conducted by JAMS in the English language pursuant to the JAMS International Arbitration Rules and Procedures. No person shall be eligible to serve as arbitrator in any such proceeding unless he or she shall have served as a state or federal Judge or Justice of a court within the State of New Jersey for at least five years. The prevailing party or parties to any such dispute shall be entitled to recover all of its or their reasonable attorneys' fees and other costs of the arbitration, and any related judicial proceedings, from the non-prevailing party or parties. Each party to this Agreement hereby consents irrevocably to the jurisdiction of the state and federal courts located in the State of New Jersey for the purpose of enforcing this Agreement to arbitrate and for the purposes of any proceedings to confirm, vacate or modify any arbitration award rendered hereunder. Any party may also apply to any court anywhere in the world for the purpose of enforcing any such arbitration award. Without limiting the foregoing, each Party agrees that service of process on such Party as provided in Section 8.1 shall be deemed effective service of process on such Party.

 

8.6 Counterparts. This Agreement and any amendments hereto may be executed in any number of counterparts, each of which shall be deemed to be an original but all of which together shall constitute but one and the same instrument.

 

8.7 Entire Agreement. This Agreement, together with the Transaction Documents, constitutes the entire understanding among the parties with respect to the subject matter hereof. Any agreement, discussions, or negotiations among the parties prior to the date hereof with respect to the subject matter hereof is superseded by this Agreement. Except as expressly provided herein, nothing in this Agreement, express or implied, is intended to confer upon any party, other than the parties hereto, any rights, remedies, obligations or liabilities under or by reason of this Agreement.

 

8.8 Amendment; Waiver. No provision of this Agreement may be amended except in a written instrument signed by Purchaser and Seller. No provision of this Agreement may be waived except in a written instrument signed by the party waiving the benefit to which it is otherwise entitled. No waiver of any provision, condition, or requirement of this Agreement shall be deemed to be a waiver continuing into the future or a waiver on a subsequent occasion or a waiver of any other provision, condition, or requirement of this Agreement, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair such party’s ability to exercise such right.

 

8.9 Expenses. Each party hereto shall pay its own costs and expenses involved in carrying out the Transactions.

 

 
13

 

 

8.10 Remedies Are Exclusive. The remedies provided in this Agreement for a breach of a party’s obligations hereunder shall be exclusive and shall preclude the assertion by any party hereto of any other rights or the seeking of any other remedies against any other party hereto, whether at law or equity.

 

8.11 Further Assurances. Subject to the terms and conditions of this Agreement, each of the Parties shall use all reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things necessary, proper or advisable, under applicable Law and regulations or otherwise, to fulfill its obligations under this Agreement and to consummate the Transactions.

 

ARTICLE 9
DEFINITIONS

 

9.1 Definitions. For purposes hereof, the following terms when used herein shall have the respective meanings set forth below:

 

Action” means any action, arbitration, claim, litigation, proceeding or lawsuit (whether civil, criminal or administrative) commenced, brought, conducted or heard by or before any Governmental Entity.

 

Affiliate” of any particular Person means any other Person directly or indirectly controlling, controlled by or under common control with such particular Person, where “control” means the possession, directly or indirectly, of the power to direct the management and policies of a Person whether through the ownership of voting securities, contract or otherwise.

 

Agreement” is defined in the Preamble.

 

Claim Notice” is defined in Section 7.4(a).

 

Closing” is defined in Section 2.1.

 

Closing Date” is defined in Section 2.1.

 

Contracts,” when described as being those of or applicable to any Person, shall mean any and all written contracts, agreements, commitments, franchises, understandings, arrangements, leases, licenses, registrations, mortgages, bonds, notes, guaranties or other undertakings to which such Person is a party or to which or by which such Person or the property of such Person is subject or bound, excluding any Permits.

 

Dispute Notice” is defined in Section 7.4(a).

 

Encumbrances” is defined in Section 1.1.

 

Environmental and Safety Requirements” is defined in Section

 

Environmental Permits” is defined in Section

 

Fundamental Representations” means the representations and warranties of the Seller set forth in Section 1.1 (Organization and Authority of Seller), Section 3.1 (Organization, Authority and Qualification of the Seller), Section 1.1 (Capitalization) and Section 3.8 (Broker’s Fees).

 

Governmental Entity” means any supranational, federal, national, state, foreign, provincial, local or other government or any governmental, regulatory, administrative or self-regulatory authority, agency, bureau, board, commission, court, judicial or arbitral body, department, political subdivision, tribunal or other instrumentality thereof.

 

 
14

 

 

Hazardous Substance” means any substance, material or waste that is defined or listed by a Governmental Entity pursuant to any Environmental and Safety Requirements as “toxic”, “hazardous”, “a pollutant”, or radioactive”, including asbestos, urea formaldehyde, polychlorinated biphenyls, petroleum, or any petroleum-based products or radon gas.

 

Indemnified Persons” is defined in Section 7.3.

 

Insurance Policies” is defined in Section 3.5.

 

Law” means any law, statute, code, ordinance, rule, regulation, judgment, injunction, Order or decree of any Governmental Entity.

 

Liability” means any indebtedness, debts, claims, obligations and other liabilities of a Person, whether known, unknown, accrued, absolute, direct or indirect, contingent or otherwise, whether due or to become due, and including all costs and expense relating thereto.

 

Losses” is defined in Section 7.1.

 

Material Adverse Effect” means any fact, circumstance, development, event, condition, occurrence or change that (a) has, or would be reasonably expected to have, either individually or in the aggregate with all other facts, circumstances, developments, events, conditions, damages, losses, occurrences or changes, a material adverse effect on the business, properties, assets, liabilities, condition (financial or otherwise) business (as conducted as of the date hereof) or results of operation of the Seller, but excluding, for purposes of this clause (a) in each case any such fact, circumstance, development, event, condition, occurrence or change resulting or arising from: (i) any change, after the date hereof, in GAAP or applicable Law or the application or interpretation thereof; (ii) any change in general economic conditions in the industries or markets in which the Seller operates or affecting United States or foreign economies in general, including changes in interest or exchange rates; (iii) any national or international political or social conditions, including the engagement by the United States in hostilities, whether or not pursuant to the declaration of a national emergency, acts of war (whether declared or not declared) or terrorism, or the escalation thereof; (iv) hurricanes, earthquakes, tornadoes, floods or other natural disaster; (v) changes in financial, banking, or securities markets (including any suspension of trading in, or limitation on prices for, securities on the New York Stock Exchange or NASDAQ National Market for a period in excess of one day or any decline of either the Dow Jones Industrial Average or the Standard & Poor’s Index of 500 Industrial Companies by an amount in excess of 15% measured from the close of business on the date hereof; except that facts, circumstances, developments, events, conditions, damages, losses, occurrences or changes set forth in the foregoing clauses (i) - (v) may be taken into account in determining whether there has been or is a Material Adverse Effect to the extent such facts, circumstances, developments, events, conditions, damages, losses, occurrences or changes have a disproportionate adverse effect on the Seller relative to the other Persons in the industries and markets in which the Seller operates; or (b) has, or would be reasonably expected to have, a material adverse effect on the ability of the Seller to consummate the Transactions.

 

Order” means any settlement, stipulation, order, writ, judgment, injunction, decree, ruling, determination or award of any court or of any Governmental Entity.

 

Ordinary Course of Business” means in accordance with the ordinary and customary day-to-day operations of the Seller consistent with its past practice with respect to the activity in question.

 

 
15

 

 

Organizational Documents” means the organizational documents of a non-natural Person, including, as applicable, the charter, articles or certificate of incorporation, bylaws, articles of organization or certificate of formation, limited liability company agreement, limited partnership agreement, operating agreement or similar governing documents, as amended.

 

Party” and “Parties” is defined in the Preamble.

 

Permits” means all permits, licenses, approvals, consents, notices, waivers, qualifications, filings, registrations, exemptions and authorizations by or of, or registrations with, any Governmental Entity necessary to conduct the business and own the assets of the Seller as currently conducted and owned.

 

Person” means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization, a Governmental Entity or any department, agency or political subdivision thereof or any other organization or entity of any kind.

 

Purchase Consideration” is defined in Section 1.6.

 

Purchaser” is defined in the Preamble.

 

Purchaser Indemnified Persons” is defined in Section 7.3.

 

Purchaser’s Knowledge” means, with respect to any fact, circumstance, event or other matter in question, the actual knowledge of any officer of Purchaser.

 

Response Action” shall mean any action required by a Governmental Entity to investigate, abate, monitor, remediate, remove, mitigate or otherwise address any violation of Environmental and Safety Requirements, any Contamination of any property owned, leased or occupied by the Seller or any release or threatened release of Hazardous Substances. Without limitation, Response Action shall include any action that would be a “response” as defined by the Comprehensive Environmental Response, Compensation and Liability Act, as amended at the date of Closing, 42 U.S.C. § 9601 (25).

 

Responsible Party” is defined in Section 7.4(a).

 

Securities Act” is defined in Section 1.1.

 

Secured Note” is defined in Section 1.2.

 

Seller” is defined in the Preamble.

 

Seller Indemnified Persons” is defined in Section 7.1.

 

Seller’s Knowledge” means, with respect to any fact, circumstance, event or other matter in question, the actual knowledge of Derek Peterson and Michael Nahass.

 

 
16

 

 

Tax” or “Taxes” means (i) any and all U.S. federal, state, local, territorial and non-U.S. taxes, assessments and other governmental charges, duties, impositions, withholdings, fees, levies, imposts and liabilities relating to taxes, including taxes based upon or measured by gross receipts, income, profits, gains, capital gains, sales, use, business and occupation, license, registration, and value added, goods and services, ad valorem, capital, windfall profit, production, transfer, stamp, alternative or add-on minimum, intangibles, estimated, franchise, withholding, payroll (including social security contributions), employment, severance, recapture, employment, excise and property (real and personal) taxes, together with all interest, penalties, fines and additions imposed with respect to such amounts, (ii) any liability for the payment of any amounts of the type described in clause (i) of this section as a result of being a member of an affiliated, consolidated, combined goods and services, unitary or similar group for any period (including an arrangement for group or consortium relief or similar arrangement) and (iii) any liability for the payment of any amounts of the type described in clauses (i) and (ii) of this section as a result of any express or implied obligation to indemnify any other person or as a result of any obligations under any agreements or arrangements with any other Person with respect to such amounts and including any liability for Taxes of a predecessor or transferor or otherwise by operation of Law.

 

Tax Proceeding” means an audit, examination, suit, action or proceeding in respect of, relating to or attributable to Taxes or any Tax Return of the Seller.

 

Tax Returns” is defined in Section 3.8(a).

 

Third-Party Claim” is defined in Section 7.4(b).

 

Transaction Documents” means this Agreement, the Secured Note, the Security Agreement, the Transition Services Agreement and all other agreements to be executed and delivered by a Party in connection with the consummation of the Transactions.

 

[remainder of page intentionally left blank; signature page follows]

 

 
17

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date first above written.

 

 

SELLER:

 

 

 

 

 

 

EDIBLE GARDEN CORP.

 

 

 

 

 

 

By:

/s/ Michael Nahass

 

 

Name:

Michael Nahass

 

 

Title:

President/COO

 

 

 

 

 

 

PURCHASER:

 

 

 

 

 

 

EDIBLE GARDEN INCORPORATED

 

 

 

 

 

 

By:

/s/ Michael C. James

 

 

Name:

Michael C. James

 

 

Title:

Treasurer

 

 

 
18

 

EXHIBIT 10.2

 

PURCHASE AGREEMENT

 

This Agreement (“Agreement”) is made as of March 30, 2020, by and among Terra Tech Corp. (the “Seller”) and Edible Garden Incorporated (the “Purchaser”).

 

WHEREAS, Seller owns all of the membership interests (the “Membership Interests”) of EG Transportation LLC (the “Company”);

 

WHEREAS, Seller desires to sell and Purchaser desires to purchase the Membership Interests.

 

NOW, THEREFORE, the parties hereto agree as follows:

 

Section 1. Purchase and Sale.

 

1.1 Pursuant to the terms and conditions of this Agreement, Seller hereby agrees to sell to Purchaser and Purchaser hereby agrees to purchase from Seller the Membership Interests.

 

1.2 The total purchase price (the “Purchase Price”) for the Membership Interests to be paid by the Purchaser to the Seller at the Closing, as provided in Section 1.3 hereof, shall be $1.00.

 

1.3 The Purchase Price shall be paid by delivery of $1.00 to Seller by check or to one or more accounts designated by the Seller.

 

Section 2. Closing.

 

2.1 The closing shall take place, subject to the conditions set forth in Section 2.2 hereof, on the date hereof or such other time as the parties hereto may mutually agree. The date and time of closing are herein referred to as the “Closing Date” or the “Closing.”

 

2.2 Delivery of Purchase Price.

 

2.2.1 Delivery of Membership Interests. The Seller shall deliver to Purchaser any certificates evidencing such Membership Interests, duly endorsed to the Purchaser.

 

2.2.2 Delivery of Purchase Price. The Purchaser shall deliver the Purchase Price by check or to one or more accounts designated by the Seller.

 

Section 3. Miscellaneous.

 

3.1 Counterparts. This Agreement may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute but one and the same instrument.

 

3.2 Amendment. Neither this Agreement nor any of the terms hereof may be terminated, amended, supplemented, waived or modified orally, but only by an instrument in writing which purports to terminate, amend, supplement, waive or modify this Agreement or any of the terms hereof and is signed by the party against which the enforcement of the termination, amendment, supplement, waiver or modification is sought.

 

 
1

 

 

3.3 Successors and Assigns. The terms of this Agreement shall be binding on, and inure to the benefit of, the parties hereto and their respective successors and assigns.

 

3.4 Governing Law. This Agreement, including all matters of construction, validity and performance, shall in all respects be governed by, and construed in accordance with, the laws of the State of California.

 

3.5 Notices. Except as otherwise provided in this Agreement, all notices hereunder shall be in writing and shall be given by mail, personal delivery, overnight courier, telecopy or any other customary means of written communication at the addresses set forth on the signature pages hereof, or at such other addresses as may be specified by written notice to the parties hereto, and shall become effective when received by the addressees.

 

3.6 Severability of Provisions. Any provision of this Agreement, which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof or affecting the validity or enforceable of such provision in any other jurisdiction.

 

3.7 Headings. The headings used herein are for convenience of reference only and shall not define or limit any of the terms or provisions hereof.

 

3.8 Entire Agreement. This Agreement embodies the entire agreement and understanding between the parties hereto and supersedes all prior agreements and understandings between the parties hereto relating to the subject matter hereof.

 

[signature page follows]

 

 
2

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered by their respective officers thereunto duly authorized as of the date and year first above written.

 

 

Terra Tech Corp.

 

 

 

 

 

By:

/s/ Michael Nahass

 

 

Name:

Michael Nahass

 

 

Title:

President/COO

 

 

  

 

 

 

Address: 

 

 

 

 

 

 

Edible Garden Incorporated

 

 

 

 

 

 

By:

/s/ Michael C. James

 

 

Name:

Michael C. James

 

 

Title:

Treasurer

 

 

 

 

 

 

Address:

283 County Rd 519

 

 

 

Belvidere, NJ 07823

 

 

 
3

 

EXHIBIT 10.3

 

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THIS NOTE UNDER SUCH ACT UNLESS SUCH REGISTRATION IS NOT REQUIRED PURSUANT TO A VALID EXEMPTION THEREFROM UNDER THE ACT.

 

Edible Garden Incorporated

 

Secured Promissory Note

 

Face Amount: $3,000,000

 March 30, 2020

 

FOR VALUE RECEIVED, the undersigned Edible Garden Incorporated, (the “Borrower”), promises to pay to the order of Sament Capital Investments, Inc., its successors or assigns (the “Lender”), Three Million Dollars ($3,000,000) (the “Face Amount”) by March 30, 2025 (the “Maturity Date”), in accordance with the terms hereof, together with interest.

 

Interest at the simple rate of (3.50%) per annum, calculated on the basis of a 360-day year of twelve 30-day months, until the Maturity Date or repayment is made as provided herein, and any other amounts due hereunder are payable in lawful money of the United States of America to the Lender. Interest calculated for the first year of this Note shall be added to the Face Amount, after the first-year interest shall be paid on a monthly basis until the Maturity Date.

 

Section 1. Security and Priority. As security for payment of the Face Amount under this Note, the Borrower and the Lender have entered into that certain Security Agreement of even date herewith (the “Security Agreement”). The Security Agreement and the Note are sometimes hereinafter referred to as the “Loan Documents.” The Borrower and the Lender have agreed that all obligations under this Note will be secured by all of the Collateral (as that term is defined in the Security Agreement) of the Borrower.

 

Section 2. Maturity. The Face Amount, along with the interest accrued thereon, shall be repaid in cash at the Maturity Date, unless repaid earlier at the option of Borrower.

 

Section 3. Prepayment. This Note may be prepaid in whole or in part at any time and from time-to-time upon three (3) prior business days’ written notice, without penalty. Such repayment shall satisfy Borrower’s obligations pursuant to this Note in full and this Note shall be of no further force and effect.

 

Section 4. Transferability. This Note and any of the rights granted hereunder are freely transferable or assigned by Lender, in whole or in part, in its sole discretion; provided, that the Lender provides notice to the Borrower of its transfer or assignment.

 

Section 5. Event of Default.

 

(a) In the event that any one of the following events shall occur (whatever the reason and whether it shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body), it shall be deemed an Event of Default:

 

 
1

 

 

(i) Any default in the payment of the principal, interest on, or other charges in respect of this Note, or any other note issued by the Borrower, as and when the same shall become due and payable;

 

(ii) Borrower shall fail to observe or perform any other material covenant, agreement or warranty contained in, or otherwise commit any breach or default of any provision of this Note or any other agreement between the Borrower and the Lender;

 

(iii) There shall be a breach of any of the representations and warranties set forth in this Note or any transaction document executed contemporaneously herewith; or

 

(iv) Borrower, shall commence, or there shall be commenced against Borrower any applicable bankruptcy or insolvency laws as now or hereafter in effect or any successor thereto, or Borrower commences any other proceeding under any reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction whether now or hereafter in effect relating to Borrower or there is commenced against Borrower any such bankruptcy, insolvency or other proceeding which remains undismissed for a period of sixty (60) days; or Borrower is adjudicated insolvent or bankrupt; or any order of relief or other order approving any such case or proceeding is entered; or Borrower suffers any appointment of any custodian, private or court appointed receiver or the like for it or any substantial part of its property which continues undischarged or unstayed for a period of sixty (60) days; or Borrower makes a general assignment for the benefit of creditors; or Borrower shall fail to pay or shall state that it is unable to pay or shall be liable to pay, its debts as they become due or by any act or failure to act expressly indicate its consent to, approval of or acquiescence in any of the foregoing; or any corporate or other action is taken by the Borrower for the purpose of effecting any of the foregoing.

 

(b) Upon the occurrence of an Event of Default, the Lender shall give the Borrower notice of such occurrence, at which time the Borrower shall have five (5) business days from receipt of such notice to pay the outstanding amount of the Note, with any unpaid interest thereof, in full. In the event that full payment is not made upon the expiry of the five (5) day period, a default penalty equal to two percent (2%) of the Face Amount per month during the period of Default (the “Default Penalty”). Lender may then, at its sole discretion declare the entire then outstanding Face Amount of this Note together with any unpaid interest and the Default Penalty immediately due and payable (a “Default Declaration”), in which event the Lender may, at its sole discretion take any action it deems necessary to recover amounts due under this Note.

 

(c) Upon the occurrence of an Event of Default, the Lender shall be entitled to receive, in addition to the Face Amount of the Note, interest thereon and the Default Penalty, the Lender shall be entitled to recover all of its costs, fees (including without limitation, reasonable attorney’s fees and disbursements), and expenses relating collection and enforcement Note, including all costs and expenses incurred by it in enforcing its rights under the Note and any transaction document entered into contemporaneously herewith.

 

 
2

 

 

(d) The failure of Lender to exercise any of its rights hereunder in any particular instance shall not constitute a waiver of the same or of any other right in that or any subsequent instance with respect to Lender or any subsequent holder. Lender need not provide and Borrower hereby waives any presentment, demand, protest or other notice of any kind, and Lender may immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable law. The remedies available to the Lender upon the occurrence of an Event of Default shall be cumulative.

 

Section 6. Notices. Any and all notices, service of process or other communications or deliveries required or permitted to be given or made pursuant to any of the provisions of this Note shall be deemed to have been duly given or made for all purposes when hand delivered or sent by certified or registered mail, return receipt requested and postage prepaid, overnight mail or courier, or via electronic mail (provided that the sender of such electronic mail does not receive a notice or message indicating that such email was unsuccessful) as follows:

 

If to Borrower, at:

 

Edible Garden Incorporated

283 Country Road 519

Belvidere, NJ 07823

Attn: CEO

 

Or such other address as may be given to the Borrower from time to time

 

If to Lender, at:

 

2040 Main St., Suite 225

Irvine, CA 92614

Attn: President

 

Or such other address as may be given to the Lender from time to time

 

Section 7. Usury. This Note is hereby expressly limited so that in no event whatsoever, whether by reason of acceleration of maturity of the loan evidenced hereby or otherwise, shall the amount paid or agreed to be paid to the Lender hereunder for the loan, use, forbearance or detention of money exceed that permissible under applicable law. If at any time the performance of any provision of this Note or of any other agreement or instrument entered into in connection with this Note involves a payment exceeding the limit of the interest that may be validly charged for the loan, use, forbearance or detention of money under applicable law, then automatically and retroactively, ipso facto, the obligation to be performed shall be reduced to such limit, it being the specific intent of the Borrower and the Lender that all payments under this Note are to be credited first to interest as permitted by law, but not in excess of (i) the agreed rate of interest set forth herein or therein or (ii) that permitted by law, whichever is the lesser, and the balance toward the reduction of principal. The provision of this Section 6 shall never be superseded or waived and shall control every other provision of this Note and all other agreements and instruments between the Borrower and the Lender entered into in connection with this Note. To the extent permitted by applicable law, Borrower waives any right to assert the defense of usury.

 

 
3

 

 

Section 8. Governing Law; Waiver of Jury Trial. This Note and the provisions hereof are to be construed according to and are governed by the laws of the State of California, without regard to principles of conflicts of laws thereof. Borrower agrees that the California State Court located in the County of Orange, State of California shall have exclusive jurisdiction in connection with any dispute concerning or arising out of this Note or otherwise relating to the parties’ relationship. In any action, lawsuit or proceeding brought to enforce or interpret the provisions of this Note and/or arising out of or relating to any dispute between the parties, Lender shall be entitled to recover all of its costs and expenses relating collection and enforcement of this Note (including without limitation, reasonable attorney’s fees and disbursements) in addition to any other relief to which Lender may be entitled and all costs of collection, including any legal fees associated with this Note will be paid by the Borrower. Each party agrees that any process or notice to be served or delivered in connection with any action, lawsuit or proceeding brought hereunder may be accomplished in accordance with the notice provisions set forth above or as otherwise provided by applicable law.

 

BORROWER HEREBY WAIVES TRIAL BY JURY IN ANY ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM, WHETHER IN CONTRACT OR TORT, AT LAW OR IN EQUITY, ARISING OUT OF OR IN ANY WAY RELATING TO THIS NOTE.

 

Section 9. Successors and Assigns. Subject to applicable securities laws, this Note, and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of Borrower and the successors and assigns of Lender.

 

Section 10. Amendment. This Note may be modified or amended, or the provisions hereof waived only with the written consent of Lender and Borrower.

 

Section 11. Severability. Wherever possible, each provision of this Note shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Note shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Note.

 

[SIGNATURE PAGE TO FOLLOW]

 

 
4

 

 

IN WITNESS WHEREOF, Borrower has caused this Promissory Note to be duly authorized officer and/or such individual borrower as of the date first above indicated.

 

 

Edible Garden Incorporated

 

 

  

 

 

By:

/s/ Michael C. James

 

 

Name:

Michael C. James

 

 

Title:

Treasurer

 

 

 
5

 

EXHIBIT 10.4

 

SECURITY AGREEMENT

 

THIS AGREEMENT, made this 30th day of March 2020, under the laws of the State of New Jersey.

 

BETWEEN SAMENT CAPITAL INVESTMENTS, INC. (herein called the “Secured Party”) whose address is 2040 Main Street, Suite 225, Irvine CA 92614 and EDIBLE GARDEN INCORPORATED (herein called the “Debtor”), whose address is 283 Country Road 519, Belvidere, NJ 079823.

 

WITNESSETH:

 

To secure:

 

1. The payment of an indebtedness of the Debtor to the Secured Party in the amount of Three Million ($3,000,000) Dollars as evidenced by the promissory note signed on the date herewith (the “Promissory Note”),

 

2. Any other indebtedness or liability of the Debtor to the Secured Party hereafter arising, including all future advances or loans which may be made by Secured Party to Debtor, (all hereinafter called the “obligations”).

 

3. All costs and expenses incurred by the Secured Party in the collection of the foregoing, including reasonable attorney’s fees and other expenses for pursuing, searching for, receiving, taking, keeping, storing, advertising, and selling the collateral. If the Debtor shall default, after written notice and a 10 day cure period in the performance of any of the provisions of this agreement on the Debtor’s part to be performed, Secured Party may perform same for the Debtor’s account and any monies expended in so doing shall be chargeable with interest to the Debtor and added to the indebtedness.

 

Debtor hereby grants and conveys to the Secured Party, a security interest in, and mortgages to the Secured Party, the following collateral (the “Collateral”):

 

a. All of the tangible greenhouse assets (“Assets”) of the Debtor located at 283 County Road 519, Belvidere, NJ 07823. The Debtor and Secured Party have agreed that all of the obligations of this agreement will be secured by the Assets.

 

b. All proceeds thereof, if any,

 

c. All substitutions, replacements and accessions thereto

 

DEBTOR WARRANTS, COVENANTS AND AGREES AS FOLLOWS:

 

1. To pay and perform all of the obligations secured by this Agreement according to their terms.

 

2. To defend the title to the collateral granted Secured Party against all persons and against all claims and demands whatsoever, which collateral, except for the security interest granted hereby, is lawfully owned by the Debtor and is now free and clear of any and all liens, security interests, claims, charges, encumbrances, taxes and assessments except as may be set forth in the schedule attached hereto.

 

3. On demand of the Secured Party to do the following: furnish further assurance of title, execute any written agreement or do any other acts reasonably necessary to effectuate the purposes and provisions of this Agreement, execute any instrument or statement required by law or otherwise in order to perfect, continue or terminate the security interest of the Secured Party in the collateral and pay all filing fees in connection therewith.

 

 
1

 

 

4. To retain possession of the collateral during the existence of this Agreement and not to sell, exchange, assign, loan, deliver, lease, mortgage or otherwise dispose of same, except in the ordinary course of business without the written consent of the Secured Party.

 

5. Except as mutually agreed to by the parties, to keep the collateral free and clear of all liens, charges, encumbrances, taxes and assessments.

 

6. To pay, when due, all taxes, assessments and license fees relating to the collateral.

 

7. To keep the collateral, at Debtor’s own cost and expense, in good repair and condition and not to misuse, abuse, waste or allow it to deteriorate except for normal wear and tear and to make same available for inspection by the Secured Party at all reasonable times upon two (2) day written notice.

 

8. To keep the collateral insured against loss by fire (including extended coverage), theft and other hazards as the Secured Party may reasonably require. Policies shall be in such form and in an aggregate amount equal to or exceeding the principal balance due under the Promissory Note at the time such policy is issued or renewed and with such companies as the Secured Party may approve, such approval not to be unreasonably withheld. Policies shall be obtained from responsible insurers authorized to do business in New Jersey. Certificates of insurance or policies, payable to the respective parties as their interest may appear, shall be deposited with the Secured Party who is authorized, but under no duty, to obtain such insurance upon failure of the Debtor to do so after written notice to Debtor and a 10-day cure period thereafter. Debtor shall give immediate written notice to the Secured Party and to insurers of loss or damage to the collateral and shall promptly file proofs of loss with insurers. Debtor hereby assigns to the Secured Party all sums which may become payable under such insurance, including return premiums and dividends, as additional security for the indebtedness, but such assignment may only be exercised by Secured Party if Debtor is in default and 10 days have passed since notice of such default was given to Debtor by Secured Party and such default remains substantially uncured. Any other return premiums and/or dividends shall be paid to Debtor.

 

9. To immediately notify the Secured Party in writing of any change in or discontinuance of Debtor’s place or places of business.

 

DEFAULT:

 

1. The following shall constitute a default by Debtor:

 

a. Failure to pay the principal or interest on the Promissory Note and any other indebtedness when due and to then cure such failure after 10 days written notice thereof by Secured Party to Debtor.

 

b. Failure by Debtor to comply with or perform any provision of this agreement, after notice and a 10-day cure period.

 

c. False or misleading written material representations or warranties made or given by Debtor in connection with this agreement to Secured Party.

 

 
2

 

 

d. Subjection of the collateral to levy of execution or other judicial process.

 

e. Commencement of any insolvency proceeding by or against the Debtor or of any guarantor of or surety for the Debtor’s obligations which is not dismissed or otherwise disposed of within 60 days of commencement.

 

2. Upon any default of the Debtor and at the option of the Secured Party, the obligations secured by this Agreement shall, after written notice thereof by Secured Party to Debtor and the passage of 10 days’ time without such default being substantially cured, immediately become due and payable in full and the Secured Party shall have all the rights, remedies and privileges with respect to repossession, retention and sale of the collateral and disposition of the proceeds as are accorded to a Secured Party by the applicable sections of the Uniform Commercial Code as enacted in New Jersey respecting “Default”, in effect as of the date of this Security Agreement.

 

GENERAL PROVISIONS:

 

1. Debtor consents to any extension of time or payment.

 

2. All items of collateral shall not become part of the freehold regardless of the manner of affixation and be kept at Debtor’s places of business in Belvidere, New Jersey, except in the ordinary course of business.

 

3. The Debtor shall remain liable for any deficiency resulting from a commercially reasonable sale of collateral, and Debtor shall pay any such deficiency forthwith on demand and upon presentment of proof of the deficiency amount.

 

4. The Uniform Commercial Code as enacted in the State of New Jersey shall govern the rights, duties and remedies of the parties and any provisions herein declared invalid under any law shall not invalidate any other provision of this agreement. In addition to its statutory rights, the Secured Party may:

 

a. require Debtor to assemble the collateral and make it available to the Secured Party at a place to be designated by the Secured Party, reasonably convenient to both parties;

 

b. unless the collateral is perishable or threatens to decline speedily in value or is of a type customarily sold on a recognized market, Secured Party will give Debtor reasonable notice of the time and place of any public sale thereof or of the time after which any private sale or any other intended disposition thereof is to be made. The requirements of reasonable notice will be met if such notice is mailed, postage prepaid, to the address of the Debtor shown above, at least three business days before the time of sale or disposition.

 

5. In addition to any rights granted to Secured Party under the Uniform Commercial Code as enacted in the State of New Jersey, in the event of an unremedied default by the Debtor, Secured Party may elect to take over the operations of the Debtor in its Belvidere, New Jersey location and continue to operate said business. Such election shall be deemed to be full satisfaction of Debtor’s obligations to Secured Party hereunder and under the Promissory Note.

 

6. Any waiver of or acquiescence in any default by the Debtor, or failure of the Secured Party to insist upon strict performance by the Debtor of any warranties or agreements in this Agreement, shall not constitute a waiver of any subsequent or other default or failure, except as provided otherwise at law or in equity.

 

7. The terms, warranties and agreements herein contained shall bind and inure to the benefit of the respective parties hereto, and any legal representatives, successors and assignees.

 

8. Secured Party may assign this agreement only upon written approval of Debtor, which approval shall not be unreasonably withheld and if assigned the assignee shall be entitled, upon notifying the Debtor, to performance of all of Debtor’s obligations and agreements hereunder and the assignee shall be entitled to all of the rights and remedies of the Secured Party hereunder.

 

 
3

 

 

9. The Secured Party is hereby authorized to file a Financing Statement as executed by Debtor.

 

10. Miscellaneous Provisions

 

a. This Agreement supersedes any and all other agreements, either oral or in writing, between the parties hereto with respect to the subject matter hereof, and no other agreement, statement, or promise relating to the subject matter of this Agreement which is not contained herein shall be valid or binding.

 

b. This Agreement shall be binding on the heirs, executors, administrators, legal representatives, successors, and assigns of the respective parties.

 

c. The validity of this Agreement and any of its terms or provisions, as well as the rights and duties of the parties hereunder, shall be governed by the laws of the State of New Jersey. This Agreement is made, and is performable, in Warren County, New Jersey.

 

d. This Agreement may only be amended by the mutual agreement of the parties herein in a properly executed written instrument specifically referencing this Agreement.

 

e. The headings used in this Agreement are used for administrative purposes only and do not constitute substantive matter to be considered in construing the terms of this Agreement.

 

f. Wherever the context shall so require, all words herein in the male gender shall be deemed to include the female or neuter gender, all singular words shall include the plural, and all plural words shall include the singular.

 

g. Except as specifically provided otherwise herein, any and all notices or other communications required or permitted by this Agreement or by law to be delivered to, served on, or given to any party to this Agreement by any other party to this Agreement shall be in writing and shall be deemed properly delivered, given, or served when personally delivered to the party to whom it is directed, or in lieu of personal service, when deposited in the United States mail, first-class postage prepaid, certified mail, return receipt requested, at the hereafter indicated addresses for notice. Any party may change his, her, or its address for the purposes of this Paragraph by giving written notice of the change to all other parties in the manner provided in this Paragraph. The parties’ addresses for notice hereunder shall be as set forth on the first page of this Agreement.

 

h. Any signatory to this Agreement who is the prevailing party in any legal proceeding against any other signatory under or with relation to this Agreement or the transaction(s) contemplated herein shall be additionally entitled to recover Court costs and reasonable attorneys’ fees from the non-prevailing party.

 

i. This Agreement may be executed in multiple counterparts, each of which shall be an original, but all of which, when taken together, shall constitute but one Agreement.

 

[Signature page follows]

 

 
4

 

 

IN WITNESS WHEREOF, the Parties have respectively signed and sealed these presents the day and year first above written.

 

SAMENT CAPITAL INVESTMENTS, INC. 

 

EDIBLE GARDEN INCORPORATED

 

 

 

 

 

 

By:

/s/ Michael Nahass

 

By:

/s/ Michael C. James

 

 

 

 

 

 

 

Name:

Michael Nahass

 

Name:

Michael C. James

 

 

 

 

 

 

 

Title:

President/COO

 

Title:

Treasurer

 

 

 
5

 

EXHIBIT 10.5

 

OPTION AGREEMENT #1

 

This OPTION AGREEMENT (this “Agreement”) is effective as of March 30, 2020, by and between Sament Capital Investments, Inc., a California corporation (“Sament”), and Edible Garden Incorporated, a Wyoming corporation (the “Company” and together with Sament, each a “Party” and collectively, the “Parties”).

 

RECITALS

 

The Company desires to offer Sament an option to purchase shares (the “Shares”) of the Company’s common stock (the “Common Stock”), and Sament desires to accept such option from the Company, upon the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of the mutual promises and covenants herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

 

AGREEMENT

 

ARTICLE 1

OPTION

 

1.1 Grant of Option. On the terms and subject to the conditions set forth in this Agreement, the Company hereby grants Sament an option (the “Option”) to purchase eighty-nine (89) Shares (the “Option Shares”), upon the occurrence of one of the events described in clauses (a)-(e) below, or as otherwise mutually agreed to by the Parties, or at any time between the one (1) year and five (5) year anniversary of the date of this Agreement (the “Option Exercise Period”).

 

(a) an acquisition by an individual, entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Securities Exchange Act of 1934, as amended) of effective control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of fifty percent (50%) or more of the aggregate votes of the then-issued and outstanding voting securities of the Company, (b) the Company merges into or consolidates with any other individual or corporation, partnership, trust, association, limited liability company, or other entity of any kind (a “Person”), or any Person merges into or consolidates with the Company and, after giving effect to such transaction, the stockholders of the Company immediately prior to such transaction own fifty percent (50%) or less of the aggregate voting power of the Company or the successor entity of such transaction, (c) the Company sells or transfers all or substantially all of its assets to another Person and the stockholders of the Company immediately prior to such transaction own fifty percent (50%) or less of the aggregate voting power of the acquiring entity immediately after such transaction, (d) an underwritten public offering by the Company of its Common Stock, a registered direct offering by the Company of its Common Stock, or a reverse merger of the Company into a public company, or (e) the sale by the Company of Common Stock or securities that are convertible into or exercisable or exchangeable for Common Stock in one or a series of related transactions at a valuation of at least $10,000,000.

 

 
1

 

 

1.2 Exercise of Option

 

(a) Notice of Intent to Exercise Option. The Option shall be exercised automatically immediately prior to the occurrence of one of the events described in clauses (a)-(e) above. If an event described in clauses (a)-(e) above does not occur prior to the one year anniversary of the date of this Agreement, Sament may exercise the Option during the Option Exercise Period by delivering written notice thereof to the Company (the “Exercise Notice”).

 

(b) Purchase of Shares. The closing (the “Closing”) of the purchase of the Option Shares shall take place immediately prior to the occurrence of one of the events described in clauses (a)-(e) above, or two (2) business days after receipt by the Company of the Exercise Notice. At the Closing, (i) the Company shall transfer all of its rights, title and interest in the Option Shares to Sament, and (ii) Sament shall deliver to the Company $1.00 by check or wire transfer of immediately available funds. Each Party hereby agrees to execute and deliver all documents and instruments reasonably necessary to effectuate the Closing.

 

ARTICLE 2
MISCELLANEOUS

 

2.1 Notices. All notices, demands and requests required or permitted to be given under the provisions of this Agreement shall be in writing and shall be deemed delivered (i) upon personal delivery if during business hours or, if not, on the next business day, (ii) three (3) business days after deposit of the same in the U.S. mail if mailed by certified mail (return receipt requested), or (iii) one (1) business day after deposit of the same with a nationally recognized overnight courier service if mailed for next business day delivery, in each case, to the addressee thereof at its address set forth below (or at such other address of such Party as such Party shall have specified in a notice to the other Party):

 

If to the Company:

 

Edible Garden Incorporated

283 County Road 519

Belvidere, NJ 07823

Attention: Michael James

Email: MJames@ediblegarden.com

 

If to Sament:

 

Sament Capital Investments, Inc.

2040 Main Street, Suite 225

Irvine, CA 92614

Attention: Michael Nahass

 

2.2 Successors and Assigns; Assignment. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective heirs, legal representatives, successors and assigns of the Parties hereto; provided, that, no Party may assign any of its rights or obligations under this Agreement without the prior written consent of the other non-assigning Party. Any purported assignment in contravention of the foregoing shall be deemed null and void.

 

 
2

 

 

2.3 Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If the final judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, the Parties agree that the court making the determination of invalidity or unenforceability shall have the power to reduce the scope, duration or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified after the expiration of the time within which the judgment may be appealed.

 

2.4 Governing Law. All issues and questions concerning the construction, validity, interpretation and enforceability of this Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of the State of New Jersey, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of New Jersey or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of New Jersey.

 

2.5 Arbitration. Any and all claims or disputes between the Parties that arise from or relate or pertain in any way to this Agreement, to the Parties’ rights or obligations under this Agreement, to the subject matter of this Agreement, or the arbitrability of any such claim or dispute shall be resolved solely and exclusively by binding arbitration in the State of New Jersey before a panel of three Arbitrators in a confidential arbitration proceeding to be conducted by JAMS in the English language pursuant to the JAMS International Arbitration Rules and Procedures. No person shall be eligible to serve as arbitrator in any such proceeding unless he or she shall have served as a state or federal Judge or Justice of a court within the State of New Jersey for at least five years. The prevailing Party or Parties to any such dispute shall be entitled to recover all of its or their reasonable attorneys' fees and other costs of the arbitration, and any related judicial proceedings, from the non-prevailing Party or Parties. Each Party to this Agreement hereby consents irrevocably to the jurisdiction of the state and federal courts located in the State of New Jersey for the purpose of enforcing this Agreement to arbitrate and for the purposes of any proceedings to confirm, vacate or modify any arbitration award rendered hereunder. Any Party may also apply to any court anywhere in the world for the purpose of enforcing any such arbitration award. Without limiting the foregoing, each Party agrees that service of process on such Party as provided in this Agreement shall be deemed effective service of process on such Party.

 

2.6 Counterparts. This Agreement and any amendments hereto may be executed in any number of counterparts, each of which shall be deemed to be an original but all of which together shall constitute but one and the same instrument.

 

2.7 Entire Agreement. This Agreement constitutes the entire understanding among the Parties with respect to the subject matter hereof. Any agreement, discussions, or negotiations among the Parties prior to the date hereof with respect to the purchase of the Shares is superseded by this Agreement. Except as expressly provided herein, nothing in this Agreement, express or implied, is intended to confer upon any party, other than the Parties hereto, any rights, remedies, obligations or liabilities under or by reason of this Agreement.

 

 
3

 

 

2.8 Amendment; Waiver. No provision of this Agreement may be amended except in a written instrument signed by the Parties. No provision of this Agreement may be waived except in a written instrument signed by the Party waiving the benefit to which it is otherwise entitled. No waiver of any provision, condition, or requirement of this Agreement shall be deemed to be a waiver continuing into the future or a waiver on a subsequent occasion or a waiver of any other provision, condition, or requirement of this Agreement, nor shall any delay or omission of any Party to exercise any right hereunder in any manner impair such Party’s ability to exercise such right.

 

2.9 Expenses. Each Party hereto shall pay its own costs and expenses involved in carrying out the transactions contemplated by this Agreement.

 

2.10 Exclusive Remedies. The remedies provided in this Agreement for a breach of a Party’s obligations hereunder shall be exclusive and shall preclude the assertion by any Party hereto of any other rights or the seeking of any other remedies against any other Party hereto, whether at law or equity.

 

2.11 Further Assurances. Subject to the terms and conditions of this Agreement, each of the Parties shall use all reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things necessary, proper or advisable, under applicable law or otherwise, to fulfill its obligations under this Agreement.

 

2.12 Stock Dividends and Stock Splits. If the Company, at any time while this Agreement is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock, (ii) subdivides outstanding shares of Common Stock into a larger number of shares, or (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, then the number of Shares of Common Stock issuable to Sament pursuant to this Agreement shall be automatically adjusted proportionately.

 

[remainder of page intentionally left blank; signature page follows]

 

 
4

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date first above written.

 

 

 

SAMENT:

 

 

 

 

SAMENT CAPITAL INVESTMENTS, INC.

 

       
By:

/s/ Michael Nahass

 

Name:

Michael Nahass

 
  Title:

President/COO

 
       

 

 

 

 

 

COMPANY:

 

 

 

 

 

Edible Garden Incorporated

 

 

 

 

 

 

By:

Michael C. James

 

 

Name:

Michael C. James

 

 

Title:

Treasurer

 

  

 

5

 

EXHIBIT 10.6

 

OPTION AGREEMENT #2

 

This OPTION AGREEMENT (this “Agreement”) is effective as of March 30, 2020, by and between Sament Capital Investments, Inc., a California corporation (“Sament”), and Edible Garden Incorporated, a Wyoming corporation (the “Company” and together with Sament, each a “Party” and collectively, the “Parties”).

 

RECITALS

 

The Company desires to offer Sament an option to purchase shares (the “Shares”) of the Company’s common stock (the “Common Stock”), and Sament desires to accept such option from the Company, upon the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of the mutual promises and covenants herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

 

AGREEMENT

 

ARTICLE 1
OPTION

 

1.1 Grant of Option. On the terms and subject to the conditions set forth in this Agreement, the Company hereby grants Sament an option (the “Option”) to purchase one hundred and eleven (111) Shares (the “Option Shares”), exercisable at any time prior to the five (5) year anniversary of the date of this Agreement (the “Option Exercise Period”).

 

1.2 Exercise of Option

 

(a) Notice of Intent to Exercise Option. Sament may exercise the Option, at any time during the Option Exercise Period by delivering written notice thereof to the Company (the “Exercise Notice”).

 

(b) Purchase of Shares. The closing (the “Closing”) of the purchase of the Option Shares shall take place two (2) business days after receipt by the Company of the Exercise Notice. At the Closing, (i) the Company shall transfer all of its rights, title and interest in the Option Shares to Sament, and (ii) Sament shall deliver to the Company $1.00 by check or wire transfer of immediately available funds. Each Party hereby agrees to execute and deliver all documents and instruments reasonably necessary to effectuate the Closing.

 

1.3 Termination of Option. The Option shall automatically terminate upon payment in full by the Company of all principal and accrued interest on that certain Secured Promissory Note issued by the Company to Sament Capital Investments, Inc. in the original principal amount of $3,000,000, dated on or about the date hereof.

 

 
1

 

 

ARTICLE 2
MISCELLANEOUS

 

2.1 Notices. All notices, demands and requests required or permitted to be given under the provisions of this Agreement shall be in writing and shall be deemed delivered (i) upon personal delivery if during business hours or, if not, on the next business day, (ii) three (3) business days after deposit of the same in the U.S. mail if mailed by certified mail (return receipt requested), or (iii) one (1) business day after deposit of the same with a nationally recognized overnight courier service if mailed for next business day delivery, in each case, to the addressee thereof at its address set forth below (or at such other address of such Party as such Party shall have specified in a notice to the other Party):

 

If to the Company:

 

Edible Garden Incorporated

283 County Road 519

Belvidere, NJ 07823

Attention: Michael James

Email: MJames@ediblegarden.com

 

If to Sament:

 

Sament Capital Investments, Inc.

2040 Main Street, Suite 225

Irvine, CA 92614

Attention: Michael Nahass

 

2.2 Successors and Assigns; Assignment. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective heirs, legal representatives, successors and assigns of the Parties hereto; provided, that, no Party may assign any of its rights or obligations under this Agreement without the prior written consent of the other non-assigning Party. Any purported assignment in contravention of the foregoing shall be deemed null and void.

 

2.3 Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If the final judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, the Parties agree that the court making the determination of invalidity or unenforceability shall have the power to reduce the scope, duration or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified after the expiration of the time within which the judgment may be appealed.

 

2.4 Governing Law. All issues and questions concerning the construction, validity, interpretation and enforceability of this Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of the State of New Jersey, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of New Jersey or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of New Jersey.

 

 
2

 

 

2.5 Arbitration. Any and all claims or disputes between the Parties that arise from or relate or pertain in any way to this Agreement, to the Parties’ rights or obligations under this Agreement, to the subject matter of this Agreement, or the arbitrability of any such claim or dispute shall be resolved solely and exclusively by binding arbitration in the State of New Jersey before a panel of three Arbitrators in a confidential arbitration proceeding to be conducted by JAMS in the English language pursuant to the JAMS International Arbitration Rules and Procedures. No person shall be eligible to serve as arbitrator in any such proceeding unless he or she shall have served as a state or federal Judge or Justice of a court within the State of New Jersey for at least five years. The prevailing Party or Parties to any such dispute shall be entitled to recover all of its or their reasonable attorneys' fees and other costs of the arbitration, and any related judicial proceedings, from the non-prevailing Party or Parties. Each Party to this Agreement hereby consents irrevocably to the jurisdiction of the state and federal courts located in the State of New Jersey for the purpose of enforcing this Agreement to arbitrate and for the purposes of any proceedings to confirm, vacate or modify any arbitration award rendered hereunder. Any Party may also apply to any court anywhere in the world for the purpose of enforcing any such arbitration award. Without limiting the foregoing, each Party agrees that service of process on such Party as provided in this Agreement shall be deemed effective service of process on such Party.

 

2.6 Counterparts. This Agreement and any amendments hereto may be executed in any number of counterparts, each of which shall be deemed to be an original but all of which together shall constitute but one and the same instrument.

 

2.7 Entire Agreement. This Agreement constitutes the entire understanding among the Parties with respect to the subject matter hereof. Any agreement, discussions, or negotiations among the Parties prior to the date hereof with respect to the purchase of the Shares is superseded by this Agreement. Except as expressly provided herein, nothing in this Agreement, express or implied, is intended to confer upon any party, other than the Parties hereto, any rights, remedies, obligations or liabilities under or by reason of this Agreement.

 

2.8 Amendment; Waiver. No provision of this Agreement may be amended except in a written instrument signed by the Parties. No provision of this Agreement may be waived except in a written instrument signed by the Party waiving the benefit to which it is otherwise entitled. No waiver of any provision, condition, or requirement of this Agreement shall be deemed to be a waiver continuing into the future or a waiver on a subsequent occasion or a waiver of any other provision, condition, or requirement of this Agreement, nor shall any delay or omission of any Party to exercise any right hereunder in any manner impair such Party’s ability to exercise such right.

 

2.9 Expenses. Each Party hereto shall pay its own costs and expenses involved in carrying out the transactions contemplated by this Agreement.

 

2.10 Exclusive Remedies. The remedies provided in this Agreement for a breach of a Party’s obligations hereunder shall be exclusive and shall preclude the assertion by any Party hereto of any other rights or the seeking of any other remedies against any other Party hereto, whether at law or equity.

 

2.11 Further Assurances. Subject to the terms and conditions of this Agreement, each of the Parties shall use all reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things necessary, proper or advisable, under applicable law or otherwise, to fulfill its obligations under this Agreement.

 

2.12 Stock Dividends and Stock Splits. If the Company, at any time while this Agreement is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock, (ii) subdivides outstanding shares of Common Stock into a larger number of shares, or (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, then the number of Shares of Common Stock issuable to Sament pursuant to this Agreement shall be automatically adjusted proportionately.

 

[remainder of page intentionally left blank; signature page follows]

 

 
3

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date first above written.

 

 

SAMENT:

 

 

 

 

SAMENT CAPITAL INVESTMENTS, INC.

 

       
By:

/s/ Michael Nahass

 

Name:

Michael Nahass

 
  Title:

President/COO

 
     

 

 

 

 

 

COMPANY:

 

 

 

 

 

Edible Garden Incorporated

 

 

 

 

 

 

By:

Michael C. James

 

 

Name:

Michael C. James

 

 

Title:

Treasurer

 

 

 
4

 

EXHIBIT 10.7

 

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THIS NOTE UNDER SUCH ACT UNLESS SUCH REGISTRATION IS NOT REQUIRED PURSUANT TO A VALID EXEMPTION THEREFROM UNDER THE ACT.

 

Edible Garden Incorporated

 
Secured Promissory Note

 

Face Amount: $653,870

 

June 3, 2020

 

FOR VALUE RECEIVED, the undersigned Edible Garden Incorporated, (the “Borrower”), promises to pay to the order of Sament Capital Investments, Inc., its successors or assigns (the “Lender”), six hundred and fifty three thousand, eight hundred and seventy Dollars ($653,870) (the “Face Amount”) by June 3, 2023 (the “Maturity Date”), in accordance with the terms hereof, together with interest.

 

Interest at the simple rate of (3.50%) per annum, calculated on the basis of a 360-day year of twelve 30-day months, until the Maturity Date or repayment is made as provided herein, and any other amounts due hereunder are payable in lawful money of the United States of America to the Lender. Interest calculated for the first year of this Note shall be added to the Face Amount, after the first-year interest shall be paid on a monthly basis until the Maturity Date.

 

Section 1. Security and Priority. As security for payment of the Face Amount under this Note, the Borrower and the Lender have entered into that certain Security Agreement dated as of March 30, 2020 (the “Security Agreement”). The Security Agreement and the Note are sometimes hereinafter referred to as the “Loan Documents.” The Borrower and the Lender have agreed that all obligations under this Note will be secured by all of the Collateral (as that term is defined in the Security Agreement) of the Borrower.

 

Section 2. Maturity. The Face Amount, along with the interest accrued thereon, shall be repaid in cash at the Maturity Date, unless repaid earlier at the option of Borrower.

 

Section 3. Prepayment. This Note may be prepaid in whole or in part at any time and from time-to-time upon three (3) prior business days’ written notice, without penalty. Such repayment shall satisfy Borrower’s obligations pursuant to this Note in full and this Note shall be of no further force and effect.

 

Section 4. Transferability. This Note and any of the rights granted hereunder are freely transferable or assigned by Lender, in whole or in part, in its sole discretion; provided, that the Lender provides notice to the Borrower of its transfer or assignment.

 

 
1

 

 

Section 5. Event of Default.

 

(a) In the event that any one of the following events shall occur (whatever the reason and whether it shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body), it shall be deemed an Event of Default:

 

(i) Any default in the payment of the principal, interest on, or other charges in respect of this Note, or any other note issued by the Borrower, as and when the same shall become due and payable;

 

(ii) Borrower shall fail to observe or perform any other material covenant, agreement or warranty contained in, or otherwise commit any breach or default of any provision of this Note or any other agreement between the Borrower and the Lender;

 

(iii) There shall be a breach of any of the representations and warranties set forth in this Note or any transaction document executed contemporaneously herewith; or

 

(iv) Borrower, shall commence, or there shall be commenced against Borrower any applicable bankruptcy or insolvency laws as now or hereafter in effect or any successor thereto, or Borrower commences any other proceeding under any reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction whether now or hereafter in effect relating to Borrower or there is commenced against Borrower any such bankruptcy, insolvency or other proceeding which remains undismissed for a period of sixty (60) days; or Borrower is adjudicated insolvent or bankrupt; or any order of relief or other order approving any such case or proceeding is entered; or Borrower suffers any appointment of any custodian, private or court appointed receiver or the like for it or any substantial part of its property which continues undischarged or unstayed for a period of sixty (60) days; or Borrower makes a general assignment for the benefit of creditors; or Borrower shall fail to pay or shall state that it is unable to pay or shall be liable to pay, its debts as they become due or by any act or failure to act expressly indicate its consent to, approval of or acquiescence in any of the foregoing; or any corporate or other action is taken by the Borrower for the purpose of effecting any of the foregoing.

 

(b) Upon the occurrence of an Event of Default, the Lender shall give the Borrower notice of such occurrence, at which time the Borrower shall have five (5) business days from receipt of such notice to pay the outstanding amount of the Note, with any unpaid interest thereof, in full. In the event that full payment is not made upon the expiry of the five (5) day period, a default penalty equal to two percent (2%) of the Face Amount per month during the period of Default (the “Default Penalty”). Lender may then, at its sole discretion declare the entire then outstanding Face Amount of this Note together with any unpaid interest and the Default Penalty immediately due and payable (a “Default Declaration”), in which event the Lender may, at its sole discretion take any action it deems necessary to recover amounts due under this Note.

 

(c) Upon the occurrence of an Event of Default, the Lender shall be entitled to receive, in addition to the Face Amount of the Note, interest thereon and the Default Penalty, the Lender shall be entitled to recover all of its costs, fees (including without limitation, reasonable attorney’s fees and disbursements), and expenses relating collection and enforcement Note, including all costs and expenses incurred by it in enforcing its rights under the Note and any transaction document entered into contemporaneously herewith.

 

 
2

 

 

(d) The failure of Lender to exercise any of its rights hereunder in any particular instance shall not constitute a waiver of the same or of any other right in that or any subsequent instance with respect to Lender or any subsequent holder. Lender need not provide and Borrower hereby waives any presentment, demand, protest or other notice of any kind, and Lender may immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable law. The remedies available to the Lender upon the occurrence of an Event of Default shall be cumulative.

 

Section 6. Notices. Any and all notices, service of process or other communications or deliveries required or permitted to be given or made pursuant to any of the provisions of this Note shall be deemed to have been duly given or made for all purposes when hand delivered or sent by certified or registered mail, return receipt requested and postage prepaid, overnight mail or courier, or via electronic mail (provided that the sender of such electronic mail does not receive a notice or message indicating that such email was unsuccessful) as follows:

 

 

If to Borrower, at:

 

 

 

Edible Garden Incorporated
283 Country Road 519
Belvidere, NJ 07823
Attn: CEO

 

 

Or such other address as may be given to the Borrower from time to time

 

 

 

If to Lender, at:

 

 

2040 Main St., Suite 225
Irvine, CA 92614
Attn: President

 

Or such other address as may be given to the Lender from time to time

 

Section 7. Usury. This Note is hereby expressly limited so that in no event whatsoever, whether by reason of acceleration of maturity of the loan evidenced hereby or otherwise, shall the amount paid or agreed to be paid to the Lender hereunder for the loan, use, forbearance or detention of money exceed that permissible under applicable law. If at any time the performance of any provision of this Note or of any other agreement or instrument entered into in connection with this Note involves a payment exceeding the limit of the interest that may be validly charged for the loan, use, forbearance or detention of money under applicable law, then automatically and retroactively, ipso facto, the obligation to be performed shall be reduced to such limit, it being the specific intent of the Borrower and the Lender that all payments under this Note are to be credited first to interest as permitted by law, but not in excess of (i) the agreed rate of interest set forth herein or therein or (ii) that permitted by law, whichever is the lesser, and the balance toward the reduction of principal. The provision of this Section 6 shall never be superseded or waived and shall control every other provision of this Note and all other agreements and instruments between the Borrower and the Lender entered into in connection with this Note. To the extent permitted by applicable law, Borrower waives any right to assert the defense of usury.

 

 
3

 

 

Section 8. Governing Law; Waiver of Jury Trial. This Note and the provisions hereof are to be construed according to and are governed by the laws of the State of California, without regard to principles of conflicts of laws thereof. Borrower agrees that the California State Court located in the County of Orange, State of California shall have exclusive jurisdiction in connection with any dispute concerning or arising out of this Note or otherwise relating to the parties’ relationship. In any action, lawsuit or proceeding brought to enforce or interpret the provisions of this Note and/or arising out of or relating to any dispute between the parties, Lender shall be entitled to recover all of its costs and expenses relating collection and enforcement of this Note (including without limitation, reasonable attorney’s fees and disbursements) in addition to any other relief to which Lender may be entitled and all costs of collection, including any legal fees associated with this Note will be paid by the Borrower. Each party agrees that any process or notice to be served or delivered in connection with any action, lawsuit or proceeding brought hereunder may be accomplished in accordance with the notice provisions set forth above or as otherwise provided by applicable law.

 

BORROWER HEREBY WAIVES TRIAL BY JURY IN ANY ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM, WHETHER IN CONTRACT OR TORT, AT LAW OR IN EQUITY, ARISING OUT OF OR IN ANY WAY RELATING TO THIS NOTE.

 

Section 9. Successors and Assigns. Subject to applicable securities laws, this Note, and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of Borrower and the successors and assigns of Lender. Amendment. This Note may be modified or amended, or the provisions hereof waived only with the written consent of Lender and Borrower. Severability. Wherever possible, each provision of this Note shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Note shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Note.

 

[SIGNATURE PAGE TO FOLLOW]

 

 
4

 

 

IN WITNESS WHEREOF, Borrower has caused this Promissory Note to be duly authorized officer and/or such individual borrower as of the date first above indicated.

 

 

 

Edible Garden Incorporated

 

 

 

 

 

 

By:

/s/ Michael C. James

 

 

Name:

Michael C. James

 

 

Title:

Chief Financial Officer

 

 

 
5

 

EXHIBIT  10.8

 

Edible Garden AG Incorporated

 

Form of Demand Note

 

Face Amount: $[__]

 

[DATE]

 

For value received, the undersigned Edible Garden AG Incorporated, (the “Borrower”), promises to pay to the order of [__], its successors or assigns (the “Lender”), [__] ($[__]) (the “Face Amount”).

 

There will not be any interest charged for the time that it is outstanding.

 

________________________________________

Michael C. James

Chief Financial Officer

Edible Garden AG Incorporated

 

Date:

 

EXHIBIT 10.9

 

FORM OF CONVERTIBLE PROMISSORY NOTE

 

$[__]

[DATE]

 

FOR VALUE RECEIVED, and subject to the terms and conditions set forth herein, Edible Garden AG Incorporated (the “Maker”), hereby promises to pay to the order of [__] or his assigns (the “Noteholder”, and together with the Maker, the “Parties”), the principal amount of [__] ($[__]) (the “Loan”), together with all accrued interest thereon, as provided in this Convertible Promissory Note (the “Note”, as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with its terms).

 

1. Maturity Date; Optional Prepayments.

 

1.1 Maturity Date. The aggregate unpaid principal amount of the Loan, all accrued and unpaid interest, and all other amounts payable under this Note shall be due and payable on the earlier of (a) [__], 202[  ], (b) the closing of the Maker’s next sale of equity securities in which the Maker raises at least $5 million in gross proceeds (excluding the value of any instruments converting into equity in such equity financing), (c) the sale, lease, license or other disposition of all or substantially all of the assets of the Maker, (d) a transaction or series of related transactions in which any person becomes the beneficial owner of more than 50% of the Maker’s outstanding voting securities, and (e) the date on which all amounts under this Note shall become due and payable pursuant to Section 9.

 

2. Interest.

 

2.1 Interest Rate. Except as otherwise provided herein, the outstanding principal amount of the Loan made hereunder shall bear interest at a rate per annum equal to 12% (twelve percent) from the date the Loan was made until the Loan is paid in full, whether at maturity, upon acceleration, by prepayment or otherwise.

 

2.2 Computation of Interest. All computations of interest shall be made on the basis of a year of 360 days and the actual number of days elapsed. Interest shall accrue on the Loan on the day on which such Loan is made, and shall not accrue on the Loan on the day on which it is paid.

 

3. Payment Mechanics.

 

3.1 Manner of Payment. All payments of interest and principal shall be made in lawful money of the United States of America on the date on which such payment is due by wire transfer of immediately available funds to the Noteholder’s account at a bank specified by the Noteholder in writing to the Maker from time to time.

 

3.2 Application of Payments. All payments made hereunder shall be applied first, to the payment of any fees or charges outstanding hereunder, second, to accrued interest and third, to the payment of the principal amount outstanding under the Note.

 

 
1

 

 

4. Conversion.

 

a) Voluntary Conversion. At any time after the Original Issue Date until all amounts due under this have been paid in full, this Note shall be convertible, in whole or in part, into shares of Common Stock at the option of the Holder, at any time and from time to time. The Holder shall effect conversions by delivering to the Company a Notice of Conversion, the form of which is attached hereto as Annex A (each, a “Notice of Conversion”), specifying therein the principal amount of this Note and/or any other amounts due under this Note to be converted and the date on which such conversion shall be effected (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. To effect conversions hereunder, the Holder shall not be required to physically surrender this Note to the Company unless the entire principal amount of this Note, all accrued and unpaid interest thereon and all other amounts due under this Note have been so converted. Conversions hereunder shall have the effect of lowering the outstanding principal amount of this Note in an amount equal to the applicable conversion amount. The Holder and the Company shall maintain a Conversion Schedule showing the principal amount(s) and/or any other amounts due under this Note converted and the date of such conversion(s). The Company may deliver an objection to any Notice of Conversion within one (1) Business Day of delivery of such Notice of Conversion. In the event of any dispute or discrepancy, the records of the Holder shall be controlling and determinative in the absence of manifest error. The Holder, and any assignee by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted principal amount of this Note may be less than the amount stated on the face hereof.

 

b) Conversion Price. The conversion price in effect on any Conversion Date shall be equal to the lowest of (i) $18.50 (subject to adjustment for forward and reverse stock splits and the like after the Original Issue Date) (the “Fixed Conversion Price”). All such foregoing determinations will be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock during such measuring period. Nothing herein shall limit a Holder’s right to pursue actual damages or declare an Event of Default pursuant to Section 9 hereof and the Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity.

 

c) Mechanics of Conversion.

 

i. Conversion Shares Issuable Upon a Conversion. The number of Conversion Shares issuable upon a conversion hereunder shall be determined by the quotient obtained by dividing (x) the sum of all outstanding (i) principal, (ii) interest, and (iii) any other amount due under this Note to be converted as provided in the applicable Notice of Conversion by (y) the Conversion Price.

 

 
2

 

 

d) Delivery of Certificate Upon Conversion. Not later than two (2) Days after each Conversion Date (the “Share Delivery Date”), the Company shall deliver, or cause to be delivered, to the Holder (A) a certificate or certificates representing the Conversion Shares.

 

Section 5. Certain Adjustments.

 

a) Stock Dividends and Stock Splits. If the Company, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion of, or payment of interest on, the Notes), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Company, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or reclassification.

 

b) Subsequent Equity Sales. If, at any time while this Note is outstanding, the Company or any Subsidiary, as applicable, sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock at an effective price per share that is lower than the then Conversion Price (such lower price, the “Base Conversion Price” and such issuances, collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is lower than the Conversion Price, such issuance shall be deemed to have occurred for less than the Conversion Price on such date of the Dilutive Issuance), then the Conversion Price shall be reduced and only reduced to equal the Base Conversion Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing, no adjustment will be made under this Section 5(b) in respect of an Exempt Issuance. The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of any Common Stock or Common Stock Equivalents subject to this Section 5(b), indicating therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 5(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Conversion Shares based upon the Base Conversion Price on or after the date of such Dilutive Issuance, regardless of whether the Holder accurately refers to the Base Conversion Price in the Notice of Conversion.

 

 
3

 

 

c) Notice to the Holder.

 

Adjustment to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 5, the Company shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

 

6. Prepayment.

 

At any time upon ten (10) days’ prior written notice to the Holder, but subject to the Holder’s conversion rights set forth herein, the Company may prepay any portion of the principal amount of this Note, all accrued and unpaid interest relating to such prepaid portion of the principal and all other amounts due under this Note. The written notice shall, among other items, state the date such Prepayment Amount (as defined below) is to be paid to the Holder, which shall not in any event be later than ten (10) calendar days from the date of mailing of the prepayment notice to the Holder (the “Prepayment Date”). If the Company exercises its right to prepay the Note, the Company shall make payment to the Holder of an amount in cash equal to the product of (i) the sum of (x) the then-outstanding principal amount of this Note and (y) all accrued but unpaid interest. The Holder may continue to convert the Note from the date notice of the prepayment is given until the date the Holder receives in full, the Prepayment Amount.

 

 
4

 

 

7. Subordination.

 

The Noteholder acknowledges and agrees that payment and enforcement of this Note is subordinate to any other debt of the Maker. If requested by the Maker, the Noteholder (by accepting this Note) agrees to enter into a subordination agreement with a senior lender of the Maker having terms to be agreed upon by the Maker and Noteholder.

 

8. Events of Default. The occurrence of any of the following shall constitute an Event of Default hereunder:

 

8.1 the Maker fails to pay any amount of the Loan when due and such failure continues for ten (10) days after written notice to the Maker;

 

8.2 the commencement of a voluntary or involuntary proceeding with respect to Maker under the United States Bankruptcy Code or otherwise, for arrangement, reorganization, dissolution, liquidation or settlement of claims against or winding up of affairs, which is not discharged within sixty (60) days from the commencement of such proceedings;

 

8.3 a judgment or decree is entered against the Maker and such judgment or decree has not been vacated, discharged, stayed or bonded pending appeal within sixty (60) days from the entry thereof; or

 

8.4 the dissolution of Maker or the Maker ceases to exist.

 

9. Remedies. Upon the occurrence of an Event of Default and at any time thereafter during the continuance of such Event of Default, the Noteholder may at its option, by written notice to the Maker (a) declare the entire principal amount of this Note, together with all accrued interest thereon and all other amounts payable hereunder, immediately due and payable and/or (b) exercise any or all of its rights, powers or remedies under applicable law; provided, however that, if an Event of Default described in Section 8 shall occur, the principal of and accrued interest on the Loan shall become immediately due and payable without any notice, declaration or other act on the part of the Noteholder.

 

10. Miscellaneous.

 

10.1 Governing Law. This Note and any claim, controversy, dispute or cause of action (whether in contract or tort or otherwise) based upon, arising out of or relating to this Note and the transactions contemplated hereby shall be governed by the laws of the State of New Jersey.

 

10.2 Submission to Jurisdiction. The Maker hereby irrevocably and unconditionally agrees that any legal action, suit or proceeding arising out of or relating to this Note may be brought in the courts of the State of New Jersey or of the United States of America for the District of New Jersey, and submits to the exclusive jurisdiction of any such court in any such action, suit or proceeding. Final judgment against the Maker in any action, suit or proceeding shall be conclusive and may be enforced in any other jurisdiction by suit on the judgment. Nothing in this Section 10 shall affect the right of the Noteholder to commence legal proceedings or otherwise sue the Maker in any other court having jurisdiction over the Maker, or serve process upon the Maker in any manner authorized by the laws of any such jurisdiction.

 

 
5

 

 

10.3 Waiver of Jury Trial. THE MAKER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY RELATING TO THIS NOTE OR THE TRANSACTIONS CONTEMPLATED HEREBY WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY.

 

10.4 Integration. This Note constitutes the entire contract between the Parties with respect to the subject matter hereof and supersedes all previous agreements and understandings, oral or written, with respect thereto.

 

10.5 Successors and Assigns. This Note may be assigned, transferred or negotiated by the Noteholder to any person at any time without notice to or the consent of the Maker. The Maker may not assign or transfer this Note or any of its rights hereunder without the prior written consent of the Noteholder. This Note shall inure to the benefit of and be binding upon the Parties hereto and their permitted assigns.

 

10.6 Amendments and Waivers. No term of this Note may be waived, modified or amended except by an instrument in writing signed by both of the Parties hereto. Any waiver of the terms hereof shall be effective only in the specific instance and for the specific purpose given.

 

10.7 No Waiver; Cumulative Remedies. No failure to exercise and no delay in exercising on the part of the Noteholder, of any right, remedy, power or privilege hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.

 

10.8 Severability. If any term or provision of this Note is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Note or invalidate or render unenforceable such term or provision in any other jurisdiction.

 

[Signature Page Follows]

 

 
6

 

 

IN WITNESS WHEREOF, the Maker has executed this Note as of [__], 2021.

 

 

 

 

Edible Garden AG Incorporated

 

 

 

 

 

 

 

 

By:

 

 

 

 

Name:

 

 

 

 

Title:

 

 

 

 

 

 

 

AGREED AND ACCEPTED:

 

 

 

 

as of the date first written above

 

 

 

 

 

 

 

 

 

[___________]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

 

ANNEX A

 

NOTICE OF CONVERSION

 

The undersigned hereby elects to convert principal, accrued but unpaid interest and/or any of amounts due under the 12% Convertible Promissory Note due [__], 202[  ] of Edible Garden AG Incorporated, a Delaware corporation (the “Company”), into shares of common stock (the “Common Stock”), of the Company according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as reasonably requested by the Company in accordance therewith. No fee will be charged to the holder for any conversion, except for such transfer taxes, if any.

 

Conversion calculations:

 

Date to Effect Conversion: ______________________________________________

 

Principal Amount of Note to be Converted: _________________________________

 

Payment of Interest in Common Stock __ yes __ no

 

If yes, $_____ of Interest Accrued on Account of Conversion at Issue.

 

Other Amounts Owed Under this Note to be Converted including Late Fees: _________

 

Number of shares of Common Stock to be issued: ______________________________

 

Signature: ____________________________________

 

Name: _________________

 

Delivery Instructions: ________________

 

 

 

   

Schedule 1

 

CONVERSION SCHEDULE

 

This 12% Convertible Promissory Note due on [__], 202[  ] in the principal amount of $[__] is issued by Edible Garden AG Incorporated, a Delaware corporation. This Conversion Schedule reflects conversions made under Section 4 of the above referenced Note.

 

Dated:

 

Date of Conversion

(or for first entry, Original Issue Date)

Amount of Conversion

Aggregate Principal Amount Remaining Subsequent to Conversion

(or original Principal Amount)

Company Attest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EXHIBIT 10.10

 

FORM OF PROMISSORY NOTE

 

$[__]

[DATE]

 

FOR VALUE RECEIVED, and subject to the terms and conditions set forth herein, Edible Garden AG Incorporated (the “Maker”), hereby promises to pay to the order of [__] or his assigns (the “Noteholder”, and together with the Maker, the “Parties”), the principal amount of [__] ($[__]) (the “Loan”), together with all accrued interest thereon, as provided in this Convertible Promissory Note (the “Note”, as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with its terms).

 

1. Maturity Date; Optional Prepayments.

 

1.1 Maturity Date. The aggregate unpaid principal amount of the Loan, all accrued and unpaid interest, and all other amounts payable under this Note shall be due and payable on the earlier of (a) [__], 202[  ], (b) the closing of the Maker’s next sale of equity securities in which the Maker raises at least $5 million in gross proceeds (excluding the value of any instruments converting into equity in such equity financing), (c) the sale, lease, license or other disposition of all or substantially all of the assets of the Maker, (d) a transaction or series of related transactions in which any person becomes the beneficial owner of more than 50% of the Maker’s outstanding voting securities, and (e) the date on which all amounts under this Note shall become due and payable pursuant to Section 9.

 

2. Interest.

 

2.1 Interest Rate. Except as otherwise provided herein, the outstanding principal amount of the Loan made hereunder shall bear interest at a rate per annum equal to 12% (twelve percent) from the date the Loan was made until the Loan is paid in full, whether at maturity, upon acceleration, by prepayment or otherwise.

 

2.2 Computation of Interest. All computations of interest shall be made on the basis of a year of 360 days and the actual number of days elapsed. Interest shall accrue on the Loan on the day on which such Loan is made, and shall not accrue on the Loan on the day on which it is paid.

 

3. Payment Mechanics.

 

3.1 Manner of Payment. All payments of interest and principal shall be made in lawful money of the United States of America on the date on which such payment is due by wire transfer of immediately available funds to the Noteholder’s account at a bank specified by the Noteholder in writing to the Maker from time to time.

 

3.2 Application of Payments. All payments made hereunder shall be applied first, to the payment of any fees or charges outstanding hereunder, second, to accrued interest and third, to the payment of the principal amount outstanding under the Note.

 

 
1

 

 

4. Prepayment.

 

At any time upon ten (10) days’ prior written notice to the Holder, the Company may prepay any portion of the principal amount of this Note, all accrued and unpaid interest relating to such prepaid portion of the principal and all other amounts due under this Note. The written notice shall, among other items, state the date such Prepayment Amount (as defined below) is to be paid to the Holder, which shall not in any event be later than ten (10) calendar days from the date of mailing of the prepayment notice to the Holder (the “Prepayment Date”). If the Company exercises its right to prepay the Note, the Company shall make payment to the Holder of an amount in cash equal to the product of (i) the sum of (x) the then-outstanding principal amount of this Note and (y) all accrued but unpaid interest.

 

5. Subordination.

 

The Noteholder acknowledges and agrees that payment and enforcement of this Note is subordinate to any other debt of the Maker. If requested by the Maker, the Noteholder (by accepting this Note) agrees to enter into a subordination agreement with a senior lender of the Maker having terms to be agreed upon by the Maker and Noteholder.

 

6. Events of Default. The occurrence of any of the following shall constitute an Event of Default hereunder:

 

6.1 the Maker fails to pay any amount of the Loan when due and such failure continues for ten (10) days after written notice to the Maker;

 

6.2 the commencement of a voluntary or involuntary proceeding with respect to Maker under the United States Bankruptcy Code or otherwise, for arrangement, reorganization, dissolution, liquidation or settlement of claims against or winding up of affairs, which is not discharged within sixty (60) days from the commencement of such proceedings;

 

6.3 a judgment or decree is entered against the Maker and such judgment or decree has not been vacated, discharged, stayed or bonded pending appeal within sixty (60) days from the entry thereof; or

 

6.4 the dissolution of Maker or the Maker ceases to exist.

 

7. Remedies. Upon the occurrence of an Event of Default and at any time thereafter during the continuance of such Event of Default, the Noteholder may at its option, by written notice to the Maker (a) declare the entire principal amount of this Note, together with all accrued interest thereon and all other amounts payable hereunder, immediately due and payable and/or (b) exercise any or all of its rights, powers or remedies under applicable law; provided, however that, if an Event of Default described in Section 6 shall occur, the principal of and accrued interest on the Loan shall become immediately due and payable without any notice, declaration or other act on the part of the Noteholder.

 

 
2

 

 

8. Miscellaneous.

 

8.1 Governing Law. This Note and any claim, controversy, dispute or cause of action (whether in contract or tort or otherwise) based upon, arising out of or relating to this Note and the transactions contemplated hereby shall be governed by the laws of the State of New Jersey.

 

8.2 Submission to Jurisdiction. The Maker hereby irrevocably and unconditionally agrees that any legal action, suit or proceeding arising out of or relating to this Note may be brought in the courts of the State of New Jersey or of the United States of America for the District of New Jersey, and submits to the exclusive jurisdiction of any such court in any such action, suit or proceeding. Final judgment against the Maker in any action, suit or proceeding shall be conclusive and may be enforced in any other jurisdiction by suit on the judgment. Nothing in this Section 0 shall affect the right of the Noteholder to commence legal proceedings or otherwise sue the Maker in any other court having jurisdiction over the Maker, or serve process upon the Maker in any manner authorized by the laws of any such jurisdiction.

 

8.3 Waiver of Jury Trial. THE MAKER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY RELATING TO THIS NOTE OR THE TRANSACTIONS CONTEMPLATED HEREBY WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY.

 

8.4 Integration. This Note constitutes the entire contract between the Parties with respect to the subject matter hereof and supersedes all previous agreements and understandings, oral or written, with respect thereto.

 

8.5 Successors and Assigns. This Note may be assigned, transferred or negotiated by the Noteholder to any person at any time without notice to or the consent of the Maker. The Maker may not assign or transfer this Note or any of its rights hereunder without the prior written consent of the Noteholder. This Note shall inure to the benefit of and be binding upon the Parties hereto and their permitted assigns.

 

8.6 Amendments and Waivers. No term of this Note may be waived, modified or amended except by an instrument in writing signed by both of the Parties hereto. Any waiver of the terms hereof shall be effective only in the specific instance and for the specific purpose given.

 

 
3

 

 

8.7 No Waiver; Cumulative Remedies. No failure to exercise and no delay in exercising on the part of the Noteholder, of any right, remedy, power or privilege hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.

 

8.8 Severability. If any term or provision of this Note is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Note or invalidate or render unenforceable such term or provision in any other jurisdiction.

 

[Signature Page Follows]

 

 
4

 

 

IN WITNESS WHEREOF, the Maker has executed this Note as of [___], 2021.

 

 

 

 

Edible Garden AG Incorporated

 

 

     

 

By:

 

 

Name:

 
 

 

Title:  
 

 

     

AGREED AND ACCEPTED:

 

 

 

 

as of the date first written above

 

 

 

 

 

 

 

 

 

[___________________]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

EXHIBIT 10.11

 

ACCOUNTS RECEIVABLE PURCHASING AGREEMENT

 

THIS ACCOUNTS RECEIVABLE PURCHASING AGREEMENT (“ARPA”) is made as of 03/30/2021 (“Effective Date”), by and between Edible Garden AG Incorporated, a Wyoming corporation, with its principal office at 283 Country Rd 519 Belvidere, NJ 07823 (the “Seller”), and Quasar Capital Partners, LLC, with an office at 9330 LBJ Frwy. Suite 943B. Dallas, TX 75243 (including any successors and assigns, the “Purchaser”), on the following terms and conditions:

  

1.

Definitions. The following terms used herein shall have the following meanings. All capitalized terms not herein defined shall have the meaning set forth in the UCC:

 

 

 

 

1.1

Account” - means any right of the Seller to payment as a result of the Seller’s sale of goods and/or services, and the proceeds thereof, as well as all security interests, guaranties, and other contractual and statutory rights of Seller that support or secure such right to payment, including, but not limited to, any rights of Seller under any mechanic’s lien, payment bond or other similar laws, whether any of such rights are now existing or hereafter created.

 

 

 

 

1.2

Account Debtor” - means the party or parties obligated to pay an Account.

 

 

 

 

1.3

Additional Discount” - 0.60% of the Face Amount.

 

 

 

 

1.4

Affiliated” - means, with respect to a given person, any person or entity which, directly or indirectly, controls, is controlled by, or is under common control with, the given person. For purposes of this definition, “control” means, with respect to any corporation, limited liability company, partnership, or other legal person, the possession, directly or indirectly, of the power (i) to vote five percent (5%) or more of the stock, membership interests, partnership interests, or other equity interests of such legal person; or (ii) to direct or cause the direction of the management and policies of that legal person, whether through the ownership of equity interests, or by contract, or otherwise.

 

 

 

 

1.5

Anniversary Fee” - $0

 

 

 

 

1.6

AR Purchase Certificate” - A document titled “Accounts Receivable Purchase - Certificate,” or such other documents as Purchaser shall require from time to time, wherein Seller identifies such of its Accounts as it requests that Purchaser purchase under this ARPA, and, by delivery of same to Purchaser, thereby transfers, assigns and sells such Accounts to Purchaser in accordance with the terms of this ARPA, subject only to Purchaser’s acceptance thereof as set forth in Section 2 of this ARPA.

 

 

 

 

1.7

Audit Fee” - $750 per day.

 

 
Page 1 of 30

 

 

 

1.8

Avoidance Claim” - any claim that any payment received by Purchaser from or for the account of an Account Debtor is avoidable under the United States Bankruptcy Code or any other Insolvency Law.

 

 

 

 

1.9

Business Day” - any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of Texas are authorized or required by law or other governmental action to close.

 

 

 

 

1.10

Discount” - the Discount Percent multiplied by the original Face Amount of each Purchased Account.

 

 

 

 

1.11

Discount Percent” - 1.85% of the Face Amount

 

 

 

 

1.12

Discount Percent” - 1.05% of the Face Amount - Applicable to Meijer only “Clearance Days” 1 days, excluding Saturdays, Sundays and Legal Holidays.

 

 

 

 

1.13

Closed” - a Purchased Account is closed upon the first to occur of (i) receipt of full payment by Purchaser or (ii) the Purchased Account has been repurchased by the Seller, including without limitation by charging the unpaid Face Amount to the Reserve Account as set forth herein.

 

 

 

 

1.14

Collateral” - all now owned and hereafter acquired Accounts, Accounts Receivable, Chattel Paper, Inventory, Instruments (including, without limitation, Promissory Notes), Commercial Tort Claims, Documents, Payment Intangibles and all of Seller’s interest in the Reserve Account and any other property or other funds held by Purchaser on behalf of Seller, together with the proceeds of any of the foregoing (including proceeds of proceeds), and any other property in which Seller grants a security interest to Purchaser pursuant to the Collateral Documents.

 

 

 

 

1.15

Collateral Documents” - any security agreement executed by Seller pursuant to Section 6 of this Agreement; any other document pursuant to which Seller, any guarantor or any other person grants to Purchaser liens, security interests, or other collateral rights in personal property; and any other instrument, certificate, notice, or other document incidental to any of the foregoing.

 

 

 

 

1.16

Delay Discount” - 2.20%

 

 
Page 2 of 30

 

 

 

1.17

Eligible Account” - an Account which is acceptable for purchase as determined by Purchaser in the exercise of its sole judgment and discretion. Without limiting the generality of the foregoing, Purchaser may determine that an Account is not an Eligible Account, regardless of the creditworthiness of the Account Debtor or any other factor, if purchasing such Account would cause the unpaid balance of all Purchased Accounts to exceed the Maximum Amount. Without limiting the fact that the determination of which Accounts are eligible for purchase is a matter of Purchaser’s discretion, the following are the minimum requirements for an Account to be an Eligible Account: (i) the Account must not be outstanding for more than sixty (60) days from its invoice date (the “Eligibility Period”); (ii) the Account must represent goods or merchandise that have been delivered and accepted by the Account Debtor or services that have been fully performed by the Seller, and furnished to and accepted by Account Debtor; (iii) the Account must not represent work-in-progress, “bill and hold” arrangement, due under a fulfillment or requirements contract with the Account Debtor, or progress or milestone billings (unless accompanied by a fully-executed contract milestone sign-off agreement acceptable to Purchaser in its sole discretion),; (iv) the Account must not be subject to any contingencies (including Accounts arising from sales on consignment, guaranteed sale or other terms pursuant to which payment by the Account Debtor may be conditional); (v) the Account must not be owing from an Account Debtor with whom Seller has any dispute (whether or not relating to the particular Account); (vi) the Account must not be owing from an Affiliate of Seller; (vii) the Account must not be owing from an Account Debtor which is subject to any insolvency or bankruptcy proceeding, or whose financial condition is not acceptable to Purchaser, or which, fails or goes out of a material portion of its business; (viii) the Account must not be owing from the United States or any department, agency or instrumentality thereof (unless there has been compliance, to Purchaser’s satisfaction, with the United States Assignment of Claims Act); (ix) the Account must not be owing from an Account Debtor located outside the United States or Canada (unless pre-approved by Purchaser in its discretion in writing, or covered by a credit risk insurance policy satisfactory to Purchaser); (x) the Account must not be owing from an Account Debtor to whom Seller is or may be liable for goods or serviced purchased from such Account Debtor or otherwise; (xi) the Account must not constitute a retention billing/invoice; (xii) the Account must not be assigned for collection or designated for such assignment, or an Account for which Purchaser in its good faith business judgment determines collection to be doubtful; (xiii) the Account must not be for C.O.D., cash in advance, or similar terms; and (xiv) if more than 25.00% of the Accounts owing from an Account Debtor are outstanding for a period longer than their Eligibility Period or are otherwise not eligible Accounts, then all Accounts owing from that Account Debtor will be deemed ineligible.

 

 

 

 

1.18

Events of Default” - See Section 14.1.

 

 

 

 

1.19

Exposed Payments” - payments received by Purchaser from or for the account of a Payor that has become subject to a proceeding under any Insolvency Law, to the extent such payments cleared the Payor’s deposit account within ninety days of the commencement of said proceeding or are otherwise reasonably susceptible to an Avoidance Claim.

 

 

 

 

1.20

Face Amount” - the total amount shown to be due on an Account at the time of Purchase.

 

 

 

 

1.21

Initial Term” - See Section 16.1.

 

 
Page 3 of 30

 

 

 

1.22

Insolvency Law” - the United States Bankruptcy Code, 11 U.S.C. § 101 et seq., any successor statute, and any similar law, whether federal, state, local or foreign, that provides relief to debtors against their creditors generally.

 

 

 

 

1.23

Invoice” - any document that evidences or is intended to evidence an Account. Where the context so requires, reference to an Invoice shall be deemed to refer to the Account to which it relates.

 

 

 

 

1.24

Invoice Date” - the date an Invoice representing the Purchased Account is first transmitted to the Account Debtor, provided, however, that the date printed on the face of an Invoice shall be presumed to be the Invoice Date unless proven otherwise by clear and convincing evidence.

 

 

 

 

1.25

Late Payment Date” - the date which is ninety (90) days from the Invoice Date.

 

 

 

 

1.26

Legal Holiday” - any day on which federal banks situated in Austin, Travis County, Texas, are closed for business.

 

 

 

 

1.27

Maximum Amount” - $1,000,000

 

 

 

 

1.28

Misdirected Payment Fee” - fifteen percent (15%) of the amount of any payment on any Account which is received by Seller and not delivered in kind to Purchaser on the next Business Day following the date of receipt by Seller.

 

 

 

 

1.29

Missing Notation Fee” - fifteen percent (15%) of the Face Amount of the applicable Invoice.

 

 

 

 

1.30

Net Funds Employed” - at any given time: the aggregate Purchase Price of all Purchased Accounts that have not been Closed minus any amounts held on behalf of Seller in the Reserve Account, plus (i) any unpaid fees or reimbursable expenses due from Seller under this ARPA and (ii) the amount of the Reserve Shortfall, if any.

 

 

 

 

1.31

Notation” - a notice imprinted on the face of all Invoices that payments are to be made to the Controlled Account, or such other form of writing as may be issued or required by Purchaser from time to time.

 

 

 

 

1.32

Obligations” - all present and future obligations owing by Seller to Purchaser whether arising hereunder or otherwise, and whether for the payment of money or evidenced by any note or other instrument, direct or indirect, absolute or contingent, due or to become due, joint or several, primary or secondary, liquidated or unliquidated, secured or unsecured, original or renewed or extended, arising before, during or after the commencement of any bankruptcy case in which Seller is a debtor, including, without limitation, any amounts charged to Seller for the repurchase of Accounts under section 5 of this ARPA.

 

 

 

 

1.33

Origination Fee” - 0.6%

 

 
Page 4 of 30

 

 

 

1.34

Payments” - See Section 19.1.

 

 

 

 

1.35

Payor” -An Account Debtor or other obligor on an Account, or entity making payment thereon for the account of such party.

 

 

 

 

1.36

Preference Reserve” - See Section 16.5.1.

 

 

 

 

1.37

Purchase Date” - the earlier of (i) the date on which Purchaser advises Seller in writing that Purchaser has agreed to purchase an Account; or (ii) the date on which Purchaser pays the Purchase Price for an Account pursuant to Section 2.1.4.

 

 

 

 

1.38

Purchase Price” - The Face Amount of a Purchased Account less the Discount.

 

 

 

 

1.39

Purchased Accounts” - Accounts purchased hereunder which have not been Closed.

 

 

 

 

1.40

Purchaser” - See introductory paragraph.

 

 

 

 

1.41

Renewal Term” - See Section 16.1.

 

 

 

 

1.42

Repurchased” - an Account has been repurchased when Seller has paid to Purchaser the then unpaid Face Amount of the Account.

 

 

 

 

1.43

Repurchase Price” - with respect to any Purchased Account at any time, the sum of (a) the then-unpaid Face Amount of such Purchased Account and (b) all then-outstanding discounts, fees, expenses, and other Obligations relating to such Purchased Account.

 

 

 

 

1.44

Required Reserve Amount” - the Reserve Percentage multiplied by the unpaid balance of Purchased Accounts.

 

 

 

 

1.45

Reserve Account” - A bookkeeping account on the books of Purchaser representing the portion of the Purchase Price which has not been paid by Purchaser to Seller, maintained by Purchaser to secure Seller’s performance with the provisions hereof.

 

 

 

 

1.46

Reserve Excess” - at any time, the amount (if any) by which the Reserve Account exceeds the Required Reserve Amount.

 

 

 

 

1.47

Reserve Percentage” - 15%

 

 

 

 

1.48

Reserve Percentage” - 10% - Applicable for Meijer invoices only

 

 

 

 

1.49

Reserve Shortfall” - at any time, the amount (if any) by which the Required Reserve Account exceeds the amount in the Reserve Account.

 

 

 

 

1.50

Seller” - See introductory paragraph.

 

 
Page 5 of 30

 

 

 

1.51

Transaction Documents” - this ARPA, the Collateral Documents, and all other certificates, instruments, and other documents of whatever nature executed or delivered in connection with this ARPA.

 

 

 

 

1.52

UCC” - means the Uniform Commercial Code as in effect from time to time in the State of Texas.

 

2. 

Sale; Estimated Purchase Price; Billing; Reserve; Lockbox.

 

 

 

 

2.1

Assignment and Sale.

 

 

2.1.1

Seller agrees to sell to Purchaser as absolute owner, with full recourse, Seller Accounts offered to Purchaser for sale and that are approved by Purchaser as Eligible Accounts, at a price equal to the Purchase Price for such Accounts (which shall be reduced by the Discount, Additional Discount, and Delay Discount, as applicable).

 

 

 

 

2.1.2

No less than once per week, Seller shall furnish a completed AR Purchase Certificate to Purchaser, identifying all of Seller’s Accounts that have been generated since the prior AR Purchase Certificate. Each AR Purchase Certificate shall be accompanied by such documentation supporting and evidencing the Accounts as Purchaser shall from time to time require, including, without limitation, accounts receivable aging reports, supporting invoices, and bills of lading. Purchaser may rely on any facsimile, electronic mail or telephone request for the transmission of the AR Purchase Certificate and request for funds given by a person whom Purchaser believes, in its discretion, to be an authorized representative of Seller, and Seller will indemnify Purchaser for any loss Purchaser suffers as a result of that reliance.

 

 

 

 

2.1.3

Purchaser may, but shall not be required to, purchase from Seller such Accounts as Purchaser determines to be Eligible Accounts. Such purchases are subject at all times to client verifications and such other items as Purchaser may require from time to time.

 

 

 

 

2.1.4

Purchaser shall pay the Purchase Price of Purchased Accounts, less the Reserve Percentage and any other amounts due to Purchaser from Seller (including, without limitation, any amounts due under Section 2.3.1 hereof). Such net amount shall be paid to any demand deposit account maintained by Seller, or represented by an employee of Seller to be maintained by Seller, within two (2) Business Days of the Purchase Date, whereupon the Accounts shall be deemed fully purchased by, paid for by, and transferred to Purchaser.

 

 

 

 

2.1.5

Purchaser does not intend to purchase any Account which will cause a Reserve Shortfall or the unpaid balance of Purchased Accounts to exceed the Maximum Amount. The foregoing notwithstanding, in the event Purchaser’s purchases cause a Reserve Shortfall or the unpaid balance of Purchased Accounts to exceed the Maximum Amount, Seller shall be liable for all such amounts as well as any and all fees, discounts and other charges as set forth in this Agreement, including, if applicable, at any default rate.

 

 
Page 6 of 30

 

 

 

2.2

Billing. Purchaser may send a monthly statement to all Account Debtors itemizing their account activity during any preceding billing period; however, Purchaser is under no obligation to do so. All 5 Account Debtors will be informed that Seller’s Accounts have been sold and assigned to Purchaser, and instructed to make payments to Purchaser.

 

 

 

 

2.3

Reserve Account.

 

 

2.3.1

Seller shall pay to Purchaser on demand the amount of any Reserve Shortfall, and the amount so paid shall be credited to the Reserve Account.

 

 

 

 

2.3.2

Except during any period in which an Event of Default remains uncured, Purchaser shall pay to Seller the Reserve Excess. At Purchaser’s discretion, the Reserve Excess shall be paid to the Seller on the Friday following the week collections are posted by Purchaser.

 

 

 

 

2.3.3

Purchaser may, in its good faith business judgment, withhold the Reserve Excess for any one or more of the following reasons: (a) to reflect events, conditions, contingencies or risks which, as determined by Purchaser in its good faith business judgment, do or may adversely affect (i) the Collateral or any other property which is security for the Obligations or its value (including without limitation any increase in delinquencies of Accounts), (ii) the assets, business or prospects of Seller any Guarantor, or (iii) the security interests and other rights of Purchaser in the Collateral (including the enforceability, perfection and priority thereof); or (b) to reflect Purchaser’s good faith belief that any collateral report or financial information furnished by or on behalf of Seller or any Guarantor to Purchaser is or may have been incomplete, inaccurate or misleading in any material respect; or (c) in respect of any state of facts which Purchaser determines in good faith constitutes an Event of Default or may, with notice or passage of time or both, constitute an Event of Default.

 

 

 

 

2.3.4

Purchaser may, without demand or prior notice, charge the Reserve Account with any Obligation. The Reserve Account shall be debited from time to time to reflect the accrual of the Additional Discount or other amounts owed to Purchaser.

 

 

 

 

2.3.5

Purchaser may pay any amounts due Seller hereunder by a credit to the Reserve Account. In such event, Purchaser shall be deemed to have released the Reserve Shortfall to Seller to the extent of the credit.

 

 

 

 

2.3.6

Upon termination of this ARPA, Purchaser may use the Reserve Account to fund the Preference Reserve as set forth in Section 16.5.

 

 
Page 7 of 30

 

 

 

2.4

Collection of Accounts/Lockbox. Seller agrees that all payments due on Accounts must be made by check issued payable to Purchaser or by wire transfer deposited and directed to a lockbox account controlled by Purchaser (the “Controlled Account”). If Seller receives any payments, whether by check, cash receipts, other cash instruments or otherwise, from its customers, Seller will hold the same in trust for Purchaser and promptly (not later than the following Business Day from receipt) deposit the same into the Controlled Account. As the funds deposited into the Controlled Account clear the banking system, they will be swept daily, and applied to reduce the Obligations pursuant to the terms of this Agreement. Purchaser may also notify all Account Debtors to make all payments to such lockbox.

 

3.

Authorization for Purchases/Seller Instructions. Subject to the terms and conditions of this ARPA, Purchaser is authorized to purchase Accounts upon telephonic, facsimile, electronic mail, or other instructions received from anyone purporting to be an officer, employee or representative of Seller. In addition, Purchaser is authorized to comply with any other instructions, including vendor payment instructions, upon telephonic, facsimile, electronic mail, or other instructions received from anyone purporting to be an officer, employee or representative of Seller. Under no circumstances shall Purchaser ever be liable to Seller or any third party for complying with such instructions, whether verbal or in writing, either on the basis of lack of authority, identity theft, fraud or otherwise, such claims hereby fully waived and released, whether now existing or hereafter arising.

 

 

4.

Discount. The Discount shall be applied (and the Purchase Price adjusted accordingly) upon the purchase of an Account. In addition to the Discount, the Purchase Price shall be adjusted so as to include the discounts described below, to the extent that such discounts are applicable.

 

 

4.1

Additional Discount. The Additional Discount shall be applied to any Purchased Account that remains unpaid for more than 30 days from the purchase date. The Additional Discount shall be applied to the Purchase Price for such Purchased Account once for each 10 day period or portion thereof during which the Purchased Account remains unpaid, commencing as of the end of the initial ten day period and continuing to the date on which such Purchased Account is Closed.

 

 

 

 

4.2

Delay Discount. The Delay Discount shall be applied each day on which there exists (a) any past due Obligations from Seller under this Agreement; or (b) a Reserve Shortfall. The Purchaser may allocate the Delay Discount among Purchased Accounts on a pro rata basis, or in any other way that the Purchaser, in its sole discretion, deems appropriate.

 

 

 

5.

Repurchase Of Accounts.

 

 

 

5.1   

Requirement to Repurchase. Purchaser may require that Seller repurchase at the Repurchase Price:

 

 

5.1.1

Any Purchased Account, the payment of which has been disputed by the Account Debtor obligated thereon, Purchaser being under no obligation to determine the bona fides of such dispute;

 

 
Page 8 of 30

 

  

 

5.1.2

Any Purchased Account as to which Seller has breached a covenant under Section 11 or 12, or a representation or warranty under section 13;

 

 

 

 

5.1.3

All Purchased Accounts upon the occurrence of an Event of Default, or upon the termination of this ARPA;

 

 

 

 

5.1.4

Any Purchased Account that remains unpaid beyond the Late Payment Date; and

 

 

 

 

5.1.5

Any Purchased Account owing from an Account Debtor or Payor which (i) in Purchaser’s reasonable judgment has become insolvent or (ii) which has indicated an inability or unwillingness to pay the Purchased Account when due.

 

 

5.2

Payment of Repurchase Price. In the event that Purchaser requires that Seller repurchase one or more Accounts pursuant to Section 5.1, Seller shall pay the Repurchase Price on demand, or, at Purchaser’s option, without notice or demand, by Purchaser’s charge to the Reserve Account.

 

 

 

 

5.3

Security Interest in Repurchased Accounts. Accounts shall not be deemed Repurchased until the Repurchase Price has been paid; provided, however, that if the Repurchase Price is paid by charging the Reserve Account, such Accounts shall not be deemed Repurchased until the next succeeding Business Day on which, as of the close of business, the Reserve Shortfall is zero and there are no past-due Obligations. At such time as an Account is deemed Repurchased pursuant to this subsection, it shall be transferred and re-assigned to Seller, but shall constitute Collateral for all purposes under this ARPA and the Collateral Documents, as applicable.

 

 

 

6.

Security Interest. In order to secure the Obligations, Seller assigns the Collateral to Purchaser and grants to Purchaser a continuing first priority security interest in and lien upon the Collateral, which security interest is evidenced and more fully described in a separate security agreement that has been executed and delivered by Seller in connection herewith. Notwithstanding the granting to Purchaser of a security interest, it is acknowledged that Purchased Accounts are the sole property of Purchaser, and as such, are not Collateral.

 

 

 

 

6.1

Seller authorizes Purchaser to file any initial financing statements and amendments thereto that:

 

 

6.1.1.1

Identify the Collateral;

 

 
Page 9 of 30

 

 

 

6.1.1.2

Contain any other information required by part 5 of Article 9 of the UCC for the sufficiency or filing office acceptance of any financing statement or amendment, including (i) whether the Seller is an organization, the type of organization, and any organization identification number issued to the Seller;

 

 

 

 

6.1.1.3

Contain a notification that the Seller has granted a negative pledge to the Purchaser, and that any subsequent lienor may be tortiously interfering with Purchaser’s rights; and

 

 

 

 

6.1.1.4

Advise third parties that any notification of Seller’s Account Debtors will interfere with Purchaser’s collection rights.

 

 7.

Guaranty. As further security for the payment of the Obligations, certain parties have fully and unconditionally personally guaranteed the Seller’s obligations and performance of this ARPA, as evidenced by Personal Guarantee(s) executed contemporaneously herewith. Such Personal Guarantee(s) and shall be fully enforceable in accordance with their terms. Notwithstanding anything contained herein, the liability of Seller and all guarantors is joint and several, such that Purchaser may proceed against any such persons, or any collateral securing the Obligations, without first proceeding against or joining any other such person or pursuing any other remedy.

 

 

 

8.

Fees; Reimbursement of Expenses. In addition to the Discount, the Additional Discount, the Delay Discount and other fees and charges owing hereunder, Seller shall pay to Purchaser the items set forth in this Section 8. Unless otherwise expressly indicated, such items shall be due and payable without demand or notice, and may be charged to the Reserve Account pursuant to Section 2.3.3 hereof:

 

 

 

 

8.1

The Audit Fee, which shall be incurred and due each day during which Purchaser or its agents are on-site at Seller’s facilities or spend at least six (6) working hours working on the audit of Seller’s business.

 

 

 

 

8.2

The Missing Notation Fee, which shall accrue on any Invoice that is transmitted by Seller to the applicable Account Debtor and that does not include the Notation.

 

 

 

 

8.3

The Misdirected Payment Fee, which shall accrue on any customer payment that is received by Seller and not delivered in kind to Purchaser on the next Business Day following the date of receipt by Seller.

 

 

 

 

8.4

The Early Termination Fee as provided in Section 16.3 of this ARPA.

 

 

 

 

8.5

Attorney fees and other legal costs reimbursable by Seller pursuant to Section 18 of this ARPA.

 

 

 

 

8.6

Reimbursement for all out-of-pocket expenses directly incurred by Purchaser in the administration of this ARPA, including but not limited to wire transfer fees, postage, audit-related expenses (which shall be charged in addition to the Audit Fee) and all other actual out-of-pocket costs.

 

 
Page 10 of 30

 

 

 

8.7

Any other cost or charge set forth in this ARPA or any other Transaction Document or otherwise owed by Seller.

 

 

 

9.

ACH Authorization. Seller shall execute EXHIBIT A, hereto, granting to Purchaser an irrevocable Power of Attorney authorizing Purchaser to initiate electronic debit or credit entries through the ACH system to any deposit account maintained by Seller wherever located. Seller warrants and represents that under no circumstances will it reverse, void, or otherwise render invalid any electronic debit or credit initiated by Purchaser.

 

 

 

10.

Account Statement. Purchaser shall provide Seller with information on all Accounts and a monthly reconciliation of the factoring relationship relating to billing, collection and account maintenance such as aging, posting, error resolution and mailing of statements. All of the foregoing shall be in a format and in such detail, as Purchaser, in its sole discretion, deems appropriate including, but not limited to, electronic access on a website hosted by Purchaser. Purchaser’s books and records shall be admissible in evidence without objection as prima facie evidence of the status of the Purchased Accounts and non-purchased Accounts and Reserve Account between Purchaser and Seller. Each statement, report, or accounting rendered, issued or other information regularly made available by Purchaser to Seller on any website shall be deemed conclusively accurate and binding on Seller unless within fifteen (15) days after the date of issuance of any written statement or the first of each month as to Purchaser’s website content Seller notifies Purchaser to the contrary by registered or certified mail, setting forth with specificity the reasons why Seller believes such statement, report, accounting or website information is inaccurate, as well as what Seller believes to be correct amount(s) therefor. Seller’s failure to receive any monthly statement shall not relieve it of the responsibility to request such statement and Seller’s failure to do so shall nonetheless bind Seller to the information contained in Purchaser’s records and website information at the time. Seller acknowledges that the information Purchaser makes available to Seller electronically pursuant to this Section constitutes and satisfies any duty to respond to a “request for an accounting” or a “request regarding a statement of account” as defined in Section 9.210 of the UCC.

 

 

 

11.

Affirmative Covenants By Seller.

 

 

 

 

11.1

Access. From time to time as requested by Purchaser, at the sole expense of Seller, Purchaser or its designee shall have access, during reasonable business hours if prior to an Event of Default and at any time if on or after an Event of Default, to Seller’s primary business premises as well as all other premises where Collateral is located for the purposes of inspecting (and removing, if after the occurrence of an Event of Default) any of the Collateral, including Seller’s books and records, and Seller shall permit Purchaser or its designee to make copies of such books and records or extracts therefrom as Purchaser may request. Without expense to Purchaser, Purchaser may use any of Seller’s personnel, equipment, including computer equipment, programs, printed output and computer readable media, supplies and premises for the collection of accounts and realization on other Collateral as Purchaser, in its sole discretion, deems appropriate. Seller hereby irrevocably authorizes and shall direct each current or later engaged accountant and third party to disclose and deliver to Purchaser at Seller’s expense all financial information, books and records, work papers, management reports and other information in their possession relating to Seller.

 

 
Page 11 of 30

 

 

 

11.2

Taxes. Seller shall pay when due all payroll and other taxes, and shall provide proof thereof to Purchaser in such form as Purchaser shall reasonably require. Seller will notify Purchaser in writing immediately upon imposition or assessment of any lien, levy, tax lien, assessment or similar action against Seller or any of Seller’s assets.

 

 

 

 

11.3

Insurance. Seller shall maintain insurance on all insurable property owned or leased by Seller in the manner, to the extent and against at least such risks (in any event, including but not limited to fire and business interruption insurance) as usually maintained by owners of similar businesses and properties in similar geographic areas. All such insurance shall be in amounts and form and with insurance companies acceptable to Purchaser in its sole discretion, and shall reflect the Purchaser as the loss payee; and the Purchaser shall be listed in the policy as an additional insured entitled to receive notices. Seller shall furnish to Purchaser: (a) upon written request, any and all information concerning such insurance carried; (b) as requested by Purchaser, loss payable endorsements (or their equivalent) in favor of Purchaser. All policies of insurance shall provide for not less than thirty (30) day’s prior written cancellation notice to Purchaser.

 

 

 

 

11.4

Payments Received by Seller. Notwithstanding that Seller has agreed to pay the Misdirected Payment Fee, if the Seller shall receive any payments with respect to any Account, whether such Account has been purchased by Purchaser or represents Collateral of Purchaser, then the Seller shall hold such payments in trust for the benefit of the Purchaser, shall not commingle such payments with Seller’s other assets, and shall turn over the check in kind (or if payment was made electronically, the funds), within one (1) Business Day following the date of receipt by Seller of the payment. Seller shall make its best efforts to insure that each Account Debtor shall receive and comply with any Notation and make payment to Purchaser in accordance therewith, whether indebted on a Purchased Account or a non-Purchased Account.

 

 

 

 

11.5

Additional Access and Notification. Seller shall (i) permit the Purchaser access to all books and records of the Seller during normal business hours; (ii) notify the Purchaser in writing immediately upon imposition or assessment of any lien, levy, tax lien, assessment or similar action against the Seller or any of the Seller’s assets; and (iii) furnish the Purchaser, upon request, any and all papers, documents, or records of whatever nature related directly or indirectly to any Accounts.

 

 

 

 

11.6

Returned Merchandise Held in Trust. In the event any Goods sold giving rise to an Account shall be returned to or repossessed by the Seller, such Goods shall be held by the Seller in trust for the Purchaser, separate and apart from the Seller’s own property, and subject to the Purchaser’s directions and control.

 

 

 

 

11.7

Information/Reporting Requirements. Seller shall provide to Purchaser the following documents and reports within the time frames indicated:

 

 
Page 12 of 30

 

 

 

11.7.1

Within ten (10) days of the close of each month, the following reports for the previous month, each of which shall be dated as of the close of such fiscal month and prepared or certified by Seller’s management:

 

 

 

 

 

 

11.7.1.1

monthly accounts receivable aging reports;

 

 

 

 

 

 

11.7.1.2

monthly accounts payable aging reports

 

 

 

 

 

 

11.7.1.3

profit and loss statements;

 

 

 

 

 

 

11.7.1.4

balance sheet; and

 

 

 

 

 

 

11.7.1.5

bank statements for each operating account.

 

 

 

 

 

11.7.2

Within fifteen (15) days of the close of each calendar quarter, unaudited quarterly financial statements, each of which shall be dated as of the close of such quarter and prepared or certified by Seller’s management

 

 

 

 

 

11.7.3

On an annual basis, copies of the following once completed:

 

 

 

 

 

 

11.7.3.1

All federal, state and county income or franchise tax returns or reports;

 

 

 

 

 

 

11.7.3.2

All federal and state payroll tax returns or reports; and

 

 

 

 

 

 

11.7.3.3

Year-end financial statements.

 

 

 

 

 

11.7.4

On an annual basis within fifteen (15) days of the close of each calendar year, annual sales projections;

 

 

 

 

 

11.7.5

On an annual basis, audited financial statements, within 120 days of the Seller’s fiscal year end; and

 

 

 

 

 

11.7.6

On an annual basis no later than December 31, 2020, and the 31st of December of every year thereafter that the ARPA is in effect or any Obligations are owed to Purchaser, a personal financial and cash flow statement and the most recently-filed federal tax return on all personal guarantors of this ARPA.

 

 

 

 

 

11.7.7

Seller agrees to ensure Purchaser has continuous and interrupted online access to all Purchased Account data of Seller, including, without limitation, all accounts receivable aging reports and collection reports.

 

 

11.8

Dealing with Returned Goods. With respect to any returned or repossessed Goods, the Seller, at its sole cost and expense, shall (a) provide proper storage therefor, (b) maintain adequate insurance coverage thereon, (c) prepare the same for sale, (d) defend title thereto, (e) take all other actions necessary for the protection thereof, (f) pay freight and related shipping costs, (g) be responsible for any other costs or expenses incurred in connection with the foregoing, including attorney’s fees, and (h) immediately notify Purchaser of any authorization Seller provides for the return of Goods.

 

 
Page 13 of 30

 

 

 

11.9

Indemnification. Seller hereby agrees to indemnify Purchaser and its affiliates, subsidiaries, parent, directors, officers, employees, agents, and attorneys, and to hold them harmless from and against any and all claims, debts, liabilities, demands, obligations, actions, causes of action, penalties, costs and expenses (including reasonable attorneys’ fees), of every kind, which they may sustain or incur based upon or arising out of any of the Obligations, or any relationship or agreement between Seller and Purchaser, or any other matter, relating to Seller or the Obligations; provided that this indemnity shall not extend to damages proximately caused by the indemnitee’s own gross negligence or willful misconduct. Notwithstanding any provision in this Agreement to the contrary, the indemnity agreement set forth in this Section shall survive any termination of this Agreement and shall for all purposes continue in full force and effect.

 

 

 

 

11.10

Taxpayer Authorizations. Seller shall fully complete and execute, as taxpayer, prior to or immediately upon the execution of this Agreement, a form 8821 (Rev. October 2011) and/or form 4506 (Rev. January 2012) or form 4506-T (Rev. January 2012) issued by the Department of the Treasury, Internal Revenue Service, as updated and revised from time to time, and such additional forms as may be requested by Purchaser, irrevocably authorizing Purchaser to, among other things, inspect or receive tax information relating to any type of tax, tax form, years or periods or otherwise desired by Purchaser on an ongoing basis.

 

 

 

 

11.11

Further Assurances. Seller shall promptly execute, acknowledge and deliver such further documents and do such other acts and things as Purchaser may reasonably request in order to effect fully the purposes of this ARPA and the other Transaction Documents.

 

 

 

12.

Negative Covenants by Seller.

 

 

 

 

12.1

Dealing with Account Debtors. Seller will not, without the prior written consent of Purchaser in each instance: (a) grant, or purport to grant, any extension of time for payment of any of the Accounts, (b) compromise or settle, or purport to compromise or settle, any Account for less than the full amount thereof, (c) release, or purport to release, in whole or in part, any Account Debtor or authorize or allow or purport to authorize or allow any Account Debtor to make payments to Seller, or (d) grant or purport to grant any credits, discounts, allowances, deductions, return authorizations or the like with respect to any of the Accounts. Each of the covenants contained in clauses (a) through (d) applies to all of the Accounts, regardless of whether such Accounts constitute Purchased Accounts or Collateral.

 

 

 

 

12.2

Notice of Assignment. Seller will not send any Invoice to an Account Debtor if such Invoice does not include the Notation.

 

 
Page 14 of 30

 

 

 

12.3

Liens. Except for Permitted Liens, Seller will not, without the express prior written consent of Purchaser, create, incur, assume or permit to exist any security interest, lien or encumbrance upon or with respect to any Account and/or Collateral now owned or hereafter acquired by Seller. In addition, Seller shall not enter into any agreement with any third party that prohibits the creation or perfection of a lien in favor of Purchaser upon any of Seller’s properties or assets, whether now owned or hereafter acquired. For purposes of this Section 12.3, “Permitted Liens” shall mean liens and security interests in favor of Purchaser and security interests and liens which are subordinate to the security interest of Purchaser, are consented to in writing by Purchaser, and for which Purchaser and the subordinate lienholder have entered into a subordination agreement acceptable to Purchaser in its good faith business judgment.

 

 

 

 

12.4

No Other Sales of Accounts. Seller will not, without express prior written consent of Purchaser, sell, pledge, assign or factor any of its Accounts other than to Purchaser until all Purchased Accounts are Closed, all Obligations due Purchaser have been fully satisfied, and Purchaser has filed a UCC termination.

 

 

 

 

12.5

Fundamental Changes in Business. Seller will not, without prior written consent by the Purchaser, (a) use any trade name other than that set out at the beginning of this ARPA, (b) change its name or use an assumed name; (c) change its jurisdiction of organization (d) merge or consolidate with any other corporation or entity, (e) dissolve or cease its operations as they are now conducted, or (f) hold any “going out of business” sale or otherwise state publicly that Seller is going out of business, or (g) take any other action that is reasonably likely to cause Account Debtors to withhold, delay, or refuse payment (rightfully or wrongfully) on the Accounts.

 

 

 

 

12.6

Distributions, Dividends, and Other Junior Payments. Seller will not, without the prior written consent of Purchaser, declare any dividends, or purchase, redeem, retire or otherwise acquire any of its capital stock or make any distribution of its assets to any of its shareholders or other investors, or make any payments of any kind to its shareholders, members, partners, or other equity investors, other than (i) the reimbursement of actual, ordinary and necessary business expenses incurred by such shareholders or other investors on behalf of Seller in the ordinary course of business; and (ii) if such shareholders or other investors are employed by Seller, salaries or other regular compensation at the same rates as are in effect as of the date hereof.

 

 

 

 

12.7

Transactions With Affiliates. Seller will not, directly or indirectly, enter into or permit any transaction with any Affiliate of Seller on terms that are less favorable to the Seller than those that might be obtained at the time from a person who is not an Affiliate of Seller.

 

 

 

 

12.8

No Deposit of Account Proceeds. Seller shall not deposit Account proceeds, whether the funds represent payments for purchased Accounts or non-Purchased Accounts, but shall hold such payments in trust for the benefit of the Purchaser, shall not commingle such payments with Seller’s other assets, and shall turn over the check in kind (or if payment was made electronically, the funds), within one (1) Business Day following the date of receipt by Seller of the payment. Seller shall make its best efforts to insure that each Account Debtor shall receive and comply with any Notation and make payment to Purchaser in accordance therewith, whether indebted on a Purchased Account or a non-Purchased Account.

 

 
Page 15 of 30

 

   

13.

Representations and Warranties. The following representations and warranties are made by Seller to Purchaser, with the understanding that Purchaser is relying upon them in entering into this ARPA and purchasing the Purchased Accounts. Each delivery of an AR Purchase Certificate shall constitute Seller’s reaffirmation that these representations and warranties are true and correct as of the date of such AR Purchase Certificate, unless Purchaser has been specifically advised otherwise in writing. All of such representations and warranties shall be considered to have been relied upon by Purchaser, regardless of any investigation made by Purchaser or on its behalf.

 

 

 

 

13.1

Authority. Seller is fully authorized to enter into this ARPA and to perform hereunder.

 

 

 

 

13.2

Binding Nature. Each of the Transaction Documents constitutes the legal, valid and binding obligation of Seller, and is fully enforceable against Seller according to its terms.

 

 

 

 

13.3

Solvent and Good Standing. Seller is solvent and in good standing in the State of its organization.

 

 

 

 

13.4

Nature of Accounts.

 

 

13.4.1

The Accounts are bona fide existing, outstanding obligations created by the unconditional and fully-completed sale and delivery of goods by the Seller or the complete, full and unconditional rendition of services, in any case, in the ordinary course of Seller’s business. The Accounts are unconditionally owed by the Account Debtor free of any and all defenses, including, but not limited to, any disputes, offsets, counterclaims, rights of recoupment, or rights of return or cancellation. The Accounts have not been paid, satisfied or discharged in any manner, in whole or in part.

 

 

 

 

13.4.2

The Account Debtors on all Accounts, whether Purchased or constituting the Collateral of Purchaser, have been notified and advised that payment on the Accounts shall be made to Purchaser, and have not been given any contrary or conflicting instructions by Seller or its employees, representatives, or Affiliates. All Invoices to Account Debtors include the Notation.

 

 

 

 

13.4.3

With respect to each Account, the applicable Account Debtor is not Affiliated with Seller, and the terms and conditions of the transactions giving rise to such Account are no more or less favorable to Seller than those that would be offered to an unaffiliated third party dealing with the Seller at arms’ length in a free market.

 

 
Page 16 of 30

 

 

 

13.5

No Notice of Adverse Claims, Bankruptcy, Insolvency, Etc. Seller has not received notice of, and does not have actual knowledge of, any of the following: (a) the actual or imminent bankruptcy, insolvency, or material impairment of the financial condition of the Account Debtor; (b) any claim or assertion by the Account Debtor which, if successful, would constitute a defense to, payment or satisfaction of, or offset against, the Account; or (c) any claim by any third party pertaining to an Account which, if asserted, would likely cause the Account Debtor to withhold or delay payment on such Account to the Purchaser.

 

 

 

 

13.6

No Associated Entities In Competition With Seller. To the best of Seller’s knowledge, there exists no corporation, partnership, limited liability, or other person or entity to which Section 15 of this ARPA applies.

 

 

 

 

13.7

Accuracy of Information. All written information previously provided to Purchaser by Seller (or on Seller’s behalf) in connection with this ARPA, including but not limited to all applications, certificates, financial statements, and other written information furnished to Purchaser in contemplation of any transaction, is true and correct.

 

 

 

 

13.8

Account Purchase Transaction. None of the payments contemplated by this ARPA constitute payments for the use, forbearance, or detention of money. All transactions contemplated hereby are account purchase transactions as defined in Section 306.001 and Section 306.103 of the Texas Finance Code. The purchase of the Accounts by Purchaser constitutes an outright conveyance and true sale of Accounts by the Seller to Purchaser. The Discount, Additional Discount, Delay Discount and other accrued discounts, fees or charges hereunder are intended by the parties as “discounts” under Section 306.103 of the Texas Finance Code.

 

 

 

 

13.9

Consulting With Attorney. Seller has consulted with an attorney of Seller’s choice with respect to this ARPA and the transactions contemplated herein (or in the alternative, Seller acknowledges that Purchaser has recommended that Seller consult with an attorney and Seller has knowingly elected not to do so), and Seller has relied solely on the advice of such attorney and/or on its own judgment in deciding to enter into this ARPA.

 

 

 

 

13.10

Determination of Purchase Price. The Purchase Price of the Accounts has been fairly determined pursuant to arms’ length negotiations between Purchaser and Seller, and represents the fair market value thereof, after due consideration has been given to the nature of the Accounts, the probability of prompt collection thereof, the creditworthiness of the Account Debtors, the payment history of the Account Debtors, other economical factors relative to the Accounts; and the services rendered and services that will be rendered in the future by Purchaser in connection with credit investigations of Account Debtors, supervision of ledgering of Accounts, collection of Purchased Accounts, and the assumption of certain credit risks.

 

 
Page 17 of 30

 

 

14.

Default.

 

 

 

 

14.1

Events of Default. The occurrence of any one (1) or more of the following events constitutes an immediate Event of Default hereunder: (a) Seller fails to pay any monetary Obligation to Purchaser, or deliver any of the reports or other documents described in Section 11.7, within two (2) Business Days of the date on which such payment or report, as applicable, is due; (b) Seller breaches any of the negative covenants set forth in Section 12 of this ARPA; (c) Seller fails to perform any of the affirmative covenants described in Section 11 (other than Section 11.7, addressed above) within two (2) days from the date on which Seller receives Purchaser’s written notice of such failure; (d) any representation or warranty contained in this ARPA or any Transaction Document is false when made (provided, however, that Purchaser’s failure to discover such falsity until a later date shall in no way be deemed a waiver of such Event of Default); (e) any guarantor of the Obligations becomes subject to any debtor-relief proceedings, fails to perform or observe any of such guarantor’s obligations to Purchaser or shall notify Purchaser of its intention to rescind, modify, terminate or revoke any guaranty of the Obligations, or any such guaranty shall cease to be in full force and effect for any reason whatever, including if such guarantor is an individual, the death of such individual guarantor; (f) Purchaser for any reason, in good faith, deems itself insecure with respect to the prospect of repayment or performance of the Obligations; (g) Seller shall generally not pay, or shall be unable to pay, or shall admit in writing its inability to pay its debts as such debts become due; (h) Seller shall make an assignment for the benefit of creditors, or petition or apply to any tribunal for the appointment of a custodian, receiver, or trustee for it or a substantial part of its assets; (i) Seller shall commence any proceeding under any Insolvency Law, whether now or hereafter in effect; (j) Seller shall have had any such petition or application filed or any such proceeding commenced against it in which an order for relief is entered or an adjudication or appointment is made; (k) Seller shall take any corporate action indicating its consent to, approval of, or acquiescence in any such petition, application, proceeding, or order for relief or the appointment of a custodian, receiver, or trustee for all or any substantial part of its properties; (1) Seller shall suffer any such custodianship, receivership, or trusteeship; (m) Seller shall have failed to comply in any respect with the terms and conditions of this ARPA or related documents; or (n) Purchaser’s purchase of Accounts causes a Reserve Shortfall or the unpaid balance of Purchased Accounts to exceed the Maximum Amount.

 

 

 

 

14.2

Effect of Default. Upon the occurrence of any Event of Default, Purchaser may immediately take the following actions (and all of such remedies are cumulative and not exclusive of any other remedy to which Purchaser may be entitled under this Agreement or applicable law):

 

 

14.2.1

require the immediate repurchase of all Purchased Accounts at the Repurchase Price;

 

 

 

 

14.2.2

declare all Obligations to be immediately due and payable;

 

 
Page 18 of 30

 

 

 

14.2.3

limit or terminate Seller’s access to Purchaser’s online services;

 

 

 

 

14.2.4

terminate this Agreement, effective immediately, by written notice to Seller, at which point, in addition to the other Obligations, the Early Termination Fee shall be immediately due and payable;

 

 

 

 

14.2.5

exercise any and all other remedies allowed under this ARPA and the other Transaction Documents; and

 

 

 

 

14.2.6

take any action otherwise allowed by law and/or in equity.

 

Without limiting any of Purchaser’s rights or remedies following an Event of Default, the Delay Discount shall continue to accrue on all past due Obligations.

 

 

14.3

No Implied Waivers, Etc. No failure to exercise and no delay in exercising any right, power, or remedy hereunder shall impair any right, power, or remedy which Purchaser may have, nor shall any such delay be construed to be a waiver of any of such rights, powers, or remedies, or any acquiescence in any breach or default hereunder; nor shall any waiver by Purchaser of any breach or default by Seller hereunder be deemed a waiver of any default or breach subsequently occurring. Further, Purchaser’s failure to charge or accrue any discounts or fees at the rate to which Purchaser is entitled shall not be deemed a waiver by Purchaser of its claim thereto. All rights and remedies granted to Purchaser hereunder shall remain in full force and effect notwithstanding any single or partial exercise of, or any discontinuance of action begun to enforce, any such right or remedy. Any waiver, permit, consent or approval by Purchaser of any breach or default hereunder must be in writing and shall be effective only to the extent set forth in such writing and only as to that specific instance.

 

 

 

 

14.4

Seller’s Remedy; Limitation of Liability. NEITHER PURCHASER NOR ITS PARENT, NOR ANY OF ITS AFFILIATES, SUBSIDIARIES, DIRECTORS, OFFICERS, EMPLOYEES, AGENTS OR ATTORNEYS SHALL BE LIABLE FOR ANY CLAIMS, DEMANDS, LOSSES OR DAMAGES, OF ANY KIND WHATSOEVER, MADE, CLAIMED, INCURRED OR SUFFERED BY SELLER OR ANY OTHER PARTY THROUGH THE ORDINARY NEGLIGENCE OF PURCHASER, OR ITS PARENT OR ANY OF ITS AFFILIATES, SUBSIDIARIES, DIRECTORS, OFFICERS, EMPLOYEES, AGENTS OR ATTORNEYS, BUT NOTHING HEREIN SHALL RELIEVE PURCHASER FROM LIABILITY FOR ITS OWN GROSS NEGLIGENCE OR WILLFUL MISCONDUCT. NEITHER PURCHASER NOR ITS PARENT, NOR ANY OF ITS AFFILIATES, SUBSIDIARIES, DIRECTORS, OFFICERS, EMPLOYEES, AGENTS OR ATTORNEYS SHALL BE RESPONSIBLE OR LIABLE TO SELLER OR TO ANY OTHER PARTY FOR ANY INDIRECT, PUNITIVE, EXEMPLARY OR CONSEQUENTIAL DAMAGES WHICH MAY BE ALLEGED AS A RESULT OF ANY FINANCIAL ACCOMMODATION HAVING BEEN EXTENDED, SUSPENDED OR TERMINATED UNDER THIS AGREEMENT OR AS A RESULT OF ANY OTHER ACT, OMISSION OR TRANSACTION.

 

 
Page 19 of 30

 

 

15.

Associated Entities. In the event Seller’s principal(s) including, but not limited to its officer(s) or director(s), during the term of this Agreement or while Seller remains liable to Purchaser for any Obligations under this Agreement, directly or indirectly, including acting by, through or in conjunction with any other person, causes to be formed a new entity or otherwise become associated with any new or existing entity, whether corporate, partnership, limited liability company or otherwise in a business similar to or competitive with that of Seller, such entity shall be deemed to have expressly assumed the Obligations due Purchaser under this Agreement. With respect to any such entity, Purchaser shall be deemed to have been granted Purchaser an irrevocable power of attorney with authority to file, naming such newly formed or existing entity as Debtor, an initial UCC-1 financing statement and to have it filed with any and all appropriate secretaries of state or other UCC filing offices. Purchaser shall be held harmless by Seller and its principals and be relieved of any liability as a result of Purchaser’s authentication and filing of any such financing statement or the resulting perfection of its ownership or security interests in such entity’s assets. Purchaser shall have the right to notify such entity’s Account Debtors of Purchaser’s rights, including without limitation, Purchaser’s right to collect all Accounts, and to notify any creditor of such entity that Purchaser has such rights in such entity’s assets.

 

 

 

16.

Termination; Effective Date.

 

 

 

 

16.1

Term; Renewal. This Agreement shall take effect on the Effective Date and shall remain in full force for a period of twelve months (the “Initial Term”). The Agreement shall be automatically extended and renewed for successive twelve month periods following the Initial Term unless notice of non-renewal is provided by the Seller as hereinafter provided (each such 12-month period, a “Renewal Term”). Notice of non-renewal under this Agreement must be in writing and delivered to Purchaser by Seller not less than ninety (90) days prior to the conclusion of the Initial Term or any Renewal Term.

 

 

 

 

16.2

Termination by Purchaser. This Agreement may be terminated by Purchaser: (a) at any time upon ninety (90) days prior written notice to Seller; or (b) if an Event of Default has occurred and is continuing, upon written notice to Seller, in which case, such termination shall be effective immediately upon the delivery of such notice (or any later date and time specified in such notice). In the event the ARPA is terminated by Purchaser as a result of an Event of Default, in addition to all other Obligations, Seller shall pay Purchaser the Early Termination Fee (defined below).

 

 

 

 

16.3

Termination by Seller. If the Agreement is terminated by Purchaser as a result of an Event of Default or by Seller other than as a result of timely non-renewal under section 16.1, prior to the end of the Initial Term or any Renewal Term, in addition to all other Obligations, Seller shall pay to Purchaser an early termination fee (“Early Termination Fee”) equal to 1.00% of the Maximum Amount. Purchaser’s right to the Early Termination Fee under this section shall be without prejudice to any of Purchaser’s other rights and remedies under this Agreement.

 

 
Page 20 of 30

 

 

 

16.4

Effect of Termination. Upon the effective date of termination all Obligations of Seller to Purchaser, including the Early Termination Fee, if applicable, shall become immediately due and payable without further notice or demand irrespective of any maturity dates established prior thereto, and Seller shall be obligated to satisfy all Obligations, which shall include the repurchase of all Purchased Accounts which are not Closed, in accordance with Section 5 of this ARPA. No termination of this Agreement will in any way affect or impair any right of Purchaser arising prior thereto or by reason thereof, nor will any such termination relieve Seller of any duty to Purchaser under, nor deny Purchaser any benefit from, this Agreement or otherwise until all of Obligations have been fully discharged. In recognition of the Purchaser’s right to have its attorneys’ fees and other expenses incurred in connection with this Agreement secured by the Collateral, as well as all indemnities of Seller with respect to dishonored payment items and Avoidance Claims, notwithstanding payment in full of all Obligations by Seller, Purchaser shall not be required to record any terminations or satisfactions of any of Purchaser’s liens on the Collateral unless and until Seller and each guarantor has executed and delivered to Purchaser a general release in the form of EXHIBIT B hereto. Seller understands that this provision constitutes a waiver of its rights under §9.513 of the UCC.

 

 

 

 

 

16.5  

Exposed Payments.

 

 

 

 

 

 

16.5.1

Upon termination of this Agreement, Seller shall pay to Purchaser (or Purchaser may retain), to hold in a non-segregated non-interest bearing account, an amount equal to the aggregate of all Exposed Payments as of the date of termination (the “Preference Reserve”).

 

 

 

 

 

 

16.5.2

Purchaser may charge the Preference Reserve with the amount of any Exposed Payments that Purchaser pays to the estate of the Payor that made the Exposed Payment, on account of a claim asserted under any Insolvency Law.

 

 

 

 

 

 

16.5.3

Purchaser shall refund to Seller from time to time that balance of the Preference Reserve for which a claim under Insolvency Laws can no longer be asserted due to the passage of the statute of limitations, settlement with the bankruptcy estate of the Payor, or otherwise.

 

 

 

 

 

16.6

Survival. Notwithstanding the termination of this ARPA and the full payment and performance of all Obligations, all covenants, representation and warranties made in this Agreement as well as the following provisions of this ARPA shall survive and constitute continuing covenants of the parties: Section 11.9; Section 14.4; Section 16.5; Section 17 (all subsections); Sections 18.2, 18.3, 18.5, and 18.6; Section 20 (all subsections); and Section 21 (all subsections).

 

 
Page 21 of 30

 

 

17. 

WAIVERS

 

 

 

 

17.1

JURY TRIAL WAIVER. IN RECOGNITION OF THE HIGHER COSTS AND DELAY WHICH MAY RESULT FROM A JURY TRIAL, THE PARTIES HERETO WAIVE ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING HEREUNDER, OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE; AND EACH PARTY FURTHER WAIVES ANY RIGHT TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED.

 

 

 

 

17.2

Attorney Fees and Legal Expenses. Notwithstanding the existence of any law, statute or rule, in any jurisdiction which may provide Seller with a right to attorney’s fees or costs, Seller hereby waives any and all rights to hereafter seek attorney’s fees or costs hereunder and Seller agrees that Purchaser exclusively shall be entitled to indemnification and recovery of any and all attorney’s fees or costs in respect to any litigation based hereon, arising out of, or related hereto, whether under, or in connection with, this ARPA and/or any Transaction Document, or any course of conduct, course of dealing, statements (whether verbal or written) or actions of either party.

 

 

 

 

17.3

WAIVER OF CONSUMER RIGHTS. IN CONNECTION WITH THIS ARPA, SELLER WAIVES ITS RIGHTS, IF ANY, UNDER THE DECEPTIVE TRADE PRACTICES-CONSUMER PROTECTION ACT, TEXAS BUSINESS AND COMMERCE CODE SECTION 17.41 ET SEQ., A LAW THAT GIVES CONSUMERS SPECIAL RIGHTS AND PROTECTIONS. AFTER CONSULTATION WITH AN ATTORNEY OF SELLER’S OWN SELECTION, SELLER VOLUNTARILY CONSENTS TO THIS WAIVER.

 

 

 

 

17.4

Notices and Demands. Except for any notices to which they are specifically entitled under the express terms of this ARPA, Seller and each guarantor hereby waives any right to notices to which it may otherwise be entitled in connection with the collection or enforcement of the Obligations. Without limiting the generality of the foregoing, Seller and each guarantor hereby waives demand, notice of nonpayment, notice of intent to accelerate, and notice of acceleration. In addition, each guarantor waives notice of any and all renewals, extensions, amendments, and modifications of this ARPA or the other Transaction Documents.

 

 

 

 

17.5

Dealings With Account Debtors. Seller understands that the Purchaser may notify an Account Debtor to make payment to the Purchaser, and in advance waives any rights and claims which it may hereafter have, or hereafter claim to have, based in any way upon such contacts with and/or notifications to such account debtors, including but not limited to claims for disparagement, interference with business relationships, or any other form of damage to the Seller or its business(es).

 

 
Page 22 of 30

 

 

18.

Attorneys’ Fees. Seller agrees to reimburse Purchaser on demand for the actual amount of all costs and expenses, including attorneys’ fees, photocopying (which, if performed by Purchaser’s employees, shall be at the rate of $.10/page), courier delivery, postage, and reasonable travel expenses, which Purchaser has incurred or may incur:

 

 

 

 

18.1

in negotiating, preparing, or administering this ARPA and any documents prepared in connection herewith, all of which shall be paid contemporaneously with the execution of this ARPA;

 

 

 

 

18.2

in enforcing this ARPA or protecting, preserving or enforcing any lien, security interest or other right granted by Seller to Purchaser or arising under applicable law, whether or not suit is brought, including but not limited to the defense of any Avoidance Claims;

 

 

 

 

18.3

in connection with any proceeding commenced by or against Seller under any Insolvency Law, including those (i) arising out the automatic stay, (ii) seeking dismissal or conversion of the bankruptcy proceeding or (iii) opposing confirmation of Seller’s plan thereunder;

 

 

 

 

18.4

in collecting or attempting to collect any Accounts from Account Debtors;

 

 

 

 

18.5

in complying with any subpoena or other legal process attendant to any litigation to which Seller is a party; and

 

 

 

 

18.6

in any other way arising out of or related to this ARPA.

 

 

 

19.

 

Power of Attorney. For so long as any Obligations are owed under this ARPA or any Account remains outstanding, Purchaser is hereby irrevocably authorized as Seller’s Attorney-in-Fact, with full authority in the place of Seller and in the name of Seller or otherwise, in Purchaser’s discretion, to take any action and to execute any instrument which Purchaser may deem necessary or advisable to accomplish the purposes of this ARPA, including, without limitation:

 

 

 

 

19.1

Collection/Endorsement. Receive, take, endorse, assign, deliver, accept and deposit, in the name of Purchaser or Seller, proceeds of any Collateral, including, without limitation, taking all actions necessary to collect for deposit to Purchaser’s account, all checks, drafts and other forms of trade acceptances, negotiable instruments and other forms of payment (hereinafter collectively referred to as the “Payments”) which are tendered in payment of Accounts or in payment of insurance claims relating to the Accounts, or which are received by Purchaser. The authorization includes, without limitation, the power to open, cash, endorse, deposit and otherwise collect all such Payments in the event they are not made payable to Purchaser;

 

 
Page 23 of 30

 

 

 

19.2

Contact Account Debtors. To contact Account Debtors at any time in order to verify and/or collect Accounts and notify any Payor obligated with respect to an Account that the Account has been assigned to Purchaser and that payment thereof is to be made to Purchaser;

 

 

 

 

19.3

Insurance. To obtain and adjust insurance required to be paid to Purchaser;

 

 

 

 

19.4

With Regard to Accounts. To ask, demand, collect, sue for, recover, settle and compromise, extend the time of payment, compound, receive and give acquittance and receipts for moneys due and to become due under or in respect of any of the Accounts or release or discharge any Account Debtor or other obligor without affecting the Obligations;

 

 

 

 

19.5

Filings. To file, at Seller’s expense and in its name, any claims or take any action or institute any proceedings which Purchaser may deem necessary or desirable for the collection of any of the Accounts or any of the collateral securing payment of the Accounts or otherwise to enforce the rights of Purchaser with respect to the Accounts, including filing any claim under any bond or any trust fund.

 

 

 

 

19.6

Lien Discharge. To pay any sums necessary for the discharge of any lien or encumbrances senior to Purchaser’s security interest in any assets of the Seller, which sums shall be included as Obligations.

 

 

 

 

19.7

Filing Mechanic’s Lien and Bond Claims. File in the name of Seller or Purchaser or both:

 

 

(a)

Mechanics line or related notices; or

 

 

 

 

(b)

Claims under any payment bond, in connection with goods or services sold by Seller in connection with the improvement of realty.

 

 

 

 

 

19.8

Change of Mailing Address. After the occurrence of an Event of Default, change the address for delivery of mail to Purchaser and receive and open mail addressed to Seller.

 

 

 

This Power of Attorney is irrevocable and coupled with an interest. Seller hereby acknowledges that Seller is not entitled to any notice, demand or presentation with respect to payment of any Account and agrees that Purchaser may extend or renew or settle and compromise from time to time the payment of any Account without notice to or consent by Seller.

 

 

 

20.

Alternative Dispute Resolution. The alternative dispute resolution methods described in this Section 20 shall apply to any dispute between the parties arising under or related to this ARPA, other than a dispute arising out of an Event of Default by Seller.

 

 

 

 

20.1

Negotiation. In the event of a dispute to which this Section 20 applies, the parties shall first meet within two (2) Business Days of receipt of any request and, in good faith, shall seek to resolve the dispute through good faith negotiation. The parties shall continue such negotiations for a period of five (5) Business Days, or such longer period to which they may mutually agree, and neither party shall commence any legal action or other proceeding during such period, unless necessary to satisfy applicable legal deadlines or otherwise prevent irreparable harm.

 

 
Page 24 of 30

 

 

 

20.2

Arbitration. If the parties are unable to resolve the dispute through the negotiation process described in the preceding subsection, either party may, if it so chooses, submit the dispute to binding arbitration pursuant to this subsection; provided, however, that if an Event of Default has occurred and is continuing, Seller may not submit any dispute to arbitration, regardless of whether such dispute arises out of such Event of Default. Any arbitration pursuant to this subsection shall be conducted in accordance with the commercial arbitration rules of the American Arbitration Association (AAA), but only to the extent that such Rules do not conflict with the terms of this Agreement. Arbitration under this subsection shall take place in Austin, Texas, and shall be conducted by one impartial arbitrator selected by the AAA. The Arbitrator shall have the power (a) to gather such materials, information, testimony and evidence as it deems relevant to the dispute before it (and each party will provide such materials, information, testimony and evidence requested by the Arbitrator, except to the extent any information so requested is proprietary, subject to a third-party confidentiality restriction or to an attorney-client or other privilege) and (b) to grant injunctive relief and enforce specific performance. The decision of the Arbitrator (which shall be rendered in writing) shall be final, nonappealable and binding upon the parties and may be enforced in any court of competent jurisdiction. The prevailing party in such arbitration shall be awarded costs and expenses of the arbitration

 

 

 

 

20.3

Provisional Relief. Nothing contained in this Section 20 is intended to limit the right of any party to petition an appropriate court of competent jurisdiction for any temporary or preliminary relief, such as an injunction or garnishment, as such party may deem necessary to protect its interests. The filing for such relief shall not be considered a waiver of any right to arbitration under this section.

 

 

 

21.

Jurisdiction; Venue.

 

 

 

 

21.1

TRAVIS COUNTY. SUBJECT TO THE ARBITRATION PROVISIONS OF SECTION 20 OF THE ARPA, ANY LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS ARPA OR ANY OTHER TRANSACTION DOCUMENTS MUST BE BROUGHT IN THE COURTS OF THE STATE OF TEXAS OR OF THE UNITED STATES LOCATED IN TRAVIS COUNTY, TEXAS AND, BY EXECUTION AND DELIVERY OF THIS ARPA, SELLER HEREBY IRREVOCABLY ACCEPTS FOR ITSELF AND IN RESPECT OF SELLER’S PROPERTY, UNCONDITIONALLY, THE JURISDICTION OF THE AFORESAID COURTS WITH RESPECT TO ANY SUCH ACTION OR PROCEEDING. SELLER FURTHER IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS OUT OF ANY OF THE AFOREMENTIONED COURTS IN ANY SUCH ACTION OR PROCEEDING BY THE MAILING OF COPIES THEREOF BY REGISTERED OR CERTIFIED MAIL, POSTAGE PREPAID, TO SELLER PURSUANT TO SECTION 29, SUCH SERVICE TO BECOME EFFECTIVE FIVE (5) DAYS AFTER SUCH MAILING (OR SUCH LATER DATE AS MAY BE REQUIRED BY APPLICABLE LAW). NOTHING IN THIS ARPA SHALL AFFECT THE RIGHT OF PURCHASER TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR TO COMMENCE LEGAL PROCEEDINGS OR OTHERWISE PROCEED AGAINST SELLER IN ANY OTHER JURISDICTION.

 

 
Page 25 of 30

 

 

 

21.2

VENUE. SELLER HEREBY IRREVOCABLY WAIVES ANY OBJECTION WHICH SELLER MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY OF THE AFORESAID ACTIONS OR PROCEEDINGS ARISING OUT OF OR IN CONNECTION WITH THIS ARPA BROUGHT IN THE COURTS REFERRED TO IN THIS SECTION 21 AND HEREBY FURTHER IRREVOCABLY WAIVES AND AGREES NOT TO PLEAD OR CLAIM IN ANY SUCH ACTION THAT SUCH ACTION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

22.

Amendment. Neither this ARPA nor any provisions hereof may be changed, waived, discharged or terminated, nor may any consent to the departure from the terms hereof be given, other than by an instrument in writing signed by all parties to this ARPA. Any waiver or consent so given shall be effective only in the specific instance and for the specific purpose for which given.

 

 

23.

Conflict. Unless otherwise expressly stated in any other Transaction Document, if a conflict exists between the provisions of this ARPA and the provisions of such other Transaction Document, the provisions of this ARPA shall control.

 

 

24.

Severability. In the event any one or more of the provisions contained in this ARPA is held to be invalid, illegal or unenforceable in any respect, then such provision shall be ineffective only to the extent of such prohibition or invalidity, and the validity, legality, and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby.

 

 

25.

Enforcement. This ARPA and all agreements relating to the subject matter hereof shall be deemed to be the product of negotiation and preparation by and among each party and its respective attorneys, and shall be construed accordingly.

 

 

26.

Relationship of Parties. Notwithstanding that the Purchaser has the rights of a secured party, the relationship of the parties hereto shall not be that of lender and borrower. Purchaser shall at no time be deemed a fiduciary of the Seller, although Seller may be a fiduciary of the Purchaser.

 

 

27.

Choice of Law. This ARPA and all transactions contemplated hereunder and/or evidenced hereby shall be governed by, construed under, and enforced in accordance with the laws of the State of Texas, without regard to choice of law principals.

 

 

28.

Assignment. This ARPA may not be assigned by Seller without the express prior written consent of Purchaser. Purchaser may assign this ARPA, the Purchased Accounts, the Obligations, or any of Purchaser’s rights under this ARPA, in whole or in part, to any person, and such assignment shall be binding upon Seller without notice or consent.

 

 
Page 26 of 30

 

 

29.

Notice. Any notice or communication required or permitted hereunder shall be deemed to be delivered, whether actually received or not, when deposited in the United States mail, postage fully prepaid, registered or certified mail, and addressed to the intended recipient at the address on the signature page of this ARPA. Any address for notice may be changed by written notice delivered as provided herein.

 

 

30.

No Obligation to Purchase Future Receivables. Seller specifically acknowledges and agrees that, anything herein to the contrary notwithstanding, Purchaser has the right to approve or reject any or all future accounts receivable proposed for sale under this ARPA IN ITS SOLE DISCRETION, and no course of conduct or prior course of dealing shall establish any commitment, obligation or agreement to purchase future accounts receivable.

 

 

31.

Usury Savings Clause. In the event that this ARPA is characterized as a contract for the use, forbearance, or detention of money (which characterization would be contrary to the parties’ specific intent as expressed throughout this Agreement), the aggregate interest rate charged or agreed to be paid hereunder, including all charges or fees deemed in the nature of interest under applicable law, shall not exceed the highest rate permitted by applicable law. In the event the Purchaser collects moneys deemed to constitute interest, and which would increase the effective rate of interest to a rate in excess of that permitted by law, all such honeys shall upon such determination and at Purchaser’s election be returned to Seller or credited against outstanding Obligations hereunder.

 

 

32.

Headings, Construction. The headings contained in this ARPA are for reference purposes only and shall not modify or affect the terms of this ARPA in any manner.

 

 

33.

Saturday, Sunday or Legal Holiday. If any day provided in this ARPA for the performance of any obligation should fall on a Saturday, Sunday or Legal Holiday, the compliance with such obligation or delivery shall be deemed acceptable on the next Business Day following such day.

 

 

34.

Receipt of Payment. Any payment received by Purchaser on a Saturday, Sunday or Legal Holiday, or any payment that is received by Purchaser after 3:00 p.m. on any other day, shall be deemed received on the next day that is not a Saturday, Sunday or Legal Holiday, plus Clearance Days.

 

 

35.

Use of Facsimiles/Scans/Electronic Signatures. The parties acknowledge and agree that it is anticipated that execution of this ARPA, as well as schedules or other documents executed in connection herewith, may be evidenced by electronic signatures, and/or facsimile or scanned signatures, and such documents containing such signatures shall be of the same force and effect as if original signatures had been obtained.

 

 

36.

Headings. The headings and captions given to the provisions of this ARPA are provided for convenience of reference only, and do not modify or limit the scope of such provisions in any way.

 

 
Page 27 of 30

 

 

37.

Counterparts. This ARPA may be signed in any number of counterparts, each of which shall be an original, with the same effect as if all signatures were upon the same instrument. Delivery of an executed counterpart of the signature page to this ARPA by facsimile shall be effective as delivery of a manually executed counterpart of this ARPA, and any party delivering such an executed counterpart of the signature page to this ARPA by facsimile to any other party shall thereafter also promptly deliver a manually executed counterpart of this ARPA to such other party, provided that the failure to deliver such manually executed counterpart shall not affect the validity, enforceability, or binding effect of this ARPA.

 

 

38.

Entire Agreement. This ARPA, together with the other Transaction Documents executed on or after the date of this ARPA, contains the entire understanding and agreement between the parties, and supersedes all other prior or contemporaneous agreements and understandings between the parties, verbal or written, express or implied, relating to the subject matter hereof. No promises, warranties, representations, or understandings of any kind have been made by Purchaser or any third party that are not contained in this ARPA. No course of dealing, course of performance or trade usage, and no parol evidence of any nature, shall be allowable in order to supplement or modify any terms of this ARPA.

 

IN WITNESS WHEREOF, the Parties have executed this ARPA as of the day and year first above written.

 

PURCHASER:

 

 

SELLER:

 

 

 

QUASAR CAPITAL PARTNERS, LLC

EDIBLE GARDEN AG INCORPORATED

 

 

 

By:

/s/ Brian Center

 

By:

/s/ Michael C. James

Name:

Brian Center

 

Name:

Michael C. James

Title:

Chief Executive Officer

 

Title:

Chief Financial Officer

 

 

 

 

 

Address:

9330 LBJ Frwy.

 

Address:

283 County Road 519

 

Suite 943B

 

 

Belvidere, NJ 07823

 

Dallas, TX 75243

 

 

 

 

 

 

 

 

Date:

April 13, 2021

 

Date:

April 13, 2021

 

 
Page 28 of 30

 

 

EXHIBIT A

 

ACH POWER OF ATTORNEY RIDER
TO ACCOUNTS RECEIVABLE PURCHASING AGREEMENT

 

The undersigned, _______________________, as _______________ of Edible Garden AG Incorporated (Grantor) hereby appoints and irrevocably authorizes QUASAR CAPITAL PARTNERS, LLC as Grantor’s attorney-in-fact, with full and absolute authority in the place of Grantor and in the name of Grantor or otherwise, to initiate electric debit or credit entries from any deposit account maintained, held or owned by Grantor, wherever located, through the Automated Clearing House network (ACH).

 

This Power of Attorney is irrevocable and coupled with an interest.

 

 

Grantor:

 

 

 

 

 

Edible Garden AG Incorporated

 

 

 

 

 

By:

 

 

 

Name:

 

 

 

Title:

 

 

Address:

 

 

 
Page 29 of 30

 

 

EXHIBIT B

 

GENERAL RELEASE

 

FOR GOOD AND VALUABLE CONSIDERATION, the receipt and adequacy of which are hereby acknowledged, the undersigned and each of them (collectively, the “Releasors”) hereby forever release, discharge and acquit Quasar Capital Partners, LLC, its successors and assigns, parent companies, subsidiaries, officers, directors, shareholders, agents and employees (collectively, the “Releasees”), of and from any and all claims of every type, kind, nature, description or character, and irrespective of how, why, or by reason of what facts, whether heretofore existing, now existing or hereafter arising, or which could, might, or may be claimed to exist, of whatever kind or name, whether known or unknown, suspected or unsuspected, liquidated or unliquidated, each as though fully set forth herein at length, to the extent that they arise out of or are in way connected to or are related to that certain Accounts Receivable Purchase Agreement dated ____________________ (collectively, the “Claims”).

 

Releasors agree that the matters released herein are not limited to matters which are known or disclosed.

 

Releasors acknowledge that factual matters now unknown to it may have given or may hereafter give rise to Claims which are presently unknown, unanticipated and unsuspected, and it acknowledges that this Release has been negotiated and agreed upon in light of that realization and that it nevertheless hereby intends to release, discharge and acquit the Releasees from any such unknown Claims.

 

Acceptance of this Release shall not be deemed or construed as an admission of liability by any party released.

 

In the event of any litigation arising out of or related to this Release, the prevailing party shall recover its reasonable attorney’s fees and expenses from the unsuccessful party. It shall be presumed (subject to rebuttal only by the introduction of competent evidence to the contrary) that the amount recoverable is the amount billed to the prevailing party by its counsel and that such amount will be reasonable if based on the billing rates charged to the prevailing party by its counsel in similar matters.

 

Releasors acknowledge that either (a) they have had advice of counsel of its own choosing in negotiations for and the preparation of this release, or (b) they have knowingly determined that such advice is not needed.

 

DATED:

 

 

 

 

 

Seller:

 

 

 

 

 

Guarantor(s):

 

 

 

 

 
Page 30 of 30

 

EXHIBIT 10.12

  

SECURITY AGREEMENT

 

This Security Agreement (“Agreement”) is made as of the 30th day of March, 2021, by Edible Garden AG Incorporated, a Wyoming corporation, with its principal office at 283 County Rd 519 Belvidere, NJ 07823 (the “Debtor”), and Quasar Capital Partners, LLC, with its principal office at 9330 LBJ Frwy. Suite 943B, Dallas, Texas 75243 (including any successors and assigns, the “Secured Party”).

 

Recitals

 

A. Secured Party and Debtor have entered into an Accounts Receivable Purchasing Agreement (the “ARPA”) of substantially even date herewith (the “ARPA”). Capitalized terms used but not otherwise defined herein have the meanings given to them in the ARPA.

 

B. The ARPA contemplates that Debtor will sell and assign to Secured Party as absolute owner, with full recourse, certain accounts receivable that are defined in the ARPA as the “Purchased Accounts.” This Security Agreement is delivered by Debtor to secure the Debtor’s Obligations arising under the ARPA; provided, however, that the Purchased Accounts are the sole property of the Secured Party, and as such, shall not constitute Collateral hereunder until such time (if any) as they are repurchased by Debtor pursuant to the ARPA.

 

NOW THEREFORE, in consideration and furtherance of the foregoing, the Debtors hereby agree as follows:

 

1. Definitions. As used in this Agreement, the following terms shall have the meanings indicated below:

 

(a) The term “Obligor” shall mean Debtor.

 

(b) The term “Code” shall mean the Uniform Commercial Code as in effect in the State of Texas (or, if this Agreement is governed by the law of another state, such other state) on the date of this Agreement, or as it may hereafter be amended from time to time.

 

(c) The term “Collateral” shall mean all of the personal property of Debtor as set forth below (as indicated), wherever located, and now owned or hereafter acquired:

 

(i) All “accounts”, as defined in the Code (including health-care-insurance receivables), together with any and all books of account, customer lists and other records relating in any way to the foregoing (including, without limitation, computer software, whether on tape, disk, card, strip, cartridge or any other form), and in any case where an account arises from the sale of goods, the interest of Debtor in such goods.

 

(ii) All “inventory” as defined in the Code, and all records relating in any way to the foregoing (including, without limitation, any computer software, whether on tape, disk, card, strip, cartridge or any other form).

 

(iii) All “chattel paper” as defined in the Code, and all records relating in any way to the foregoing (including, without limitation, any computer software, whether on tape, disk, card, strip, cartridge or any other form).

  

Quasar Capital | Security Agreement

 

Page 1 of 18

 
 

 

 

(iv) All “instruments” as defined in the Code (including promissory notes), and all records relating in any way to the foregoing (including, without limitation, any computer software, whether on tape, disk, card, strip, cartridge or any other form).

 

(v) All “letter of credit rights” as defined in the Code, and all records relating in any way to the foregoing (including, without limitation, any computer software, whether on tape, disk, card, strip, cartridge or any other form).

 

(vi) All “payment intangibles” as defined in the Code, and all records relating in any way to the foregoing, including all contract rights or rights to the payment of money, insurance claims and proceeds, and any statutory lien rights of Debtor with respect to work or services furnished by Debtor under any Account, including Debtor’s statutory rights under the mechanic lien laws of any applicable state;

 

(vii) All “commercial tort claims” as defined in the Code, and all records relating in any way to the foregoing;

 

(viii) All “supporting obligations” as defined in the Code, and all records relating in any way to the foregoing (including, without limitation, any computer software, whether on tape, disk, card, strip, cartridge or any other form); and

 

(ix) Property held by Secured Party on behalf of Debtor, including, without limitation, funds held in the Reserve Account (as defined in the ARPA).

 

The term Collateral, as used herein, shall also include all products and proceeds of all of the foregoing (including without limitation, insurance payable by reason of loss or damage to the foregoing property) and any property, securities, guaranties or monies of Debtor which may at any time come into the possession of Secured Party. The designation of proceeds does not authorize Debtor to sell, transfer or otherwise convey any of the foregoing property except finished goods intended for sale in the ordinary course of Debtor’s business or as otherwise provided herein.

 

(d) The term “Indebtedness” shall mean and refer to the Obligations, as such term is defined in the ARPA, including all renewals, extensions, modifications and rearrangements thereof.

 

(e) The term “Transaction Documents” shall have the meaning ascribed to it in the ARPA.

 

(f) The term “Obligated Party” shall mean any party other than Obligor, including, without limitation, Debtor and any guarantor, who secures, guarantees and/or is otherwise obligated to pay all or any portion of the Indebtedness.

 

(g) The term “Permitted Liens” shall mean and include all of the following: (i) liens of ad valorem taxing authorities upon the Collateral for indebtedness that is not yet due and payable; (ii) additional security interests and liens which are subordinate to the security interest of Secured Party and are consented to in writing by Secured Party, which consent may be withheld in its good faith business judgment; and (iii) security interests being terminated substantially concurrently with the execution of this Agreement.

 

Quasar Capital | Security Agreement

 

Page 2 of 18

 
 

 

 

All words and phrases used herein which are expressly defined in Section 1.201 or Chapter 9 of the Code shall have the meaning provided for therein. Other words and phrases defined elsewhere in the Code shall have the meaning specified therein except to the extent such meaning is inconsistent with a definition in Section 1.201 or Chapter 9 of the Code.

 

2. Security Interest. Debtor grants to Secured Party, to secure the payment and performance in full of all of the Indebtedness, a security interest in and to and pledges and assigns to Secured Party the Collateral.

 

3. Representations and Warranties. In addition to any representations and warranties of Debtor set forth in the Transaction Documents, which are incorporated herein by this reference, Debtor hereby represents and warrants the following to Secured Party:

 

(a) Authority. The execution, delivery and performance of this Agreement and all of the other Transaction Documents by Debtor have been duly authorized by all necessary corporate action of Debtor, to the extent Debtor is a corporation, by all necessary partnership action, to the extent Debtor is a partnership, or by all necessary limited liability company action, to the extent Debtor is a limited liability company.

 

(b) Accuracy of Information. All information heretofore, herein or hereafter supplied to Secured Party by or on behalf of Debtor with respect to the Collateral is true and correct. The exact legal name, social security number (if applicable), tax identification number, employee identification number and organization number of Debtor is correctly shown in the first paragraph hereof.

 

(c) Enforceability. This Agreement and the other Transaction Documents constitute legal, valid and binding obligations of Debtor, enforceable in accordance with their respective terms, except as limited by bankruptcy, insolvency or similar laws of general application relating to the enforcement of creditors’ rights and except to the extent specific remedies may generally be limited by equitable principles.

 

(d) Ownership and Liens. Debtor has good and marketable title to the Collateral free and clear of all liens, security interests, encumbrances or adverse claims, except for the Permitted Liens. No dispute, right of setoff, counterclaim or defense exists with respect to Debtor’s ownership of all or any material part of the Collateral. Debtor has not executed any other security agreement currently affecting the Collateral and no effective financing statement or other instrument similar in effect covering all or any part of the Collateral is on file in any recording office except (i) as may have been executed or filed in favor of Secured Party; (ii) financing statements or instruments relating to the Permitted Liens.

 

(e) No Conflicts or Consents. Neither the ownership, the intended use of the Collateral by Debtor, the grant of the security interest by Debtor to Secured Party herein nor the exercise by Secured Party of its rights or remedies hereunder, will (i) conflict with any provision of (A) any domestic or foreign law, statute, rule or regulation, (B) the articles or certificate of incorporation, charter, bylaws, partnership agreement, articles or certificate of organization, or regulations as the case may be, of Debtor, or (C) any agreement, judgment, license, order or permit applicable to or binding upon Debtor, or (ii) result in or require the creation of any lien, charge or encumbrance upon any assets or properties of Debtor or of any person except as may be expressly contemplated in the Transaction Documents. Except as expressly contemplated in the Transaction Documents, no consent, approval, authorization or order of, and no notice to or filing with, any court, governmental authority or third party is required in connection with the grant by Debtor of the security interest herein or the exercise by Secured Party of its rights and remedies hereunder.

 

Quasar Capital | Security Agreement

 

Page 3 of 18

 
 

 

  

(f) Security Interest. Debtor has and will have at all times full right, power and authority to grant a security interest in the Collateral to Secured Party in the manner provided herein, free and clear of any lien, security interest or other charge or encumbrance. This Agreement creates a legal, valid and binding security interest in favor of Secured Party in the Collateral securing the Indebtedness. To the extent permitted in the Code, possession by Secured Party of all certificates, instruments and cash constituting Collateral from time to time and/or the filing of the financing statements delivered prior hereto and/or concurrently herewith by Debtor to Secured Party will perfect and establish the first priority (except with respect to the Permitted Liens) of Secured Party’s security interest hereunder in the Collateral.

 

(g) Location/Identity. Debtor’s principal residence or place of business and chief executive office (as those terms are used in the Code), as the case may be is located at the address set forth on the first page hereof. Except as specified elsewhere herein, all Collateral and records concerning the Collateral shall be kept at such address or the addresses set forth on Exhibit A. Debtor’s organizational structure and state of organization (the “Organizational Information”) are as set forth on the first page hereof. Except as specified herein, the Organizational Information shall not change without at least thirty (30) days’ advance written notice to the Secured Party.

 

4. Affirmative Covenants. In addition to all covenants and agreements of Debtor set forth in the Transaction Documents, which are incorporated herein by this reference, Debtor will comply with the covenants contained in this Section 4 at all times during the period of time this Agreement is effective unless Secured Party shall otherwise consent in writing.

 

(a) Ownership and Liens. Debtor will maintain good and marketable title to all Collateral free and clear of all liens, security interests, encumbrances or adverse claims, except for the Permitted Liens and the security interest created by this Agreement and the security interests and other encumbrances expressly permitted herein or by the other Transaction Documents. Debtor will not permit any dispute, right of setoff, counterclaim or defense to exist with respect to all or any part of the Collateral. Debtor will cause any financing statement or other security instrument with respect to the Collateral to be terminated, except with respect to the Permitted Liens or as may exist or as may have been filed in favor of Secured Party. Debtor will defend at its expense Secured Party’s right, title and security interest in and to the Collateral against the claims of any third party.

 

(b) Further Assurances. Debtor will from time to time at its expense promptly execute and deliver all further instruments and documents and take all further action necessary -or appropriate or that Secured Party may request in order (i) to perfect and protect the security interest created or purported to be created hereby and the first priority of such security interest, (ii) to enable Secured Party to exercise and enforce its rights and remedies hereunder in respect of the Collateral, and (iii) to otherwise effect the purposes of this Agreement, including without limitation: (A) executing (if requested) and filing such financing or continuation statements, or amendments thereto; and (B) furnishing to Secured Party from time to time statements and schedules further identifying and describing the Collateral and such other reports in connection with the Collateral, all in reasonable detail satisfactory to Secured Party.

 

Quasar Capital | Security Agreement

 

Page 4 of 18

 
 

 

  

(c) Inspection of Collateral. Debtor will keep adequate records concerning the Collateral and will permit Secured Party and all representatives and agents appointed by Secured Party to inspect any of the Collateral and the books and records of or relating to the Collateral at any time during normal business hours, to make and take away photocopies, photographs and printouts thereof and to write down and record any such information.

 

(d) Payment of Taxes. Debtor (i) will timely pay all property and other taxes, assessments and governmental charges or levies imposed upon the Collateral or any part thereof, (ii) will timely pay all lawful claims which, if unpaid, might become a lien or charge upon the Collateral or any part thereof, and (iii) will maintain appropriate accruals and reserves for all such liabilities in a timely fashion in accordance with generally accepted accounting principles. Debtor may, however, delay paying or discharging any such taxes, assessments, charges, claims or liabilities so long as the validity thereof is contested in good faith by proper proceedings and provided Debtor has set aside on Debtor’s books adequate reserves therefor; provided, however, Debtor understands and agrees that in the event of any such delay in payment or discharge and upon Secured Party’s written request, Debtor will establish with Secured Party an escrow acceptable to Secured Party adequate to cover the payment of such taxes, assessments and governmental charges with interest, costs and penalties and a reasonable additional sum to cover possible costs, interest and penalties (which escrow shall be returned to Debtor upon payment of such taxes, assessments, governmental charges, interests, costs and penalties or disbursed in accordance with the resolution of the contest to the claimant) or furnish Secured Party with an indemnity bond secured by a deposit in cash or other security acceptable to Secured Party. Notwithstanding any other provision contained in this Subsection, Secured Party may at its discretion exercise its rights under Subsection 6(c) at any time to pay such taxes, assessments, governmental charges, interest, costs and penalties.

 

(e) Mortgagee’s and Landlord’s Waivers. Debtor shall use reasonable efforts to cause each mortgagee of real property owned by Debtor and each landlord of real property leased by Debtor to execute and deliver agreements satisfactory in form and substance to Secured Party by which such mortgagee or landlord waives or subordinates any rights it may have in the Collateral.

 

(f) Control Agreements. Debtor will cooperate with Secured Party in obtaining a control agreement in form and substance satisfactory to Secured Party with respect to Collateral consisting of:

 

(i) Letter-of-credit rights; and

 

(ii) Electronic chattel paper.

 

(g) Condition of Goods. Debtor will maintain, preserve, protect and keep all Collateral which constitutes goods in good condition, repair and working order and will cause such Collateral to be used and operated in good and workmanlike manner, in accordance with applicable laws and in a manner which will not make void or cancelable any insurance with respect to such Collateral. Debtor will promptly make or cause to be made all repairs, replacements and other improvements to or in connection with the Collateral which Secured Party may request from time to time.

  

Quasar Capital | Security Agreement

 

Page 5 of 18

 
 

 

 

(h) Insurance. Debtor will, at its own expense, maintain insurance with respect to all Collateral which constitutes goods in such amounts, against such risks, in such form and with such insurers, as shall be reasonably satisfactory to Secured Party from time to time. If requested by Secured Party, each policy for property damage insurance shall provide for all losses to be paid directly to Secured Party. If requested by Secured Party, each policy of insurance maintained by Debtor shall (i) name Debtor and Secured Party as insured parties thereunder (without any representation or warranty by or obligation upon Secured Party) as their interests may appear, (ii) contain the agreement by the insurer that any loss thereunder shall be payable to Secured Party notwithstanding any action, inaction or breach of representation or warranty by Debtor, (iii) provide that there shall be no recourse against Secured Party for payment of premiums or other amounts with respect thereto, and (iv) provide that at least thirty (30) days prior written notice of cancellation or of lapse shall be given to Secured Party by the insurer. Debtor will, if requested by Secured Party, deliver to Secured Party original or duplicate policies of such insurance and, as often as Secured Party may reasonably request, a report of a reputable insurance broker with respect to such insurance. Debtor will also, at the request of Secured Party, duly execute and deliver instruments of assignment of such insurance policies and cause the respective insurers to acknowledge notice of such assignment. All insurance payments in respect of loss of or damage to any Collateral shall be paid to Secured Party and applied as Secured Party in its sole discretion deems appropriate.

 

(i) Chattel Paper, Documents and Instruments. Debtor will take such action as may be requested by Secured Party in order to cause any chattel paper, documents or instruments to be valid and enforceable and will cause all chattel paper to have only one original counterpart. Upon request by Secured Party, Debtor will deliver to Secured Party all originals of chattel paper, documents or instruments and will mark all chattel paper with a legend indicating that such chattel paper is subject to the security interest granted hereunder.

 

(j) Accounts. Debtor’s affirmative duties with respect to the handling of Accounts, including both Purchased Accounts and Accounts constituting Collateral, are set forth in the ARPA, which is incorporated herein by reference, as supplemented by any relevant terms contained herein.

 

5. Negative Covenants. Debtor will comply with the covenants contained in this Section 5 at all times during the period of time this Agreement is effective, unless Secured Party shall otherwise consent in writing.

 

(a) Transfer or Encumbrance. Debtor will not (i) sell, assign (by operation of law or otherwise), transfer, exchange, lease or otherwise dispose of any of the Collateral, other than in the ordinary course of business, with the prior written consent of Secured Party, not to be unreasonably withheld or delayed, (ii) grant a lien or security interest in or execute, authorize, file or record any financing statement or other security instrument with respect to the Collateral to any party other than Secured Party, or (iii) deliver actual or constructive possession of any of the Collateral to any party other than Secured Party.

 

Quasar Capital | Security Agreement

 

Page 6 of 18

 
 

 

 

(b) Impairment of Security Interest. Debtor will not take or fail to take any action which would in any manner impair the value or enforceability of Secured Party’s security interest in any Collateral.

 

(c) Possession of Collateral. Debtor will not cause or permit the removal of any Collateral from its possession, control and risk of loss, nor will Debtor cause or permit the removal of any Collateral (or records concerning the Collateral) from the address on the first page hereof other than (i) as permitted by Subsection 5(a), or (ii) in connection with the possession of any Collateral by Secured Party or by its bailee. If any Collateral is in the possession of a third party, Debtor will join with Secured Party in notifying the third party of Secured Party’s security interest therein and obtaining an acknowledgment from the third party that it is holding the Collateral for the benefit of Secured Party.

 

(d) Goods. Debtor will not permit any Collateral which constitutes goods to at any time (i) be covered by any document except documents in the possession of the Secured Party, (ii) become so related to, attached to or used in connection with any particular real property so as to become a fixture upon such real property (unless such real property, or Debtor’s interest therein, also constitutes Collateral), or (iii) be installed in or affixed to other goods so as to become an accession to such other goods unless such other goods are subject to a perfected first priority (except with respect to the Permitted Liens) security interest under this Agreement.

 

(e) Compromise of Collateral. Debtor will not adjust, settle, compromise, amend or modify any Collateral, except an adjustment, settlement, compromise, amendment or modification in good faith and in the ordinary course of business; provided, however, this exception shall automatically terminate upon the occurrence of an Event of Default or upon Secured Party’s written request. Debtor shall provide to Secured Party such information concerning (i) any adjustment, settlement, compromise, amendment or modification of any Collateral, and (ii) any claim asserted by any account debtor for credit, allowance, adjustment, dispute, setoff or counterclaim, as Secured Party may request from time to time.

 

(f) Financing Statement Filings. Debtor recognizes that financing statements pertaining to the Collateral have been or may be filed in one or more of the following jurisdictions: the location of Debtor’s principal residence, the location of Debtor’s place of business, the location of Debtor’s chief executive office, or other such place as the Debtor may be “located” under the provisions of the Code; where Debtor maintains any Collateral, or has its records concerning any Collateral, as the case may be. Without limitation of any other covenant herein, Debtor will neither cause nor permit any change in the location of (i) any Collateral, (ii) any records concerning any Collateral, or (iii) Debtor’s principal residence, the location of Debtor’s place of business, or the location of Debtor’s chief executive office, as the case may be, to a jurisdiction other than as represented to Secured Party herein, nor will Debtor change its name or Organizational Information unless Debtor shall have notified Secured Party in writing of such change at least thirty (30) days prior to the effective date of such change, and shall have first taken all action required by Secured Party for the purpose of further perfecting or protecting the security interest in favor of Secured Party in the Collateral. In any written notice furnished pursuant to this Subsection, Debtor will expressly state that the notice is required by this Agreement and contains facts that may require additional filings of financing statements or other notices for the purpose of continuing perfection of Secured Party’s security interest in the Collateral.

 

Quasar Capital | Security Agreement

 

Page 7 of 18

 
 

 

  

Without limiting Secured Party’s rights hereunder, Debtor authorizes Secured Party to file financing statements and amendments thereto under the provisions of the Code as amended from time to time.

 

(g) Marking of Chattel Paper. Debtor will not create any Chattel Paper without placing a legend on the Chattel Paper acceptable to Secured Party indicating that Secured Party has a security interest in the Chattel Paper.

 

6. Rights of Secured Party. Secured Party shall have the rights contained in this Section 6 at all times during the period of time this Agreement is effective.

 

(a) Financing Statements Filings. Debtor hereby authorizes Secured Party to file, without the signature of Debtor, one or more financing or continuation statements, and amendments thereto, relating to the Collateral. Debtor further agrees that a carbon, photographic or other reproduction of this Security Agreement or any financing statement describing any Collateral is sufficient as a financing statement and may be filed in any jurisdiction Secured Party may deem appropriate. Such financing statements may, among other things:

 

 

(i)

indicate the Collateral as “all assets” of the Debtor or words of similar effect, regardless of whether any particular asset comprised in the Collateral falls within the scope of Article 9 of the UCC, or as being of an equal or lesser scope or with greater detail;

 

 

 

 

(ii)

contain any other information required by part 5 of Article 9 of the UCC for the sufficiency or filing office acceptance of any financing statement or amendment, including (i) whether the Debtor is an organization, the type of organization, the state of organization and any organization identification number issued to the Debtor; and

 

 

 

 

(iii)

contain a notification that the Debtor has granted a negative pledge to the Secured Party, and that any subsequent lien or may be tortiously interfering with Secured Party’s rights;

 

 

 

 

(iv)

advises third parties that any contact with Debtor’s Account Debtors may be tortiously interfering with Secured Party’s collection rights.

 

(b) Power of Attorney. Debtor hereby irrevocably appoints Secured Party as Debtor’s attorney-in-fact, such power of attorney being coupled with an interest, with full authority in the place and stead of Debtor and in the name of Debtor or otherwise, to take any action and to execute any instrument which Secured Party may deem necessary or appropriate to accomplish the purposes of this Agreement, including without limitation: (i) to obtain and adjust insurance required by Secured Party hereunder; (ii) to demand, collect, sue for, recover, compound, receive and give acquittance and receipts for moneys due and to become due under or in respect of the Collateral; (iii) to receive, endorse and collect any checks, drafts or other instruments, documents and chattel paper in connection with clause (i) or (ii) above; and (iv) to file any claims or take any action or institute any proceedings which Secured Party may deem necessary or appropriate for the collection arid/or preservation of the Collateral or otherwise to enforce the rights of Secured Party with respect to the Collateral.

   

Quasar Capital | Security Agreement

 

Page 8 of 18

 
 

 

 

(c) Performance by Secured Party. If Debtor fails to perform any agreement or obligation provided herein, Secured Party may itself perform, or cause performance of, such agreement or obligation, and the expenses of Secured Party incurred in connection therewith shall be a part of the Indebtedness, secured by the Collateral and payable by Debtor on demand.

 

(d) Debtor’s Receipt of Proceeds. All amounts and proceeds (including instruments and writings) received by Debtor in respect of such accounts or general intangibles shall be received in trust for the benefit of Secured Party hereunder and shall be delivered to Secured Party in the time and manner provided in the ARPA.

 

(e) Notification of Account Debtors. Secured Party may at its discretion from time to time notify any or all obligors under any accounts or general intangibles (i) of Secured Party’s security interest in such accounts or general intangibles and direct such obligors to make payment of all amounts due or to become due to Debtor thereunder directly to Secured Party, and (ii) to verify the accounts or general intangibles with such obligors. Secured Party shall have the right, at the expense of Debtor, to enforce collection of any such accounts or general intangibles and to adjust, settle or compromise the amount or payment thereof, in the same manner and to the same extent as Debtor. DEBTOR WAIVES, IN ADVANCE, ANY RIGHTS AND CLAIMS WHICH IT MAY HEREAFTER HAVE, OR HEREAFTER CLAIM TO HAVE, BASED IN ANY WAY UPON SUCH CONTACTS WITH AND/OR NOTIFICATIONS TO SUCH ACCOUNT DEBTORS, INCLUDING BUT NOT LIMITED TO CLAIMS FOR DISPARAGEMENT, INTERFERENCE WITH BUSINESS RELATIONSHIPS, OR ANY OTHER FORM OF DAMAGE TO THE DEBTOR OR ITS BUSINESS.

 

(f) Authorization to Deposit. Debtor authorizes Secured Party to accept, indorse and deposit on behalf of Debtor any checks tendered by an Account Debtor “in full payment” of its obligation to Debtor. Debtor shall not assert against Secured Party any claim arising therefrom, irrespective of whether such action by Secured Party effects an accord and satisfaction of Debtor’s claims, under §3-311 of the UCC, or otherwise.

 

(g) Offset Rights. The Secured Party shall have the right to offset from amounts received by Secured Party any amounts that the Secured Party believes that the Debtor owes the Secured Party. However, as to any Account proceeds that do not represent Purchased Accounts, and so long as Debtor is not in default, Secured Party shall be deemed to have received any such proceeds of Accounts as a pure pass-through for and on account of Debtor.

 

7. Events of Default. Each of the following constitutes an “Event of Default” under this Agreement:

 

(a) Default under ARPA. Any Event of Default as such term is defined in the ARPA; or

 

(b) Non-Performance of Covenants. The failure of Obligor or any Obligated Party to timely and properly observe, keep or perform any covenant, agreement, warranty or condition required herein; provided, however, that the Obligor’s failure to observe any of the affirmative covenants set forth in Section 4 will not constitute an Event of Default unless and until Secured Party has notified Obligor of such failure, and Obligor has failed to take the required action within fifteen (15) business days from the date of such notice; or

 

Quasar Capital | Security Agreement

 

Page 9 of 18

 
 

 

 

(c) Default Under other Transaction Documents. The occurrence of a default or default under any of the other Transaction Documents; or

 

(d) False Representation. Any representation contained herein or in any of the other Transaction Documents made by Obligor or any Obligated Party is false or misleading in any material respect; or

 

(e) Default to Third Party. The occurrence of any event which permits the acceleration of the maturity of any indebtedness owing by Obligor or any Obligated Party to any third party under any agreement or undertaking; or

 

(f) Execution on Collateral. The Collateral or any portion thereof is taken on execution or other process of law in any action against Debtor; or

 

(g) Abandonment. Debtor abandons the Collateral or any portion thereof; or

 

(h) Action by Other Lienholder. The holder of any lien or security interest on any of the assets of Debtor, including without limitation, the Collateral (without hereby implying the consent of Secured Party to the existence or creation of any such lien or security interest on the Collateral), declares a default thereunder or institutes foreclosure or other proceedings for the enforcement of its remedies thereunder; or

 

(i) Liquidation, Death and Related Events. If Obligor or any Obligated Party is an entity, the liquidation, dissolution, merger or consolidation of any such entity or, if Obligor or any Obligated Party is an individual, the death or legal incapacity of any such individual; or

 

(j) Insecurity. It shall appear at any time, after a reasonable investigation, that Secured Party’s security interest is not prior to all other security interests against the Collateral (other than Permitted Liens).

 

8. Remedies and Related Rights. If an Event of Default shall have occurred, and without limiting any other rights and remedies provided herein, under any of the other Transaction Documents or otherwise available to Secured Party, Secured Party may exercise one or more of the rights and remedies provided in this Section.

 

(a) Remedies. Secured Party may from time to time at its discretion, without limitation and without notice except as expressly provided in any of the Transaction Documents:

 

(i) exercise in respect of the Collateral all the rights and remedies of a secured party under the Code (whether or not the Code applies to the affected Collateral), including without limitation, under UCC section 9-607(a), which allows the secured party, upon default, to notify an account debtor or other person obligated on collateral to make payment or otherwise render performance to or for the benefit of the secured party;

 

(ii) require Debtor to, and Debtor hereby agrees that it will at its expense and upon request of Secured Party, assemble the Collateral as directed by Secured Party and make it available to Secured Party at a place to be designated by Secured Party which is reasonably convenient to both parties;

 

Quasar Capital | Security Agreement

 

Page 10 of 18

 
 

 

 

(iii) reduce its claim to judgment or foreclose or otherwise enforce, in whole or in part, the security interest granted hereunder by any available judicial procedure;

 

(iv) sell or otherwise dispose of, at its office, on the premises of Debtor or elsewhere, the Collateral, as a unit or in parcels, by public or private proceedings, and by way of one or more contracts (it being agreed that the sale or other disposition of any part of the Collateral shall not exhaust Secured Party’s power of sale, but sales or other dispositions may be made from time to time until all of the Collateral has been sold or disposed of or until the Indebtedness has been paid and performed in full), and at any such sale or other disposition it shall not be necessary to exhibit any of the Collateral;

 

(v) buy the Collateral, or any portion thereof, at any public sale;

 

(vi) buy the Collateral, or any portion thereof, at any private sale if the Collateral is of a type customarily sold in a recognized market or is of a type which is the subject of widely distributed standard price quotations;

 

(vii) apply for the appointment of a receiver for the Collateral, and Debtor hereby consents to any such appointment; and

 

(viii) at its option, retain the Collateral in satisfaction of the Indebtedness whenever the circumstances are such that Secured Party is entitled to do so under the Code or otherwise, to the full extent permitted by the Code, Secured Party shall be permitted to elect whether such retention shall be in full or partial satisfaction of the Indebtedness.

 

In the event Secured Party shall elect to sell the Collateral, Secured Party may sell the Collateral without giving any warranties as and shall be permitted to specifically disclaim any warranties of title or the like. Further, if Secured Party sells any of the Collateral on credit, Debtor will be credited only with payments actually made by the purchaser, received by Secured Party and applied to the Indebtedness. In the event the purchaser fails to pay for the Collateral, Secured Party may resell the Collateral and Debtor shall be credited with the proceeds of the sale. Debtor agrees that in the event Debtor or any Obligor is entitled to receive any notice under the Code, as it exists in the state governing any such notice, of the sale or other disposition of any Collateral, reasonable notice shall be deemed given when such notice is deposited in a depository receptacle under the care and custody of the United States Postal Service, postage prepaid, at such party’s address set forth on the first page hereof, ten (10) days prior to the date of any public sale, or after which a private sale, of any of such Collateral is to be held. Secured Party shall not be obligated to make any sale of Collateral regardless of notice of sale having been given. Secured Party may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned.

 

(b) Application of Proceeds. If any Event of Default shall have occurred, Secured Party may at its discretion apply or use any cash held by Secured Party as Collateral, and any cash proceeds received by Secured Party in respect of any sale or other disposition of, collection from, or other realization upon, all or any part of the Collateral as follows in such order and manner as Secured Party may elect:

 

Quasar Capital | Security Agreement

 

Page 11 of 18

 
 

 

 

(i) to the repayment or reimbursement of the reasonable costs and expenses (including, without limitation, reasonable attorneys’ fees and expenses) incurred by Secured Party in connection with (A) the administration of the Transaction Documents, (B) the custody, preservation, use or operation of, or the sale of, collection from, or other realization upon, the Collateral, and (C) the exercise or enforcement of any of the rights and remedies of Secured Party hereunder;

 

(ii) to the payment or other satisfaction of any liens and other encumbrances upon the Collateral;

 

(iii) to the satisfaction of the Indebtedness;

 

(iv) by holding such cash and proceeds as Collateral;

 

(v) to the payment of any other amounts required by applicable law (including without limitation, Section 9.615(a)(3) of the Code or any other applicable statutory provision); and

 

(vi) by delivery to Debtor or any other party lawfully entitled to receive such cash or proceeds whether by direction of a court of competent jurisdiction or otherwise.

 

(c) Deficiency. In the event that the proceeds of any sale of, collection from, or other realization upon, all or any part of the Collateral by Secured Party are insufficient to pay all amounts to which Secured Party is legally entitled, Obligor and any party who guaranteed or is otherwise obligated to pay all or any portion of the Indebtedness shall be liable for the deficiency, together with interest thereon as provided in the Transaction Documents, to the full extent permitted by the Code.

 

(d) Non-Judicial Remedies. In granting to Secured Party the power to enforce its rights hereunder without prior judicial process or judicial hearing, Debtor expressly waives, renounces and knowingly relinquishes any legal right which might otherwise require Secured Party to enforce its rights by judicial process. Debtor recognizes and concedes that non-judicial remedies are consistent with the usage of trade, are responsive to commercial necessity and are the result of a bargain at arm’s length. Nothing herein is intended to prevent Secured Party or Debtor from resorting to judicial process at either party’s option.

 

(e) Other Recourse. Debtor waives any right to require Secured Party to proceed against any third party, exhaust any Collateral or other security for the Indebtedness, or to have any third party joined with Debtor in any suit arising out of the Indebtedness or any of the Transaction Documents, or pursue any other remedy available to Secured Party. Debtor further waives any and all notice of acceptance of this Agreement and of the creation, modification, rearrangement, renewal or extension of the Indebtedness. Debtor further waives any defense arising by reason of any disability or other defense of any third party or by reason of the cessation from any cause whatsoever of the liability of any third party. Until all of the Indebtedness shall have been paid in full, Debtor shall have no right of subrogation and Debtor waives the right to enforce any remedy which Secured Party has or may hereafter have against any third party, and waives any benefit of and any right to participate in any other security whatsoever now or hereafter held by Secured Party. Debtor authorizes Secured Party, and without notice or demand and without any reservation of rights against Debtor and without affecting Debtor’s liability hereunder or on the Indebtedness to (i) take or hold any other property of any type from any third party as security for the Indebtedness, and exchange, enforce, waive and release any or all of such other property, (ii) apply such other property and direct the order or manner of sale thereof as Secured Party may in its discretion determine, (iii) renew, extend, accelerate, modify, compromise, settle or release any of the Indebtedness or other security for the Indebtedness, (iv) waive, enforce or modify any of the provisions of any of the Transaction Documents executed by any third party, and (v) release or substitute any third party.

 

Quasar Capital | Security Agreement

 

Page 12 of 18

 
 

 

 

9. Indemnity. Debtor hereby indemnifies and agrees to hold harmless Secured Party, and its officers, directors, employees, agents and representatives (each an “Indemnified Person”) from and against any and all liabilities, obligations, claims, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature (collectively, the “Claims”) which may be imposed on, incurred by, or asserted against, any Indemnified Person arising in connection with the Transaction Documents, the Indebtedness or the Collateral (including without limitation, the enforcement of the Transaction Documents and the defense of any Indemnified Person’s actions and/or inactions in connection with the Transaction Documents). The indemnification provided for in this Section shall survive the termination of this Agreement and shall extend and continue to benefit each individual or entity who is or has at any time been an Indemnified Person hereunder.

 

10. Miscellaneous.

 

(a) Entire Agreement. This Agreement contains the entire agreement of Secured Party and Debtor with respect to the Collateral. If the parties hereto are parties to any prior agreement, either written or oral, relating to the Collateral, the terms of this Agreement shall amend and supersede the terms of such prior agreements as to transactions on or after the effective date of this Agreement, but all security agreements, financing statements, guaranties, other contracts and notices for the benefit of Secured Party shall continue in full force and effect to secure the Indebtedness unless Secured Party specifically releases its rights thereunder by separate release.

 

(b) Amendment. No modification, consent or amendment of any provision of this Agreement or any of the other Transaction Documents shall be valid or effective unless the same is authenticated by the party against whom it is sought to be enforced, except to the extent of amendments specifically permitted by the Code without authentication by the Debtor or Obligor.

 

(c) Actions by Secured Party. The lien, security interest and other security rights of Secured Party hereunder shall not be impaired by (i) any renewal, extension, increase or modification with respect to the Indebtedness, (ii) any surrender, compromise, release, renewal, extension, exchange or substitution which Secured Party may grant with respect to the Collateral, or (iii) any release or indulgence granted to any endorser, guarantor or surety of the Indebtedness. The taking of additional security by Secured Party shall not release or impair the lien, security interest or other security rights of Secured Party hereunder or affect the obligations of Debtor hereunder.

 

(d) Waiver by Secured Party. Secured Party may waive any Event of Default without waiving any other prior or subsequent Event of Default. Secured Party may remedy any default without waiving the Event of Default remedied. Neither the failure by Secured Party to exercise, nor the delay by Secured Party in exercising, any right or remedy upon any Event of Default shall be construed as a waiver of such Event of Default or as a waiver of the right to exercise any such right or remedy at a later date. No single or partial exercise by Secured Party of any right or remedy hereunder shall exhaust the same or shall preclude any other or further exercise thereof, and every such right or remedy hereunder may be exercised at any time. No waiver of any provision hereof or consent to any departure by Debtor therefrom shall be effective unless the same shall be in writing and signed by Secured Party and then such waiver or consent shall be effective only in the specific instances, for the purpose for which given and to the extent therein specified. No notice to or demand on Debtor in any case shall of itself entitle Debtor to any other or further notice or demand in similar or other circumstances.

 

Quasar Capital | Security Agreement

 

Page 13 of 18

 
 

 

 

(e) Costs and Expenses. Debtor will upon demand pay to Secured Party the amount of any and all costs and expenses (including without limitation, attorneys’ fees and expenses), which Secured Party may incur in connection with (i) the custody, preservation, use or operation of, or the sale of, collection from, or other realization upon, the Collateral, (ii) the exercise or enforcement of any of the rights of Secured Party under the Transaction Documents, or (iii) the failure by Debtor to perform or observe any of the provisions hereof.

 

(f) RELEASE. DEBTOR HEREBY RELEASES AND DISCHARGES SECURED PARTY, ITS OFFICERS, EMPLOYEES AND DESIGNEES, FROM ANY LIABILITY ARISING FROM ANY ACTS UNDER THIS SECURITY AGREEMENT OR IN FURTHERANCE THEREOF WHETHER OF OMISSION OR COMMISSION, AND WHETHER BASED UPON ANY ERROR OF JUDGMENT OR MISTAKE OF LAW OR FACT, EXCEPT FOR MATTERS ARISING FROM SECURED PARTY’S GROSS NEGLIGENCE OR INTENTIONAL OR WILLFUL MISCONDUCT. IN NO EVENT WILL SECURED PARTY HAVE ANY LIABILITY TO DEBTOR FOR LOST PROFITS OR OTHER SPECIAL OR CONSEQUENTIAL DAMAGES. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, DEBTOR RELEASES SECURED PARTY FROM ANY CLAIMS WHICH DEBTOR MAY NOW OR HEREAFTER HAVE ARISING OUT OF SECURED PARTY’S ENDORSEMENT AND DEPOSIT OF CHECKS ISSUED BY DEBTOR’S CUSTOMERS STATING THAT THEY WERE IN FULL PAYMENT OF AN ACCOUNT, BUT ISSUED FOR LESS THAN THE FULL AMOUNT WHICH MAY HAVE BEEN OWED ON THE ACCOUNT. FURTHER, THE SECURED PARTY SHALL HAVE NO LIABILITY TO THE SELLER FOR ANY MISTAKE IN ITS DEALINGS WITH ANY ACCOUNT DEBTORS OR IN THE APPLICATION OF ANY PAYMENT RECEIVED BY IT WITH RESPECT TO ANY ACCOUNT EXCEPT TO THE EXTENT OF THE AMOUNT OF THE MISAPPLICATION UNLESS BASED ON SECURED PARTY’S GROSS NEGLIGENCE OR INTENTIONAL WILLFUL MISCONDUCT. DEBTOR ACKNOWLEDGES THAT THIS PROVISION RELEASES SECURED PARTY FROM THE CONSEQUENCES OF ITS OWN FUTURE NEGLIGENCE.

 

(g) GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF TEXAS AND APPLICABLE FEDERAL LAWS, EXCEPT TO THE EXTENT PERFECTION AND THE EFFECT OF PERFECTION OR NON-PERFECTION OF THE SECURITY INTEREST GRANTED HEREUNDER, IN RESPECT OF ANY PARTICULAR COLLATERAL, ARE GOVERNED BY THE LAWS OF A JURISDICTION OTHER THAN THE STATE OF TEXAS.

 

Quasar Capital | Security Agreement

 

Page 14 of 18

  
 

 

  

(h) Venue. This Agreement has been entered into in the county in Texas where Secured Party’s address for notice purposes is located, and it shall be performable for all purposes in such county. Courts within the State of Texas shall have jurisdiction over any and all disputes arising under or pertaining to this Agreement and venue for any such disputes shall be in Travis County, Texas.

 

(i) Severability. If any provision of this Agreement is held by a court of competent jurisdiction to be illegal, invalid or unenforceable under present or future laws, such provision shall be fully severable, shall not impair or invalidate the remainder of this Agreement and the effect thereof shall be confined to the provision held to be illegal, invalid or unenforceable.

 

(j) No Obligation. Nothing contained herein shall be construed as an obligation on the part of Secured Party to extend or continue to extend credit to Obligor.

 

(k) Notices. All notices, requests, demands or other communications required or permitted to be given pursuant to this Agreement or the other Transaction Documents shall be in writing and given by (i) personal delivery, (ii) expedited delivery service with proof of delivery, or (iii) United States mail, postage prepaid, registered or certified mail, return receipt requested, sent to the intended addressee at the address set forth on the first page hereof or to such different address as the addressee shall have designated by written notice sent pursuant to the terms hereof and shall be deemed to have been received either, in the case of personal delivery, at the time of personal delivery, in the case of expedited delivery service, as of the date of first attempted delivery at the address and in the manner provided herein, or in the case of mail, upon deposit in a depository receptacle under the care and custody of the United States Postal Service. Either party shall have the right to change its address for notice hereunder to any other location within the continental United States by notice to the other party of such new address at least thirty (30) days prior to the effective date of such new address.

 

(l) Binding Effect and Assignment. This Agreement (i) creates a continuing security interest in the Collateral, (ii) shall be binding on Debtor and the heirs, executors, administrators, personal representatives, successors and assigns of Debtor, and (iii) shall inure to the benefit of Secured Party and its successors and assigns. Without limiting the generality of the foregoing, Secured Party may pledge, assign or otherwise transfer the Indebtedness and its rights under this Agreement and any of the other Transaction Documents to any other party. Debtor’s rights and obligations hereunder may not be assigned or otherwise transferred without the prior written consent of Secured Party.

 

(m) Cumulative Rights. All rights and remedies of Secured Party hereunder are cumulative of each other and of every other right or remedy which Secured Party may otherwise have at law or in equity or under any of the other Transaction Documents, and the exercise of one or more of such rights or remedies shall not prejudice or impair the concurrent or subsequent exercise of any other rights or remedies.

   

Quasar Capital | Security Agreement

 

Page 15 of 18

 
 

 

 

(n) Conflicts with ARPA. To the extent that the ARPA, on the one hand, and this Security Agreement, on the other hand, address the same or similar covenants, representations, warranties, rights, remedies, or other subject matter, such documents shall be construed, if possible, in a manner by which all such covenants, representations, warranties, rights, remedies or other subject matter are independent of one another and each fully enforceable according to its own terms, it being the parties’ explicit intention that all rights and remedies of the parties described in the Transaction Documents shall be cumulative of one another. In the event that a harmonious construction of the documents is not reasonably possible, then this Security Agreement (including any provisions of the ARPA that are incorporated herein by reference) shall control solely with respect to the Collateral, and the ARPA shall control as to all other matters.

 

(o) Gender and Number. Within this Agreement, words of any gender shall be held and construed to include the other gender, and words in the singular number shall be held and construed to include the plural and words in the plural number shall be held and construed to include the singular, unless in each instance the context requires otherwise.

 

(p) Descriptive Headings. The headings in this Agreement are for convenience only and shall in no way enlarge, limit or define the scope or meaning of the various and several provisions hereof.

 

(q) Jury Trial Waiver. IN RECOGNITION OF THE HIGHER COSTS AND DELAY WHICH MAY RESULT FROM A JURY TRIAL, THE PARTIES HERETO WAIVE ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING HEREUNDER, OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE; AND EACH PARTY FURTHER WAIVES ANY RIGHT TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED.

 

[Remainder of page left blank]

 

 

Quasar Capital | Security Agreement

 

Page 16 of 18

  
 

 

 

EXECUTED as of the date first written above.

 

 

DEBTOR:

 

Edible Garden AG Incorporated

       
By: /s/ Michael C. James

 

Name:

Michael C. James  
  Title: Chief Financial Officer  
  Date: April 13, 2021  

 

 

 

 

 

SECURED PARTY:

 
Quasar Capital Partners, LLC

 

 

 

 

 

 

By:

/s/ Brian Center

 

 

Name:

Brian Center

 

 

Date:

April 13, 2021

 

 

 

Quasar Capital | Security Agreement

 

Page 17 of 18

 
 

 

 

EXHIBIT A


LOCATIONS OF COLLATERAL

 

Address: 283 County Road 519

 

Belvidere, NJ 07823

 

 

 

 

 

 

 

Quasar Capital | Security Agreement

 

Page 18 of 18

 

 

 

EXHIBIT 10.13

 

INTERCREDITOR AGREEMENT AND AMENDMENT

 

This INTERCREDITOR AGREEMENT AND AMENDMENT, dated as of April 13, 2021 (this “Agreement”), is among SAMENT CAPITAL INVESTMENTS, INC., a California corporation (the “Subordinating Creditor”), Edible Garden AG Incorporated, a Wyoming corporation (the “Debtor”), and Quasar Capital Partners, LLC, a Texas limited liability company (the “Senior Creditor”).

 

RECITALS

 

A. The Senior Creditor has or expects to acquire a security interest in the Senior Creditor Collateral, which consists of assets of the Debtor in which the Subordinating Creditor also has a security interest.

 

B. The Debtor and the Subordinating Creditor are parties to certain financing agreements pursuant to which Debtor has granted Subordinated Creditor a security interest in certain of the Senior Creditor Collateral.

 

C. The Creditors are executing this Agreement to set forth their lien priorities with respect to the Senior Creditor Collateral.

 

D. To induce Senior Creditor to extend financial accommodations to the Debtor, the Subordinating Creditor has agreed to subordinate in favor of Senior Creditor its security interest in the Senior Creditor Collateral.

 

NOW, THEREFORE, in consideration of the premises, and intending to be legally bound hereby, the Creditors hereby agree as follows:

 

AGREEMENT

 

1. DEFINITIONS. THE FOLLOWING TERMS USED HEREIN SHALL HAVE THE FOLLOWING MEANING. ALL CAPITALIZED TERMS NOT HEREIN DEFINED SHALL HAVE THE MEANING SET FORTH IN THE UNIFORM COMMERCIAL CODE, AS ENACTED IN THE CHOSEN STATE ON THE DATE HEREOF:

 

1.1 “Bankruptcy Code” — Title 11 of the United States Code.

 

1.2 “Chosen State” - Texas.

 

1.3 “Creditors” —The Subordinating Creditor and the Senior Creditor.

 

1.4 “Debtor” — See preamble.

 

1.5 “Party” — Each of the Subordinating Creditor, the Debtor, and the Senior Creditor.

 

1.6 “Senior Creditor” — See preamble

 

1.7 “Senior Creditor Collateral” - All now owned and hereafter acquired Accounts, Accounts Receivable, Chattel Paper, Inventory, Instruments (including, without limitation, Promissory Notes), Commercial Tort Claims, Documents, Payment Intangibles and all of Debtor’s interest in the Reserve Account and any other property or other funds held by Purchaser on behalf of Seller, together with the proceeds of any of the foregoing (including proceeds of proceeds).

 

 
Page 1 of 8

 

    

1.8 “Senior Creditor Obligations” - Obligations of the Debtor to the Senior Creditor secured by the Senior Creditor Collateral.

 

1.9 “Subordinating Creditor” — See Preamble.

 

1.10 “Subordinating Creditor Agreements” — All agreements now or hereafter entered into between Subordinating Creditor and Debtor secured by the Senior Creditor Collateral.

 

1.11 “Subordinating Creditor Obligations” — Indebtedness owed by the Debtor to the Subordinating Creditor secured by Senior Creditor Collateral.

 

2. PRIORITY.

 

2.1 Notwithstanding the terms or provisions of any agreement or arrangement which either Creditor may now or hereafter have with the Debtor or any rule of law, and irrespective of the time, order, or method of attachment or perfection of any security interest or the recordation or other filing in any public record of any financing statement, the Senior Creditor Obligations and any security interests in the Senior Creditor Collateral now or hereafter held by the Senior Creditor, whether or not perfected, are and shall remain senior to the Subordinating Creditor Obligations and any lien or security interest therein now or hereafter held by the Subordinating Creditor in the Senior Creditor Collateral.

 

3. ENFORCEMENT OF SECURITY INTEREST.

 

3.1 The Subordinating Creditor shall have no right to take any action with respect to the Senior Creditor Collateral, whether by judicial or non-judicial foreclosure, recordation or enforcement of mechanics liens, notification to the Debtor’s Account Debtors, the seeking of the appointment of a receiver for any portion of the Debtor’s assets, setoff, or otherwise, unless and until all Senior Creditor Obligations have been fully and indefeasibly paid.

 

3.2 If the Subordinating Creditor, in contravention of the terms of this Agreement, shall commence, prosecute, or participate in any suit, action, or proceeding against the Debtor or initiate any foreclosure sale or proceeding or any other action to enforce its lien on any of the Senior Creditor Collateral, then the Debtor may interpose as a defense or plead the making of this Agreement, and the Senior Creditor may intervene and interpose such defense or plea in its name or in the name of the Debtor. If the Subordinating Creditor, in contravention of the terms of this Agreement, shall attempt to enforce any remedies prohibited by this Agreement, then the Senior Creditor or the Debtor may, by virtue of this Agreement, restrain the enforcement thereof in the name of the Senior Creditor or in the name of the Debtor.

 

3.3 If Senior Creditor, pursuant to the rights granted to the Senior Creditor under the terms of this Agreement or applicable law, shall dispose of any or all of the Senior Creditor Collateral such disposition shall be deemed commercially reasonable if, in the written opinion of three (3) commercial loan officers with three (3) or more years of workout experience each, the manner of the disposition is not inconsistent with the manner in which such commercial loan officers would have handled the disposition.

 

 
Page 2 of 8

 

    

4. PROCEEDS OF COLLATERAL.

 

4.1 Any proceeds of the Senior Creditor Collateral, or proceeds of proceeds, received by the Subordinating Creditor shall be, immediately upon discovery, paid to the Senior Creditor.

 

5. SUBORDINATING CREDITOR COVENANTS AND WARRANTIES.

 

5.1 The Subordinating Creditor warrants covenants and represents that it:

 

5.1.1 Is the owner of the Subordinating Creditor Obligations;

 

5.1.2 Is the Secured Party of record in each UCC Financing Statement listed on the attached Exhibit A.

 

5.1.3 Will not, at any time while this Agreement is in effect assign any of the Subordinating Creditor Obligations to any entity which does not agree in a writing, satisfactory in form and substance to the Senior Creditor, to be bound by all of the obligations of the Subordinating Creditor hereunder. In the case of any such proposed assignment by the Subordinating Creditor, it will notify the Senior Creditor at least five (5) business days prior to the date of any of such assignment.

 

5.1.4 Waives any rights it may have to claim that the enforceability of this Agreement may be affected by any subsequent modification, release, extension, or other change, material or otherwise, in the Senior Creditor Obligations or the Senior Creditor Collateral.

 

5.1.5 Will reasonably cooperate with Senior Creditor in notifying the Debtor’s Account Debtors that proceeds of Accounts should be paid to Senior Creditor and not to Subordinating Creditor.

 

6. REMEDY FOR BREACH.

 

6.1 Any breach hereof is likely to cause irreparable damage to the aggrieved party. Therefore, the relief to which such party shall be entitled in such event shall include, but not be limited to: (a) a mandatory injunction for specific performance, (b) judicial relief to prevent a violation of any of the provisions of this Agreement, (c) damages, and (d) any other relief to which it may be entitled at law or in equity.

 

7. AMENDMENT OF SUBORDINATING CREDITOR AGREEMENTS.

 

7.1 This Agreement shall be deemed an amendment to all present and future Subordinating Creditor Agreements, which cannot be further amended to affect the rights of Senior Creditor hereunder.

 

7.2 The consent of Senior Creditor shall not be required for any further amendment of the Subordinating Creditor Agreements.

 

7.3 The parties agree that Subordinating Creditor may accept from Debtor regularly-scheduled principal and interest payments on the Subordinating Creditor Obligations. The foregoing notwithstanding, Subordinating Creditor agrees that it will not accelerate the maturity date of any Subordinating Creditor Obligation under any Subordinating Creditor Agreement without first giving Senior Creditor no less than thirty (30) days prior written notice.

 

 
Page 3 of 8

 

    

8. EFFECT OF BANKRUPTCY.

 

8.1 This Agreement shall remain in full force and effect notwithstanding the filing of a petition for relief by or against the Debtor under the Bankruptcy Code and, without limiting the foregoing shall apply with full force and effect with respect to all Senior Creditor Collateral acquired by the Debtor, and obligations incurred by the Debtor to the Subordinating Creditor, subsequent to the date of any such petition.

 

8.2 If the Debtor shall become subject to a proceeding under the Bankruptcy Code and if Senior Creditor shall permit the use of cash collateral or provides financing to Debtor under either Section 363 or Section 364 of the Bankruptcy Code:

 

8.2.1 Adequate notice to Subordinating Creditor shall have been provided if Subordinating Creditor receives notice one business day prior to the entry of the appropriate order; and

 

8.2.2 Subordinating Creditor will raise no objection thereto on the ground of a failure to provide adequate protection for Subordinating Creditor’s security interest in the Senior Creditor Collateral.

 

9. NO DUTY TO PROVIDE FINANCIAL ACCOMMODATIONS.

 

9.1 Nothing contained herein or in any prior agreement or understanding between the Creditors shall be deemed to create any duty on the part of either Creditor to extend or continue to extend financial accommodations to the Debtor.

 

10. CHOICE OF LAW.

 

10.1 This Agreement and all transactions contemplated hereunder and/or evidenced hereby shall be governed by, construed under, and enforced in accordance with the internal laws of the Chosen State.

 

11. AMENDMENT AND WAIVER.

 

11.1 Only a writing signed by all parties hereto may amend this Agreement. No failure or delay in exercising any right hereunder shall impair any such right that Senior Creditor may have, nor shall any waiver by Senior Creditor hereunder be deemed a waiver of any default or breach subsequently occurring. Senior Creditor’s rights and remedies herein are cumulative and not exclusive of each other or of any rights or remedies that Senior Creditor would otherwise have.

 

12. CONSTRUCTION OF AGREEMENT.

 

12.1 This Agreement and all agreements relating to the subject matter hereof is the product of negotiation and preparation by and among each Party and its respective attorneys.

 

13. BENEFITS OF THIS AGREEMENT.

 

13.1 This Agreement is solely for the benefit of and shall bind the Creditors and their respective successors and assigns and no other entity shall have any right, benefit, priority, or interest hereunder.

 

13.2 In the event that Senior Creditor assigns its rights hereunder in connection with an assignment of the Senior Creditor Obligations, the assignee (“Assignee”) shall enjoy the benefits hereof, without any requirement of the consent of the Subordinating Creditor so long as the Assignee notifies the Subordinating Creditor:

  

 
Page 4 of 8

 

  

13.2.1 Of such assignment, and

 

13.2.2 That the Assignee agrees to bound by the terms hereof as if it were the Senior Creditor.

 

14. TERM.

 

14.1 The subordination by Subordinating Creditor as set forth herein may only be terminated with the written consent of the Senior Creditor.

 

14.2 The Senior Creditor must consent to the termination of this subordination upon the occurrence of all of the following:

 

14.2.1 Payment in full of the Senior Creditor Obligations;

 

14.2.2 Termination of all security agreements securing the Senior Creditor Obligations.

 

14.2.3 Upon the occurrence of Sections 14.2.1 and 14.2.2, written receipt for a request for such consent is received by Senior Creditor from Subordinating Creditor.

 

15. ATTORNEYS FEES.

 

15.1 In the event that any Party finds it necessary to retain counsel in connection with the interpretation, defense, or enforcement of this agreement, the prevailing Party shall recover its reasonable attorney’s fees and expenses from the unsuccessful Party. It shall be presumed (subject to rebuttal only by the introduction of competent evidence to the contrary) that the amount recoverable is the amount billed to the prevailing Party by its counsel and that such amount will be reasonable if based on the billing rates charged to the prevailing Party by its counsel in similar matters.

 

16. COUNTERPARTS.

 

16.1 This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if all signatures were upon the same instrument. Delivery of an executed counterpart of the signature page to this Agreement by facsimile shall be effective as delivery of a manually executed counterpart of this Agreement, and any Party delivering such an executed counterpart of the signature page to this Agreement by facsimile to any other Party shall thereafter also promptly deliver a manually executed counterpart of this Agreement to such other Party, provided that the failure to deliver such manually executed counterpart shall not affect the validity, enforceability, or binding effect of this Agreement.

 

 
Page 5 of 8

 

    

17. NOTICE.

 

17.1 All notices shall be effective upon: (a) the sending of an email to one of the email addresses below or (b) delivery to a recognized overnight delivery service of a properly addressed notice, delivery prepaid, with instructions to make delivery on the next business day. For purposes hereof, the addresses of the parties are as set forth below or as may otherwise be specified from time to time in a writing sent by one party to the other in accordance with the provisions hereof:

 

 

Subordinating Creditor

 

Address:

3242 S. Halladay St., Suite 202

Santa Ana, CA 92705

Attention:

CEO

Email:

 

 

Debtor

 

Address:

283 Country Rd 519 Belvidere, NJ 07823

Attention:

--

Email:

--

 

Senior Creditor

 

Address:

9330 LBJ Frwy. Suite 943B, Dallas, Texas 75243

Attention:

Brian Center, CEO

Email:

brian@quasarfunds.com

 

[signature page follows]

 

 
Page 6 of 8

 

  

IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered by their respective officers thereunto duly authorized as of the date first above written.

 

Subordinating Creditor:

SAMENT CAPITAL INVESTMENTS, INC.

 

 

 

 

 

By:

/s/ Francis Knuettel II

 

 

Name:

Francis Knuettel II

 

 

Title:

Chief Executive Officer

 

 

 

 

 

 

 

 

 

Debtor:

Edible Garden AG Incorporated,

a Wyoming corporation

 

 

 

 

 

By:

/s/ Michael C. James

 

 

Name:

Michael C. James

 

 

Title:

Chief Financial Officer

 

 

 

 

 

 

 

 

 

Senior Creditor:

Quasar Capital Partners, LLC,

a Texas limited liability company

 

 

 

 

 

By:

/s/ Brian Center

 

 

Name:

Brian Center

 

 

Title:

Chief Executive Officer

 

 

 
Page 7 of 8

 

 

EXHIBIT A

 

FILING

DATE

 

FILING

NUMBER

 

FILING OFFICE JURISDICTION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Page 8 of 8

 

 

EXHIBIT 10.14

 

PERFORMANCE GUARANTY AND SURETYSHIP

 

THIS PERFORMANCE GUARANTY AND SURETYSHIP (“Guaranty”), made as of the date set forth on the signature page hereof, is by and between Michael James (the “Guarantor”) and Quasar Capital Partners, LLC (“QUASAR”).

 

RECITALS:

 

WHEREAS, Edible Garden AG, Incorporated , a Wyoming Company (the “Company”) and QUASAR intend to enter into an Accounts Receivable Purchasing Agreement of even or approximate date hereof (as amended from time to time, and including all riders, schedules and exhibits thereto and all agreements and documents executed in connection therewith, the “Agreement”) pursuant to which QUASAR will purchase certain accounts receivable billed to customers of the Company (“Accounts Receivable”) and extend other credit accommodations to the Company on the basis of, and in reliance upon, the representations, warranties and covenants of the Company contained in the Agreement; and

 

WHEREAS, as a condition precedent to the obligation of QUASAR to enter into the Agreement and to purchase accounts of Company pursuant thereto and extend other credit accommodations to Company, QUASAR requires that the Guarantor shall have entered into this Guaranty, guaranteeing the performance by the Company of the representations, warranties and covenants of the Company in the Agreement and the payment and performance by the Company of its other obligations under the Agreement and otherwise.

 

NOW, THEREFORE, in order to induce QUASAR to enter into the Agreement and to purchase Accounts Receivable and extend other credit accommodations pursuant thereto, and in consideration thereof and for other valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the Guarantor, it is agreed as follows:

 

WITNESSETH:

 

1. Liabilities of Guarantor. The Guarantor hereby absolutely and unconditionally guarantees (a) the accuracy and completeness of the Company’s representations and warranties (including those set forth in Section 13 of the Agreement), and the prompt and complete performance by the Company of the Company’s covenants and obligations in the Agreement, (b) the prompt and complete payment and performance of all present and future obligations owing from Company to QUASAR, including, without limitation, all obligations incurred by Company under the Agreement, any rider thereto, and any renewals, restatements, modifications or amendments thereof (and Guarantor expressly waives any consent or notice right that Guarantor may have with respect to such modification or amendment); (c) the prompt and complete payment and performance of all expenses and obligations of any nature that may become due or owing by Company to QUASAR under the Transaction Documents (as defined in the Agreement), and (d) the payment of any costs or expenses incurred by QUASAR in enforcing any of the foregoing (the foregoing obligations set forth in subsections (a) - (d) hereof collectively referred to herein as the “Guaranteed Obligations”). This is a guaranty of payment, and not of collection, and a debt of Guarantor for its own account. Accordingly, QUASAR shall not be obligated or required before enforcing the obligations of Guarantor: (a) to pursue any right or remedy QUASAR may have against the Company or any other person or commence any suit or other proceeding against the Company or any other person in any court or other tribunal; (b) to make any claim in a liquidation or bankruptcy of the Company or any other person; or (c) to make demand of the Company or any other person or to enforce or seek to enforce or realize upon any collateral security held by QUASAR which may secure any of the Guaranteed Obligations. This Guaranty is a continuing guaranty which shall extend until all Guaranteed Obligations have been paid in full and become unavoidable under the United States Bankruptcy Code and any other debtor-relief statute. Payments to be made by the Guarantor hereunder may be required by QUASAR on any number of occasions.

   

Quasar Capital | Performance Guaranty and Suretyship

 

 Page 1 of 5

    

 

 

    

2. Costs of Enforcement. The Guarantor shall pay to QUASAR forthwith upon demand, all reasonable costs and expenses (including court costs and legal expenses) incurred or expended by QUASAR in enforcing its rights under this Guaranty.

 

3. Waiver of Right of Subrogation/Subordination. Notwithstanding any payment or payments made by the Guarantor hereunder, the Guarantor will not exercise any rights of QUASAR against the Company by way of subrogation, reimbursement or indemnity, and shall have no right of recourse to any assets or property of the Company held for the payment and performance of its Guaranteed Obligations, until such time as all Guaranteed Obligations have been satisfied and the Agreement has been terminated. If there is more than one Guarantor, each Guarantor agrees not to seek contribution from any other Guarantor until all the Guaranteed Obligations shall have been paid in full and the Agreement has been terminated. If any amount shall nevertheless be paid to the Guarantor, such amount shall be held in trust for the benefit of QUASAR and shall forthwith be paid to QUASAR to be credited and applied to the Guaranteed Obligations, whether matured or not matured. The provisions of this Section shall survive termination of this Guaranty. Furthermore, Guarantor agrees that the indebtedness guaranteed, whether now existing or hereafter created, shall be superior to any claim that Guarantor may now have or hereafter acquire against Company, whether or not Company becomes insolvent, including claims with respect to any existing or hereafter acquired debt or obligations of Company to Guarantor. Guarantor hereby expressly subordinates such debt, obligations and claims against Company, and any security interest or lien granted in favor of Guarantor against any assets of Company, to any security interest, lien or claim QUASAR may now have or hereafter acquire against Company or its assets. Guarantor further agrees that, until the Guaranteed Obligations have been fully and indefeasibly paid to QUASAR, Guarantor will not accelerate the maturity date of any existing or hereafter acquired debt or obligations owing to Guarantor by Company or seek to enforce Guarantor’s security interest or lien in any assets of Company.

 

4. Waiver. Guarantor waives all rights of Guarantor under Chapter 43 of the Texas Civil Practice and Remedies Code. Guarantor also waives any and all rights or defenses based on suretyship or impairment of collateral and hereby assents, to the extent permitted by law, to all the terms and conditions of the Guaranteed Obligations. Additionally, Guarantor waives: (a) notice of acceptance of this Guaranty and all notice of the creation, extension or accrual of any Guaranteed Obligations; (b) presentment, demand for payment, notice of dishonor and protest; (c) notice of any other nature whatsoever; (d) any requirement of diligence or promptness on the part of Lender in the enforcement of its rights under the provisions of the Agreement or any related document; (e) any requirement that Lender take any action whatsoever against the Company or any other party or file any claim in the event of the bankruptcy of the Company; (f) failure of Lender to protect, preserve, or resort to any collateral; (g) any defense or right arising by reason of any disability, lack of corporate authority or power, impairment of recourse or of collateral under Section 3.605 of the Texas Uniform Commercial Code or otherwise, lack of good faith under Section 1.304 of the Texas Uniform Commercial Code or otherwise; (h) any defense or right under Sections 51.003, 51.004 and/or 51.005 of the Texas Property Code, (i) failure to sell any collateral securing the Guaranteed Obligations in a commercially reasonable manner under the Texas Uniform Commercial Code or otherwise; or (j) other any other defense of Company or any other guarantor of any of the Guaranteed Obligations, and will remain liable on this Guaranty regardless of whether Company or any other guarantor is not liable thereon for any reason. Guarantor further waives and agrees not to assert or claim at any time any deductions to the Guaranteed Obligations for any claim, setoff, counterclaim, counter demand, recoupment or similar right, whether such claim, demand, or right may be asserted by the Company, the Guarantor, or both. The waivers set forth in this Section shall be effective notwithstanding the fact that the Company ceases to exist by reason of its liquidation, merger, consolidation or otherwise.

   

Quasar Capital | Performance Guaranty and Suretyship

 

 Page 2 of 5

     

 

 

    

5. Consent. The Guarantor hereby consents that from time to time, and without further notice to or consent of the Guarantor, QUASAR may take any or all of the following actions without affecting the liability of the Guarantor: (a) extend, renew, modify, compromise, settle or release the Guaranteed Obligations; (b) release or compromise any liability of any party or parties with respect to the Guaranteed Obligations; (c) release its security interest in the collateral or exchange, surrender or otherwise deal with the collateral as QUASAR may determine; or (d) exercise or refrain from exercising any right or remedy of QUASAR.

 

6. Obligations of Guarantor Unconditional. The obligations of the Guarantor under this Guaranty shall be absolute and unconditional, irrespective of the validity, regularity or enforceability of any Obligation or any instrument or agreement evidencing the same or relating thereto or any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Guarantor. The obligations of the Guarantor hereunder shall not be discharged except by complete payment or performance of the Guaranteed Obligations and the liabilities of the Guarantor hereunder. This is an irrevocable, absolute, completed, and continuing guaranty of payment and not a guaranty of collection, and will not be affected by the release or discharge of Company from, or impairment or modification of, Company’s obligations with respect to any of the Guaranteed Obligations in any bankruptcy, receivership, or other insolvency proceeding or otherwise. No notice of any extension of credit already or hereafter contracted by or extended to Company need be given to Guarantor. The fact that the Guaranteed Obligations may be rearranged, increased, reduced, modified, extended for any period, and/or renewed from time to time, or paid in full without notice to Guarantor will not release, discharge, or reduce the obligation of Guarantor with respect to the Guaranteed Obligations, and Guarantor will remain fully bound under this Guaranty Agreement. It is the intention of QUASAR and Guarantor that Guarantor’s obligations under this Guaranty Agreement will not be discharged at any time prior to the occurrence of both (i) payment in full of the Guaranteed Obligations and (ii) expiration of QUASAR’S obligation to advance monies to Company pursuant to the Agreement and the documents executed in connection therewith. This Guaranty Agreement may be enforced by QUASAR and any subsequent holder of the Guaranteed Obligations, and will not be discharged by the assignment or negotiation of all or part of the Guaranteed Obligations. This Guaranty Agreement may not be revoked by Guarantor and will continue to be effective or be reinstated, as the case may be, if at any time any payment of any of the Guaranteed Obligations is rescinded or must otherwise be returned or refunded by QUASAR to the payor thereof or to any other person, as a preferential transfer, voidable transfer or otherwise upon any insolvency, bankruptcy, reorganization, receivership, or other debtor relief proceeding involving Company or any other payor of such amounts, or after any attempted revocation by Guarantor, all as though such payment had not been made. Guarantor expressly waives presentment, demand, notice of non-payment, protest, notice of protest and dishonor, notice of intention to accelerate, notice of acceleration, notice of intention to foreclose, notice of foreclosure, and any other notice whatsoever on any and all forms of such Guaranteed Obligations, and also notice of acceptance of this Guaranty Agreement, acceptance on the part of QUASAR being conclusively presumed by its request for this Guaranty Agreement and delivery of the same to QUASAR.

 

7. Notices. All notices and other communications hereunder shall be deemed given when delivered or deposited in the mails, and sent first class, certified mail with postage prepaid, and if to a party hereto addressed as set forth beneath its name at the foot hereof unless a party shall give notice of a different address in the manner provided herein.

 

8. Payment Due Date. Guarantor unconditionally and irrevocably guarantees the prompt payment when due, whether at maturity or otherwise, of all of the Guaranteed Obligations. If Guarantor fails to make any payment of any part of the Guaranteed Obligations when due or, if the Agreement under which such payment is due provides any cure period, before the expiration of said cure period, then said failure will constitute a default under this Guaranty Agreement.

   

Quasar Capital | Performance Guaranty and Suretyship

 

 Page 3 of 5

   

 

 

    

9. Survival of Agreement. This Guaranty shall inure to the benefit of and be binding upon the Guarantor and QUASAR and their respective heirs, successors and assigns, including any subsequent holder or holders of any Guaranteed Obligations, and the term “QUASAR” shall include any such holder or holders whenever the context permits.

 

10. Independent Obligation. QUASAR may proceed against the Guarantor under this Guaranty without first proceeding against the Company, against any other surety or any other person or any security held by QUASAR and without pursuing any other remedy. It is expressly agreed that the liability of the Guarantor for the payment of the Guaranteed Obligations secured hereby shall be primary and not secondary.

 

11. Governing Law and Venue. THIS GUARANTY SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF TEXAS. For purposes of any suit relating to this Guaranty, the Guarantor and QUASAR submit themselves to the jurisdiction of any court sitting in the State of Texas and further agree that venue in any suit arising out of this Guaranty shall be fixed in Travis County, Texas. Final judgment in any suit shall be conclusive and may be enforced in any jurisdiction within or without the United States of America, by suit on the judgment, a certified or exemplified copy of which shall be conclusive evidence of such liability.

 

12. Entire Agreement. This Guaranty represents the entire agreement between the parties with respect to the subject matter contained herein, and may not be amended or modified except by written instrument executed by the Guarantor and QUASAR. This Guaranty supersedes and replaces any prior agreement among the parties, oral or written with respect to the subject matter hereof. No representations, whether oral or written, are being relied upon which are not expressly set forth in this Guaranty, in the Agreement or in any Transaction Document. The parties recognize that any oral representations and prior written representations with respect to the subject matter hereof are “merged” into this Guaranty, and no reliance can be placed thereon.

 

13. No Interest Paid in Excess of Permitted Amounts. Should a court of competent jurisdiction rule that any consideration paid hereunder is in fact or in law to be treated as interest, in no event shall the Guarantor be obligated to pay that interest at a rate in excess of the maximum amount permitted by law, and all agreements, conditions, or stipulations contained herein, if any, which may in any event or contingency whatsoever operate to bind, obligate, or compel the Guarantor to pay a rate of interest exceeding the maximum rate of interest permitted by law shall be without binding force or effect at law or in equity to the extent only of the excess of interest over such maximum rate of interest permitted by law. Also in such event, QUASAR may “spread” all charges characterized as interest over the entire term of all transactions with the Guarantor or the Company and will refund to the Company or the Guarantor the excess of any payments made over the highest lawful rate. It is the intention of the parties hereto that in the construction and interpretation of this Guaranty, the foregoing sentence shall be given precedence over any other agreement, condition, or stipulation herein contained which is in conflict with same.

 

14. Jury Trial Waiver. IN RECOGNITION OF THE HIGHER COSTS AND DELAY WHICH MAY RESULT FROM A JURY TRIAL, THE PARTIES HERETO WAIVE ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING HEREUNDER, OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE; AND EACH PARTY FURTHER WAIVES ANY RIGHT TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED.

 

15. Reporting Requirements. Guarantor agrees to provide QUASAR with a personal financial and cash flow statement and the most recently-filed federal tax return on an annual basis- no later than the 31st of December of every year the ARPA is in effect or any Obligations are owed to QUASAR, or at any such other time upon request by QUASAR.

   

Quasar Capital | Performance Guaranty and Suretyship

 

 Page 4 of 5

  

 

 

     

IN WITNESS WHEREOF, this Guaranty has been executed as of the date below.

 

 

GUARANTOR:

 

QUASAR:
 

 

     
/s/ Michael James

 

By: /s/ Brian Center

Name: Michael James, individually

 

Name:

Brian Center  
 

 

Date: April 13, 2021  
Address:

 

     

XXXXX
XXXXX

 

 

 

 

 

 

 

 

 

Date: April 13, 2021

 

 

 

 

 

Quasar Capital | Performance Guaranty and Suretyship

 

 Page 5 of 5

 

 

EXHIBIT 10.15

 

EXECUTIVE EMPLOYMENT AGREEMENT

  

THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered effective as of August 18, 2021, by and between Edible Garden AG Incorporated, a Delaware Corporation (the “Company”), and James E. Kras (the “Executive”).

 

W I T N E S S E T H:

 

WHEREAS, the Board of Directors of the Company (the “Board”) has approved the Company entering into an employment agreement with the Executive; and

 

WHEREAS, the Executive is now the Chief Executive Officer of the Company; and

 

WHEREAS, the Company and the Executive would like to set forth the terms of the Executive’s continued employment;

 

NOW THEREFORE, in consideration of the recitals and the mutual agreements herein set forth, the Company and the Executive agree as follows:

 

ARTICLE 1
EMPLOYMENT AND TERM

 

1.1 Employment. The Company hereby employs the Executive and the Executive accepts employment as the Chief Executive Officer of the Company. As Chief Executive Officer, the Executive shall render such services to the Company as are customarily rendered by a comparable officer of comparable companies and as required by the Certificate of Incorporation and By-laws of the Company. The Executive accepts such employment and, consistent with fiduciary standards which exist between an employer and an employee, shall perform and discharge the duties commensurate with his position that may be assigned to him from time to time by the Board.

 

1.2 Term and Renewal. The term of this Agreement shall commence on the date first written above (the “Commencement Date”), and shall continue for a term of two (2) years (the “Initial Term”); provided, however, that commencing on the second (2nd) anniversary of the Commencement Date and on each anniversary of the Commencement Date thereafter (each, an “Extension Date”), the term of the Executive’s employment under this Agreement shall be automatically extended for an additional one (1) year period (each, a “Renewal Term”), unless the Company or the Executive provides the other at least ninety (90) days prior written notice before the next Extension Date that the Initial Term or Renewal Term, as applicable, shall not be extended (a “Non-Renewal Notice”). The period of time between the Commencement Date and the termination of this Agreement shall be referred to herein as the “Term.”

 

 
1

 

    

ARTICLE 2
COMPENSATION AND BENEFITS

 

2.1 Base Salary. During the Term, the Company shall pay the Executive an annual base salary of Three Hundred Thousand Dollars ($300,000) (or any increased amount approved by the Board or the Compensation Committee of the Board (the “Compensation Committee”)), payable in accordance with the Company’s standard payroll practices for senior executives (the “Base Salary”).

 

2.2 Annual Performance Bonus. During the Term, the Executive shall be eligible to receive an annual cash bonus (the “Annual Performance Bonus”), with the target amount of such Annual Performance Bonus equal to one hundred percent (100%) of the Base Salary (the “Target Performance Bonus”) in the year to which the Annual Performance Bonus relates; provided that the actual amount of the Annual Performance Bonus may be greater or less than the Target Performance Bonus. The Annual Performance Bonus shall be based on performance and achievement of Company goals and objectives as defined by the Board or Compensation Committee. The amount of the Annual Performance Bonus shall be determined by the Board or Compensation Committee in its sole discretion, and shall be paid to the Executive no later than March 15th of the calendar year immediately following the calendar year to which it relates.

 

2.3 Transaction Bonus. The Executive shall be entitled to a special cash bonus (the “Transaction Bonus”) upon the first to occur of the completion of an IPO (as defined below) or the closing of a SPAC Transaction (as defined below). The Transaction Bonus shall be equal to $700,000. The Transaction Bonus, if any, will not be deemed “earned” until the date that that the IPO or SPAC Transaction closes. Accordingly, the Executive must be employed by the Company on the date that the IPO or SPAC Transaction closes in order to be eligible to receive payment of the Transaction Bonus. Payment of the Transaction Bonus, less applicable tax withholding, will be made with the first normal payroll period that follows the completion of the IPO or SPAC Transaction. For purposes of this Agreement, (a) ”IPO” shall mean the first sale of equity securities of the Company through a firm underwritten public offering under a registration statement on Form S-1 pursuant to the Securities Act of 1933, as amended, that results in the Company’s securities being listed on a national securities exchange, and (b) ”SPAC Transaction” shall mean the closing of a transaction contemplated by a business combination agreement between the Company and a special purpose acquisition company that results in the surviving corporation’s securities being listed on a national securities exchange.

 

2.4 Paid Time Off. During the Term, the Executive shall be entitled to four (4) weeks paid time off pursuant to the terms and conditions of the Company’s policy and practices as applied to the Company’s senior executives.

  

 
2

 

  

2.5 Health & Welfare Benefits. During the Term, the Executive shall be eligible to participate in all health and welfare benefits provided generally to other employees of the Company.

 

2.6 Retirement Benefits. During the Term, the Executive shall be eligible to participate in all retirement benefits provided generally to other employees of the Company.

 

ARTICLE 3
TERMINATION OF EMPLOYMENT & SEVERANCE BENEFITS

 

3.1 Termination for Cause, Resignation without Good Reason, Death, or Disability. If, during the Term, (a) the Executive’s employment is terminated by the Company for Cause (as defined below), (b) the Executive resigns without Good Reason (as defined below), or (c) the Executive’s employment with the Company ends due to the Executive’s death or “permanent and total disability” (within the meaning Section 22(e)(3) of Internal Revenue Code of 1986, as amended (the “Code”)), then the Executive shall only be entitled to any earned but unpaid Base Salary, as well as any other amounts or benefits owed to the Executive under the terms of any employee benefit plan of the Company (the “Accrued Benefits”). For purposes of this Agreement, the Accrued Benefits shall include any accrued paid time off pursuant to the Company’s policy and practices. The Accrued Benefits shall be payable upon the Executive’s termination within the time provided by law.

 

3.2 Termination without Cause or Resignation for Good Reason. If, during the Term: (a) the Executive’s employment with the Company is terminated by the Company other than for Cause, or (b) the Executive resigns for Good Reason (a “Qualified Termination”), then the Executive shall be entitled to the Accrued Benefits and the Severance Benefits described in Section 3.3.

 

3.3 Severance Benefits.

 

(a) In the event of a Qualified Termination, the Company shall pay and provide the Executive with the following (the “Severance Benefits”):

 

(i) two (2) times the Executive’s then current Base Salary, less any taxes and withholding as may be necessary pursuant to law, to be paid in accordance with the Company’s normal payroll practices, but in no event less frequently than monthly, beginning with the first normal payroll period after the effective date of the release referred to in Section 3.3(b);

 

(ii) a pro-rated Target Performance Bonus for the calendar year in which the Qualified Termination occurs based on the number of days from the beginning of the calendar year through the date of the Qualified Termination, less all amounts required to be deducted or withheld under applicable law or under any employee benefit plan in which the Executive participates, which bonus will be paid with the first normal payroll period after the effective date of the release referred to in Section 3.3(b);

 

 
3

 

  

(iii) vesting of the Executive’s outstanding and unvested stock options will accelerate and become fully vested, and the Executive may exercise the outstanding stock options until the expiration date of such stock options, and the restrictions applicable to the Executive’s outstanding awards of restricted stock and restricted stock units will lapse and become fully vested; and

 

(iv) an aggregate amount equal to the applicable monthly premium for the Executive’s group medical, dental, and vision coverage (for the coverage tier in which the Executive was enrolled at the time of the Executive’s termination) at the rate in effect (as determined under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”)) at the time of the Executive’s termination, multiplied by twelve (12), which aggregate amount will be paid with the first normal payroll period after the effective date of the release referred to in Section 3.3(b).

 

(b) As a condition to receiving the Severance Benefits contemplated by this Section 3.3, within thirty (30) days after the effective date of the Qualified Termination, the Executive shall execute and deliver an irrevocable general release (including, but not limited to, all matters relating to employment with the Company) in favor of the Company and its affiliates in such form as the Company shall reasonably request (the effective date of which shall be eight (8) days after the Executive delivers the signed release to the Company). Notwithstanding anything herein to the contrary, in the event such thirty- (30-) day period falls into two (2) calendar years, the payments contemplated in this Section 3.3 shall not commence until the second calendar year.

 

(c) The Severance Benefits shall terminate immediately upon the Executive violating any of the provisions of Article 4.

 

3.4 Cause. For purposes of this Agreement, “Cause” shall be deemed to exist upon any of the following events: (a) the Executive’s conviction of, or plea of nolo contendere, to a felony, (b) the Executive’s failure to substantially perform his essential job functions as appropriate for his position, (c) the failure of the Executive to adhere to directives of the Board, (d) the Executive’s material misconduct or gross negligence, (e) the Executive’s material violation of any Company policy, or (f) any material breach of this Agreement by the Executive. The Board must provide thirty (30) days written notice of its intent to terminate the Executive’s employment for Cause and if such grounds for Cause are curable, the Executive shall have thirty (30) days following the receipt of such written notice to cure such curable event that would otherwise constitute Cause; provided, however, the Company shall have the right to place the Executive on a paid leave of absence during any portion of such notice or cure periods.

 

 
4

 

    

3.5 Good Reason. For purposes of this Agreement, “Good Reason” shall be deemed to exist upon any of the following, without the Executive’s prior written consent: (a) a material reduction in the Base Salary, (b) a relocation of the Executive’s primary place of employment to a location more than fifty (50) miles from the Company’s New Jersey office location at the time of the Commencement Date, (c) any requirement that the Executive report to anyone other than the Board, (d) the Company provides a Non-Renewal Notice within one (1) year following a Change of Control (as defined below), or (e) any material breach of this Agreement by the Company. The Executive must provide the Company with written objection to the event or condition within thirty (30) days following the occurrence thereof, the Company shall have thirty (30) days following the receipt of such written notice to cure such curable event that would otherwise constitute Good Reason, and the Executive resigns his employment within ten (10) days following the expiration of that cure period.

 

3.6 Change of Control. For purposes of this Agreement, a “Change of Control” shall mean the occurrence of any of the following events:

 

(a) any “Person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the “Beneficial Owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities (excluding for this purpose any such voting securities held by the Company, or any affiliate, parent or subsidiary of the Company, or by any employee benefit plan of the Company) pursuant to a transaction or a series of related transactions; or

 

(b) a merger or consolidation of the Company or a subsidiary of the Company or an acquisition of assets or an entity by the Company or a subsidiary of the Company whether or not approved by the Board, other than a merger or consolidation or acquisition of assets or an entity which would result in the holders of the voting securities of the Company outstanding immediately prior thereto continuing to hold (either by remaining outstanding or by being converted into voting securities of the surviving entity or the parent of such corporation) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or parent of such entity, as the case may be, outstanding immediately after such merger or consolidation; or

 

(c) the sale or disposition by the Company of all or substantially all of the Company’s assets; or

 

(d) a change in the composition of the Board, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors” shall mean directors who either (A) are directors of the Company as of the date of this Agreement, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors, or by a committee of the Board made up of at least a majority of the Incumbent Directors, at the time of such election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors).

 

Notwithstanding the foregoing, a dividend or distribution to the Company’s stockholders of any or all of the shares of capital stock of a subsidiary of the Company shall not be deemed to constitute a Change of Control.

 

 
5

 

    

ARTICLE 4
RESTRICTIVE COVENANTS

 

4.1 Confidentiality and Nondisclosure. The Executive will not use or disclose to any individual or entity any Confidential Information (as defined below) except (a) in the performance of the Executive’s duties for the Company, (b) as authorized in writing by the Company, or (c) as required by subpoena or court order, provided that, prior written notice of such required disclosure is provided to the Company and, provided further that all reasonable efforts to preserve the confidentiality of such information shall be made. As used in this Agreement, “Confidential Information” shall mean information that (i) is used or potentially useful in the business of the Company, (ii) the Company treats as proprietary, private or confidential, and (iii) is not generally known to the public. “Confidential Information” includes, without limitation, information relating to the Company’s products or services, processing, manufacturing, marketing, selling, customer lists, call lists, customer data, memoranda, notes, records, technical data, sketches, plans, drawings, chemical formulae, trade secrets, composition of products, research and development data, sources of supply and material, operating and cost data, financial information, personnel department information and information contained in manuals or memoranda. “Confidential Information” also includes proprietary and/or confidential information of the Company’s customers, suppliers and trading partners who may share such information with the Company pursuant to a confidentiality agreement or otherwise. The Executive agrees to treat all such customer, supplier or trading partner information as “Confidential Information” hereunder. The foregoing restrictions on the use or disclosure of Confidential Information shall continue after the Executive’s employment terminates for any reason for so long as the information is not generally known to the public.

 

4.2 Defend Trade Secrets Act Information. The Executive acknowledges that, notwithstanding the foregoing limitations on the disclosure of trade secrets, the Executive may not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (a) is made (i) in confidence to a Federal, State or local government official, either directly or indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation of law, or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, if the Executive files a proceeding against the Company in connection with a report of a suspected legal violation, the Executive may disclose the trade secret to the attorney representing the Executive and use the trade secret in the court proceeding, if the Executive files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.

 

 
6

 

    

4.3 Non-Competition. In exchange for the Company’s agreement to provide the Executive Confidential Information of the Company, the Company providing such Confidential Information to the Executive, and the Company entering into and providing the compensation and benefits under this Agreement, the Executive will not, during the period of the Executive’s employment with the Company, and for a period of the greater of (i) one (1) year thereafter or (ii) while the Executive is receiving Severance Benefits (the “Restricted Period”), directly or indirectly, (a) engage in (as a principal, partner, director, officer, stockholder (except as permitted below), agent, employee, consultant or otherwise); or (b) be financially interested in, any entity materially engaged in any portion of the business of the Company within the territory served, or contemplated to be entered, by the Company on the date of such termination of employment. Nothing contained herein shall prevent the Executive from owning beneficially or of record not more than five percent (5%) of the outstanding equity securities of any entity whose equity securities are registered under the Securities Act of 1933, as amended, or are listed for trading on any recognizable United States or foreign stock exchange or market. The business of the Company shall be defined to include hydroponic farming of herbs and lettuces.

 

4.4 Non-Solicitation.

 

(a) In exchange for the Company’s agreement to provide the Executive Confidential Information of the Company, the Company providing such Confidential Information to the Executive, and the Company entering into and providing the compensation and benefits under this Agreement, during the Restricted Period, the Executive shall not, on behalf of the Executive or any other person (except on behalf of the Company), directly or indirectly, solicit, recruit or hire any (i) employee of the Company with whom the Executive had material contact during the Term, or (ii) former employee of the Company with whom the Executive had material contact during the Term and whose relationship with the Company was terminated less than twelve (12) months prior to the termination of the Executive’s employment, in each case for the purpose of being employed by, a consultant to or an independent contractor of, or otherwise providing services to, the Executive or any person on whose behalf the Executive is acting as an agent, representative, employee or otherwise.

 

(b) In exchange for the Company’s agreement to provide the Executive Confidential Information of the Company, the Company providing such Confidential Information to the Executive, and the Company entering into and providing the compensation and benefits under this Agreement, during the Restricted Period, the Executive shall not persuade or encourage or attempt to persuade or encourage any customer, client, partner, affiliate, supplier, or vendor of the Company of whom the Executive was aware or with whom the Executive had material contact to cease doing business with the Company or to compete with the Company on its own or to do business with any competitor of the Company.

  

 
7

 

  

4.5 Non-Disparagement.

 

(a) In exchange for the Company’s agreement to provide the Executive Confidential Information of the Company, the Company providing such Confidential Information to the Executive, and the Company entering into and providing the compensation and benefits under this Agreement, the Executive will not at any time during employment with the Company, or after the termination of employment with the Company, directly or indirectly (i) disparage, libel, defame, ridicule or make negative comments regarding, or encourage or induce others to disparage, libel, defame, ridicule or make negative comments regarding, the Company, or any of the Company’s officers, directors, employees or agents, or the Company’s products, services, business plans or methods; or (ii) engage in any conduct or encourage or induce any other person to engage in any conduct that is in any way injurious or potentially injurious to the reputation or interests of the Company or any of the Company’s, officers, directors, employees or agents.

 

(b) The Company and its officers, directors, employees or agents will not at any time during the Executive’s employment with the Company, or after the termination of employment with the Company, directly or indirectly (i) disparage, libel, defame, ridicule or make negative comments regarding, or encourage or induce others to disparage, libel, defame, ridicule or make negative comments regarding, the Executive; or (ii) engage in any conduct or encourage or induce any other person to engage in any conduct that is in any way injurious or potentially injurious to the reputation or interests of the Executive.

 

4.6 Survival of Termination Covenants. The Executive’s obligations under this Agreement shall survive the Executive’s termination of employment with the Company and the termination of this Agreement.

 

4.7 Equitable Relief. The Executive hereby acknowledges and agrees that the Company and its goodwill would be irreparably injured by, and that damages at law are an insufficient remedy for, a breach or violation of the provisions of this Agreement, and agrees that the Company, in addition to other remedies available to it for such breach shall be entitled to a preliminary injunction, temporary restraining order, or other equivalent relief, restraining the Executive from any actual breach of the provisions hereof, and that the Company’s rights to such equitable relief shall be cumulative and in addition to any other rights or remedies to which the Company may be entitled. Any breach of Section 4.1, 4.2, 4.3, 4.4 or 4.5 shall constitute a material breach of this Agreement.

 

 
8

 

    

ARTICLE 5
INVENTIONS

  

5.1 Transfer of Inventions. The Executive agrees to transfer, convey and assign and hereby transfers, conveys and assigns to the Company all of the Executive’s right, title and interest in and to Inventions (as defined below) made, designed, conceived, devised or discovered by the Executive during the Executive’s employment by the Company (regardless of whether they were discovered or developed as an employee or independent contractor of the Company or of any other person, firm or corporation and regardless of whether they were invented solely by the Executive or jointly with any other person or persons) which are (a) related in any manner to the actual or anticipated business, work, research, development or operations of the Company, or (b) made with the use of Confidential Information, time, materials or facilities of the Company. The rights conveyed to the Company include all rights to own, use and license any Invention, including all domestic and foreign patent rights, copyrights and rights, trade secrets, including all renewals of any of the foregoing. The Executive shall use the Executive’s best efforts to cause any person in conjunction with whom such Inventions were made to convey all of such person’s right, title and interest in and to such Inventions to the Company. The Executive shall promptly disclose to the Company all such Inventions and shall make, maintain and make available to the Company complete and up-to-date written records, including drawings, sketches, notes, memoranda or other evidence of such inventions, all of which shall be property of the Company. The provisions of this Article 5 shall apply to all Inventions conceived or developed during the Term whether or not further development or reduction to practice may take place after a termination of the Executive’s employment, for which purpose it shall be presumed that any Inventions conceived by the Executive which are reduced to practice within one (1) year after a termination of the Executive’s employment were conceived during the Term unless the Executive is able to establish a later conception date by clear and convincing evidence.

 

5.2 Execution of Documents. The Executive shall from time to time, both during and after the Term, execute, and shall use reasonable efforts to cause others having rights in any Invention described in this Article 5 to execute, including applications for letters patent, copyright registrations and assignments thereof, and shall perform all other acts as may be reasonably deemed by the Company to be necessary or desirable to effect the provisions of this Agreement or to enable the Company or its nominees to secure patent protection, copyright registration and legal title in and to any of the aforementioned Inventions; provided, however, that all expenses for filing or prosecuting and such applications shall be borne solely by the Company. In the event that the Company is unable for any reason whatsoever after reasonable effort to secure the Executive’s signature to any document reasonably necessary or appropriate for any of the foregoing purposes the Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the Executive’s agents and attorneys-in-fact to act for the Executive and on the Executive’s behalf, but only for the purpose of executing and filing any such documents and doing all other lawfully permitted acts to accomplish the foregoing purposes with the same legal force and effect as if executed by the Executive.

 

5.3 Definition of Invention. For purposes of this Article 5, the term “Invention” shall include discoveries, concepts, ideas, formulas, products, processes, devices, methods, works and writings, inventions, improvements, designs, systems, developments, “know-how,” suggestions, devices and trade secrets or improvements of any of the foregoing, whether patentable or not.

 

 
9

 

    

ARTICLE 6
MISCELLANEOUS

 

6.1 Entire Agreement. This Agreement contains the entire understanding of the Company and the Executive with respect to the subject matter hereof. This Agreement supersedes and replaces any prior oral or written employment, severance or similar agreement between the Executive and the Company.

 

6.2 Subsidiaries. Where appropriate in this Agreement, the term “Company” shall also include any direct or indirect subsidiaries of the Company.

 

6.3 Code Sections 409A and 280G.

 

(a) In the event that the payments or benefits set forth in Article 3 constitute “non-qualified deferred compensation” subject to Section 409A of the Code and the regulations and guidance promulgated thereunder (collectively, “Section 409A”), then the following conditions apply to such payments or benefits:

 

(i) Any termination of the Executive’s employment triggering payment of benefits under Article 3 must constitute a “separation from service” under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h) before distribution of such benefits can commence. To the extent that the termination of the Executive’s employment does not constitute a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h) (as the result of further services that are reasonably anticipated to be provided by the Executive to the Company at the time the Executive’s employment terminates), any such payments under Article 3 that constitute deferred compensation under Section 409A shall be delayed until after the date of a subsequent event constituting a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h). For purposes of clarification, this Section 6.3(a)(i) shall not cause any forfeiture of benefits on the Executive’s part, but shall only act as a delay until such time as a “separation from service” occurs.

 

(ii) Notwithstanding any other provision with respect to the timing of payments under Article 3 if, at the time of the Executive’s termination, the Executive is deemed to be a “specified employee” of the Company (within the meaning of Section 409A(a)(2)(B)(i) of the Code), then limited only to the extent necessary to comply with the requirements of Section 409A, any payments to which the Executive may become entitled under Article 3 which are subject to Section 409A (and not otherwise exempt from its application) shall be withheld until the first (1st) business day of the seventh (7th) month following the termination of the Executive’s employment, at which time the Executive shall be paid an aggregate amount equal to the accumulated, but unpaid, payments otherwise due to the Executive under the terms of Article 3.

 

 
10

 

    

(iii) It is intended that each installment of the payments and benefits provided under Article 3 shall be treated as a separate “payment” for purposes of Section 409A. Neither the Company nor the Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A.

 

(iv) Notwithstanding any other provision of this Agreement to the contrary, this Agreement shall be interpreted and at all times administered in a manner that avoids the inclusion of compensation in income under Section 409A, or the payment of increased taxes or other penalties or interest under Section 409A. The parties intend this Agreement to be in compliance with Section 409A. The Executive acknowledges and agrees that the Company does not guarantee the tax treatment or tax consequences associated with any payment or benefit arising under this Agreement, including but not limited to consequences related to Section 409A.

 

(b) If any payment or benefit the Executive would receive under this Agreement, when combined with any other payment or benefit the Executive receives pursuant to a Change of Control (for purposes of this section, a “Payment”) would: (i) constitute a “parachute payment” within the meaning of Section 280G the Code; and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be either: (A) the full amount of such Payment; or (B) such lesser amount (with cash payments being reduced before stock option compensation) as would result in no portion of the Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local employments taxes, income taxes, and the Excise Tax, results in the Executive’s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.

 

6.4 Severability. It is mutually agreed and understood by the parties that should any of the restrictions and covenants contained in Article 4 be determined by any court of competent jurisdiction to be invalid by virtue of being vague, overly broad, unreasonable as to time, territory or otherwise, then this Agreement shall be amended retroactive to the date of its execution to include the terms and conditions which such court deems to be reasonable and in conformity with the original intent of the parties and the parties hereto consent that under such circumstances, such court shall have the power and authority to determine what is reasonable and in conformity with the original intent of the parties to the extent that such restrictions and covenants are enforceable. In the event any other provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Agreement, and this Agreement shall be construed and enforced as if the illegal or invalid provision had not been included.

 

 
11

 

    

6.5 Modification. No provision of this Agreement may be modified, waived, or discharged unless such modification, waiver, or discharge is agreed to in writing and signed by the Executive and by an authorized officer of the Company on the Company’s behalf, or by the respective parties’ legal representations and successors.

 

6.6 Dispute Resolution & Applicable Law. All disputes regarding this agreement shall be resolved by arbitration to be administered by the American Association of Arbitration. To the extent not preempted by the laws of the United States, the terms and provisions of this agreement are governed by and shall be interpreted in accordance with, the laws of Delaware, without giving effect to any choice of law principles.

 

6.7 Successors and Assigns. This Agreement shall inure to the benefit of and be enforceable by the Company’s successors and/or assigns and shall be enforceable by the Executive against the Company’s successors and assigns.

 

6.8 Headings/References. The headings in this Agreement are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect the meaning thereof. References to Articles and Sections refer to Articles and Sections of this Agreement unless otherwise indicated.

 

6.9 Indemnification. As additional consideration for the Executive’s agreement to perform the duties outlined herein, the Executive shall be indemnified and held harmless by the Company for any and all claims, costs or expenses including legal fees and advancement of expenses, except in the case of willful, reckless or grossly negligent misconduct, for any activity in any suit brought against him or the Company for actions undertaken by the Executive on behalf of the Company to the maximum extent provided by law, regardless of whether such indemnification is specifically authorized by statute, the Company’s Articles of Incorporation or Bylaws or any other agreement.

  

 
12

 

    

6.10 Notices. Any notice, request, instruction, or other document to be given hereunder shall be in writing and shall be deemed to have been given: (a) on the day of receipt, if sent by overnight courier; (b) upon receipt, if given in person; (c) five days after being deposited in the mail, certified or registered mail, postage prepaid, and in any case addressed as follows:

 

If to the Company:

 

283 County Road 519

Belvidere, NJ 07823

Attn: Chairman of the Board of Directors

 

If to the Executive:

 

James E. Kras

XXXXXX

XXXXXX

 

or to such other address or to the attention of such other person as the recipient party has specified by prior written notice to the sending party.

 

6.11 Counterparts. This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

[Signatures on following page.]

  

 
13

 

   

IN WITNESS WHEREOF, the parties have executed this Agreement on the date first set forth above.

 

 

EDIBLE GARDEN AG INCORPORATED

       
By: /s/ Dennis Rodrigues

 

Name:

Dennis Rodrigues  
  Title: Board Director  
       

 

EXECUTIVE

 

 

 

 

 

/s/ James E. Kras

 

 

James Kras,

Chief Executive Officer

 

 

 
14

 

EXHIBIT 10.16

 

EXECUTIVE EMPLOYMENT AGREEMENT

  

THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered effective as of August 18, 2021, by and between Edible Garden AG Incorporated, a Delaware Corporation (the “Company”), and Michael James (the “Executive”).

 

W I T N E S S E T H:

 

WHEREAS, the Board of Directors of the Company (the “Board”) has approved the Company entering into an employment agreement with the Executive; and

 

WHEREAS, the Executive is now the Chief Financial Officer of the Company; and

 

WHEREAS, the Company and the Executive would like to set forth the terms of the Executive’s continued employment;

 

NOW THEREFORE, in consideration of the recitals and the mutual agreements herein set forth, the Company and the Executive agree as follows:

 

ARTICLE 1
EMPLOYMENT AND TERM

 

1.1 Employment. The Company hereby employs the Executive and the Executive accepts employment as the Chief Financial Officer of the Company. As Chief Financial Officer, the Executive shall render such services to the Company as are customarily rendered by a comparable officer of comparable companies and as required by the Certificate of Incorporation and By-laws of the Company. The Executive accepts such employment and, consistent with fiduciary standards which exist between an employer and an employee, shall perform and discharge the duties commensurate with his position that may be assigned to him from time to time by the Board.

 

1.2 Term and Renewal. The term of this Agreement shall commence on the date first written above (the “Commencement Date”), and shall continue for a term of two (2) years (the “Initial Term”); provided, however, that commencing on the second (2nd) anniversary of the Commencement Date and on each anniversary of the Commencement Date thereafter (each, an “Extension Date”), the term of the Executive’s employment under this Agreement shall be automatically extended for an additional one (1) year period (each, a “Renewal Term”), unless the Company or the Executive provides the other at least ninety (90) days prior written notice before the next Extension Date that the Initial Term or Renewal Term, as applicable, shall not be extended (a “Non-Renewal Notice”). The period of time between the Commencement Date and the termination of this Agreement shall be referred to herein as the “Term.”

  

 
1

 

    

ARTICLE 2
COMPENSATION AND BENEFITS

 

2.1 Base Salary. During the Term, the Company shall pay the Executive an annual base salary of Three Hundred Thousand Dollars ($300,000) (or any increased amount approved by the Board or the Compensation Committee of the Board (the “Compensation Committee”)), payable in accordance with the Company’s standard payroll practices for senior executives (the “Base Salary”).

 

2.2 Annual Performance Bonus. During the Term, the Executive shall be eligible to receive an annual cash bonus (the “Annual Performance Bonus”), with the target amount of such Annual Performance Bonus equal to one hundred percent (100%) of the Base Salary (the “Target Performance Bonus”) in the year to which the Annual Performance Bonus relates; provided that the actual amount of the Annual Performance Bonus may be greater or less than the Target Performance Bonus. The Annual Performance Bonus shall be based on performance and achievement of Company goals and objectives as defined by the Board or Compensation Committee. The amount of the Annual Performance Bonus shall be determined by the Board or Compensation Committee in its sole discretion, and shall be paid to the Executive no later than March 15th of the calendar year immediately following the calendar year to which it relates.

 

2.3 Transaction Bonus. The Executive shall be entitled to a special cash bonus (the “Transaction Bonus”) upon the first to occur of the completion of an IPO (as defined below) or the closing of a SPAC Transaction (as defined below). The Transaction Bonus shall be equal to $700,000. The Transaction Bonus, if any, will not be deemed “earned” until the date that that the IPO or SPAC Transaction closes. Accordingly, the Executive must be employed by the Company on the date that the IPO or SPAC Transaction closes in order to be eligible to receive payment of the Transaction Bonus. Payment of the Transaction Bonus, less applicable tax withholding, will be made with the first normal payroll period that follows the completion of the IPO or SPAC Transaction. For purposes of this Agreement, (a) ”IPO” shall mean the first sale of equity securities of the Company through a firm underwritten public offering under a registration statement on Form S-1 pursuant to the Securities Act of 1933, as amended, that results in the Company’s securities being listed on a national securities exchange, and (b) ”SPAC Transaction” shall mean the closing of a transaction contemplated by a business combination agreement between the Company and a special purpose acquisition company that results in the surviving corporation’s securities being listed on a national securities exchange.

 

2.4 Paid Time Off. During the Term, the Executive shall be entitled to four (4) weeks paid time off pursuant to the terms and conditions of the Company’s policy and practices as applied to the Company’s senior executives.

 

 
2

 

    

2.5 Health & Welfare Benefits. During the Term, the Executive shall be eligible to participate in all health and welfare benefits provided generally to other employees of the Company.

 

2.6 Retirement Benefits. During the Term, the Executive shall be eligible to participate in all retirement benefits provided generally to other employees of the Company.

 

ARTICLE 3
TERMINATION OF EMPLOYMENT & SEVERANCE BENEFITS

 

3.1 Termination for Cause, Resignation without Good Reason, Death, or Disability. If, during the Term, (a) the Executive’s employment is terminated by the Company for Cause (as defined below), (b) the Executive resigns without Good Reason (as defined below), or (c) the Executive’s employment with the Company ends due to the Executive’s death or “permanent and total disability” (within the meaning Section 22(e)(3) of Internal Revenue Code of 1986, as amended (the “Code”)), then the Executive shall only be entitled to any earned but unpaid Base Salary, as well as any other amounts or benefits owed to the Executive under the terms of any employee benefit plan of the Company (the “Accrued Benefits”). For purposes of this Agreement, the Accrued Benefits shall include any accrued paid time off pursuant to the Company’s policy and practices. The Accrued Benefits shall be payable upon the Executive’s termination within the time provided by law.

 

3.2 Termination without Cause or Resignation for Good Reason. If, during the Term: (a) the Executive’s employment with the Company is terminated by the Company other than for Cause, or (b) the Executive resigns for Good Reason (a “Qualified Termination”), then the Executive shall be entitled to the Accrued Benefits and the Severance Benefits described in Section 3.3.

 

3.3 Severance Benefits.

 

(a) In the event of a Qualified Termination, the Company shall pay and provide the Executive with the following (the “Severance Benefits”):

 

(i) two (2) times the Executive’s then current Base Salary, less any taxes and withholding as may be necessary pursuant to law, to be paid in accordance with the Company’s normal payroll practices, but in no event less frequently than monthly, beginning with the first normal payroll period after the effective date of the release referred to in Section 3.3(b);

 

(ii) a pro-rated Target Performance Bonus for the calendar year in which the Qualified Termination occurs based on the number of days from the beginning of the calendar year through the date of the Qualified Termination, less all amounts required to be deducted or withheld under applicable law or under any employee benefit plan in which the Executive participates, which bonus will be paid with the first normal payroll period after the effective date of the release referred to in Section 3.3(b);

  

 
3

 

   

(iii) vesting of the Executive’s outstanding and unvested stock options will accelerate and become fully vested, and the Executive may exercise the outstanding stock options until the expiration date of such stock options, and the restrictions applicable to the Executive’s outstanding awards of restricted stock and restricted stock units will lapse and become fully vested; and

 

(iv) an aggregate amount equal to the applicable monthly premium for the Executive’s group medical, dental, and vision coverage (for the coverage tier in which the Executive was enrolled at the time of the Executive’s termination) at the rate in effect (as determined under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”)) at the time of the Executive’s termination, multiplied by twelve (12), which aggregate amount will be paid with the first normal payroll period after the effective date of the release referred to in Section 3.3(b).

 

(b) As a condition to receiving the Severance Benefits contemplated by this Section 3.3, within thirty (30) days after the effective date of the Qualified Termination, the Executive shall execute and deliver an irrevocable general release (including, but not limited to, all matters relating to employment with the Company) in favor of the Company and its affiliates in such form as the Company shall reasonably request (the effective date of which shall be eight (8) days after the Executive delivers the signed release to the Company). Notwithstanding anything herein to the contrary, in the event such thirty- (30-) day period falls into two (2) calendar years, the payments contemplated in this Section 3.3 shall not commence until the second calendar year.

 

(c) The Severance Benefits shall terminate immediately upon the Executive violating any of the provisions of Article 4.

 

3.4 Cause. For purposes of this Agreement, “Cause” shall be deemed to exist upon any of the following events: (a) the Executive’s conviction of, or plea of nolo contendere, to a felony, (b) the Executive’s failure to substantially perform his essential job functions as appropriate for his position, (c) the failure of the Executive to adhere to directives of the Board, (d) the Executive’s material misconduct or gross negligence, (e) the Executive’s material violation of any Company policy, or (f) any material breach of this Agreement by the Executive. The Board must provide thirty (30) days written notice of its intent to terminate the Executive’s employment for Cause and if such grounds for Cause are curable, the Executive shall have thirty (30) days following the receipt of such written notice to cure such curable event that would otherwise constitute Cause; provided, however, the Company shall have the right to place the Executive on a paid leave of absence during any portion of such notice or cure periods.

 

 
4

 

      

3.5 Good Reason. For purposes of this Agreement, “Good Reason” shall be deemed to exist upon any of the following, without the Executive’s prior written consent: (a) a material reduction in the Base Salary, (b) a relocation of the Executive’s primary place of employment to a location more than fifty (50) miles from the Company’s New Jersey office location at the time of the Commencement Date, (c) any requirement that the Executive report to anyone other than the Board, (d) the Company provides a Non-Renewal Notice within one (1) year following a Change of Control (as defined below), or (e) any material breach of this Agreement by the Company. The Executive must provide the Company with written objection to the event or condition within thirty (30) days following the occurrence thereof, the Company shall have thirty (30) days following the receipt of such written notice to cure such curable event that would otherwise constitute Good Reason, and the Executive resigns his employment within ten (10) days following the expiration of that cure period.

 

3.6 Change of Control. For purposes of this Agreement, a “Change of Control” shall mean the occurrence of any of the following events:

 

(a) any “Person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the “Beneficial Owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities (excluding for this purpose any such voting securities held by the Company, or any affiliate, parent or subsidiary of the Company, or by any employee benefit plan of the Company) pursuant to a transaction or a series of related transactions; or

 

(b) a merger or consolidation of the Company or a subsidiary of the Company or an acquisition of assets or an entity by the Company or a subsidiary of the Company whether or not approved by the Board, other than a merger or consolidation or acquisition of assets or an entity which would result in the holders of the voting securities of the Company outstanding immediately prior thereto continuing to hold (either by remaining outstanding or by being converted into voting securities of the surviving entity or the parent of such corporation) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or parent of such entity, as the case may be, outstanding immediately after such merger or consolidation; or

 

(c) the sale or disposition by the Company of all or substantially all of the Company’s assets; or

 

(d) a change in the composition of the Board, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors” shall mean directors who either (A) are directors of the Company as of the date of this Agreement, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors, or by a committee of the Board made up of at least a majority of the Incumbent Directors, at the time of such election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors).

 

Notwithstanding the foregoing, a dividend or distribution to the Company’s stockholders of any or all of the shares of capital stock of a subsidiary of the Company shall not be deemed to constitute a Change of Control.

 

 
5

 

      

ARTICLE 4
RESTRICTIVE COVENANTS

 

4.1 Confidentiality and Nondisclosure. The Executive will not use or disclose to any individual or entity any Confidential Information (as defined below) except (a) in the performance of the Executive’s duties for the Company, (b) as authorized in writing by the Company, or (c) as required by subpoena or court order, provided that, prior written notice of such required disclosure is provided to the Company and, provided further that all reasonable efforts to preserve the confidentiality of such information shall be made. As used in this Agreement, “Confidential Information” shall mean information that (i) is used or potentially useful in the business of the Company, (ii) the Company treats as proprietary, private or confidential, and (iii) is not generally known to the public. “Confidential Information” includes, without limitation, information relating to the Company’s products or services, processing, manufacturing, marketing, selling, customer lists, call lists, customer data, memoranda, notes, records, technical data, sketches, plans, drawings, chemical formulae, trade secrets, composition of products, research and development data, sources of supply and material, operating and cost data, financial information, personnel department information and information contained in manuals or memoranda. “Confidential Information” also includes proprietary and/or confidential information of the Company’s customers, suppliers and trading partners who may share such information with the Company pursuant to a confidentiality agreement or otherwise. The Executive agrees to treat all such customer, supplier or trading partner information as “Confidential Information” hereunder. The foregoing restrictions on the use or disclosure of Confidential Information shall continue after the Executive’s employment terminates for any reason for so long as the information is not generally known to the public.

 

4.2 Defend Trade Secrets Act Information. The Executive acknowledges that, notwithstanding the foregoing limitations on the disclosure of trade secrets, the Executive may not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (a) is made (i) in confidence to a Federal, State or local government official, either directly or indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation of law, or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, if the Executive files a proceeding against the Company in connection with a report of a suspected legal violation, the Executive may disclose the trade secret to the attorney representing the Executive and use the trade secret in the court proceeding, if the Executive files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.

 

 
6

 

    

4.3 Non-Competition. In exchange for the Company’s agreement to provide the Executive Confidential Information of the Company, the Company providing such Confidential Information to the Executive, and the Company entering into and providing the compensation and benefits under this Agreement, the Executive will not, during the period of the Executive’s employment with the Company, and for a period of the greater of (i) one (1) year thereafter or (ii) the period the Executive is receiving Severance Benefits (the “Restricted Period”), directly or indirectly, (a) engage in (as a principal, partner, director, officer, stockholder (except as permitted below), agent, employee, consultant or otherwise); or (b) be financially interested in, any entity materially engaged in any portion of the business of the Company within the territory served, or contemplated to be entered, by the Company on the date of such termination of employment. Nothing contained herein shall prevent the Executive from owning beneficially or of record not more than five percent (5%) of the outstanding equity securities of any entity whose equity securities are registered under the Securities Act of 1933, as amended, or are listed for trading on any recognizable United States or foreign stock exchange or market. The business of the Company shall be defined to include hydroponic farming of herbs and lettuces.

 

4.4 Non-Solicitation.

 

(a) In exchange for the Company’s agreement to provide the Executive Confidential Information of the Company, the Company providing such Confidential Information to the Executive, and the Company entering into and providing the compensation and benefits under this Agreement, during the Restricted Period, the Executive shall not, on behalf of the Executive or any other person (except on behalf of the Company), directly or indirectly, solicit, recruit or hire any (i) employee of the Company with whom the Executive had material contact during the Term, or (ii) former employee of the Company with whom the Executive had material contact during the Term and whose relationship with the Company was terminated less than twelve (12) months prior to the termination of the Executive’s employment, in each case for the purpose of being employed by, a consultant to or an independent contractor of, or otherwise providing services to, the Executive or any person on whose behalf the Executive is acting as an agent, representative, employee or otherwise.

 

(b) In exchange for the Company’s agreement to provide the Executive Confidential Information of the Company, the Company providing such Confidential Information to the Executive, and the Company entering into and providing the compensation and benefits under this Agreement, during the Restricted Period, the Executive shall not persuade or encourage or attempt to persuade or encourage any customer, client, partner, affiliate, supplier, or vendor of the Company of whom the Executive was aware or with whom the Executive had material contact to cease doing business with the Company or to compete with the Company on its own or to do business with any competitor of the Company.

 

 
7

 

    

4.5 Non-Disparagement.

 

(a) In exchange for the Company’s agreement to provide the Executive Confidential Information of the Company, the Company providing such Confidential Information to the Executive, and the Company entering into and providing the compensation and benefits under this Agreement, the Executive will not at any time during employment with the Company, or after the termination of employment with the Company, directly or indirectly (i) disparage, libel, defame, ridicule or make negative comments regarding, or encourage or induce others to disparage, libel, defame, ridicule or make negative comments regarding, the Company, or any of the Company’s officers, directors, employees or agents, or the Company’s products, services, business plans or methods; or (ii) engage in any conduct or encourage or induce any other person to engage in any conduct that is in any way injurious or potentially injurious to the reputation or interests of the Company or any of the Company’s, officers, directors, employees or agents.

 

(b) The Company and its officers, directors, employees or agents will not at any time during the Executive’s employment with the Company, or after the termination of employment with the Company, directly or indirectly (i) disparage, libel, defame, ridicule or make negative comments regarding, or encourage or induce others to disparage, libel, defame, ridicule or make negative comments regarding, the Executive; or (ii) engage in any conduct or encourage or induce any other person to engage in any conduct that is in any way injurious or potentially injurious to the reputation or interests of the Executive.

 

4.6 Survival of Termination Covenants. The Executive’s obligations under this Agreement shall survive the Executive’s termination of employment with the Company and the termination of this Agreement.

 

4.7 Equitable Relief. The Executive hereby acknowledges and agrees that the Company and its goodwill would be irreparably injured by, and that damages at law are an insufficient remedy for, a breach or violation of the provisions of this Agreement, and agrees that the Company, in addition to other remedies available to it for such breach shall be entitled to a preliminary injunction, temporary restraining order, or other equivalent relief, restraining the Executive from any actual breach of the provisions hereof, and that the Company’s rights to such equitable relief shall be cumulative and in addition to any other rights or remedies to which the Company may be entitled. Any breach of Section 4.1, 4.2, 4.3, 4.4 or 4.5 shall constitute a material breach of this Agreement.

 

 
8

 

    

ARTICLE 5
INVENTIONS

   

5.1 Transfer of Inventions. The Executive agrees to transfer, convey and assign and hereby transfers, conveys and assigns to the Company all of the Executive’s right, title and interest in and to Inventions (as defined below) made, designed, conceived, devised or discovered by the Executive during the Executive’s employment by the Company (regardless of whether they were discovered or developed as an employee or independent contractor of the Company or of any other person, firm or corporation and regardless of whether they were invented solely by the Executive or jointly with any other person or persons) which are (a) related in any manner to the actual or anticipated business, work, research, development or operations of the Company, or (b) made with the use of Confidential Information, time, materials or facilities of the Company. The rights conveyed to the Company include all rights to own, use and license any Invention, including all domestic and foreign patent rights, copyrights and rights, trade secrets, including all renewals of any of the foregoing. The Executive shall use the Executive’s best efforts to cause any person in conjunction with whom such Inventions were made to convey all of such person’s right, title and interest in and to such Inventions to the Company. The Executive shall promptly disclose to the Company all such Inventions and shall make, maintain and make available to the Company complete and up-to-date written records, including drawings, sketches, notes, memoranda or other evidence of such inventions, all of which shall be property of the Company. The provisions of this Article 5 shall apply to all Inventions conceived or developed during the Term whether or not further development or reduction to practice may take place after a termination of the Executive’s employment, for which purpose it shall be presumed that any Inventions conceived by the Executive which are reduced to practice within one (1) year after a termination of the Executive’s employment were conceived during the Term unless the Executive is able to establish a later conception date by clear and convincing evidence.

 

5.2 Execution of Documents. The Executive shall from time to time, both during and after the Term, execute, and shall use reasonable efforts to cause others having rights in any Invention described in this Article 5 to execute, including applications for letters patent, copyright registrations and assignments thereof, and shall perform all other acts as may be reasonably deemed by the Company to be necessary or desirable to effect the provisions of this Agreement or to enable the Company or its nominees to secure patent protection, copyright registration and legal title in and to any of the aforementioned Inventions; provided, however, that all expenses for filing or prosecuting and such applications shall be borne solely by the Company. In the event that the Company is unable for any reason whatsoever after reasonable effort to secure the Executive’s signature to any document reasonably necessary or appropriate for any of the foregoing purposes the Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the Executive’s agents and attorneys-in-fact to act for the Executive and on the Executive’s behalf, but only for the purpose of executing and filing any such documents and doing all other lawfully permitted acts to accomplish the foregoing purposes with the same legal force and effect as if executed by the Executive.

 

5.3 Definition of Invention. For purposes of this Article 5, the term “Invention” shall include discoveries, concepts, ideas, formulas, products, processes, devices, methods, works and writings, inventions, improvements, designs, systems, developments, “know-how,” suggestions, devices and trade secrets or improvements of any of the foregoing, whether patentable or not.

 

 
9

 

    

ARTICLE 6
MISCELLANEOUS

 

6.1 Entire Agreement. This Agreement contains the entire understanding of the Company and the Executive with respect to the subject matter hereof. This Agreement supersedes and replaces any prior oral or written employment, severance or similar agreement between the Executive and the Company.

 

6.2 Subsidiaries. Where appropriate in this Agreement, the term “Company” shall also include any direct or indirect subsidiaries of the Company.

 

6.3 Code Sections 409A and 280G.

 

(a) In the event that the payments or benefits set forth in Article 3 constitute “non-qualified deferred compensation” subject to Section 409A of the Code and the regulations and guidance promulgated thereunder (collectively, “Section 409A”), then the following conditions apply to such payments or benefits:

 

(i) Any termination of the Executive’s employment triggering payment of benefits under Article 3 must constitute a “separation from service” under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h) before distribution of such benefits can commence. To the extent that the termination of the Executive’s employment does not constitute a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h) (as the result of further services that are reasonably anticipated to be provided by the Executive to the Company at the time the Executive’s employment terminates), any such payments under Article 3 that constitute deferred compensation under Section 409A shall be delayed until after the date of a subsequent event constituting a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h). For purposes of clarification, this Section 6.3(a)(i) shall not cause any forfeiture of benefits on the Executive’s part, but shall only act as a delay until such time as a “separation from service” occurs.

 

(ii) Notwithstanding any other provision with respect to the timing of payments under Article 3 if, at the time of the Executive’s termination, the Executive is deemed to be a “specified employee” of the Company (within the meaning of Section 409A(a)(2)(B)(i) of the Code), then limited only to the extent necessary to comply with the requirements of Section 409A, any payments to which the Executive may become entitled under Article 3 which are subject to Section 409A (and not otherwise exempt from its application) shall be withheld until the first (1st) business day of the seventh (7th) month following the termination of the Executive’s employment, at which time the Executive shall be paid an aggregate amount equal to the accumulated, but unpaid, payments otherwise due to the Executive under the terms of Article 3.

 

 
10

 

    

(iii) It is intended that each installment of the payments and benefits provided under Article 3 shall be treated as a separate “payment” for purposes of Section 409A. Neither the Company nor the Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A.

 

(iv) Notwithstanding any other provision of this Agreement to the contrary, this Agreement shall be interpreted and at all times administered in a manner that avoids the inclusion of compensation in income under Section 409A, or the payment of increased taxes or other penalties or interest under Section 409A. The parties intend this Agreement to be in compliance with Section 409A. The Executive acknowledges and agrees that the Company does not guarantee the tax treatment or tax consequences associated with any payment or benefit arising under this Agreement, including but not limited to consequences related to Section 409A.

 

(b) If any payment or benefit the Executive would receive under this Agreement, when combined with any other payment or benefit the Executive receives pursuant to a Change of Control (for purposes of this section, a “Payment”) would: (i) constitute a “parachute payment” within the meaning of Section 280G the Code; and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be either: (A) the full amount of such Payment; or (B) such lesser amount (with cash payments being reduced before stock option compensation) as would result in no portion of the Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local employments taxes, income taxes, and the Excise Tax, results in the Executive’s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.

 

6.4 Severability. It is mutually agreed and understood by the parties that should any of the restrictions and covenants contained in Article 4 be determined by any court of competent jurisdiction to be invalid by virtue of being vague, overly broad, unreasonable as to time, territory or otherwise, then this Agreement shall be amended retroactive to the date of its execution to include the terms and conditions which such court deems to be reasonable and in conformity with the original intent of the parties and the parties hereto consent that under such circumstances, such court shall have the power and authority to determine what is reasonable and in conformity with the original intent of the parties to the extent that such restrictions and covenants are enforceable. In the event any other provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Agreement, and this Agreement shall be construed and enforced as if the illegal or invalid provision had not been included.

 

 
11

 

    

6.5 Modification. No provision of this Agreement may be modified, waived, or discharged unless such modification, waiver, or discharge is agreed to in writing and signed by the Executive and by an authorized officer of the Company on the Company’s behalf, or by the respective parties’ legal representations and successors.

 

6.6 Dispute Resolution & Applicable Law. All disputes regarding this agreement shall be resolved by arbitration to be administered by the American Association of Arbitration. To the extent not preempted by the laws of the United States, the terms and provisions of this agreement are governed by and shall be interpreted in accordance with, the laws of Delaware, without giving effect to any choice of law principles.

 

6.7 Successors and Assigns. This Agreement shall inure to the benefit of and be enforceable by the Company’s successors and/or assigns and shall be enforceable by the Executive against the Company’s successors and assigns.

 

6.8 Headings/References. The headings in this Agreement are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect the meaning thereof. References to Articles and Sections refer to Articles and Sections of this Agreement unless otherwise indicated.

 

6.9 Indemnification. As additional consideration for the Executive’s agreement to perform the duties outlined herein, the Executive shall be indemnified and held harmless by the Company for any and all claims, costs or expenses including legal fees and advancement of expenses, except in the case of willful, reckless or grossly negligent misconduct, for any activity in any suit brought against him or the Company for actions undertaken by the Executive on behalf of the Company to the maximum extent provided by law, regardless of whether such indemnification is specifically authorized by statute, the Company’s Articles of Incorporation or Bylaws or any other agreement.

 

 
12

 

    

6.10 Notices. Any notice, request, instruction, or other document to be given hereunder shall be in writing and shall be deemed to have been given: (a) on the day of receipt, if sent by overnight courier; (b) upon receipt, if given in person; (c) five days after being deposited in the mail, certified or registered mail, postage prepaid, and in any case addressed as follows:

 

If to the Company:

 

283 County Road 519

Belvidere, NJ 07823

Attn: Chairman of the Board of Directors

 

If to the Executive:

 

Michael James

XXXXXX

XXXXXX

 

or to such other address or to the attention of such other person as the recipient party has specified by prior written notice to the sending party.

 

6.11 Counterparts. This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

[Signatures on following page.]

  

 
13

 

   

IN WITNESS WHEREOF, the parties have executed this Agreement on the date first set forth above.

 

 

EDIBLE GARDEN AG INCORPORATED

       
By: /s/ Dennis Rodrigues

 

Name:

Dennis Rodrigues  
  Title: Board Director  
       

 

EXECUTIVE

 

 

 

 

 

/s/ Michael James

 

 

Michael James, Chief Financial Officer

 

 

 
14

EXHIBIT 10.17

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of October 7, 2021, between Edible Garden AG Incorporated, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company.

 

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

 

1.1 Definitions. In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Notes (as defined herein), and (b) the following terms have the meanings set forth in this Section 1.1:

 

Acquiring Person” shall have the meaning ascribed to such term in Section 4.7.

 

Action” shall have the meaning ascribed to such term in Section 3.1(j).

 

Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

Board of Directors” means the board of directors of the Company.

 

Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

Closing Date” means, with respect to each Closing, the Business Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto in connection with such Closing, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount and (ii) the Company’s obligations to deliver the Securities as to such Closing, in each case, have been satisfied or waived.

 

Closing” means each closing of the purchase and sale of the Securities pursuant to Section 2.1.

 

Commission” means the United States Securities and Exchange Commission.

 

Common Stock” means the common stock, par value $0.0001 per share, of the Company and any other class of securities into which such securities may hereafter be reclassified or changed.

  

 
1

 

    

Common Stock Equivalents” means any securities of the Company or the Subsidiaries that would entitle the holder thereof to acquire at any time shares of Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common Stock.

 

Company Counsel” means Harter Secrest & Emery LLP, with offices located at 1600 Bausch & Lomb Place, Rochester, New York 14604.

 

Conversion Price” shall have the meaning ascribed to such term in the Notes.

 

Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of the Notes.

 

Disclosure Schedules” shall have the meaning ascribed to such term in Section 3.1.

 

Evaluation Date” shall have the meaning ascribed to such term in Section 3.1(r).

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

Exempt Issuance” means the issuance of (a) shares of Common Stock or options to employees, officers, directors or consultants of the Company pursuant to the Company’s existing stock option and/or restricted stock plans or stock option and/or restricted stock plans which way come into effect following the date hereof, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock, issued and outstanding on the date of this Agreement, or pursuant to other agreements of the Company existing prior to the date hereof and listed on Schedule 3.1(g), provided that such securities and/or agreements have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.

 

Factoring Agreement” means the Accounts Receivable Purchasing Agreement, dated as of March 30, 2021, by and between the Company and Quasar Capital Partners, LLC.

 

FCPA” means the Foreign Corrupt Practices Act of 1977, as amended.

 

GAAP” shall have the meaning ascribed to such term in Section 3.1(h).

 

Guaranty and Security Agreement” means the Guaranty and Security Agreement dated the date hereof among the Company, each Subsidiary of the Company and Evergreen Capital Management LLC, as collateral agent, substantially in the form of Exhibit C hereto.

 

Intellectual Property Rights” shall have the meaning ascribed to such term in Section 3.1(o).

    

 
2

 

       

Intercreditor Agreement” means the Intercreditor Agreement dated the date hereof among Sament Capital Investments, Inc., the Company and Evergreen Capital Management LLC, as collateral agent for the Purchasers, substantially in the form of Exhibit E hereto.

 

IPO” means the consummation of the first underwritten public offering of Common Stock under the Securities Act.

 

Legend Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).

 

Liens” means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

Material Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

Material Permits” shall have the meaning ascribed to such term in Section 3.1(m).

 

Maximum Rate” shall have the meaning ascribed to such term in Section 5.17.

 

Notes” shall mean all of the Notes issued or issuable pursuant to this Agreement, substantially in the form of Exhibit A hereto.

 

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.

 

Public Information Failure” shall have the meaning ascribed to such term in Section 4.3(b).

 

Public Information Failure Payments” shall have the meaning ascribed to such term in Section 4.3(b).

Purchaser Party” shall have the meaning ascribed to such term in Section 4.10.

 

Required Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

 

Required Minimum” means, as of any date, 300% of the maximum aggregate number of shares of Common Stock then issued or potentially issuable in the future pursuant to the Transaction Documents, including any Conversion Shares issuable upon conversion in full of all of the Notes and any Warrant Shares issuable upon exercise in full of all of the Warrants, ignoring any conversion limits set forth therein.

 

Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

 
3

 

  

Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

Securities” means the Notes, the Conversion Shares, the Warrants and the Warrant Shares.

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Security Agreement” means the Security Agreement dated the date hereof between the Company and Evergreen Capital Management LLC, as collateral agent, substantially in the form of Exhibit D hereto.

 

Short Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).

 

Subscription Amount” shall mean, as to each Purchaser, the aggregate amount to be paid for the Notes and Warrants purchased hereunder as specified below such Purchaser’s name under the heading “Subscription Amount,” on the signature page hereto executed by such Purchaser, which amount in United States dollars and in immediately available funds.

 

Subsidiary” means any subsidiary of the Company as set forth on Schedule 3.1(a) and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.

 

Trading Day” means a day on which the principal Trading Market is open for trading.

 

Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, the OTC Bulletin Board or the OTC Markets (or any successors to any of the foregoing).

 

Transaction Documents” means this Agreement, the Notes, the Warrants, the Security Agreement, the Transfer Agent Instruction Letter, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.

 

Transfer Agent” means American Stock Transfer & Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 48 Wall Street, 22nd Floor, New York, New York 10005, and any successor transfer agent of the Company.

 

Transfer Agent Instruction Letter” means the letter from the Company to the Transfer Agent which instructs the Transfer Agent to issue shares of Common Stock upon conversion of the Notes and the exercise of the Warrants, substantially in the form of Exhibit F attached hereto.

 

VWAP” means, for or as of any date, the dollar volume-weighted average price for such security on the Trading Market (or, if the Trading Market is not the principal trading market for such security, then on the principal securities exchange or securities market on which such security is then traded) during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (set to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the “pink sheets” by OTC Markets Group Inc. (formerly Pink Sheets LLC). If the VWAP cannot be calculated for such security on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.

 

 
4

 

  

Warrant Amount” means, with respect to any Closing, an amount equal to the aggregate principal amount of Notes purchased by the Purchasers at such Closing divided by the initial Conversion Price of such Notes.

 

Warrants” shall mean all of the Warrants issued or issuable pursuant to this Agreement, substantially in the form of Exhibit B hereto.

 

Warrant Shares” means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.

 

ARTICLE II.

PURCHASE AND SALE

 

2.1 Closing. The Purchasers will, subject to the terms and conditions hereof, purchase an aggregate of up to $2,000,000 in aggregate Subscription Amount of Notes and Warrants (to purchase an aggregate of $2,300,000 principal amount of Notes and Warrants to purchase an aggregate of 1,028,743 shares of Common Stock, in four (4) tranches (each a “Tranche”), with the first Tranche of $1,000,000 in Subscription Amount of Notes (to purchase an aggregate of $1,150,000 in principal amount of Notes) and Warrants to purchase an aggregate of number of shares of Common Stock equal to the Warrant Amount for such Closing, being closed on upon execution of this Agreement. The Closing for the second Tranche of $350,000 in Subscription Amount of Notes (to purchase an aggregate of $402,500 in principal amount of Notes) and Warrants to purchase an aggregate of number of shares of Common Stock equal to the Warrant Amount for such Closing will occur, at the option of the Company, within five (5) Business Days of the occurrence of the receipt of comments from the Commission on the Company’s registration statement on Form S-1. The Closing for the third Tranche of $350,000 in Subscription Amount of Notes (to purchase an aggregate of $402,500 in principal amount of Notes) and Warrants to purchase an aggregate of number of shares of Common Stock equal to the Warrant Amount for such Closing will occur, at the option of the Company, within five (5) Business Days of November 11, 2021. The Closing for the fourth Tranche of $300,000 in Subscription Amount of Notes (to purchase an aggregate of $345,000 in principal amount of Notes) and Warrants to purchase an aggregate of number of shares of Common Stock equal to the Warrant Amount for such Closing will occur, at the option of the Company, within five (5) Business Days of December 11, 2021. The Purchasers shall not be required to fund the second, the third Tranche or the fourth Tranche if the Company is in default under the terms of this Agreement or the Notes or if the conditions to such Closing in Section 2.3(b) are not satisfied. At each Closing, each Purchaser shall purchase its Subscription Amount of the Notes for such Closing (as set forth on the signature page hereto executed by such Purchaser) and shall deliver to the Company, via wire transfer or a certified check, immediately available funds equal to such Purchaser’s Subscription Amount for such Closing, and the Company shall deliver to each Purchaser its respective Notes and Warrants for such Closing (as set forth on the signature page hereto executed by such Purchaser), and the Company and each Purchaser shall deliver the other items set forth in Section 2.3 deliverable at such Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4 for the applicable Closing, the Closing shall occur at the offices of the Purchaser’s counsel or such other location as the parties shall mutually agree.

 

 
5

 

  

2.2 Deliveries.

 

(a) On or prior to each Closing Date (or as otherwise indicated below), the Company shall deliver or cause to be delivered to each Purchaser the following:

 

(i) at the Closing of the first Tranche, this Agreement duly executed by the Company;

 

(ii) at the Closing of the first Tranche, the Transfer Agent Instruction Letter, duly executed by the Company and the Transfer Agent;

 

(iii) at the Closing of the first Tranche, the Security Agreement and the Guaranty and Security Agreement, each duly executed by the Company and the Subsidiaries of the Company, as applicable;

 

(iv) at each Closing, an executed Note in the principal amount equal to the principal amount of Notes to be purchased by such Purchaser at such Closing as set forth on the signature page hereto executed by such Purchaser;

 

(v) at each Closing if not previously delivered, the Transfer Agent Instruction Letter, duly executed by the Company and the Transfer Agent;

 

(vi) at the Closing of the first Tranche, the Intercreditor Agreement, duly executed by the Company and Sament Capital Investments, Inc.;

 

(vii) at each Closing, an executed Warrant to purchase the number of shares of Common Stock to be purchased by such Purchaser at such Closing as set forth on the signature page hereto executed by such Purchaser;

 

(viii) at the Closing of the first Tranche, the Disclosure Schedules of the Company;

 

(ix) evidence satisfactory to the Purchasers as to the amount required to satisfy in full all outstanding amounts under the Factoring Agreement and of the termination of the Factoring Agreement; and

 

(ix) at each Closing, an officers’ certificate executed by the Chief Executive Officer and the Chief Financial Officer of the Company certifying that the representations and warranties of the Company set forth herein are true and correct as of such Closing Date and that the Company has complied with all obligations, covenants and agreements of the Company set forth herein on or prior to such Closing Date.

 

 
6

 

  

(b) On or prior to each Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, as applicable, the following:

 

(i) at the Closing of the first Tranche, this Agreement duly executed by such Purchaser;

 

(ii) at the Closing of the first Tranche, the Security Agreement and the Guaranty and Security Agreement, each duly executed by the Evergreen Capital Management LLC, as collateral agent, and the Intercreditor Agreement, duly executed by each Purchaser; and

 

(iii) such Purchaser’s Subscription Amount for such Closing as set forth on the signature page hereto executed by such Purchaser, by wire transfer to the account specified in writing by the Company.

 

2.3 Closing Conditions.

 

(a) The obligations of the Company hereunder in connection with each Closing are subject to the following conditions being met:

 

(i) the accuracy in all material respects on the applicable Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);

 

(ii) all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the applicable Closing Date shall have been performed; and

 

(iii) the delivery by each Purchaser of the required items set forth in Section 2.2(b) of this Agreement.

 

(b) The respective obligations of the Purchasers hereunder in connection with each Closing are subject to the following conditions being met:

 

(i) the accuracy in all material respects when made and on the applicable Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein);

 

(ii) all obligations, covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall have been performed;

 

(iii) the delivery by the Company of the required items set forth in Section 2.2(a) of this Agreement;

 

(iv) there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and

 

(v) from the date hereof to the applicable Closing Date, at any time prior to the applicable Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at such Closing.

  

 
7

 

  

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

 

3.1 Representations and Warranties of the Company. Except as set forth in the disclosure schedules of the Company delivered to the Purchasers at the initial Closing (the “Disclosure Schedules”), which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:

 

(a) Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1(a). The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

 

(b) Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. Notwithstanding the foregoing, for purposes of this Agreement, “Material Adverse Effect” shall not include any event, occurrence, fact, condition or change, directly or indirectly, arising out of or attributable to: (A) general economic or political conditions; (B) conditions generally affecting the industries in which the Company operates; (C) any changes in financial, banking or securities markets in general, including any disruption thereof and any decline in the price of any security or any market index or any change in prevailing interest rates; (D) acts of war (whether or not declared), armed hostilities or terrorism, or the escalation or worsening thereof; (E) any action required or permitted by this Agreement or any action taken (or omitted to be taken) with the written consent of or at the written request of the Purchasers; (F) any changes in applicable laws or accounting rules (including GAAP (as defined below)) or the enforcement, implementation or interpretation thereof; (G) the announcement, pendency or completion of the transactions contemplated by this Agreement; (H) any natural or man-made disaster or acts of God; or (I) any failure by any Company to meet any internal or published projections, forecasts or revenue or earnings predictions provided that the underlying causes of such failures (subject to the other provisions of this definition) shall not be excluded).

 

 
8

 

  

(c) Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies, and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

(d) No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(e) Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.6 of this Agreement, and (ii) the filing of a Form D with the Commission and such filings as are required to be made under applicable state securities laws (collectively, the “Required Approvals”).

 

(f) Issuance of the Securities. The Conversion Shares and the Warrant Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock 6,172,458 shares of Common Stock for issuance of the Conversion Shares and the Warrant Shares.

 

 
9

 

   

(g) Capitalization. The capitalization of the Company is as set forth on Schedule 3.1(g), which Schedule 3.1(g) shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set forth on Schedule 3.1(g) and except as a result of the purchase and sale of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.

 

(h) Financial Statements. The Company is not and since its incorporation never has been a “shell” company as defined in Section 405 of the Securities Act and is not required to file reports with the SEC under the Exchange Act. The financial statements of the Company delivered to the Purchasers (the “Financial Statements”) have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

(i) Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest balance sheet included in the unaudited financial statements delivered to the Company, except as specifically disclosed in the Disclosure Schedules: (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice, (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP, and (C) pursuant to the Factoring Agreement, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock, and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option and restricted stock plans. Except for the issuance of the Securities contemplated by this Agreement or as set forth on Schedule 3.1(i), no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would be required to be disclosed by an issuer subject to the reporting obligations of the Exchange Act at the time this representation is made or deemed made that has not been included in the Disclosure Schedules or the Financial Statements.

 

 
10

 

 

(j) Litigation. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(k) Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(l) Compliance. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority, or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(m) Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.

 

 
11

 

  

(n) Title to Assets. Except as set forth in Schedule 3.1(n), the Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as may be disclosed in Schedule 3.1(n) of the Disclosure Schedules, (ii) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, and (iii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.

 

(o) Intellectual Property. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights as necessary or required for use in connection with their respective businesses and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(p) Insurance. Except as set forth on Schedule 3.1(p), the Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.

 

(q) Transactions With Affiliates and Employees. Except as set forth on Schedule 3.1(q), none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company, and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.

 

(r) [Reserved.]

 

(s) Certain Fees. Except for fees payable by the Company to Maxim Group LLC, no brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.

 

 
12

 

  

(t) Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby.

 

(u) No “Bad Actor” Disqualification. The Company has exercised reasonable care to determine whether any Company Covered Person (as defined below) is subject to any of the “bad actor” disqualifications described in Rule 506(d)(1)(i) through (viii), as modified by Rules 506(d)(2) and (d)(3), under the Securities Act (“Disqualification Events”). To the Company’s knowledge, no Company Covered Person is subject to a Disqualification Event. The Company has complied, to the extent required, with any disclosure obligations under Rule 506(e) under the Securities Act. For purposes of this Agreement, “Company Covered Persons” are those persons specified in Rule 506(d)(1) under the Securities Act; provided, however, that Company Covered Persons do not include (a) any Purchaser, or (b) any person or entity that is deemed to be an affiliated issuer of the Company solely as a result of the relationship between the Company and any Purchaser.

 

(v) Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended.

 

(w) Registration Rights. No Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.

 

(x) Disclosure. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.

 

(y) No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.

 

(z) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and each of its Subsidiaries (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, whether or not shown or determined to be due on such returns, reports and declarations, and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.

 

 
13

 

  

(aa) No General Solicitation. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

 

(bb) Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor any agent or other Person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any Person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.

 

(cc) Accountants. To the knowledge and belief of the Company, the Company’s accounting firm, Marcum LLP: (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s registration statement to be filed for the IPO and for the fiscal year ending December 31, 2021.

 

(dd) No Disagreements with Accountants and Lawyers. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company’s ability to perform any of its obligations under any of the Transaction Documents.

 

(ee) Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers’ purchase of the Securities. The Company further represents to each Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.

 

(ff) Acknowledgment Regarding Purchaser’s Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Section 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or “derivative” securities based on securities issued by the Company or to hold the Securities for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or “derivative” transactions, before or after a closing of this or future private placement transactions, may negatively impact the market price of the Company’s publicly-traded securities, (iii) any Purchaser, and counter-parties in “derivative” transactions to which any such Purchaser is a party, directly or indirectly, may presently have a “short” position in the Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm’s length counter-party in any “derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Conversion Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.

 

 
14

 

  

(gg) Stock Option Plans. Except as set forth on Schedule 3.1(gg), the Company does not currently have or maintain any stock option or other equity incentive plan for its directors, employees or consultants.

 

(hh) Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

(ii) U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser’s request.

 

(kk) Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(ll) Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material respects with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.

 

3.2 Representations and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein):

 

(a) Organization; Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

 
15

 

  

(b) Own Account. Such Purchaser understands that the Securities are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right to sell the Securities in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.

 

(c) Purchaser Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it converts any Notes or exercises any Warrants, it will be either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act.

 

(d) Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e) General Solicitation. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement.

 

(f) No “Bad Actor” Disqualification. Neither (A) such Purchaser nor (B) any entity that controls such Purchaser or is under the control of, or under common control with, such Person, is subject to any Disqualification Event. Such Purchaser has exercised reasonable care to determine the accuracy of the representation made by such Purchaser in this paragraph, and agrees to notify the Company if such Purchaser becomes aware of any fact that makes the representation given by such Purchaser hereunder inaccurate.

 

(g) Disclosure of Information. Purchaser acknowledges that it has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the sale of the Securities and the business, properties, prospects and financial condition of the Company and its Subsidiaries. Any questions raised by Purchaser concerning the Company and its subsidiaries or the Securities have been answered to the satisfaction of Purchaser. Purchaser’s decision to purchase the Securities is based solely on the information obtained during the course of Purchaser’s due diligence review and on the response to such questions as Purchaser has raised concerning the Securities or the Company and its Subsidiaries.

 

 
16

 

  

(h) Unlawful Activities. (i) No part of the funds used by Purchaser to acquire any Securities under this Agreement has been, or shall be, directly or indirectly derived from, or related to, any activity that may contravene United States federal or state or non-United States laws or regulations, including, without limitation, laws and regulations relating to anti-money laundering, terrorist financing and other illegal activities; (ii) no capital commitment, contribution or payment to the Company by Purchaser and no distribution to Purchaser shall cause the Company to be in violation of any applicable anti-money laundering laws or regulations, including, without limitation, the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT) Act of 2001 and the United States Department of the Treasury Office of Foreign Assets Control (“OFAC”) regulations (the “Sanction Regulations”); and (iii) none of the funds of Purchaser have been derived from any unlawful activity. Without limiting the foregoing: (1) Purchaser is in compliance with Executive Order 13224 (September 23, 2001), the rules and regulations of OFAC and any enabling legislation or other executive orders in respect thereof; (2) at all times, (I) none of the funds or other assets of Purchaser constitutes property of, or are beneficially owned, directly or indirectly, by any Person, entity or government subject to trade restrictions under U.S. law (including, without limitation, the International Emergency Economic Powers Act, 50 U.S.C. §§ 1701 et seq., Trading with the Enemy Act, 50 U.S.C. App. 1 et seq., and any executive orders or regulations promulgated thereunder) (any such Person, an “Embargoed Person”); (II) no Embargoed Person has any interest of any nature whatsoever in Investor; and (III) if applicable to Investor, Investor has implemented a corporate anti-money laundering plan that is reasonably designed to ensure compliance with applicable foreign and U.S. anti-money laundering law; and (4) none of the investors, officers, directors, managers, members or partners of Investor appear on any lists published by OFAC with respect to Persons that have been designated by executive order or by the Sanction Regulations as Persons with whom U.S. Persons may not transact business or must limit their interactions to types approved by OFAC or otherwise. Investor shall promptly notify the Company if any of these representations in this paragraph ceases to be true and accurate regarding Investor.

 

The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser’s right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transaction contemplated hereby.

 

ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES

 

4.1 Transfer Restrictions.

 

(a) The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of a Purchaser under this Agreement.

 

 
17

 

  

(b) The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following form or a substantially similar form as may be required by the Company’s Transfer Agent:

 

 

[NEITHER] THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE] [NOR THE SECURITIES FOR WHICH THIS SECURITY MAY BE EXERCISED] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON [CONVERSION/EXERCISE] OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

  

The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of the Transaction Agreements and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including, if the Securities are registered under a registration statement, the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of selling stockholders thereunder.

 

(c) The Conversion Shares and the Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof): (i) while a registration statement covering the resale of such security is effective under the Securities Act, (ii) following any sale of such Conversion Shares or Warrant Shares pursuant to Rule 144, (iii) if such Conversion Shares or Warrant Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Conversion Shares or Warrant Shares and without volume or manner-of-sale restrictions, or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). Upon request of the Purchaser, the Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the events described in clauses (i)-(iv) in the immediately preceding sentence if required by the Transfer Agent to effect the removal of the legend hereunder. If all or any Notes are converted or Warrants exercised at a time when there is an effective registration statement to cover the resale of the Conversion Shares or Warrant Shares, or if such Conversion Shares or Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current public information required under Rule 144, or if the Conversion Shares or Warrant Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Conversion Shares or Warrant Shares and without volume or manner-of-sale restrictions or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Conversion Shares or Warrant Shares shall be issued free of all legends. The Company agrees that following such time as such legend is no longer required under this Section 4.1(c), it will, no later than three Trading Days following the delivery by a Purchaser to the Company or the Transfer Agent of the Conversion Shares or Warrant Shares, as applicable, issued with a restrictive legend (such third Trading Day, the “Legend Removal Date”), deliver or cause to be delivered to such Purchaser Conversion Shares or Warrant Shares, as applicable, that are free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Conversion Shares or Warrant Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s prime broker with the Depository Trust Company System as directed by such Purchaser.

 

 
18

 

  

(d) In addition to such Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, for each $1,000 of Conversion Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the fifth (5th) Trading Day immediately following the Legend Removal Date until such certificate is delivered without a legend. Nothing herein shall limit such Purchaser’s right to pursue actual damages for the Company’s failure to deliver certificates representing any Securities as required by the Transaction Documents, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.

 

4.2 Acknowledgment of Dilution. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Conversion Shares and the Warrant Shares pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.

 

4.3 Furnishing of Information; Public Information.

 

From and after the date on which the Company completes the IPO until the date that no Purchasers own any Securities, the Company agrees to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.

 

4.4 Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.

 

 
19

 

  

4.5 Conversion and Exercise Procedures. The form of Notice of Conversion included in the Notes and the form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to convert the Notes or exercise the Warrants. Without limiting the preceding sentences, no ink-original Notice of Conversion or Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form or Notice of Exercise form be required in order to convert the Notes or exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers to convert their Notes or exercise their Warrants. The Company shall honor conversions of the Notes and exercises of the Warrants and shall deliver Conversion Shares or Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

 

4.6 Securities Laws Disclosure; Publicity. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except: (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).

 

4.7 Shareholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.

 

4.8 Non-Public Information. Following the IPO, the Company shall not, and shall cause each of its Subsidiaries and each of their respective officers, directors, employees, affiliates and agents, not to, provide any Purchaser with any material, nonpublic information regarding the Company or any of its Subsidiaries from and after the date hereof without the express prior written consent of such Purchaser. If following the IPO a Purchaser has, or believes it has, received any such material, nonpublic information regarding the Company or any of its Subsidiaries from the Company, any of its Subsidiaries or any of their respective officers, directors, employees, affiliates or agents, it may provide the Company with written notice thereof. The Company shall, within one (1) Trading Day of receipt of such notice, make public disclosure of such material, nonpublic information. In the event of a breach of the foregoing covenant by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees, affiliates and agents, in addition to any other remedy provided herein or in the Transaction Documents, a Purchaser shall have the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such material, nonpublic information without the prior approval by the Company, its Subsidiaries, or any of its or their respective officers, directors, employees, affiliates or agents. No Purchaser shall have any liability to the Company, its Subsidiaries, or any of its or their respective officers, directors, employees, affiliates, stockholders or agents for any such disclosure. To the extent that, following the IPO, the Company delivers any material, nonpublic information to a Purchaser without such Purchaser’s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries or any of their respective officers, directors, employees, affiliates or agent with respect to, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees, affiliates or agent not to trade on the basis of, such material, nonpublic information.

 

 
20

 

  

4.9 Use of Proceeds. The Company shall use the proceeds from this offering for general corporate and working capital purposes.

 

4.10 Indemnification of Purchasers. Subject to the provisions of this Section 4.10, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a breach of such Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which constitutes fraud, gross negligence, willful misconduct or malfeasance). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.10 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.

 

 
21

 

  

4.11 Reservation and Listing of Securities.

 

(a) The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the Transaction Documents in such amount as equals the Required Minimum.

 

(b) If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than (i) the Required Minimum on such date, minus (ii) the number of shares of Common Stock previously issued pursuant to the Transaction Documents, then the Board of Directors shall use commercially reasonable efforts to amend the Company’s certificate or articles of incorporation to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum at such time (minus the number of shares of Common Stock previously issued pursuant to the Transaction Documents), as soon as possible and in any event not later than the 90th day after such date, provided that the Company will not be required at any time to authorize a number of shares of Common Stock greater than the maximum remaining number of shares of Common Stock that could possibly be issued after such time pursuant to the Transaction Documents.

 

4.12 Sale of Assets. So long as the Notes remain outstanding, neither the Company, nor any Subsidiary of the Company, shall, without each Purchaser’s written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. Any consent to the disposition of any assets may be conditioned on a specified use of the proceeds of disposition.

 

4.13 Equal Treatment of Purchasers. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered to all of the parties to this Agreement. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.

 

4.14 Certain Transactions and Confidentiality. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it, will from the date of the IPO until the date that the Notes are no longer outstanding, execute any Short Sales of the Common Stock (provided that this provision shall not prohibit any sales made where a corresponding Notice of Conversion or Notice of Exercise is tendered to the Company and the shares received upon such conversion or exercise are used to close out such sale) (a “Prohibited Short Sale”). Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company in the IPO, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Transaction Documents and the Disclosure Schedules. Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced by the Company is a press release or in the registration statement for the IPO, (ii) except for a Prohibited Short Sale, following the IPO, no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws, and (iii) no Purchaser shall have any duty of confidentiality to the Company or its Subsidiaries after the IPO. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.

 

 
22

 

  

4.15 Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers under applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.

 

4.16 [Reserved].

 

4.17 Liens. So long as any of the Notes remain outstanding, the Company shall not, without the prior written consent of each Purchaser, incur, create, assume or suffer to exist any Lien on any of its property or assets, whether now owned or hereinafter acquired except for (a) Liens for taxes not yet due or which are being contested in good faith by appropriate proceedings; (b) non-consensual Liens arising by operation of law, arising in the ordinary course of business, and for amounts which are not overdue for a period of more than 30 days or that are being contested in good faith by appropriate proceedings; (c) Liens on property securing indebtedness incurred by the Company or any of its Subsidiaries to provide funds for all or a portion of the cost of acquiring, constructing, altering, expanding, improving or repairing such property; (d) Liens securing purchase money Indebtedness incurred in connection with the acquisition of capital assets by the Company or any Subsidiary in the ordinary course of business; or (e) Liens in existence on the date of this Agreement.

 

4.18 Other Indebtedness. Except as set forth on Schedule 4.18, so long as any of the Notes remain outstanding, the Company shall not (directly or indirectly through any Subsidiary or affiliate) incur or suffer to exist or guarantee any Indebtedness that is senior to or pari passu with (in priority of payment and performance) the Company’s obligations hereunder. As used herein, the term “Indebtedness” means (a) all indebtedness of the Company for borrowed money or for the deferred purchase price of property or services, including any type of letters of credit, but not including deferred purchase price obligations in place as of the Closing Date or obligations to trade creditors incurred in the ordinary course of business, (b) all obligations of the Borrower evidenced by notes, bonds, debentures or other similar instruments, (c) purchase money indebtedness hereafter incurred by the Company to finance the purchase of fixed or capital assets, including all capital lease obligations of the Company which do not exceed the purchase price of the assets funded, (d) all guarantee obligations of the Company in respect of obligations of the kind referred to in clauses (a) through (c) above that the Company would not be permitted to incur or enter into, and (e) all obligations of the kind referred to in clauses (a) through (d) above that the Company is not permitted to incur or enter into that are secured and/or unsecured by (or for which the holder of such obligation has an existing right, contingent or otherwise, to be secured and/or unsecured by) any Lien on property (including accounts and contract rights) owned by the Company, whether or not the Company has assumed or become liable for the payment of such obligation.

 

4.19 Distributions on Capital Stock. So long as any of the Notes remain outstanding, the Company shall not without each Purchaser’s written consent, (a) pay, declare or set apart for such payment, any dividend or other distribution (whether in cash, property or other securities) on shares of capital stock other than dividends on shares of Common Stock solely in the form of additional shares of Common Stock or (b) directly or indirectly or through any Subsidiary make any other payment or distribution in respect of its capital stock.

 

 
23

 

  

4.20 Restriction on Stock Repurchases and Debt Repayments. So long as any of the Notes remain outstanding, the Company shall not, without each Purchaser’s prior written consent, (a) redeem, repurchase or otherwise acquire (whether for cash or in exchange for property or other securities or otherwise) in any one transaction or series of related transactions any shares of capital stock of the Company or any warrants, rights or options to purchase or acquire any such shares, or (b) repay any pari passu or subordinated indebtedness of the Company or repay any indebtedness to the Company’s officers, directors or other Affiliates, except that indebtedness set forth on Schedule 4.20. Notwithstanding the foregoing, the Company shall be permitted to effect the following without the consent of the Purchasers (i) dividends or other distributions payable on the Common Stock solely in the form of additional shares of Common Stock and (ii) repurchases of stock from former employees, officers, directors, consultants or other persons who performed services for the Company or any subsidiary in connection with the cessation of such employment or service at no greater than the original purchase price thereof.

 

4.21 Advances and Loans; Affiliate Transactions. So long as any of the Notes remain outstanding, the Company shall not, without each Purchaser’s written consent, lend money, give credit, or make advances to any person, firm, joint venture or corporation, including, without limitation, officers, directors, employees, subsidiaries and affiliates of the Company, except loans, credits or advances (a) in existence or committed on the Closing Date and which the Company has informed each Purchaser in writing prior to the Closing Date, (b) in regard to transactions with unaffiliated third parties, made in the ordinary course of business, or (c) in regard to transactions with unaffiliated third parties, not in excess of $50,000. So long as any of the Notes remain outstanding, the Company shall not, without each Purchaser’s written consent, enter into any transaction with Affiliates, except transactions with affiliates made in the ordinary course of business; provided, however, that nothing in this Section 4.21 shall prohibit the Company from entering into any transaction with an Affiliate for the purpose of the Affiliate making a loan or advance to the Company.

 

4.22 Proceeds of IPO. The Company agrees to repay the Notes in full within one (1) Business Day of the closing of the IPO, from the net proceeds of the IPO, prior to applying the net proceeds of the IPO for any other purposes, except for the repayment of indebtedness senior to the Notes. The Purchasers hereby waive any notice of such prepayment as would otherwise be required by Section 2(e) of the Notes.

 

4.23 Additional Securities Issuances. So long as any of the Notes remain outstanding, without the prior written consent of the Purchaser, the Company shall not issue any indebtedness for money borrowed that has a variable conversion rate.

 

ARTICLE V.

MISCELLANEOUS

 

5.1 Termination. This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the initial Closing has not been consummated on or before October 15, 2021; provided, however, that such termination will not affect the right of any party to sue for any breach by any other party (or parties).

 

5.2 Fees and Expenses. Except as expressly set forth in the Transaction Documents or any other writing to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement; provided that at the Closing of the first Tranche the Company shall pay the Purchasers an amount equal to $25,000 for their legal fees (net of any expenses paid in advance) and at the Closing of any additional Tranche the Company shall pay the Purchasers an amount equal to $2,500 for their legal fees. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any conversion notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.

  

 
24

 

 

5.3 Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

5.4 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via email at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via email at the email address set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 

5.5 Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Purchasers holding at least 67% in interest of the Securities then outstanding or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.

 

5.6 Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

 

5.7 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers.”

 

5.8 No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.10 and this Section 5.8.

  

 
25

 

 

5.9 Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in Bergen, Essex and Hudson Counties, State of New Jersey. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in Bergen, Essex and Hudson Counties, State of New Jersey for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.10, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

    

5.10 Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for a period of twenty-four (24) months thereafter.

 

5.11 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

 

5.12 Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

5.13 Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of a conversion of the Notes or exercise of the Warrants, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded conversion notice or exercise notice concurrently with the restoration of such Purchaser’s right to acquire such shares pursuant to such Purchaser’s Notes or Warrants.

 

 
26

 

    

5.14 Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.

 

5.15 Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.

 

5.16 Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

5.17 Usury. To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in force, in connection with any claim, action or proceeding that may be brought by any Purchaser in order to enforce any right or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document, it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”), and, without limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate. It is agreed that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute or any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from the effective date thereof forward, unless such application is precluded by applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Purchaser with respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by such Purchaser to the unpaid principal balance of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at such Purchaser’s election.

 

5.18 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.

 

 
27

 

    

5.19 Liquidated Damages. The Company’s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.

 

5.20 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

5.21 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

 

5.22 WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

(Signature Pages Follow)

 

 
28

 

   

IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

Edible Garden AG Incorporated

Address for Notice:

 

     

By:

/s/ James Kras 283 County Road 519

 

Name: James Kras

 

Belvidere, New Jersey 07823

 

 

Title: Chief Executive Officer  

E-Mail: jkras@ediblegarden.com

 

 

       

With a copy to (which shall not constitute notice):

 

Harter Secrest & Emery LLP

 

 

 

Attn: Alexander R. McClean, Esq.

 

 

 

1600 Bausch & Lomb Place

 

 

 

Rochester, New York 14604

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

   

 
29

 

    

[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

Name of Purchaser:

Evergreen Capital Management LLC

 

 

Signature of Authorized Signatory of Purchaser:

/s/ Jeffrey S. Pazdro

 

 

Name of Authorized Signatory:

Jeffrey S. Pazdro

 

 

Title of Authorized Signatory:

Manager

 

 

Email Address of Authorized Signatory:

jpazdro@egcmllc.com

 

 

Facsimile Number of Authorized Signatory:

 

 

 

Address for Notice to Purchaser:

156 W Saddle River Road

 

Saddle River, New Jersey 07458

  

Address for Delivery of Securities to Purchaser (if not same as address for notice):

 

Aggregate Subscription Amount: $2,000,000

$2,300,000 aggregate principal amount of Notes (15% OID)

Warrants for 751,634 and 277,109 shares of Common Stock @ $1.53 and $4.15 per share, respectively.

 

First Closing: Subscription Amount: $1,000,000

$1,150,000 aggregate principal amount of Notes

Warrants for 751,634 shares of Common Stock @$1.53 per share

 

Second Closing: Subscription Amount: $350,000

$402,500 aggregate principal amount of Notes

Warrants for 96,988 shares of Common Stock @$4.15 per share

 

Third Closing: Subscription Amount: $350,000

$402,500 aggregate principal amount of Notes

Warrants for 96,988 shares of Common Stock @$4.15 per share

 

Fourth Closing: Subscription Amount: $300,000

$345,000 aggregate principal amount of Notes

Warrants for 83,133 shares of Common Stock @$4.15 per share

 

EIN Number: 84-1984800

 

[REMAINDER OF PAGE LEFT INTENTIONALLY BLANK]

  

 
30

   

 

EXHIBIT 10.17a

 

THIS NOTE HAS BEEN ISSUED WITH “ORIGINAL ISSUE DISCOUNT” FOR U.S. FEDERAL INCOME TAX PURPOSES. THE ISSUER OF THIS NOTE WILL MAKE AVAILABLE TO ANY HOLDER OF THIS NOTE: (1) THE ISSUE PRICE AND ISSUE DATE OF THE NOTE, (2) THE AMOUNT OF ORIGINAL ISSUE DISCOUNT ON THE NOTE, (3) THE YIELD TO MATURITY OF THE NOTE, AND (4) ANY OTHER INFORMATION REQUIRED TO BE MADE AVAILABLE BY U.S. TREASURY REGULATIONS UPON RECEIVING A WRITTEN REQUEST FOR SUCH INFORMATION AT THE FOLLOWING ADDRESS: 13850 MANCHESTER RD., BALLWIN, MO 63011.

 

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

Dated as of:

October 7, 2021

 

Purchase Price:

$1,000,000

Maturity Date:

July 7, 2022

 

Original Issue Discount:

$150,000

Interest Rate:

5%

 

Original Principal Amount:

$1,150,000

    

15% OID SENIOR SECURED PROMISSORY NOTE

DUE JULY 7, 2022

 

THIS 15% OID SENIOR SECURED PROMISSORY NOTE is one of a series of duly authorized and validly issued 15% OID Senior Secured Promissory Notes due July 7, 2022 of Edible Garden AG Incorporated, a Delaware corporation (the “Company”), having its principal place of business at 283 County Road 519, Belvidere, New Jersey 07823, designated as its 15% OID Senior Secured Promissory Notes due July 7, 2022 (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).

 

FOR VALUE RECEIVED, the Company hereby promises to pay to the order of Evergreen Capital Management LLC or its registered assigns or successors-in-interest (the “Holder”), or shall have paid pursuant to the terms hereunder, the principal amount set forth above on July 7, 2022 (the “Maturity Date”) or such earlier date as this Note is required or permitted to be repaid as provided hereunder, and to pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Note in accordance with the provisions hereof.

 

This Note is being issued pursuant to that Securities Purchase Agreement dated as of October 7, 2021 (the “Purchase Agreement”) between the Company and the Holder (defined below) and the other purchasers, if any, of the Notes.

 

 
1

 

    

This Note is subject to the following additional provisions:

 

1. Definitions. For the purposes hereof, in addition to the terms defined elsewhere in this Note, (a) capitalized terms not otherwise defined herein shall have the meanings set forth in the Purchase Agreement and (b) the following terms shall have the following meanings:

 

Alternate Consideration” shall have the meaning set forth in Section 5(e).

 

Bankruptcy Event” means any of the following events: (a) the Company or any Significant Subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the Company or any Significant Subsidiary thereof, (b) there is commenced against the Company or any Significant Subsidiary thereof any such case or proceeding that is not dismissed within 60 days after commencement, (c) the Company or any Significant Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding is entered, (d) the Company or any Significant Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or stayed within 60 calendar days after such appointment, (e) the Company or any Significant Subsidiary thereof makes a general assignment for the benefit of creditors, (f) the Company or any Significant Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts or (g) the Company or any Significant Subsidiary thereof, by any act or failure to act, expressly indicates its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.

 

Base Conversion Price” shall have the meaning set forth in Section 5(b).

 

Beneficial Ownership Limitation” shall have the meaning set forth in Section 4(d).

 

Change of Control Transaction” means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an individual or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in excess of 50% of the voting securities of the Company (other than by means of conversion or exercise of the Notes and the Securities issued together with the Notes), (b) the Company merges into or consolidates with any other Person, or any Person merges into or consolidates with the Company and, after giving effect to such transaction, the stockholders of the Company immediately prior to such transaction own less than 66% of the aggregate voting power of the Company or the successor entity of such transaction, (c) the Company sells or transfers all or substantially all of its assets to another Person and the stockholders of the Company immediately prior to such transaction own less than 66% of the aggregate voting power of the acquiring entity immediately after the transaction, (d) a replacement at one time or within a three-year period of more than one-half of the members of the Board of Directors which is not approved by a majority of those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors was approved by a majority of the members of the Board of Directors who are members on the date hereof), or (e) the execution by the Company of an agreement to which the Company is a party or by which it is bound, providing for any of the events set forth in clauses (a) through (d) above.

 

Conversion” shall have the meaning ascribed to such term in Section 4.

 

Conversion Date” shall have the meaning set forth in Section 4(a).

 

Conversion Price” shall have the meaning set forth in Section 4(b).

 

Conversion Schedule” means the Conversion Schedule in the form of Schedule 1 attached hereto.

 

Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of this Note in accordance with the terms hereof.

 

 
2

 

    

Dilutive Issuance” shall have the meaning set forth in Section 5(b).

 

Dilutive Issuance Notice” shall have the meaning set forth in Section 5(b).

 

Event of Default” shall have the meaning set forth in Section 6(a).

 

Fundamental Transaction” shall have the meaning set forth in Section 5(e).

 

IPO” means the consummation of the first underwritten public offering of Common Stock under the Securities Act.

 

Late Fees” shall have the meaning set forth in Section 2(c).

 

New Jersey Courts” shall have the meaning set forth in Section 7(d).

 

Note Register” shall have the meaning set forth in Section 2(b).

 

Notice of Conversion” shall have the meaning set forth in Section 4(a).

 

Original Issue Date” means the date of the first issuance of this Note, regardless of any transfers of any Note and regardless of the number of instruments which may be issued to evidence such Notes.

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Share Delivery Date” shall have the meaning set forth in Section 4(c)(ii).

 

Successor Entity” shall have the meaning set forth in Section 5(e).

 

Trading Market” means any of the following markets or exchanges on which the Common Stock (or any other common stock of any other Person that references the Trading Market for its common stock) is listed or quoted for trading on the date in question: The NASDAQ Global Market, The NASDAQ Global Select Market, The NASDAQ Capital Market, the New York Stock Exchange, NYSE Arca, the NYSE American, the OTCQX Marketplace, the OTCQB Marketplace, the OTC Pink Marketplace or any other tier operated by OTC Markets Group Inc. (or any successor to any of the foregoing).

 

2. Interest and Prepayments.

 

(a) Payment of Interest in Cash. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Note at the rate of five percent (5%) per annum. All interest payments hereunder will be payable in cash. Accrued and unpaid interest shall be due on payable on the Maturity Date, or as otherwise set forth herein.

 

(b) Interest Calculations. Interest shall be calculated on the basis of a 360-day year, consisting of twelve 30 calendar day periods, and shall accrue daily commencing on the Original Issue Date until payment in full of the outstanding principal, together with all accrued and unpaid interest, liquidated damages and other amounts which may become due hereunder, has been made. Interest hereunder will be paid to the Person in whose name this Note is registered on the records of the Company regarding registration and transfers of this Note (the “Note Register”).

 

 
3

 

    

(c) Late Fee. All overdue accrued and unpaid interest to be paid hereunder shall entail a late fee at an interest rate equal to the lesser of 18% per annum or the maximum rate permitted by applicable law (the “Late Fees”) which shall accrue daily from the date such interest is due hereunder through and including the date of actual payment in full.

 

(d) Prepayment. This Note may be prepaid by the Company in whole or in part at any time or from time to time, with the prior written consent of the Holder except in the case of a prepayment following a Qualified Financing pursuant to Section 2(e), upon at least three (3) Business Days prior written notice to the Holder, during which period Holder shall have the opportunity to convert this Note pursuant to Section 4 hereof and which notice period may be waived by the Holder. If the Company exercises its right to prepay this Note at any time on or prior to November 30, 2021, the Company shall make payment to the Holder of an amount in cash equal to the sum of the then outstanding principal amount of this Note and accrued interest thereon, plus a prepayment premium equal to 15% of the principal amount of this Note to be prepaid, within three (3) Business Days after such three (3) Business Day period. If the Company exercises its right to prepay this Note after November 30, 2021 and prior to January 1, 2022, the Company shall make payment to the Holder of an amount in cash equal to the sum of the then outstanding principal amount of this Note and accrued interest thereon, plus a prepayment premium equal to 20% of the principal amount of this Note to be prepaid, within three (3) Business Days after such three (3) Business Day period. If the Company exercises its right to prepay this Note at any time on or after January 1, 2022, the Company shall make payment to the Holder of an amount in cash equal to the sum of the then outstanding principal amount of this Note and accrued interest thereon, plus a prepayment premium equal to 30% of the principal amount of this Note to be prepaid, within three (3) Business Days after such three (3) Business Day period.

 

(e) Prepayment Upon Qualified Financing. If the Company completes a Qualified Financing (as defined below), the Company shall repay in full the then-outstanding principal amount of this Note and any accrued but unpaid interest, plus an amount equal to the applicable prepayment premium on the date of such repayment. Such repayment shall be due within one (1) Business Day of the closing of the Qualified Financing. The Company shall give written notice to Holder as soon as practicable, but in no event less than three (3) Business Days before the anticipated closing date of such Qualified Financing, during which period Holder shall have the opportunity to convert this Note pursuant to Section 4 hereof. The term “Qualified Financing” shall mean that the Company issues and sells shares of its equity securities to investors on or before the Maturity Date in an equity financing with total gross proceeds to the Company of not less than $5,000,000 (excluding the conversion of the notes or other convertible securities issued for capital raising purposes).

 

3. Registration of Transfers and Exchanges.

 

(a) Different Denominations. This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested by the Holder surrendering the same. No service charge will be payable for such registration of transfer or exchange.

 

(b) Investment Representations. This Note has been issued subject to certain investment representations of the original Holder set forth in the Purchase Agreement and may be transferred or exchanged only in compliance with the Purchase Agreement and applicable federal and state securities laws and regulations.

 

(c) Reliance on Note Register. Prior to due presentment for transfer to the Company of this Note, the Company and any agent of the Company may treat the Person in whose name this Note is duly registered on the Note Register as the owner hereof for the purpose of receiving payment as herein provided and for all other purposes, whether or not this Note is overdue, and neither the Company nor any such agent shall be affected by notice to the contrary.

 

 
4

 

    

4. Conversion.

 

(a) Voluntary Conversion. This Note shall be convertible, in whole or in part, into shares of Common Stock at the option of the Holder, at any time and from time to time (subject to the conversion limitations set forth in Section 4(d) hereof). The Holder shall effect conversions by delivering to the Company a Notice of Conversion, the form of which is attached hereto as Annex A (each, a “Notice of Conversion”), specifying therein the principal amount of this Note to be converted, accrued and unpaid interest outstanding under this Note to be converted, and the date on which such conversion shall be effected (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. To effect conversions hereunder, the Holder shall not be required to physically surrender this Note to the Company unless the entire principal amount of this Note, plus all accrued and unpaid interest thereon, has been so converted. Conversions hereunder shall have the effect of lowering the outstanding principal amount of this Note in an amount equal to the applicable conversion. The Holder and the Company shall maintain a Conversion Schedule showing the principal amount(s) converted and the date of such conversion(s). The Company may deliver an objection to any Notice of Conversion within three (3) Business Days of delivery of such Notice of Conversion. In the event of any dispute or discrepancy, the records of the Holder shall be controlling and determinative in the absence of manifest error. The Holder, and any assignee by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted principal amount of this Note may be less than the amount stated on the face hereof.

 

(b) Conversion Price. The conversion price in effect on any Conversion Date shall be equal to $1.53 (the “Conversion Price”).

 

(c) Mechanics of Conversion.

 

i. Conversion Shares Issuable Upon Conversion of Principal Amount and Interest. The number of Conversion Shares issuable upon a conversion hereunder shall be determined by the quotient obtained by dividing (x) the outstanding principal amount of this Note to be converted and any accrued and unpaid interest to be converted, by (y) the Conversion Price.

 

ii. Delivery of Certificate Upon Conversion. Not later than three (3) Trading Days after each Conversion Date (the “Share Delivery Date”), the Company shall deliver, or cause to be delivered, to the Holder (A) a certificate or certificates representing the Conversion Shares which, on or after the date on which such Conversion Shares are eligible to be sold under Rule 144 without the need for current public information and the Company has received an opinion of counsel to such effect reasonably acceptable to the Company, shall be free of restrictive legends and trading restrictions (other than those which may then be required by the Purchase Agreement) representing the number of Conversion Shares being acquired upon the conversion of this Note, and (B) a bank check in the amount of accrued and unpaid interest (if the Company has elected or is required to pay accrued interest in cash). All certificate or certificates required to be delivered by the Company under this Section 4(c) shall be delivered electronically through the Depository Trust Company or another established clearing corporation performing similar functions, if available. If the Conversion Date is prior to the date on which such Conversion Shares are eligible to be sold under Rule 144 without the need for current public information the Conversion Shares shall bear a restrictive legend in the following form, as appropriate:

 

 
5

 

 

 

“NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

       

iii. Failure to Deliver Certificates. If, in the case of any Notice of Conversion, such certificate or certificates are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Company at any time on or before its receipt of such certificate or certificates, to rescind such Conversion, in which event the Company shall promptly return to the Holder any original Note delivered to the Company and the Holder shall promptly return to the Company the Common Stock certificates issued to such Holder pursuant to the rescinded Conversion Notice. Notwithstanding the obligations of the Company contained in Section 4(c) to deliver share certificates, any requirement to deliver share certificates shall be remedied by recording share issuances in favor of the Holder in book entry form and delivery to the Holder of written evidence of such share issuances.

 

iv. Obligation Absolute; Partial Liquidated Damages. The Company’s obligations to issue and deliver the Conversion Shares upon conversion of this Note in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Company of any such action the Company may have against the Holder. Nothing herein shall limit a Holder’s right to pursue actual damages or declare an Event of Default pursuant to Section 6 hereof for the Company’s failure to deliver Conversion Shares within the period specified herein and the Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.

 

vi. Reservation of Shares Issuable Upon Conversion. The Company covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock a number of shares of Common Stock at least equal to the Required Minimum for the sole purpose of issuance upon conversion of this Note and payment of interest on this Note, each as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Notes), not less than such aggregate number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable (taking into account the adjustments and restrictions of Section 5) upon the conversion of the then outstanding principal amount of this Note and payment of interest hereunder. The Company covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.

 

 
6

 

    

vii. Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this Note. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Company shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price or round up to the next whole share.

 

viii. Transfer Taxes and Expenses. The issuance of certificates for shares of the Common Stock on conversion of this Note shall be made without charge to the Holder hereof for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificates, provided that, the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such certificate upon conversion in a name other than that of the Holder of this Note so converted and the Company shall not be required to issue or deliver such certificates unless or until the Person or Persons requesting the issuance thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion.

 

(d) Holder’s Conversion Limitations. Following the IPO, the Company shall not effect any conversion of principal and/or interest of this Note, and a Holder shall not have the right to convert any principal and/or interest of this Note, to the extent that after giving effect to the conversion set forth on the applicable Notice of Conversion, the Holder (together with the Holder’s Affiliates, and any Persons acting as a group together with the Holder or any of the Holder’s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon conversion of this Note with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted principal amount of this Note beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, any other Notes or the Warrants) beneficially owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 4(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this Section 4(d) applies, the determination of whether this Note is convertible (in relation to other securities owned by the Holder together with any Affiliates) and of which principal amount of this Note is convertible shall be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the Holder’s determination of whether this Note may be converted (in relation to other securities owned by the Holder together with any Affiliates) and which principal amount of this Note is convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, the Holder will be deemed to represent to the Company each time it delivers a Notice of Conversion that such Notice of Conversion has not violated the restrictions set forth in this paragraph and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 4(d), in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (i) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Company, or (iii) a more recent written notice by the Company or the Company’s transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Note, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of this Note held by the Holder. The Holder, upon not less than 61 days’ prior notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 4(d), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of this Note held by the Holder and the Beneficial Ownership Limitation provisions of this Section 4(d) shall continue to apply. Any such increase or decrease will not be effective until the 61st day after such notice is delivered to the Company. The Beneficial Ownership Limitation provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 4(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Note.

  

 
7

 

    

5. Certain Adjustments.

 

(a) Stock Dividends and Stock Splits. If the Company, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion of, or payment of interest on, the Notes), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Company, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re‑classification.

 

(b) Subsequent Equity Sales. If, at any time while this Note is outstanding and prior to (but including) the closing of the Qualified Offering, the Company or any Subsidiary, as applicable, sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock at an effective price per share that is lower than the then Conversion Price (such lower price, the “Base Conversion Price” and such issuances, collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is lower than the Conversion Price, such issuance shall be deemed to have occurred for less than the Conversion Price on such date of the Dilutive Issuance), then the Conversion Price shall be reduced to equal the Base Conversion Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing, no adjustment will be made under this Section 5(b) in respect of an Exempt Issuance. The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of any Common Stock or Common Stock Equivalents subject to this Section 5(b), indicating therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 5(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Conversion Shares based upon the Base Conversion Price on or after the date of such Dilutive Issuance, regardless of whether the Holder accurately refers to the Base Conversion Price in the Notice of Conversion.

 

 
8

 

    

(c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 5 above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

(d) Pro Rata Distributions. During such time as this Note is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Note, then, in each such case, upon conversion of this Note, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

(e) Fundamental Transaction. If, at any time while this Note is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent conversion of this Note, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 4(d) on the conversion of this Note), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Note is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 4(d) on the conversion of this Note). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one (1) share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Note following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Note and the other Transaction Documents (as defined in the Purchase Agreement) in accordance with the provisions of this Section 5(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the holder of this Note, deliver to the Holder in exchange for this Note a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Note which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Note (without regard to any limitations on the conversion of this Note) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Note immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Note and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Note and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

 
9

 

  

(f) Calculations. All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 5, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Company) issued and outstanding.

 

(g) Notice to the Holder.

 

i. Adjustment to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 5, the Company shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice to Allow Conversion by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be filed at each office or agency maintained for the purpose of conversion of this Note, and shall cause to be delivered to the Holder at its last address as it shall appear upon the Note Register, at least ten (10) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. The Holder shall remain entitled to convert this Note during the 10-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

(h) Adjustment for More Favorable Terms Contained in Future Financings. So long as this Note is outstanding, upon any issuance by the Company or any of its subsidiaries of any convertible security, including any convertible debt security (whether such debt begins with a convertible feature or such feature is added at a later date) or other Common Stock Equivalents, with any term more favorable to the holder of such security or with a term in favor of the holder of such security that was not similarly provided to the Holder in this Note, then the Company shall notify the Holder of such additional or more favorable term and such term, at the Holder’s option, shall become a part of this Note and its supporting documentation. The types of terms contained in the other security that may be more favorable to the holder of such security include, but are not limited to, terms addressing conversion discounts, conversion look back periods, interest rates, original issue discount percentages and warrant coverage.

 

 
10

 

  

6. Events of Default.

 

(a) “Event of Default” means, wherever used herein, any of the following events (whatever the reason for such event and whether such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body):

 

i. any default in the payment of (A) the principal amount of any Note or (B) interest, liquidated damages and other amounts owing to a Holder on any Note, as and when the same shall become due and payable (whether on a Conversion Date or the Maturity Date or by acceleration or otherwise) which default, solely in the case of an interest payment or other default under clause (B) above, is not cured within four (4) Trading Days;

 

ii. the Company shall materially fail to observe or perform any other covenant or agreement contained in the Notes (other than a breach by the Company of its obligations to deliver shares of Common Stock to the Holder upon conversion, which breach is addressed in clause (ix) below) which failure is not cured, if possible to cure, within the earlier to occur of (A) five (5) Trading Days after notice of such failure sent by the Holder or by any other Holder to the Company and (B) ten (10) Trading Days after the Company has become or should have become aware of such failure;

 

iii. the Company shall materially fail to observe or perform any other covenant or agreement contained in, or a default or event of default (subject to any grace or cure period provided in the applicable agreement, document or instrument) shall occur under the specific terms of, any of the other Transaction Documents which failure is not cured, if possible to cure, within the earlier to occur of (A) five (5) Trading Days after notice of such failure sent by the Holder or by any other Holder to the Company and (B) ten (10) Trading Days after the Company has become or should have become aware of such failure;

 

iv. any representation or warranty made in this Note, any other Transaction Documents, any written statement pursuant hereto or thereto or any other report, financial statement or certificate made or delivered to the Holder shall be untrue or incorrect in any material respect as of the date when made or deemed made;

 

v. the Company or any Significant Subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X) shall be subject to a Bankruptcy Event;

 

vii. [reserved];

 

viii. the Company shall be a party to any Change of Control Transaction or Fundamental Transaction or shall agree to sell or dispose of all or in excess of 50% of its assets in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction);

 

ix. the Company shall fail for any reason to deliver certificates to a Holder prior to the third Trading Day after a Conversion Date pursuant to Section 4(c) or the Company shall provide at any time notice to the Holder, including by way of public announcement, of the Company’s intention to not honor requests for conversions of any Notes in accordance with the terms hereof;

 

x. [reserved];

 

xi. if the Company or any Significant Subsidiary shall: (i) apply for or consent to the appointment of a receiver, trustee, custodian or liquidator of it or any of its properties, (ii) make a general assignment for the benefit of creditors, (iii) be adjudicated a bankrupt or insolvent or be the subject of an order for relief under Title 11 of the United States Code or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution or liquidation law or statute of any other jurisdiction or foreign country, or (iv) file a voluntary petition in bankruptcy, or a petition or an answer seeking reorganization or an arrangement with creditors or to take advantage or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution or liquidation law or statute, or an answer admitting the material allegations of a petition filed against it in any proceeding under any such law, or (v) take or permit to be taken any action in furtherance of or for the purpose of effecting any of the foregoing;

 

 
11

 

  

xii. if any order, judgment or decree shall be entered, without the application, approval or consent of the Company or any Significant Subsidiary, by any court of competent jurisdiction, approving a petition seeking liquidation or reorganization of the Company or any Subsidiary, or appointing a receiver, trustee, custodian or liquidator of the Company or any Subsidiary, or of all or any substantial part of its assets, and such order, judgment or decree shall continue unstayed and in effect for any period of sixty (60) days;

 

xiii. the occurrence of any levy upon or seizure or attachment of, or any uninsured loss of or damage to, any property of the Company or any Subsidiary having an aggregate fair value or repair cost (as the case may be) in excess of $250,000 individually or in the aggregate, and any such levy, seizure or attachment shall not be set aside, bonded or discharged within thirty (30) days after the date thereof;

 

xiv. the Company or any subsidiary shall default on any of its obligations under any mortgage(s), credit agreement(s) or other facility, indenture agreement(s), factoring agreement(s) or other instrument(s) under which there may be issued, or by which there may be secured or evidenced, any indebtedness for borrowed money or money due under any long term leasing or factoring arrangement that (a) involve(s) obligations greater than $500,000 in the aggregate, whether such indebtedness now exists or shall hereafter be created, and (b) results in such indebtedness becoming or being declared due and payable prior to the date on which it would otherwise become due and payable;

 

xv. any monetary judgement, writ or similar final process shall be entered or filed after the date hereof against the Company, any subsidiary or any of their respective property or assets for more than $250,000, and such judgement, writ or similar process shall remain unvacated, unbonded or unstayed for a period of 45 calendar days; or

 

xvi. the Company shall fail to maintain sufficient reserved shares pursuant to Section 4.11 of the Purchase Agreement for a period of five (5) Trading Days after the Company has become or should have become aware of such failure.

 

(b) Remedies Upon Event of Default. Subject to the Beneficial Ownership Limitation as set forth in Section 4(d), if any Event of Default occurs, then the outstanding principal amount of this Note, plus accrued but unpaid interest, liquidated damages and other amounts owing in respect thereof through the date of acceleration, shall become, at the Holder’s election, immediately due and payable in cash. After the occurrence of any Event of Default that results in the eventual acceleration of this Note, the interest rate on this Note shall accrue at an additional interest rate equal to the lesser of 2% per month (24% per annum) or the maximum rate permitted under applicable law. Upon the payment in full of the Note, the Holder shall promptly surrender this Note to or as directed by the Company. In connection with such acceleration described herein, the Holder need not provide, and the Company hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable law. Such acceleration may be rescinded and annulled by Holder at any time prior to payment hereunder and the Holder shall have all rights as a holder of the Note until such time, if any, as the Holder receives full payment pursuant to this Section 6(b). No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon.

 

7. Security. This Note is secured by the Security Agreement (as defined in the Purchase Agreement), executed by the Company in favor of the Holders encumbering the collateral set forth therein, as more specifically set forth in the Security Agreement, all the terms and conditions of which are hereby incorporated into and made a part of this Note.

 

 
12

 

  

8. Miscellaneous.

 

(a) Notices. Any and all notices or other communications or deliveries to be provided by the Holder hereunder, including, without limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, by email, or sent by a nationally recognized overnight courier service, addressed to the Company, at the address set forth above, or such other facsimile number, email or other address as the Company may specify for such purposes by notice to the Holder delivered in accordance with this Section 7(a). Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile, by email or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, email or other address of the Holder appearing on the books of the Company, or if no such facsimile number, email or other address appears on the books of the Company, at the principal place of business of such Holder, as set forth in the Purchase Agreement. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile or via email at the facsimile number or email set forth on the signature pages attached hereto prior to 12:00 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or via email at the facsimile number or email set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 12:00 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (iv) upon actual receipt by the party to whom such notice is required to be given.

 

(b) Absolute Obligation. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, liquidated damages and accrued interest, as applicable, on this Note at the time, place, and rate, and in the coin or currency, herein prescribed. This Note is a direct debt obligation of the Company.

 

(c) Lost or Mutilated Note. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note, a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Company.

 

(d) Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Note shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts sitting in Bergen, Essex and Hudson Counties, State of New Jersey (the “New Jersey Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New Jersey Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New Jersey Courts, or such New Jersey Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Note or the transactions contemplated hereby. If any party shall commence an action or proceeding to enforce any provisions of this Note, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney’s fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

 

 
13

 

  

(e) Waiver. Any waiver by the Company or the Holder of a breach of any provision of this Note shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The failure of the Company or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Note on any other occasion. Any waiver by the Company or the Holder must be in writing.

 

(f) Severability. If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other law which would prohibit or forgive the Company from paying all or any portion of the principal of or interest on this Note as contemplated herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Note, and the Company (to the extent it may lawfully do so) hereby expressly waives all benefits or advantage of any such law, and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the Holder, but will suffer and permit the execution of every such as though no such law has been enacted.

 

(g) Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note and any of the other Transaction Documents at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Note. The Company covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any such breach or any such threatened breach, without the necessity of showing economic loss and without any bond or other security being required. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company’s compliance with the terms and conditions of this Note.

 

(h) Next Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

 

(i) Headings. The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit or affect any of the provisions hereof.

 

*********************

 

(Signature Pages Follow)

 

 
14

 

 

IN WITNESS WHEREOF, the Company has caused this Note to be duly executed by a duly authorized officer as of the date first above indicated.

 

 

Edible Garden AG Incorporated

       
By: /s/ James Kras

 

 

Name: James Kras

 
  Title: Chief Executive Officer  

 

Facsimile No. for delivery of Notices: None

 

Email address for delivery of Notices: jkras@ediblegarden.com

    

 
15

 

  

ANNEX A

 

NOTICE OF CONVERSION

 

The undersigned hereby elects to convert principal and interest under the 15% OID Senior Secured Promissory Notes due July 7, 2022 of Edible Garden AG Incorporated (the “Company”), into shares of its common stock (the “Common Stock”), according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as reasonably requested by the Company in accordance therewith. No fee will be charged to the holder for any conversion, except for such transfer taxes, if any.

 

By the delivery of this Notice of Conversion the undersigned represents and warrants to the Company that its ownership of the Common Stock does not exceed the amounts specified under Section 4 of this Note, as determined in accordance with Section 13(d) of the Exchange Act.

 

The undersigned agrees to comply with the prospectus delivery requirements under the applicable securities laws in connection with any transfer of the aforesaid shares of Common Stock.

 

Conversion calculations:

 

Date to Effect Conversion:______________________________________

 

Principal Amount of Note to be Converted:________________________

 

Payment of Interest in Common Stock __ yes __ no

 

If yes, $_____ of Interest Accrued on Account of Conversion at Issue.

 

Number of shares of Common Stock to be issued:___________________

 

__________________________

Signature

 

__________________________

Name

 

Delivery Instructions:

 

__________________________

__________________________

__________________________

__________________________

__________________________

 

 
16

 

  

Schedule 1

 

CONVERSION SCHEDULE

 

This 15% OID Senior Secured Promissory Notes due July 7, 2022 in the original principal amount of $1,150,000 is issued by Edible Garden AG Incorporated (the “Company”). This Conversion Schedule reflects conversions made under Section 4 of the above referenced Note.

 

Dated:

 

Date of Conversion

(or for first entry, Original Issue Date)

Amount of Conversion

Aggregate Principal Amount Remaining Subsequent to Conversion

(or original Principal Amount)

Company Attest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
17

 

 

EXHIBIT 10.17b

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON STOCK PURCHASE WARRANT

 

Edible Garden AG Incorporated

 

Warrant Shares: 751,634

Initial Exercise Date: October 7, 2021

 

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, EVERGREEN CAPITAL MANAGEMENT LLC, or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m., New York City Time, on October 7, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Edible Garden AG Incorporated, a Delaware corporation (the “Company”), up to 751,634 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b).

 

This Warrant is being issued pursuant to that certain Securities Purchase Agreement dated as of October 7, 2021 between the Holder and the Company (the “Securities Purchase Agreement”). In addition to the terms defined elsewhere in this Warrant, capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Securities Purchase Agreement.

 

1. Exercise.

 

(a) Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise in the form annexed hereto and within five (5) Trading Days of the date said Notice of Exercise is delivered to the Company, the Company shall have received payment of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier’s check drawn on a United States bank or, if available, pursuant to the cashless exercise procedure specified in Section 1(c) below. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within five (5) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within three (3) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

 
1

 

   

(b) Exercise Price. The exercise price per share of the Common Stock under this Warrant shall initially be $1.53, subject to adjustment hereunder (the “Exercise Price”).

 

(c) Cashless Exercise. If at any time after the six-month anniversary of the Initial Exercise Date, there is no effective Registration Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may only be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

 

A =

the VWAP on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise;

 

 

 

 

B =

the Exercise Price of this Warrant, as adjusted hereunder; and

 

 

 

 

X =

the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to take any position contrary to this Section 2(c).

 

Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 1(c).

 

(d) Mechanics of Exercise.

 

i. Delivery of Warrant Shares Upon Exercise. Warrant Shares purchased hereunder shall be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is five (5) Trading Days after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 1(d)(vi) prior to the issuance of such shares, having been paid.

 

 
2

 

    

ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

iii. Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 1(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv. Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares that the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

v. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

vi. Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

vii. Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

  

 
3

 

    

(e) Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 1(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 1(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 1(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 1(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

 
4

 

    

2. Certain Adjustments.

 

(a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 2(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or reclassification.

 

(b) Subsequent Equity Sales. If, at any time while this Warrant is outstanding and prior to (and including) the closing of the Qualified Offering, the Company sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock at an effective price per share that is lower than the then Exercise Price (such lower price, the “Base Exercise Price” and such issuances, collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is lower than the then Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced to equal the Base Exercise Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing, no adjustment will be made under this Section 2(b) in respect of an Exempt Issuance. The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of any Common Stock or Common Stock Equivalents subject to this Section 2(b), indicating therein the applicable issuance price, or applicable reset price, exchange price, exercise price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 2(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base Exercise Price on or after the date of such Dilutive Issuance, regardless of whether the Holder accurately refers to the Base Exercise Price in the Notice of Exercise.

 

 
5

 

    

(c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 2(a) and 2(b) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

(d) Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, upon the exercise of this Warrant, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

(e) [Reserved.]

 

(f) Calculations. All calculations under this Section 2 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 2, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

 
6

 

    

(g) Notice to Holder.

 

i. Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 2, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that, following the closing of the IPO, any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

3. Transfer of Warrant.

 

(a) Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 3(d) hereof, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

 
7

 

    

(b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 3(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

(c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

(d) Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, make usual and customary representations as to investment intent to the Company.

 

(e) Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

 

4. Miscellaneous.

 

(a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 1(d)(i), except as expressly set forth in Section 2.

 

(b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

(c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.

 

 
8

 

    

(d) Authorized Shares.

 

i. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

ii. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

iii. Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

(e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the laws of the State of Delaware as they are applied to contracts executed, delivered and to be wholly performed within the State of Delaware.

 

(f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and if the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

(g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

 
9

 

    

(h) Notices. Any notice, request or other document required or permitted to be given or delivered to the either party to the other shall be delivered in by recognized overnight courier, facsimile or email as follows:

 

If to the Holder:

 

Evergreen Capital Management LLC

156 West Saddle River Road

Saddle River, NJ 07458

Attn: Manager

Email: jpazdro@egcmllc.com

 

If to the Company:

 

Edible Garden AG Incorporated

283 County Road 519

Belvidere, New Jersey 07823

Attn: Chief Executive Officer

Email: jkras@ediblegarden.com

 

(i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

(j) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

(k) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

(l) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

(m) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

********************

 

[Signature Page to Follow.]

 

 
10

 

   

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

 

Edible Garden AG Incorporated

       
By: /s/ James Kras

 

 

Name: James Kras

 
   

Title: Chief Executive Officer

 

   

 
11

 

 

EXHIBIT A

 

NOTICE OF EXERCISE

 

TO: Edible Garden AG Incorporated

 

(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form of (check applicable box):

 

☐ in lawful money of the United States; or

 

☐ if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in Section 1(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in Section 1(c).

 

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

__________________________________

 

The Warrant Shares shall be delivered to the following DWAC Account Number:

 

__________________________________

__________________________________

__________________________________

 

(4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

 

[SIGNATURE OF HOLDER]

 

________________________

Name of Investing Entity:

 

________________________

Signature of Authorized Signatory of Investing Entity:

 

________________________

Name of Authorized Signatory

 

________________________

Title of Authorized Signatory

 

________________________

Date

 

 
12

 

  

EXHIBIT B

 

ASSIGNMENT FORM

 

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

Name:

 

 

(Please Print)

 

 

Address:

 

 

(Please Print)

Dated: _______________ __, ______

 

 

Holder’s Signature:

 

 

 

 

 

Holder’s Address:

 

 

 

 
13

 

 

EXHIBIT 10.18

 

Edible Garden AG Incorporated

283 County Road 519

Belvidere, New Jersey 07823

 

October 14, 2021

 

Evergreen Capital Management LLC

156 W Saddle River Road

Saddle River, New Jersey 07458

 

Gentlemen:

 

Reference is made to the Securities Purchase Agreement dated as of October 7, 2021 (the “Agreement”) between Edible Garden AG Incorporated, a Delaware corporation (the “Company”), and Evergreen Capital Management LLC, a Delaware limited liability company (“Evergreen”). Terms used but not defined herein have the respective meanings set forth in the Agreement.

 

This letter will confirm our understanding and agreement that Section 2.1 of the Agreement shall be amended such that:

 

 

(i)

the Closing for the second Tranche of $350,000 in Subscription Amount of Notes (to purchase an aggregate of $402,500 in principal amount of Notes) and Warrants to purchase an aggregate of number of shares of Common Stock equal to the Warrant Amount for such Closing will occur, at the option of the Company, within thirty (30) days of the occurrence of the receipt of comments from the Commission on the Company’s registration statement on Form S-1;

 

 

 

 

(ii)

the Closing for the third Tranche of $350,000 in Subscription Amount of Notes (to purchase an aggregate of $402,500 in principal amount of Notes) and Warrants to purchase an aggregate of number of shares of Common Stock equal to the Warrant Amount for such Closing will occur, at the option of the Company, within thirty (30) days of November 11, 2021; and

 

 

 

 

(iii)

the Closing for the fourth Tranche of $300,000 in Subscription Amount of Notes (to purchase an aggregate of $345,000 in principal amount of Notes) and Warrants to purchase an aggregate of number of shares of Common Stock equal to the Warrant Amount for such Closing will occur, at the option of the Company, within thirty (30) days of December 11, 2021.

    

Except as expressly amended hereby, all of the terms and provisions of the Agreement shall remain in full force and effect.

 

If the foregoing accurately sets forth our understanding and agreement as to the matters set forth above, please acknowledge your agreement by signing below and returning to me a copy of this letter.

 

 

Very truly yours,

 

Edible Garden AG Incorporated

       
By: /s/ James Kras

 

Name:

James Kras  
  Title: Chief Executive Officer  

  

ACKNOWLEDGED and AGREED:

 

Evergreen Capital Management LLC

     
By: /s/ Jeff Pazdro

Name:

Jeff Pazdro  
Title: Manager  

 

 

 

 

EXHIBIT 10.19

 

SECURITY AGREEMENT

 

This SECURITY AGREEMENT, dated as of October 7, 2021 (as amended, supplemented or otherwise modified from time to time in accordance with the provisions hereof, this “Agreement”), made by and between Edible Garden AG Incorporated, a Delaware corporation (the “Grantor”), in favor of Evergreen Capital Management LLC, as collateral agent for the Noteholders of the Notes of the Company referred to below (the “Secured Party”).

 

WHEREAS, Grantor has issued its 15% OID Senior Secured Promissory Notes due July 7, 2022, and may issue one or more similar senior secured promissory notes (as amended, and together with any promissory note(s) issued in exchange for or upon the transfer thereof, collectively, the “Notes”) pursuant to the Securities Purchase Agreement dated as of October 7, 2021 (the “Purchase Agreement”) between the Company and the purchasers of the Notes that are parties thereto (each a “Noteholder” and collectively, the “Noteholders”); and

 

WHEREAS, it is a condition precedent to the purchase of the Notes by the Noteholders that the Grantor execute and deliver this Agreement.

 

NOW, THEREFORE, in consideration of the mutual covenants, terms and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1. Definitions.

 

(a) Unless otherwise specified herein, all references to Sections and Schedules herein are to Sections and Schedules of this Agreement.

 

(b) Unless otherwise defined herein, terms used herein that are defined in the UCC shall have the meanings assigned to them in the UCC. However, if a term is defined in Article 9 of the UCC differently than in another Article of the UCC, the term has the meaning specified in Article 9.

 

(c) For purposes of this Agreement, the following terms shall have the following meanings:

 

Collateral” has the meaning set forth in Section 2.

 

Event of Default” means the occurrence of any of the following events:

 

(a) the occurrence of an Event of Default under, and as defined in, the Notes;

 

(b) any representation or warranty of Grantor in this Agreement shall prove to have been incorrect in any material respect when made;

 

(c) the failure by Grantor to observe or perform any of its obligations hereunder for five (5) days after delivery to Grantor of notice of such failure by or on behalf of the Secured Party; or

 

(d) if any provision of this Agreement shall at any time for any reason be declared to be null and void, or the validity or enforceability thereof shall be contested by Grantor, or a proceeding shall be commenced by Grantor, or by any governmental authority having jurisdiction over Grantor, seeking to establish the invalidity or unenforceability thereof, or Grantor shall deny that Grantor has any liability or obligation purported to be created under this Agreement.

 

 
1

 

    

First Priority” means, with respect to any lien and security interest purported to be created in any Collateral pursuant to this Agreement, such lien and security interest is the most senior lien to which such Collateral is subject.

 

Proceeds” means “proceeds” as such term is defined in section 9-102 of the UCC and, in any event, shall include, without limitation, all dividends or other income from the Collateral, collections thereon or distributions with respect thereto.

 

Secured Obligations” has the meaning set forth in Section 3.

 

UCC” means the Uniform Commercial Code as in effect from time to time in the State of New York or, when the laws of any other state govern the method or manner of the perfection or enforcement of any security interest in any of the Collateral, the Uniform Commercial Code as in effect from time to time in such state.

 

2. Grant of Security Interest. The Grantor hereby pledges and grants to the Secured Party, and hereby creates a continuing lien and security interest in favor of the Secured Party, in and to all of its right, title and interest in and to the following, wherever located, whether now existing or hereafter from time to time arising or acquired (collectively, the “Collateral”):

 

(a) the properties, assets, and rights of the Grantor described in Attachment 1 hereto, wherever located, whether the Grantor now has or hereafter acquires an ownership or other interest or power to transfer; and

 

(b) all Proceeds and products of each of the foregoing, all books and records relating to the foregoing, all supporting obligations related thereto, and all accessions to, substitutions and replacements for, and rents, profits and products of, each of the foregoing, and any and all Proceeds of any insurance, indemnity, warranty or guaranty payable to the Grantor from time to time with respect to any of the foregoing, whether now or hereafter arising.

 

3. Secured Obligations. The Collateral secures the due and prompt payment and performance of:

 

(a) the obligations of the Grantor from time to time arising under the Notes, this Agreement or otherwise with respect to the due and prompt payment of (i) the principal of and premium, if any, interest (including interest accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) and Mandatory Default Amount (as defined in the Notes), if any, on the Notes when and as due, whether at maturity, by acceleration, upon one or more dates set for prepayment or otherwise and (ii) all other monetary obligations, including fees, costs, attorneys’ fees and disbursements, reimbursement obligations, contract causes of action, expenses and indemnities, whether primary, secondary, direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding), of the Grantor under or in respect of the Notes and this Agreement; and

 

(b) all other covenants, duties, debts, obligations and liabilities of any kind of the Grantor under or in respect of the Notes, this Agreement or any other document made, delivered or given in connection with any of the foregoing, in each case whether evidenced by a note or other writing, whether allowed in any bankruptcy, insolvency, receivership or other similar proceeding, whether arising from an extension of credit, issuance of a letter of credit, acceptance, loan, guaranty, indemnification or otherwise, and whether primary, secondary, direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, fixed or otherwise (all such obligations, covenants, duties, debts, liabilities, sums and expenses set forth in Section 3 being herein collectively called the “Secured Obligations”).

 

 
2

 

    

4. Perfection of Security Interest and Further Assurances.

 

(a) The Grantor shall, from time to time, as may be required by the Secured Party with respect to all Collateral, promptly take all actions as may be requested by the Secured Party or any Noteholder to perfect the security interest of the Secured Party in the Collateral, including, without limitation, with respect to all Collateral over which control may be obtained within the meaning of sections 8-106, 9-104, 9-105, 9-106 and 9-107 of the UCC, as applicable, the Grantor shall promptly take all actions as may be requested from time to time by the Secured Party or any Noteholder so that control of such Collateral is obtained and at all times held by the Secured Party. All of the foregoing shall be at the sole cost and expense of the Grantor.

 

(b) The Grantor hereby irrevocably authorizes the Secured Party at any time and from time to time to file in any relevant jurisdiction any financing statements and amendments thereto that contain the information required by Article 9 of the UCC of each applicable jurisdiction for the filing of any financing statement or amendment relating to the Collateral, including any financing or continuation statements or other documents for the purpose of perfecting, confirming, continuing, enforcing or protecting the security interest granted by the Grantor hereunder, without the signature of the Grantor where permitted by law, including the filing of a financing statement describing the Collateral as all assets now owned or hereafter acquired by the Grantor, or words of similar effect. The Grantor agrees to provide all information required by the Secured Party or any Noteholder pursuant to this Section promptly to the Secured Party or such Noteholder, as the case may be, upon request.

 

(c) If the Grantor shall at any time hold or acquire any certificated securities, promissory notes, tangible chattel paper, negotiable documents or warehouse receipts relating to the Collateral, the Grantor shall promptly endorse, assign and deliver the same to the Secured Party, accompanied by such instruments of transfer or assignment duly executed in blank as the Secured Party may from time to time specify.

 

(d) The Grantor agrees that at any time and from time to time, at the expense of the Grantor, the Grantor will promptly execute and deliver all further instruments and documents, obtain such agreements from third parties, and take all further action, that may be necessary or desirable, or that the Secured Party or any Noteholder may reasonably request, in order to create and/or maintain the validity, perfection or priority of and protect any security interest granted or purported to be granted hereby or to enable the Secured Party to exercise and enforce its rights and remedies hereunder or under any other agreement with respect to any Collateral.

 

5. Representations and Warranties. The Grantor represents and warrants as follows:

 

(a) It has previously delivered to the Secured Party and each Noteholder a certificate substantially in the form as Schedule A hereto signed by the Grantor and entitled “Perfection Certificate” (“Perfection Certificate”), and that: (i) the Grantor’s exact legal name is that indicated on the Perfection Certificate and on the signature page hereof, (ii) the Grantor is an organization of the type, and is organized in the jurisdiction, set forth in the Perfection Certificate, (iii) the Perfection Certificate accurately sets forth, the Grantor’s place of business (or, if more than one, its chief executive office), (iv) all other information set forth on the Perfection Certificate relating to the Grantor is accurate and complete and (v) there has been no change in any such information since the date on which the Perfection Certificate was signed by the Grantor.

 

 
3

 

    

(b) All information set forth on the Perfection Certificate relating to the Collateral is accurate and complete and there has been no change in any such information since the date on which the Perfection Certificate was signed by the Grantor.

 

(c) The Collateral consisting of securities (if any) have been duly authorized and validly issued, and are fully paid and non-assessable and subject to no options to purchase or similar rights. None of the Collateral constitutes, or is the proceeds of, (i) farm products, (ii) as extracted collateral, (iii) manufactured homes, (iv) health care insurance receivables, (v) timber to be cut, (vi) aircraft, aircraft engines, satellites, ships or railroad rolling stock. None of the account debtors or other persons obligated on any of the Collateral is a governmental authority covered by the Federal Assignment of Claims Act or like federal, state or local statute or rule in respect of such Collateral. The Grantor has at all times operated its business in compliance with all applicable provisions of the federal Fair Labor Standards Act, as amended, and with all applicable provisions of federal, state and local statutes and ordinances dealing with the control, shipment, storage or disposal of hazardous materials or substances.

 

(d) At the time the Collateral becomes subject to the lien and security interest created by this Agreement, the Grantor will be the sole, direct, legal and beneficial owner thereof, free and clear of any lien, security interest, encumbrance, claim, option or right of others except for (i) the security interest created by this Agreement and (ii) Permitted Liens. For the purpose of this Agreement, “Permitted Liens means (A) statutory liens of landlords and liens of carriers, warehousemen, bailees, mechanics, materialmen and other like liens imposed by law, created in the ordinary course of business and securing amounts not yet due (or which are being contested in good faith, by appropriate proceedings or other appropriate actions which are sufficient to prevent imminent foreclosure of such liens), and with respect to which adequate reserves or other appropriate provisions are being maintained by the Grantor, (B) deposits made (and the liens thereon) in the ordinary course of business of the Grantor (including, without limitation, security deposits for leases, indemnity bonds, surety bonds and appeal bonds) in connection with workers’ compensation, unemployment insurance and other types of social security benefits or to secure the performance of tenders, bids, contracts (other than for the repayment or guarantee of borrowed money or purchase money obligations), statutory obligations and other similar obligations arising as a result of progress payments under government contracts, (C) liens for taxes not yet due and payable or which are being contested in good faith and with respect to which adequate reserves are being maintained by the Grantor, (D) purchase money liens relating to the acquisition of equipment, machinery or other goods of the Grantor, and (E) the security interest of Sament Capital Investments, Inc. (“Sament”) under that certain Security Agreement, dated March 30, 2020 (the “Sament Security Agreement”), between Sament and the Grantor, as the same may be amended or modified.

 

(e) The pledge of the Collateral pursuant to this Agreement creates a valid and perfected security interest in the Collateral securing the payment and performance when due of the Secured Obligations.

 

(f) Grantor has full power, authority and legal right to issue the Notes and to pledge the Collateral pursuant to this Agreement.

 

(g) This Agreement has been duly authorized, executed and delivered by the Grantor and constitutes a legal, valid and binding obligation of the Grantor enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors’ rights generally and subject to equitable principles (regardless of whether enforcement is sought in equity or at law).

 

 
4

 

    

(h) No authorization, approval, or other action by, and no notice to or filing with, any governmental authority or regulatory body is required for the issuing of the Notes by the Grantor and the pledge by the Grantor of the Collateral pursuant to this Agreement or for the execution and delivery of this Agreement by the Grantor or the performance by the Grantor of its obligations thereunder.

 

(i) The execution and delivery of this Agreement by the Grantor and the performance by the Grantor of its obligations hereunder, will not violate any provision of any applicable law or regulation or any order, judgment, writ, award or decree of any court, arbitrator or governmental authority, domestic or foreign, applicable to the Grantor or any of its property, or the organizational or governing documents of the Grantor or any agreement or instrument to which the Grantor is party or by which it or its property is bound.

 

(j) The Grantor has taken all action required on its part for control (as defined in sections 8-106, 9-104, 9-105, 9-106 and 9-107 of the UCC, as applicable) to have been obtained by the Secured Party over all Collateral with respect to which such control may be obtained pursuant to the UCC. No person other than the Secured Party has control or possession of all or any part of the Collateral.

 

6. Voting, Distributions and Receivables.

 

(a) The Secured Party agrees that unless an Event of Default shall have occurred and be continuing, the Grantor may, to the extent the Grantor has such right as a holder of the Collateral consisting of securities, other Equity Interests or indebtedness owed by any obligor, vote and give consents, ratifications and waivers with respect thereto, except to the extent that, any such vote, consent, ratification or waiver could detract from the value thereof as Collateral or which could be inconsistent with or result in any violation of any provision of the Notes or this Agreement.

 

(b) If any Event of Default shall have occurred and be continuing, the Secured Party may, or at the request and option of the Secured Party the Grantor shall, notify account debtors and other persons obligated on any of the Collateral of the security interest of the Secured Party in any account, chattel paper, general intangible, instrument or other Collateral and that payment thereof is to be made directly to the Secured Party.

 

7. Covenants. The Grantor covenants as follows:

 

(a) The Grantor will not, without providing at least 30 days’ prior written notice to the Secured Party and each Noteholder, change its legal name, identity, type of organization, jurisdiction of organization, corporate structure, location of its chief executive office or its principal place of business or its organizational identification number. The Grantor will, prior to any change described in the preceding sentence, take all actions reasonably requested by the Secured Party to maintain the perfection and priority of the Secured Party’s security interest in the Collateral.

 

(b) The Collateral, to the extent not delivered to the Secured Party pursuant to Section 4, will be kept at those locations listed on the Perfection Certificate and the Grantor will not remove the Collateral from such locations without providing at least 30 days’ prior written notice to the Secured Party and each Noteholder. The Grantor will, prior to any change described in the preceding sentence, take all actions reasonably required by the Secured Party to maintain the perfection and priority of the Secured Party’s security interest in the Collateral.

 

(c) The Grantor shall, at its own cost and expense, defend title to the Collateral and the lien and security interest of the Secured Party therein against the claim of any person claiming against or through the Grantor and shall maintain and preserve such perfected security interest for so long as this Agreement shall remain in effect.

 

 
5

 

    

(d) The Grantor will not sell, offer to sell, dispose of, convey, assign or otherwise transfer, grant any option with respect to, restrict, or grant, create, permit or suffer to exist any mortgage, pledge, lien, security interest, option, right of first offer, encumbrance or other restriction or limitation of any nature whatsoever on, any of the Collateral or any interest therein, other than (i) Permitted Liens, (ii) the transfer of goods, inventory and Collateral in the ordinary course of the Grantor’s business, and (iii) transfers to subsidiaries of the Grantor which have pledged their assets as collateral to secure payment of the Secured Obligations.

 

(e) The Grantor will keep the Collateral in good order and repair and will not use the same in violation of law or any policy of insurance thereon. The Grantor will permit the Secured Party or any Noteholder, or its designee, to inspect the Collateral at any reasonable time, wherever located.

 

(f) The Grantor will pay promptly when due all taxes, assessments, governmental charges, and levies upon the Collateral or incurred in connection with the use or operation of the Collateral or incurred in connection with this Agreement.

 

(g) The Grantor will continue to operate its business in compliance with all applicable provisions of the federal Fair Labor Standards Act, as amended, and with all applicable provisions of federal, state and local statutes and ordinances dealing with the control, shipment, storage or disposal of hazardous materials or substances.

 

8. Secured Party Appointed Attorney-in-Fact. The Grantor hereby appoints the Secured Party the Grantor’s attorney-in-fact, with full authority in the place and stead of the Grantor and in the name of the Grantor or otherwise, from time to time during the continuance of an Event of Default in the Secured Party’s discretion to take any action and to execute any instrument which the Secured Party may deem necessary or advisable to accomplish the purposes of this Agreement (but the Secured Party shall not be obligated to and shall have no liability to the Grantor or any third party for failure to do so or take action). This appointment, being coupled with an interest, shall be irrevocable. The Grantor hereby ratifies all that said attorneys shall lawfully do or cause to be done by virtue hereof.

 

9. Secured Party May Perform. If the Grantor fails to perform any obligation contained in this Agreement, the Secured Party may itself perform, or cause performance of, such obligation, and the expenses of the Secured Party incurred in connection therewith shall be payable by the Grantor; provided that the Secured Party shall not be required to perform or discharge any obligation of the Grantor.

 

10. Reasonable Care. The Secured Party shall have no duty with respect to the care and preservation of the Collateral beyond the exercise of reasonable care. The Secured Party shall be deemed to have exercised reasonable care in the custody and preservation of the Collateral in its possession if the Collateral is accorded treatment substantially equal to that which the Secured Party accords its own property, it being understood that the Secured Party shall not have any responsibility for (a) ascertaining or taking action with respect to any claims, the nature or sufficiency of any payment or performance by any party under or pursuant to any agreement relating to the Collateral or other matters relative to any Collateral, whether or not the Secured Party has or is deemed to have knowledge of such matters, or (b) taking any necessary steps to preserve rights against any parties with respect to any Collateral. Nothing set forth in this Agreement, nor the exercise by the Secured Party of any of the rights and remedies hereunder, shall relieve the Grantor from the performance of any obligation on the Grantor’s part to be performed or observed in respect of any of the Collateral.

 

 
6

 

    

11. Remedies Upon Default.

 

(a) If any Event of Default shall have occurred and be continuing, the Secured Party, without any other notice to or demand upon the Grantor, may assert all rights and remedies of a secured party under the UCC or other applicable law, including, without limitation, the right to take possession of, hold, collect, sell, lease, deliver, grant options to purchase or otherwise retain, liquidate or dispose of all or any portion of the Collateral. If notice prior to disposition of the Collateral or any portion thereof is necessary under applicable law, written notice mailed to the Grantor at its notice address as provided in Section 15 hereof ten days prior to the date of such disposition shall constitute reasonable notice, but notice given in any other reasonable manner shall be sufficient. So long as the sale of the Collateral is made in a commercially reasonable manner, the Secured Party may sell such Collateral on such terms and to such purchaser(s) as the Secured Party in its absolute discretion may choose, without assuming any credit risk and without any obligation to advertise or give notice of any kind other than that necessary under applicable law. Without precluding any other methods of sale, the sale of the Collateral or any portion thereof shall have been made in a commercially reasonable manner if conducted in conformity with reasonable commercial practices of creditors disposing of similar property. To the extent permitted by applicable law, the Grantor waives all claims, damages and demands it may acquire against the Secured Party arising out of the exercise by it of any rights hereunder. The Grantor hereby waives and releases to the fullest extent permitted by law any right or equity of redemption with respect to the Collateral, whether before or after sale hereunder, and all rights, if any, of marshalling the Collateral and any other security for the Secured Obligations or otherwise. At any such sale, unless prohibited by applicable law, the Secured Party or any custodian may bid for and purchase all or any part of the Collateral so sold free from any such right or equity of redemption. Neither the Secured Party nor any custodian shall be liable for failure to collect or realize upon any or all of the Collateral or for any delay in so doing, nor shall it be under any obligation to take any action whatsoever with regard thereto. The Secured Party shall not be obligated to clean-up or otherwise prepare the Collateral for sale.

 

(b) If any Event of Default shall have occurred and be continuing, all rights of the Grantor to exercise the voting and other consensual rights it would otherwise be entitled to exercise pursuant to Section 6(a) shall immediately cease, and all such rights shall thereupon become vested in the Secured Party, which shall have the sole right to exercise such voting and other consensual rights and receive and hold such dividends and other distributions as Collateral.

 

(c) If any Event of Default shall have occurred and be continuing, any cash held by the Secured Party as Collateral and all cash Proceeds received by the Secured Party in respect of any sale of, collection from, or other realization upon all or any part of the Collateral shall be applied in whole or in part by the Secured Party to the payment of expenses incurred by the Secured Party in connection with the foregoing or incidental to the care or safekeeping of any of the Collateral or in any way relating to the Collateral or the rights of the Secured Party hereunder, including reasonable attorneys’ fees, and the balance of such proceeds shall be applied or set off against all or any part of the Secured Obligations in such order as the Secured Party, acting at the direction of the Noteholders, shall elect. Any surplus of such cash or cash Proceeds held by the Secured Party and remaining after payment in full of all the Secured Obligations shall be paid over to the Grantor or to whomsoever may be lawfully entitled to receive such surplus. The Grantor shall remain liable for any deficiency if such cash and the cash Proceeds of any sale or other realization of the Collateral are insufficient to pay the Secured Obligations and the fees and other charges of any attorneys employed by the Secured Party to collect such deficiency.

 

(d) If the Secured Party shall determine to exercise its rights to sell all or any of the Collateral pursuant to this Section, the Grantor agrees that, upon request of the Secured Party, the Grantor will, at its own expense, do or cause to be done all such acts and things as may be necessary to make such sale of the Collateral or any part thereof valid and binding and in compliance with applicable law.

 

 
7

 

    

12. No Waiver and Cumulative Remedies. The Secured Party shall not by any act (except by a written instrument pursuant to Section 14), delay, indulgence, omission or otherwise be deemed to have waived any right or remedy hereunder or to have acquiesced in any Event of Default. All rights and remedies herein provided are cumulative and are not exclusive of any rights or remedies provided by law.

 

13. Security Interest Absolute. The Grantor hereby waives demand, notice, protest, notice of acceptance of this Agreement, notice of loans made, credit extended, Collateral received or delivered or other action taken in reliance hereon and all other demands and notices of any description. All rights of the Secured Party and liens and security interests hereunder, and all Secured Obligations of the Grantor hereunder, shall be absolute and unconditional irrespective of:

 

(a) any illegality or lack of validity or enforceability of any Secured Obligation or any related agreement or instrument;

 

(b) any change in the time, place or manner of payment of, or in any other term of, the Secured Obligations, or any rescission, waiver, amendment or other modification of the Notes or this Agreement or any other agreement, including any increase in the Secured Obligations resulting from any extension of additional credit or otherwise;

 

(c) any taking, exchange, substitution, release, impairment or non-perfection of any Collateral or any other collateral, or any taking, release, impairment, amendment, waiver or other modification of any guaranty, for all or any of the Secured Obligations;

 

(d) any manner of sale, disposition or application of proceeds of any Collateral or any other collateral or other assets to all or part of the Secured Obligations;

 

(e) any default, failure or delay, willful or otherwise, in the performance of the Secured Obligations;

 

(f) any defense, set-off or counterclaim (other than a defense of payment or performance) that may at any time be available to, or be asserted by, the Grantor against the Secured Party; or

 

(g) any other circumstance (including, without limitation, any statute of limitations) or manner of administering the Note or any existence of or reliance on any representation by the Secured Party that might vary the risk of the Grantor or otherwise operate as a defense available to, or a legal or equitable discharge of, the Grantor or any other grantor, guarantor or surety.

 

14. Amendments. None of the terms or provisions of this Agreement may be amended, modified, supplemented, terminated or waived, and no consent to any departure by the Grantor therefrom shall be effective unless the same shall be in writing and signed by the Secured Party, acting at the direction of the Noteholders, and the Grantor, and then such amendment, modification, supplement, waiver or consent shall be effective only in the specific instance and for the specific purpose for which made or given.

 

15. Addresses For Notices. All notices and other communications provided for in this Agreement shall be in writing and shall be given in the manner and become effective as set forth in the Purchase Agreement, and addressed to the respective parties at their addresses as specified on the signature pages hereof or as to either party at such other address as shall be designated by such party in a written notice to each other party.

 

 
8

 

    

16. Continuing Security Interest; Further Actions. This Agreement shall create a continuing First Priority lien and security interest in the Collateral other than (i) Collateral subject to the security interest of Sament under the Security Agreement and (ii) Permitted Liens constituting purchase money security interests, and this Agreement shall (a) subject to Section 17, remain in full force and effect until payment and performance in full of the Secured Obligations, (b) be binding upon the Grantor, its successors and assigns, and (c) inure to the benefit of the Secured Party and its successors, transferees and assigns; provided that the Grantor may not assign or otherwise transfer any of its rights or obligations under this Agreement without the prior written consent of the Secured Party, given at the direction of the Noteholders. Without limiting the generality of the foregoing clause (c), any assignee of the Secured Party’s interests in any agreement or document which includes all or any of the Secured Obligations shall, upon assignment in accordance with the Notes and other transaction documents, become vested with all the benefits granted to the Secured Party herein with respect to such Secured Obligations.

 

17. Termination; Release. On the date on which all Secured Obligations have been paid and performed in full, the Secured Party will, at the request and sole expense of the Grantor, (a) duly assign, transfer and deliver to or at the direction of the Grantor (without recourse and without any representation or warranty) such of the Collateral as may then remain in the possession of the Secured Party, together with any monies at the time held by the Secured Party hereunder, and (b) execute and deliver to the Grantor a proper instrument or instruments acknowledging the satisfaction and termination of this Agreement.

 

18. Governing Law; Jurisdiction; Jury Trial. This Agreement and any claim, controversy, dispute or cause of action (whether in contract or tort or otherwise) based upon, arising out of or relating to this and the transactions contemplated hereby shall be governed by, and construed in accordance with, the laws of the State of New York. Grantor hereby irrevocably and unconditionally (i) agrees that any legal action, suit or proceeding arising out of or relating to this Agreement may be brought in the courts of the State of New York or of the United States of America for the Southern District of New York and (ii) submits to the jurisdiction of any such court in any such action, suit or proceeding. Final judgment against the Grantor in any action, suit or proceeding shall be conclusive and may be enforced in any other jurisdiction by suit on the judgment. GRANTOR HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY RELATING TO THIS AGREEMENT OR THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY.

 

19. Counterparts. This Agreement and any amendments, waivers, consents or supplements hereto may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or in electronic (i.e., “pdf” or “tif”) format shall be effective as delivery of a manually executed counterpart of this Agreement. This Agreement constitutes the entire contract among the parties with respect to the subject matter hereof and supersede all previous agreements and understandings, oral or written, with respect thereto.

 

[SIGNATURE PAGE FOLLOWS]

  

 
9

 

   

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

 

Edible Garden AG Incorporated, as Grantor

       
By: /s/ James Kras

 

 

Name: James Kras

 
   

Title: Chief Executive Officer

 
       

 

Address for Notices:

 

 

 

 

 

 

 

283 County Road 519

 

 

 

Belvidere, NJ 07823

 

 

 

 

 

 

EVERGREEN CAPITAL MANAGEMENT LLC, as Secured Party

 

 

 

 

 

 

By:

/s/ Jeff Pazdro

 

 

 

Name: Jeff Pazdro

 

 

 

Title: Manager

 

 

 

 

 

 

Address for Notices:

 

 

 

 

 

 

 

156 West Saddle River Road

 

 

 

Saddle River, NJ 07458

 

 

 
10

 

  

ATTACHMENT 1

 

All right, title, interest, claims and demands of the Company in and to the following property:

 

1. All Accounts;

 

2. All Chattel Paper;

 

3. All Deposit Accounts and cash;

 

4. All Documents;

 

5. All General Intangibles;

 

6. All Goods;

 

7. All Instruments;

 

8. All Intellectual Property;

 

9. All Inventory;

 

10. All Investment Property;

 

11. All Unencumbered Equipment; and

 

12. All Letter-of-Credit Rights.

 

To the extent not otherwise included, all Proceeds and products of any and all of the foregoing, and all accessions to, substitutions and replacements for, and rents and profits of each of the foregoing.

 

All capitalized terms used in this Attachment 1 and not otherwise defined herein, shall have the respective meanings given to such terms in the Uniform Commercial Code of the State of New York as in effect from time to time.

 

The term “Intellectual Property” means all intellectual and similar property of every kind and nature hereafter acquired or developed by the Company, including inventions, designs, patents (whether registered or unregistered), copyrights (whether registered or unregistered), trademarks (whether registered or unregistered), trade secrets, domain names, confidential or proprietary technical and business information, know‑how, methods, processes, drawings, specifications or other data or information and all memoranda, notes and records with respect to any research and development, software and databases and all embodiments or fixations thereof whether in tangible or intangible form or contained on magnetic media readable by machine together with all such magnetic media and related documentation, registrations and franchises, and all additions, improvements and accessions to, and books and records describing or used in connection with, any of the foregoing.

 

 
11

 

 

EXHIBIT 10.20

 

GUARANTY AND SECURITY AGREEMENT

  

This GUARANTY AND SECURITY AGREEMENT (this “Security Agreement”) is made as of October 7, 2021, by and between the subsidiaries of Edible Garden AG Incorporated, a Delaware corporation, named on the signature pages hereto (the “Grantors” and “Guarantors” and individually a “Grantor” and “Guarantor”) and Evergreen Capital Management, LLC (“Lender”). The Grantors and Lender are collectively referred to in this Security Agreement as the “Parties.”

 

WHEREAS, the Lender has agreed to lend to Edible Garden AG Incorporated, a Delaware corporation (the “Company”), up to $2,000,000 (the “Loans”) pursuant to a Securities Purchase Agreement, dated as of even date herewith (the “Securities Purchase Agreement”), between the Company and the Lender, which Loans shall be evidenced by promissory notes issued pursuant to the Securities Purchase Agreement in the original principal amounts aggregating up to $2,300,000 (the “Notes”). Capitalized terms used herein and not otherwise defined herein having the meanings set forth in the Notes or, if not defined therein, in the Securities Purchase Agreement;

 

WHEREAS, as a condition precedent to the Loans, and to further evidence the Loans and the Company’s obligation to repay them, the Company will execute and deliver in favor of the Lender the Notes;

 

WHEREAS, as a condition precedent to the Loans and as security for repayment of the Loans upon the terms set forth in the Notes and the guarantees of the Guarantors hereunder, the Grantors agree to guaranty all obligations of the Company under the Notes and the other obligations of the Company under the Transaction Documents (as defined in the Securities Purchase Agreement), execute and deliver this Security Agreement to the Lender and hereby to pledge and grant to the Lender a lien on and security interest in all of Grantors’ rights and interest the Pledged Collateral (as defined below), whether now owned or hereafter acquired.

 

NOW, THEREFORE, in consideration of the premises and in order to induce the Lender to make the Loan and accept the Notes, the Parties hereby agree as follows:

 

SECTION 1. Pledge. Each Grantor hereby pledges and delivers to the Lender, and hereby grants to the Company, a lien on and security interest in all of each Grantor’s right, title, and interest in and with respect to each of the following, whether now owned or hereafter acquired (collectively, the “Pledged Collateral”):

 

(a) the properties, assets, and rights of the Grantor described in Attachment 1 hereto, wherever located, whether the Grantor now has or hereafter acquires an ownership or other interest or power to transfer; and

 

(b) to the extent not covered by subsection (a) above, all general intangibles (including causes of action) relating to, and all proceeds of, any or all of the foregoing Pledged Collateral.

 

For purposes of this Agreement, “proceeds” includes whatever is receivable or received when Pledged Collateral or proceeds are sold, exchanged, collected, or otherwise disposed of, whether such disposition is voluntary or involuntary, and includes proceeds of any indemnity or guaranty payable to Grantor or the Company from time to time with respect to any of the Pledged Collateral.

 

 
1

 

    

SECTION 2. Security for Obligations. This Security Agreement secures the prompt and complete (a) payment of all obligations of the Company and the Guarantors to the Lender now or hereafter existing under this Security Agreement, the Notes, and any and all Transaction Documents; and (b) performance and observance by the Company and the Grantors of all of their respective covenants and conditions contained in the Transaction Documents. All such obligations, covenants and conditions described in the immediately preceding clauses (a) and (b), whether for principal, interest, fees, expenses, or otherwise, are hereinafter collectively referred to as the “Obligations.”

 

SECTION 3. UCC Financing Statements on Pledged Collateral. Grantors agree that at any time and from time to time each Grantor will promptly execute and deliver all further instruments, UCC financing statements, and documents, and take all further action that may be reasonably desirable, or that the Lender may reasonably request, in order to perfect and protect any security interest granted or purported to be granted hereby or to enable the Lender to exercise and enforce its rights and remedies hereunder with respect to any of the Pledged Collateral. Each Guarantor shall deliver to Lender within three (3) Business Days of the date of execution of this Security Agreement a form of UCC financing statement(s) with respect to the Pledged Collateral, to be filed and recorded by the Lender at its own discretion. Lender may, at any time and from time to time, upon the occurrence and during the continuance of an Event of Default, subject to grace and cure periods under the Notes and a cure period hereunder of fourteen (14) days for the Company or any Guarantor to correct any Default, in order to facilitate the Lender’s exercise of its rights and remedies hereunder, in its discretion and without notice to any Grantor, to transfer to or to register in the name of the Lender or any of its nominees, part or all of the Pledged Collateral.

 

SECTION 4. Further Assurances; Information; Legending the Certificates. Each Grantor shall cooperate in the completion of, and execute and deliver, any and all notices, forms, schedules or other documents which may be filed by the Lender on its own behalf or on behalf of Grantor, including any and all required notices or statements, and do or cause to be done all such other acts and things, necessary or, in the opinion of the Lender, advisable, for the disposition of any part of the Pledged Collateral pursuant to applicable law.

 

SECTION 5. Representations and Warranties. Each Grantor represents and warrants to the Lender that:

 

(a) No currently effective UCC financing statement covering any of the Pledged Collateral is on file in any public office other than financing statements, if any, related to Permitted Liens (for purposes of this Agreement, “Permitted Liens” means (A) statutory liens of landlords and liens of carriers, warehousemen, bailees, mechanics, materialmen and other like liens imposed by law, created in the ordinary course of business and securing amounts not yet due (or which are being contested in good faith, by appropriate proceedings or other appropriate actions which are sufficient to prevent imminent foreclosure of such liens), and with respect to which adequate reserves or other appropriate provisions are being maintained by a Grantor, (B) deposits made (and the liens thereon) in the ordinary course of business of a Grantor (including, without limitation, security deposits for leases, indemnity bonds, surety bonds and appeal bonds) in connection with workers’ compensation, unemployment insurance and other types of social security benefits or to secure the performance of tenders, bids, contracts (other than for the repayment or guarantee of borrowed money or purchase money obligations), statutory obligations and other similar obligations arising as a result of progress payments under government contracts, (C) liens for taxes not yet due and payable or which are being contested in good faith and with respect to which adequate reserves are being maintained by a Grantor, (D) purchase money liens relating to the acquisition of equipment, machinery or other goods of a Grantor, and (E) the security interest of Sament Capital Investments, Inc. (“Sament”) under that certain Security Agreement, dated March 30, 2020 (the “Sament Security Agreement”), between Sament and the Company, as the same may be amended or modified);

 

(b) Such Grantor is and will remain the legal and beneficial owner of the Pledged Collateral, free of all liens and claims whatsoever, other than Permitted Liens, and with full power and authority to execute this Security Agreement and perform its obligations hereunder, and to subject the Pledged Collateral to the security interest hereunder;

 

 
2

 

    

(c) All information with respect to the Pledged Collateral set forth in any schedule, certificate or other writing at any time hereafter furnished by Grantors to the Lender, and all other written information hereafter furnished by Grantors to the Lender, is and will be true and correct in all material respects as of the date furnished;

 

(d) The execution and delivery of this Security Agreement and the performance by each Grantor of its obligations hereunder do not and will not contravene or conflict with any provision of presently effective law or of any agreement binding upon such Grantor, and this Security Agreement is a legal, valid and binding obligation of each Grantor, enforceable in accordance with its terms, except as such enforceability may be limited by any applicable bankruptcy, insolvency or similar laws and by general principles of equity; and

 

(e) For the purposes of notices under this Agreement, the Company and each of the Grantors shall accept notice at the address for notices set forth with the Company’s signature hereto.

 

SECTION 6. Covenants. During the term of this Security Agreement, each Grantor covenants and agrees with the Lender as follows:

 

(a) Such Grantor shall give the Lender written notice of any change to the address referenced in Section 5(e);

 

(b) Such Grantor shall duly fulfill in all material respects all obligations on its part to be fulfilled under or in connection with the Pledged Collateral and shall do nothing to impair in any material respect the rights of the Lender therein;

 

(c) Following the occurrence and during the continuance of an Event of Default, any proceeds of Pledged Collateral that is not subject to a prior lien, when first received by or on behalf of such Grantor, if so requested by the Lender, shall be deposited by or on behalf of Grantor in the form so received in such account as the Lender shall specify, and until so deposited shall be held in trust for and as the Lender’s property and shall not be commingled with such Grantor’s or any other Person’s other funds or properties;

 

(d) Such Grantor shall (i) comply in all material respects with all applicable laws with respect to the Pledged Collateral or any part thereof, (ii) pay promptly when due all taxes, assessments and governmental charges or levies imposed upon the Pledged Collateral or in respect of its income or profits therefrom and all claims of any kind which, if unpaid, might by law become a lien upon the Pledged Collateral or in respect of its income or profits therefrom, except that such Grantor shall not be required to pay or discharge any such tax, assessment, charge, or claim which is being contested in good faith and by proper proceedings, and (iii) advise the Lender promptly, in reasonable detail, of any lien or claim made or asserted against any of the Pledged Collateral other than Permitted Liens;

 

(e) If the validity or priority of this Security Agreement or of any right, title, security interest, or other interest created or evidenced hereby shall be attacked, endangered, or questioned or if any legal proceedings are instituted against such Grantor with respect thereto, such Grantor will give prompt written notice thereof to the Lender and will diligently endeavor to cure any defect that may be developed or claimed, and will take all necessary and proper steps for the defense of such legal proceedings, and the Lender (whether or not named as a party to legal proceedings with respect thereto) is hereby authorized and empowered to take such additional steps as in its judgment and discretion may be necessary or proper for the defense of any such legal proceedings or the protection of the validity or priority of this Security Agreement and the right, title, security interest, and other interests created or evidenced hereby, and all expenses so incurred of every kind and character shall be a demand obligation owing by such Grantor, and the Person incurring such expenses shall be subrogated to all rights of the Person receiving such payment;

 

 
3

 

    

(f) Such Grantor will, on request of the Lender, (i) promptly correct any defect, error or omission which may be discovered in the contents of this Security Agreement or in any other instrument executed in connection herewith or in the execution or acknowledgment thereof; (ii) execute, acknowledge, deliver and record or file such further instruments (including further security agreements, financing statements and continuation statements) and do such further acts as may be necessary, desirable or proper to carry out more effectively the purposes of this Security Agreement and such other instruments and to subject to the security interests hereof and thereof any property intended by the terms hereof and thereof to be covered hereby and thereby, including any renewals, additions, substitutions, replacements or appurtenances to the Pledged Collateral; and (iii) execute, acknowledge, deliver, procure and record or file any document or instrument (including any financing statement) deemed advisable by the Lender to protect the security interest hereunder against the rights or interests of third persons;

 

(g) Such Grantor shall account fully and faithfully for and, if the Lender so elects, shall promptly pay or turn over to the Lender the proceeds in whatever form received from disposition in any manner of any of the Pledged Collateral. Such Grantor shall at all times keep the Pledged Collateral and its proceeds separate and distinct from other property of such Grantor and shall keep accurate and complete records of the Pledged Collateral and its proceeds;

 

(h) From time to time, upon demand of the Lender, such Grantor will keep and stamp or otherwise mark any and all instruments, documents and chattel paper and its individual books and records relating to any of the Pledged Collateral in such a manner as the Lender may reasonably require; and

 

(i) Such Grantor shall furnish the Lender all such information as the Lender may reasonably request with respect to the Pledged Collateral.

 

SECTION 7. Voting Rights; Dividends; Etc.

 

(a) So long as no Event of Default shall have occurred and be continuing:

 

(i) Each Grantor shall be entitled to exercise any and all voting and other consensual rights pertaining to the Pledged Collateral or any part thereof for any purpose not inconsistent with the terms of this Security Agreement or any other Transaction Document; provided, however, that each Grantor shall give the Lender at least five (5) days’ written notice of the manner in which he intends to exercise, or the reasons for refraining from exercising, any voting or other consensual rights pertaining to the Pledged Collateral or any part thereof which may have a material adverse effect on the value of the Pledged Collateral or any part thereof.

 

(ii) Any and all of the following shall be delivered in the ordinary course and pursuant to the Company’s Operating Agreement:

 

(A) dividends or interest paid or payable other than in cash in respect of, and instruments and other property received, receivable, or otherwise distributed in respect of, or in exchange for, any Pledged Collateral; and

 

(B) dividends and other distributions hereafter paid or payable in cash in respect of any Pledged Collateral in connection with a partial or total liquidation or dissolution or in connection with a reduction of capital, capital surplus or paid‑in‑surplus.

 

 
4

 

    

(iii) Any cash paid, payable or otherwise distributed in redemption of, or in exchange for, any Pledged Collateral, shall be delivered to Lender with the exception of cash distributions received to satisfy Grantor’s tax obligations due to Company profits and to fulfill Grantor’s covenant of Section 6(d) hereof to hold as, Pledged Collateral and shall, if received by Grantor, be received in trust for the benefit of the Lender, be segregated from the other property or funds of Grantor and be forthwith delivered to the Lender as Pledged Collateral in the same form as so received (with any necessary endorsements).

 

(b) Upon the occurrence and during the continuance of an Event of Default:

 

(i) All rights of each Grantor to exercise the voting and other consensual rights which he would otherwise be entitled to exercise pursuant to Section 7(a)(i) shall cease, and all such rights shall thereupon become vested in the Lender, which shall thereupon have the sole right to exercise such voting and other consensual rights.

 

(ii) Each Grantor shall execute and deliver (or cause to be executed and delivered to the Lender) all such proxies and other instruments as the Lender may reasonably request for the purpose of enabling the Lender to exercise the voting and other rights which it is entitled to exercise pursuant to Section 7(b)(i) and to receive the dividends or interest payments which it is entitled to receive and retain pursuant to this Section 7.

 

(iii) Dividends or any other cash distributions received by any Grantor in respect of the Pledged Collateral with the exception of cash distributions received from the Company to satisfy Grantor’s tax obligations due to Company profits and to fulfill Grantor’s covenant of Section 6(d) hereof prior to payment in full of all amounts due and owing under or in connection with the Obligations (including principal, premium, if any, interest, fees and expenses on or in connection with the Obligations) shall be received and held in trust for the Lender, and will be promptly paid over to the Lender in the form received for application to the payment of such obligations until all such Obligations have been paid in full in such manner and order and at such time as the Lender shall select.

 

SECTION 8. No Transfers and Other Liens. Each Grantor shall not sell, exchange or otherwise dispose of, or grant any option, warrant, or other right with respect to or any interest in, any of the Pledged Collateral or create or permit to exist any lien upon or with respect to any of the Pledged Collateral (other than (A) the lien created hereby, (B) Permitted Liens, (C) the transfer of goods, inventory and Collateral in the ordinary course of a Grantor’s business, and (D) transfers to the Company or other subsidiaries of the Company or a Grantor which have pledged their assets as collateral to secure payment of the Secured Obligations).

 

 
5

 

    

SECTION 9. The Lender Appointed Attorney-in-Fact. Each Grantor hereby irrevocably appoints the Lender to be Grantor’s attorney-in-fact, with full authority in the place and stead of Grantor and in the name of Grantor, from time to time in the Lender’s discretion, to take any action and to execute any instrument which the Lender may deem necessary or advisable to accomplish the purposes of this Security Agreement, including:

 

(a) to ask, demand, collect, sue for, recover, compound, receive, and give acquittance and receipts for moneys due and to become due under or in respect of any of the Pledged Collateral;

 

(b) to receive, endorse and collect any drafts or other instruments, documents, and chattel paper in connection with Section 9(a); and

 

(c) to file any claims or take any action or institute any proceedings which the Lender may deem necessary or desirable for the collection of any of the Pledged Collateral or otherwise to enforce the rights of the Lender with respect to any of the Pledged Collateral.

 

SECTION 10. The Lender May Perform. If any Grantor fails to perform any covenant or agreement herein, the Lender may itself perform, or cause performance of, such covenant or agreement, and the expenses of the Lender incurred in connection therewith shall be payable by Grantor.

 

SECTION 11. Reasonable Care. The Lender shall be deemed to have exercised reasonable care in the custody and preservation of the Pledged Collateral in its possession if the Pledged Collateral is accorded treatment substantially equal to that which the Lender accords its own property, it being understood that the Lender shall not have any responsibility for (a) ascertaining or taking action with respect to calls, conversions, exchanges, maturities, tenders, or other matters relative to any Pledged Collateral, whether or not the Lender has or is deemed to have knowledge of such matters, or (b) taking any necessary steps to preserve rights against any Persons with respect to any Pledged Collateral.

 

SECTION 12. Remedies upon an Event of Default; Recourse Nature of Grantor’s Obligations. If any Event of Default shall have occurred:

 

(a) The Lender may exercise in respect of the Pledged Collateral, in addition to other rights and remedies provided for herein or otherwise available to it, all the rights and remedies of a Lender on default under the UCC, or under the laws of any other applicable jurisdiction, at that time, and the Lender may also, without notice except as specified below, sell the Pledged Collateral or any part thereof in one or more parcels at public or private sale, at any exchange, broker’s board or at any of the Lender’s offices or elsewhere, for cash, on credit, or for future delivery, and upon such other terms as the Lender may deem commercially reasonable. Each Grantor agrees that, to the extent notice of sale shall be required by law, at least ten (10) days’ notice to Grantor of the time and place of any public sale or the time after which any private sale is to be made shall constitute reasonable notification. The Lender shall not be obligated to make any sale of Pledged Collateral, regardless of whether notice of sale has been given. The Lender may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned. The Lender is authorized to conduct any private sale of the Pledged Collateral or any part thereof in a manner that will not require the Pledged Collateral or any part thereof to be registered under the Securities Act or any other applicable securities laws. In this regard, each Grantor acknowledges and agrees that the Lender may, in its discretion, approach a restricted number of potential purchasers and that a sale under those circumstances may yield a lower price for the Pledged Collateral or any part thereof then would otherwise be obtainable if the sale of the Pledged Collateral or any part thereof were registered under the Securities Act and applicable state securities laws. Each Grantor agrees that (i) if the Lender shall so sell the Pledged Collateral or any part thereof at such a private sale or sales, the Lender shall have the right to rely upon the advice or opinion of any federally registered securities broker or dealer as to the best price reasonably obtainable upon such a private sale and (ii) such reliance shall be conclusive evidence that the Lender handled such matter in a commercially reasonable manner.

 

 
6

 

     

(b) In addition to the rights of the Lender under Section 7, any cash held by the Lender as Pledged Collateral and all cash proceeds received by the Lender in respect of any sale of, collection from, or other realization upon all or any part of the Pledged Collateral may, in the discretion of the Lender, be held by the Lender as collateral for, and then or at any time thereafter applied in whole or in part by the Lender against, the Obligations in such order as the Lender shall select. Any surplus of such cash or cash proceeds and interest accrued thereon, if any, held by the Lender and remaining after payment in full of all the Obligations shall be paid over to Grantors, or to whomsoever may be lawfully entitled to receive such surplus, within a reasonable period of time; provided, that the Lender shall have no obligation to invest or otherwise pay interest on any amounts held by it in connection with or pursuant to this Security Agreement.

 

(c) Without limiting in any manner any of any Grantor’s obligations or any of the Lender’s rights under any of the other terms and provisions of this Security Agreement or under any of the terms of the Notes, each Grantor’s liability, and the Lender’s recourse to any assets of Grantor other than the Pledged Collateral, upon the occurrence of any Event of Default shall be per the Guaranty between the Lender and Grantors set forth herein.

 

SECTION 13. Security Interest Absolute. All rights of the Lender hereunder and all obligations of Grantors hereunder, and the security interest created hereunder shall, to the extent permitted by applicable law, be absolute and unconditional, irrespective of:

 

(a) any lack of validity or enforceability of any of the Transaction Documents;

 

(b) any change in the time, manner, or place of payment of, or in any other term of, all or any of the Obligations or any other amendment or waiver of or any consent to any departure from any of the Transaction Documents;

 

(c) any exchange, release, or non-perfection of any collateral standing as security for the Obligations or any liabilities incurred directly or indirectly hereunder or any set-off against any of such liabilities, or any release or amendment or waiver of or consent to departure from any guaranty, for all or any of the Obligations; or

 

(d) any other circumstance which might otherwise constitute a defense available to, or a discharge of, Grantor, or any other Person that is obligated in respect of any of the Obligations.

 

SECTION 14. Continuing Security Interest; Assignment. This Security Agreement shall create a continuing security interest in the Pledged Collateral and shall (a) be binding upon each Grantor and its executors, trustees, receivers, successors and permitted assigns; and (b) inure to the benefit of and be enforceable by the Lender, and its trustees, receivers, successors and assigns. No Grantor may assign any of its rights or obligations under this Security Agreement without the Lender’s prior written consent; and any such purported assignment without such consent shall be void and ineffective.

 

SECTION 15. Waiver of Marshalling. All rights of marshalling of assets of each Grantor, including any such right with respect to the Pledged Collateral, are hereby waived by Grantors.

 

SECTION 16. No Waiver; Remedies. No failure on the part of The Lender to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. The remedies herein provided are cumulative and not exclusive of any remedies provided by law.

 

SECTION 17. GOVERNING LAW. THIS SECURITY AGREEMENT AND THE OTHER TRANSACTION DOCUMENTS SHALL BE DEEMED TO BE CONTRACTS AND AGREEMENTS EXECUTED BY THE PARTIES HERETO UNDER THE LAWS OF THE STATE OF DELAWARE, AND SHALL BE GOVERNED BY, ENFORCED UNDER, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE AND APPLICABLE FEDERAL LAW.

 

 
7

 

    

SECTION 18. Notices: Notices, reports, and other communications hereunder shall be in writing, shall be given by personal or courier service or by mail, and shall be deemed to be given and received (i) upon the addressee’s receipt if delivered in person or by courier or (ii) upon the earlier of the addressee’s receipt and three Business Days following the date such notices, reports, and payments are placed in the United States mail, if properly posted with postage prepaid, by certified mail in an envelope properly addressed, to the addresses denoted under the signatures of the Company and Lender hereto or to such other address as the Company or Lender may specify in a written notice to the other in accordance with this Section 18.

 

SECTION 19. Headings; Certain Terms. The headings in this Security Agreement are for convenience only and are in no way intended to describe, interpret, define, or limit the scope, extent, or intent of this Security Agreement or any provision hereof. In this Security Agreement, (a) “include” and “including” do not signify or imply any limitation, (b) “Section” refers to a Section of this Security Agreement, unless otherwise stated, (c) “hereunder,” “hereof,” “hereto,” and similar terms are references to this Security Agreement as a whole, and not to any particular provision of this Security Agreement, and (d) “UCC” refers to the Uniform Commercial Code in effect in the State of Delaware.

 

SECTION 20. FINAL AGREEMENT OF THE PARTIES: THIS SECURITY AGREEMENT, TOGETHER WITH THE OTHER TRANSACTION DOCUMENTS, CONSTITUTES THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO ORAL AGREEMENTS BETWEEN THE PARTIES.

 

SECTION 21. Guaranty. The Guarantors hereby, jointly and severally, absolutely, irrevocably and unconditionally guarantee the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations and the performance of all agreements of the Company now or hereafter existing under the Transaction Documents, whether for principal, interest, fees, expenses or otherwise. In the event of any failure of the Company to pay or perform when due the Obligations under the Transaction Documents, the Guarantors will, jointly and severally, immediately pay and perform the same at the time and place, and in the funds and manner, provided for in the Transaction Documents, without set-off, counterclaim or deduction of any kind.

 

[Signature Page Follows]

 

 
8

 

   

IN WITNESS WHEREOF, the Parties have caused this Security Agreement to be duly executed and delivered as of the date first above written.

 

 

LENDER:

 

Evergreen Capital Management, LLC

       
By: /s/ Jeff Pazdro

 

 

Jeff Pazdro  
    Managing Member  

 

 

156 West Saddle River Road

 

 

 

Saddle River, NJ 07458

 

 

THE COMPANY:

 

Edible Garden AG Incorporated,

a Delaware corporation

     
By: /s/ James Kras

 

James Kras

 
 

Chief Executive Officer

 
  283 County Road 519  

 

Belvidere, New Jersey 07823

 

 

 

 

GRANTORS/GUARANTORS

 

Edible Garden AG Incorporated (DE)

 

 

 

 

By:

/s/ James Kras

 

 

Name: James Kras

 

 

Title: Chief Executive Officer

 

 

 

 

EG Transportation LLC (NA)

 

 

 

 

By:

/s/ James Kras

 

 

Name: James Kras

 

 

Title: Chief Executive Officer of Edible Garden AG Incorporated,

manager of EG Transportation LLC

 

 

 
9

 

  

ATTACHMENT 1

 

All right, title, interest, claims and demands of each Grantor in and to the following property:

 

1. All Accounts;

 

2. All Chattel Paper;

 

3. All Deposit Accounts and cash;

 

4. All Documents;

 

5. All General Intangibles;

 

6. All Goods;

 

7. All Instruments;

 

8. All Intellectual Property;

 

9. All Inventory;

 

10. All Investment Property;

 

11. All Unencumbered Equipment; and

 

12. All Letter-of-Credit Rights.

 

To the extent not otherwise included, all proceeds and products of any and all of the foregoing, and all accessions to, substitutions and replacements for, and rents and profits of each of the foregoing.

 

All capitalized terms used in this Attachment 1 and not otherwise defined herein, shall have the respective meanings given to such terms in the Uniform Commercial Code of the State of Delaware as in effect from time to time.

 

The term “Intellectual Property” means all intellectual and similar property of every kind and nature hereafter acquired or developed by any Grantor, including inventions, designs, patents (whether registered or unregistered), copyrights (whether registered or unregistered), trademarks (whether registered or unregistered), trade secrets, domain names, confidential or proprietary technical and business information, know‑how, methods, processes, drawings, specifications or other data or information and all memoranda, notes and records with respect to any research and development, software and databases and all embodiments or fixations thereof whether in tangible or intangible form or contained on magnetic media readable by machine together with all such magnetic media and related documentation, registrations and franchises, and all additions, improvements and accessions to, and books and records describing or used in connection with, any of the foregoing.

 

 
10

 

 

EXHIBIT 10.21

 

INTERCREDITOR AGREEMENT AND AMENDMENT

 

This INTERCREDITOR AGREEMENT AND AMENDMENT, dated as of October 7, 2021 (this “Agreement”), is among Sament Capital Investments, Inc., a California corporation (the “Senior Creditor”), Edible Garden AG Incorporated, a Delaware corporation (the “Debtor”), and Evergreen Capital Management LLC, as collateral agent (the “Agent”) for the Noteholders of the Notes of the Company referred to below (collectively, the “Subordinating Creditors”).

 

RECITALS

 

A. The Senior Creditor has or expects to acquire a security interest in the Senior Creditor Collateral, which consists of assets of the Debtor in which the Agent, for itself and for the benefit of the Subordinating Creditors, also has a security interest.

 

B. The Debtor has issued its 15% OID Senior Secured Promissory Notes due July 7, 2022, and may issue one or more similar senior secured promissory notes (as amended, and together with any promissory note(s) issued in exchange for or upon the transfer thereof, collectively, the “Notes”) pursuant to the Securities Purchase Agreement dated as of October 7, 2021 (the “Purchase Agreement”) between the Company and the Subordinating Creditors. The Debtor and the Agent are parties to certain financing agreements pursuant to which Debtor has granted the Agent, for itself and for the benefit of the Subordinating Creditors, a security interest in certain of the Senior Creditor Collateral.

 

C. The Creditors are executing this Agreement to set forth their lien priorities with respect to the Senior Creditor Collateral.

 

D. To induce Senior Creditor to extend financial accommodations to the Debtor, the Agent and the Subordinating Creditors have agreed to subordinate in favor of Senior Creditor their security interest in the Senior Creditor Collateral.

 

NOW, THEREFORE, in consideration of the premises, and intending to be legally bound hereby, the Creditors hereby agree as follows:

 

AGREEMENT

 

1. DEFINITIONS. THE FOLLOWING TERMS USED HEREIN SHALL HAVE THE FOLLOWING MEANING. ALL CAPITALIZED TERMS NOT HEREIN DEFINED SHALL HAVE THE MEANING SET FORTH IN THE UNIFORM COMMERCIAL CODE, AS ENACTED IN THE CHOSEN STATE ON THE DATE HEREOF:

 

1.1 “Bankruptcy Code” — Title 11 of the United States Code.

 

1.2 “Chosen State” – New Jersey.

 

1.3 “Creditors” —The Subordinating Creditors and the Senior Creditor.

 

1.4 “Debtor” — See preamble.

 

1.5 “Party” — The Agent, for the benefit of the Subordinating Creditors, the Debtor, and the Senior Creditor.

 

 
Page 1 of 7

 

    

1.6 “Senior Creditor” — See preamble

 

1.7 “Senior Creditor Collateral” - All of the tangible greenhouse assets of the Debtor located at 283 County Road 519, Belvidere, New Jersey 07823, all proceeds thereof, if any, and all substitutions, replacements, and accessions thereto.

 

1.8 “Senior Creditor Obligations” - Obligations of the Debtor to the Senior Creditor secured by the Senior Creditor Collateral.

 

1.9 “Subordinating Creditor” — See Preamble.

 

1.10 “Subordinating Creditor Agreements” — All agreements now or hereafter entered into between the Debtor, the Subordinating Creditors and/or the Agent secured by the Senior Creditor Collateral.

 

1.11 “Subordinating Creditor Obligations” — Indebtedness owed by the Debtor to the Subordinating Creditors secured by Senior Creditor Collateral.

 

2. PRIORITY.

 

2.1 Notwithstanding the terms or provisions of any agreement or arrangement which either Creditor may now or hereafter have with the Debtor or any rule of law, and irrespective of the time, order, or method of attachment or perfection of any security interest or the recordation or other filing in any public record of any financing statement, the Senior Creditor Obligations and any security interests in the Senior Creditor Collateral now or hereafter held by the Senior Creditor, whether or not perfected, are and shall remain senior to the Subordinating Creditor Obligations and any lien or security interest therein now or hereafter held by the Agent, for the benefit of the Subordinating Creditors, of the Subordinating Creditors in the Senior Creditor Collateral.

 

3. ENFORCEMENT OF SECURITY INTEREST.

 

3.1 Neither the Agent nor any Subordinating Creditor shall have the right to take any action with respect to the Senior Creditor Collateral, whether by judicial or non-judicial foreclosure, recordation or enforcement of mechanics liens, notification to the Debtor’s Account Debtors, the seeking of the appointment of a receiver for any portion of the Debtor’s assets, setoff, or otherwise, unless and until all Senior Creditor Obligations have been fully paid.

 

3.2 If the Agent or any Subordinating Creditor, in contravention of the terms of this Agreement, shall commence, prosecute, or participate in any suit, action, or proceeding against the Debtor or initiate any foreclosure sale or proceeding or any other action to enforce its lien on any of the Senior Creditor Collateral, then the Debtor may interpose as a defense or plead the making of this Agreement, and the Senior Creditor may intervene and interpose such defense or plea in its name or in the name of the Debtor. If the Agent or any Subordinating Creditor, in contravention of the terms of this Agreement, shall attempt to enforce any remedies prohibited by this Agreement, then the Senior Creditor or the Debtor may, by virtue of this Agreement, restrain the enforcement thereof in the name of the Senior Creditor or in the name of the Debtor.

 

3.3 If Senior Creditor, pursuant to the rights granted to the Senior Creditor under the terms of this Agreement or applicable law, shall dispose of any or all of the Senior Creditor Collateral such disposition shall be deemed commercially reasonable if, in the written opinion of three (3) commercial loan officers with three (3) or more years of workout experience each, the manner of the disposition is not inconsistent with the manner in which such commercial loan officers would have handled the disposition.

 

 
Page 2 of 7

 

    

4. PROCEEDS OF COLLATERAL.

 

4.1 Any proceeds of the Senior Creditor Collateral, or proceeds of proceeds, received by the Agent or any Subordinating Creditor shall be, immediately upon discovery, paid to the Senior Creditor.

 

5. COVENANTS AND WARRANTIES OF THE AGENT.

 

5.1 The Agent warrants covenants and represents that:

 

5.1.1 The Subordinating Creditors are the owners of the Subordinating Creditor Obligations;

 

5.1.2 [Intentionally Omitted].

 

5.1.3 It shall cause the Subordinating Creditors to not, at any time while this Agreement is in effect, assign any of the Subordinating Creditor Obligations to any entity which does not agree in a writing, satisfactory in form and substance to the Senior Creditor, to be bound by all of the obligations of the Subordinating Creditors hereunder. In the case of any such proposed assignment by the Subordinating Creditors, the Agent will notify the Senior Creditor at least five (5) business days prior to the date of any of such assignment.

 

5.1.4 It and the Subordinating Creditors waive any rights any one of them may have to claim that the enforceability of this Agreement may be affected by any subsequent modification, release, extension, or other change, material or otherwise, in the Senior Creditor Obligations or the Senior Creditor Collateral.

 

6. REMEDY FOR BREACH.

 

6.1 Any breach hereof is likely to cause irreparable damage to the aggrieved party. Therefore, the relief to which such party shall be entitled in such event shall include, but not be limited to: (a) a mandatory injunction for specific performance, (b) judicial relief to prevent a violation of any of the provisions of this Agreement, (c) damages, and (d) any other relief to which it may be entitled at law or in equity.

 

7. AMENDMENT OF SUBORDINATING CREDITOR AGREEMENTS.

 

7.1 This Agreement shall be deemed an amendment to all present and future Subordinating Creditor Agreements, which cannot be further amended to affect the rights of Senior Creditor hereunder.

 

7.2 The consent of Senior Creditor shall not be required for any further amendment of the Subordinating Creditor Agreements.

 

7.3 The parties agree that Subordinating Creditors may accept from Debtor regularly-scheduled principal and interest payments on the Subordinating Creditor Obligations, including without limitation all prepayments of the Notes made prior to the maturity date of the Notes in accordance with the terms thereof. The foregoing notwithstanding, the Agent shall cause the Subordinating Creditors not to otherwise accelerate the maturity date of any Subordinating Creditor Obligation under any Subordinating Creditor Agreement without first giving Senior Creditor no less than thirty (30) days prior written notice.

 

 
Page 3 of 7

 

    

8. EFFECT OF BANKRUPTCY.

 

8.1 This Agreement shall remain in full force and effect notwithstanding the filing of a petition for relief by or against the Debtor under the Bankruptcy Code and, without limiting the foregoing shall apply with full force and effect with respect to all Senior Creditor Collateral acquired by the Debtor, and obligations incurred by the Debtor to the Subordinating Creditors, subsequent to the date of any such petition.

 

8.2 If the Debtor shall become subject to a proceeding under the Bankruptcy Code and if Senior Creditor shall permit the use of cash collateral or provides financing to Debtor under either Section 363 or Section 364 of the Bankruptcy Code:

 

8.2.1 Adequate notice to Subordinating Creditors shall have been provided if the Agent receives notice one business day prior to the entry of the appropriate order; and

 

8.2.2 Subordinating Creditors and the Agent will raise no objection thereto on the ground of a failure to provide adequate protection for Subordinating Creditor’s security interest in the Senior Creditor Collateral.

 

9. NO DUTY TO PROVIDE FINANCIAL ACCOMMODATIONS.

 

9.1 Nothing contained herein or in any prior agreement or understanding between the Creditors shall be deemed to create any duty on the part of either Creditor to extend or continue to extend financial accommodations to the Debtor.

 

10. CHOICE OF LAW.

 

10.1 This Agreement and all transactions contemplated hereunder and/or evidenced hereby shall be governed by, construed under, and enforced in accordance with the internal laws of the Chosen State.

 

11. AMENDMENT AND WAIVER.

 

11.1 Only a writing signed by all parties hereto may amend this Agreement. No failure or delay in exercising any right hereunder shall impair any such right that Senior Creditor may have, nor shall any waiver by Senior Creditor hereunder be deemed a waiver of any default or breach subsequently occurring. Senior Creditor’s rights and remedies herein are cumulative and not exclusive of each other or of any rights or remedies that Senior Creditor would otherwise have.

 

12. CONSTRUCTION OF AGREEMENT.

 

12.1 This Agreement and all agreements relating to the subject matter hereof is the product of negotiation and preparation by and among each Party and its respective attorneys.

 

 
Page 4 of 7

 

    

13. BENEFITS OF THIS AGREEMENT.

 

13.1 This Agreement is solely for the benefit of and shall bind the Creditors and their respective successors and assigns and no other entity shall have any right, benefit, priority, or interest hereunder.

 

13.2 In the event that Senior Creditor assigns its rights hereunder in connection with an assignment of the Senior Creditor Obligations, the assignee (“Assignee”) shall enjoy the benefits hereof, without any requirement of the consent of the Subordinating Creditors so long as the Assignee notifies the Agent, for the benefit of the Subordinating Creditors:

 

13.2.1 Of such assignment, and

 

13.2.2 That the Assignee agrees to bound by the terms hereof as if it were the Senior Creditor.

 

14. TERM.

 

14.1 The subordination by Subordinating Creditors as set forth herein may only be terminated with the written consent of the Senior Creditor.

 

14.2 The Senior Creditor must consent to the termination of this subordination upon the occurrence of all of the following:

 

14.2.1 Payment in full of the Senior Creditor Obligations;

 

14.2.2 Termination of all security agreements securing the Senior Creditor Obligations.

 

14.2.3 Upon the occurrence of Sections 14.2.1 and 14.2.2, written receipt for a request for such consent is received by Senior Creditor from Subordinating Creditor.

 

15. ATTORNEYS FEES.

 

15.1 In the event that any Party finds it necessary to commence any action or proceeding and, in connection therewith, to retain counsel with respect to the interpretation, defense, or enforcement of this agreement, the prevailing Party shall recover its reasonable attorney’s fees and expenses from the unsuccessful Party. It shall be presumed (subject to rebuttal only by the introduction of competent evidence to the contrary) that the amount recoverable is the amount billed to the prevailing Party by its counsel and that such amount will be reasonable if based on the billing rates charged to the prevailing Party by its counsel in similar matters.

 

16. COUNTERPARTS.

 

16.1 This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if all signatures were upon the same instrument. Delivery of an executed counterpart of the signature page to this Agreement by facsimile shall be effective as delivery of a manually executed counterpart of this Agreement, and any Party delivering such an executed counterpart of the signature page to this Agreement by facsimile to any other Party shall thereafter also promptly deliver a manually executed counterpart of this Agreement to such other Party, provided that the failure to deliver such manually executed counterpart shall not affect the validity, enforceability, or binding effect of this Agreement.

 

 
Page 5 of 7

 

  

17. NOTICE.

 

17.1 All notices shall be effective upon: (a) the sending of an email to one of the email addresses below or (b) delivery to a recognized overnight delivery service of a properly addressed notice, delivery prepaid, with instructions to make delivery on the next business day. For purposes hereof, the addresses of the parties are as set forth below or as may otherwise be specified from time to time in a writing sent by one party to the other in accordance with the provisions hereof:

 

Agent

 

Address:

156 W Saddle River Road

Saddle River, New Jersey 07458

 

 

Attention:

Jeffrey S. Pazdro, Manager

Email:

jpazdro@egcmllc.com

 

Debtor

 

Address:

283 Country Rd 519 Belvidere, NJ 07823

Attention:

James E. Kras, Chief Executive Officer

Email:

JKras@ediblegarden.com

 

Senior Creditor

 

Address:

3242 S. Halladay St., Suite 202

Santa Ana, CA 92705

Attention:

CEO

Email:

 

 

[signature page follows]

 

 
Page 6 of 7

 

  

IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered by their respective officers thereunto duly authorized as of the date first above written.

 

Senior Creditor:

SAMENT CAPITAL INVESTMENTS, INC.

 

 

 

 

 

By:

/s/ Francis Knuettel II

 

 

Name:

Francis Knuettel II

 

 

Title:

Chief Executive Officer

 

 

 

 

 

 

 

 

 

Debtor:

EDIBLE GARDEN AG INCORPORATED,

a Delaware corporation

 

 

 

 

 

By:

/s/ James E. Kras

 

 

Name:

James E. Kras

 

 

Title:

Chief Executive Officer

 

 

 

 

 

 

 

 

 

Agent:

EVERGREEN CAPITAL MANAGEMENT LLC,

 

 

 

 

 

By:

/s/ Jeffrey S. Pazdro

 

 

Name:

Jeffrey S. Pazdro

 

 

Title:

Manager

 

 

 
Page 7 of 7

 

 

EXHIBIT 21.1

 

Edible Garden AG Inc.

List of Subsidiaries

 

Name of Subsidiary

Jurisdiction of Incorporation or Organization

EG Transportation, LLC

Nevada

 

EXHIBIT 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the inclusion in this Registration Statement of Edible Garden AG Inc. on Form S-1 of our report dated September 10, 2021, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of Edible Garden AG Inc. as of December 31, 2020 (Successor balance sheet) and 2019 (Predecessor balance sheet) and for the period from March 28, 2020 to December 31, 2020 (Successor operations) and the period from January 1, 2020 to March 31, 2020 and the year ended December 31, 2019 (Predecessor operations), which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.

 

/s/ Marcum LLP

 

Marcum LLP

Costa Mesa, California

November 1, 2021

 

 

EXHIBIT 99.1

 

Consent to be Named as a Director Nominee

 

In connection with the filing by Edible Garden AG Incorporated of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of by Edible Garden AG Incorporated in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.

 

Dated: October 20, 2021

 

/s/ Mathew McConnell

 

 

 

Name: Mathew McConnell

 

 

EXHIBIT 99.2

 

Consent to be Named as a Director Nominee

 

In connection with the filing by Edible Garden AG Incorporated of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of by Edible Garden AG Incorporated in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.

 

Dated: October 20, 2021

 

/s/ Tracy A. Nazzaro

 

 

 

Name: Tracy A. Nazzaro

 

 

EXHIBIT 99.3

 

Consent to be Named as a Director Nominee

 

In connection with the filing by Edible Garden AG Incorporated of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of by Edible Garden AG Incorporated in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.

 

Dated: October 19, 2021

 

/s/ Ryan Rogers

 

 

 

Name: Ryan Rogers